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The concurrent experience of multiple health conditions (often termed 
multimorbidity) has become an important issue in recent years. Most research on this 
topic uses clinical data (e.g. GP or hospital records) that lack important socio-
contextual information about the lives of people with multiple conditions. Population 
health surveys can help to overcome these limitations, but identifying people who have 
multiple conditions is problematic. Decisions need to be taken regarding what is 
meant by a condition, which ones should be included, and how multiple should be 
defined. These decisions tend to be based on what data are available, rather than on 
any universal inclusion criteria or theoretical underpinnings.  
This thesis used an approach informed by sociological theory and principles drawn 
from critical realist philosophy to estimate the prevalence of multiple conditions 
among adults (16+) in the general population, using data from the 1998 and 2008-
2011 Scottish Health Surveys.  It explicitly acknowledged the multiple, contested and 
constructed nature of health, illness and diagnosis; the limits of empirical enquiry; and 
the need to approach concepts such as multiple conditions critically. To support the 
decision-making process, longitudinal analyses of mortality were used to examine the 
impact of including various contested conditions on people’s long-term chance of 
survival (if there was no evidence of impact then the definition was rejected). The final 
measure of multiple conditions arrived at suggested that 24.9% of adults had multiple 
conditions (compared with 17.2% using the survey’s original, unadjusted, measure). 
This measure was then used to explore how this status related to people’s wellbeing, 
which helped to highlight importance differences in experiences.   
Among adults with multiple conditions, 33.5% of those in the most deprived areas 
had low wellbeing compared with 13.5% of those in the least deprived areas. Low 
wellbeing was also higher among people with multiple conditions aged under 65 than 
those aged 65 and over, especially for those living in areas of high deprivation. There 
was some evidence that having multiple conditions and additional vulnerabilities (e.g. 
psychological distress, living in a deprived area, having activity limitations) before the 
age of 55 increased people’s risk of mortality, which might result in older populations 
 
 
appearing to have better wellbeing due to less healthy people not reaching old age. 
Working-age people with multiple conditions were also more likely than people of the 
same age with no conditions to be economically inactive, to not live in an owner-
occupied property, and not have a co-resident partner. All of which suggest that poor 
health at younger ages limits access to the social and economic norms enjoyed by most 
people. 
The approach adopted arguably helped to avoid over-classifying largely healthy people 
as having multiple conditions, while still ensuring that people’s own perspectives on 
their health were not under-privileged with respect to more traditional biomedically-
focused approaches. However, it was also clear that the experiences of adults with 
multiple conditions are highly varied, and in particular, socially stratified. This 
heterogeneity has implications for research in this field, as well as clinical practice and 
public health policy. Recommendations for better reflecting this diversity in future 
studies included collecting more measures of functional capacity, aspirations, illness 






Health services are usually organised around single conditions (e.g. hospital doctors 
who specialise in one condition or area of the body). Treatments are often also 
designed with one condition in mind. However, many people, especially as they get 
older, will end up with more than one diagnosed condition. Having multiple 
conditions often brings considerable stress.  
This research was designed to find out how many people aged 16 and over in Scotland 
have more than one long-term health condition. This information can help the NHS 
to plan its services. It can also be used to see what kinds of people are more likely than 
others to have multiple conditions, and to see what affect this has on quality of life.  
This project used a survey conducted in people’s homes that asked a range of 
questions about conditions and other health problems. There are many different ways 
to think about health, for example some people say that high blood pressure is a 
disease, but not everyone does. This project put together lots of different pieces of 
information about people’s health to provide a more complete picture of who had 
more than one condition. It then explored how people’s conditions affected their 
wider wellbeing – e.g. their happiness, confidence and enjoyment of life. 
The main results were that, as a group, people with more than one condition had 
lower levels of wellbeing than healthier people, and in some cases, people with 
multiple conditions died at a younger age than average. However, there were also lots 
of differences within this group of people with multiple conditions. For example, 
having low wellbeing was much more common in people under 65 with multiple 
conditions than it was for people aged 65 and over. It was also more common for 
people with multiple conditions living in the more deprived areas in Scotland than 
those living in the better off areas. People aged under 65 with multiple conditions 
were also less likely than healthy people of the same age to own their own home, live 
with a partner, or have a job. These experiences might help explain why this group also 
had low levels of wellbeing. In future, it would be useful to find out more about the 
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Chapter 1 Introduction 
Introduction 
This thesis presents analyses of the proportion of adults in Scotland living with 
multiple long-term health conditions, and explores some of the challenges this group 
of people face. Scotland’s poor health outcomes, relative to the rest of the UK, and 
most of Europe, have long been a subject of considerable interest to researchers, 
clinicians and policy makers (Leyland et al. 2007; Whyte & Ajetunmobi 2012). A vast 
body of work designed to help account for the comparatively high levels of mortality in 
Scotland – and Glasgow in particular – is currently being synthesised to try and 
address the question of why this finding persists even when factors such as deprivation 
have seemingly been taken into account (ScotPHO 2015a). The link between 
Scotland’s poor health and wider inequalities has arguably attracted a new level of 
political saliency in recent times, as illustrated by social media commentary following 
the vote against Scottish independence in the referendum on 18 September 2014 
highlighting the inverse correlation between support for independence and life 
expectancy, including Tweets from one of Scotland’s former Chief Medical Officers 
(The Sunday Post 2014).  
Beyond mortality, Scotland’s levels of healthy life expectancy at birth (projected years 
lived in a healthy state) are lower than in England and the rest of Europe for males, 
though appear to be better for females (ScotPHO 2015b). A boy born in Scotland in 
2014 would be expected to live for an average of 77.4 years, with 60.3 of those years in 
good health, while the corresponding figures for a girl are 81.4 and 62.6, respectively 
(ScotPHO 2015b), with chronic non-communicable diseases (NCDs) accounting for 
much of these gaps between total and healthy life expectancy. Considerable 
inequalities in this outcome also exist. The most recently published estimates, based 
on 2009-2013 data, show gaps in healthy life expectancy at birth of 18.1 years (male) 
and 16.7 years (female) between those in the least and most deprived area quintiles 
(ScotPHO 2015b).   
The need to understand more about the lives of the people in Scotland with the 
highest NCD burden, that is, people with multiple long-term conditions, in order to 
2 
 
improve the quality and, hopefully, duration of their lives, as well as to prevent future 
cohorts experiencing similarly poor outcomes should, therefore, be abundantly clear.  
Context 
The recognition that people often experience multiple concurrent long-term health 
conditions (typically termed multimorbidity) has become an important focus of health 
services research, epidemiology, clinical practice and public health policy in recent 
years. Despite its fairly recent emergence as a concept of interest, a sizeable body of 
research has been generated to date, highlighting a number of key concerns. These 
concerns include the fact that multimorbidity has a demonstrable association with 
negative patient outcomes; that it challenges most of the systems and guidelines 
currently in place within health systems, due to their being developed at a time when 
single disease frameworks were predominant; and the increasing costs attributed to 
treating people with multimorbidity as the population ages (in high income countries, 
at least). Much of the evidence within this field is based on data that privilege 
clinically-oriented perspectives on health and illness (e.g. primary care or hospital 
records). Such sources often lack important socio-contextual information about the 
lives of people who have multiple conditions, including their own reflections of their 
health conditions and their impact. Thus the potential to use such evidence to help 
improve outcomes by identifying key intervention opportunities can sometimes be 
constrained by the nature of the data on which it is based.  
Population health surveys can help to overcome these limitations, due to the wide 
range of information they can collect about people’s conditions as well as their wider 
life experiences and circumstances. However, reports of conditions that are based 
solely on information gathered directly from members of the public are often treated 
with scepticism, due to their tendency to underestimate prevalence (when compared 
with figures drawn from medical records). In addition to this problem, a perhaps 
greater (but not necessarily insurmountable) issue is the fact that consensus about how 
to define and measure multimorbidity is far from universal in the literature. Debates 
surround the kinds of underlying conditions that should be included in any 
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definition, the appropriate threshold for establishing the existence of multiplicity, and 
what scope there is to integrate aspects such as condition severity into any measures.  
This thesis uses detailed analyses of the health conditions data collected in the 2008-
2011 Scottish Health Surveys (the principal survey source of population-level public 
health data in Scotland), via a series of open and closed questions, to develop a 
measure of multiple conditions. The impetus for this stemmed from work I carried out 
in spring 2013 when specifying the contents for a new chapter on long-term 
conditions to be included in the 2012 survey’s report (Gray & Leyland 2013).1 This 
topic had previously been reported alongside self-rated health, wellbeing and 
psychological distress, but the Scottish Government’s increasing interest in long-term 
conditions means that this topic is now reported in its own right when space permits. 
A prevalence estimate of multiple long-term conditions had been included in previous 
reports, but using a fairly crude measure based on only one set of the survey’s 
conditions data, aggregated to reflect International Classification of Disease (ICD) 
chapter headings, and therefore potentially losing details about multiple conditions in 
the process (Chapters 3 and 5 provide an overview of all available data). I was tasked at 
that time with investigating whether the data could be used to provide a better 
measure of multiple long-term conditions. The pressures of tight delivery schedules 
within a contract research environment often lead to decisions about measures such as 
this needing to be taken quite hastily, but the more I explored the matter, the clearer it 
became that the task required more than the scant consideration that would have been 
possible at that time. The question of producing a quick measure for that year’s report 
was abandoned, and this thesis now represents the culmination of the more detailed 
work that then followed to address this issue more thoughtfully and thoroughly.  
The process took account of the various conceptual debates evident in the multiple 
conditions literature (highlighted in Chapter 2). However, the process adopted also 
followed an approach that drew heavily on the broader theoretical perspectives offered 
by sociological approaches to the meaning, classification and diagnosis of conditions, 
                                                 
1 I was Director of the 2008-2011 Scottish Health Surveys, and have been providing advice on the 2012-
2015 surveys as an independent consultant, alongside my PhD study.   
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as well as insights about medicalisation, overdiagnosis and illness experiences. These 
perspectives were integrated with longitudinal analyses of mortality to help inform a 
series of decisions about what underlying conditions and risks should be included in 
the measure of multiple conditions.  
The kinds of issues considered included hypertension (more than two-thirds of people 
with hypertension do not declare it unless prompted) and obesity (which is almost 
never self-reported), both of which revealed insights about the incongruence between 
clinical and lay perspectives, the nature of illness experiences, and a possible rejection 
of the increasing medicalisation of disease risks. Similarly, symptom and medication 
data suggested a high degree of under-reporting of mental health conditions, but, the 
consequences of potentially medicalising symptoms of normal distress (which are 
collected in the survey and are often used in similar analyses as markers of potentially 
diagnosable conditions) had to be balanced against the risk of losing important 
contextual insights. 
The overarching aim was the development of a multiple conditions measure that 
reflects, as far as possible, the lived experiences of people with those conditions. 
Creating such a measure helped move the survey away from its single disease-focus 
origins and now aligns it more closely with this increasingly important, arguably more 
holistic, conceptualisation of health experiences. A further set of analyses, using the 
newly created measure to explore the association between multiple conditions and low 
wellbeing, was used to help to provide further insights about the distinctiveness – or 
otherwise – of people with multiple conditions, and thus shape its conceptualisation as 
a singular entity.  
What is already known about multimorbidity in Scotland?  
As already noted, and as the literature review in Chapter 2 will expand on in far more 
detail, the epidemiology of multimorbidity has been extensively studied in recent years 
(Fortin et al. 2012; Huntley et al. 2012a; Violan et al. 2014). This is particularly the 
case in Scotland, thanks to the availability of an extensive primary care dataset 
(generated in 2007) covering over a third of the country (Barnett et al. 2012; McLean 
et al. 2014). Their key findings include the fact that, from the age of 55, having 
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multiple conditions is more common than having just one, and that from the age of 
65, the majority of people have multiple conditions (McLean et al. 2014). The social 
distribution of this outcome is not, however, uniform. Notable inequalities are evident 
by level of area deprivation, particularly for those of working-age, and among people 
whose conditions include a diagnosed mental illness, to the extent that people from 
the most deprived 10% of areas in Scotland can be seen to experience the onset of 
multiple conditions around 10-15 years before those from the least deprived areas 
(Barnett et al. 2012).    
In addition to these studies of prevalence, qualitative work with clinicians (O’Brien et 
al. 2011) and patients (O’Brien et al. 2014) in one of the most deprived 15% of areas 
in the West of Scotland has demonstrated the complexity of providing care to this 
group of people, and the challenges they face managing their conditions alongside 
their everyday lives. Most significantly, this work reveals the extent of the mental 
distress that accompanies living with multiple conditions in conjunction with high 
levels of social deprivation. An analysis of multiple conditions and health-related 
quality of life (HRQoL) using the 2003 Scottish Health Survey confirms this point 
(Lawson et al. 2013).  
What will this analysis address and add?     
The principal aim of the work presented in this thesis is to: 
 Quantify the experiences of adults living with multiple conditions in Scotland 
using the Scottish Health Survey. 
By answering the following questions: 
 Does the Scottish Health Survey correctly identify people with multiple 
conditions? 
o And if not, who is missing? 
 How do different definitions of multiple conditions affect its prevalence in the 
population, and across sub-groups? 





At the very least, the development of a more comprehensive measure of multiple 
conditions will ensure that this key source of population health data (the Scottish 
Health Survey) is able to meet increasing demands from policy makers and health 
service planners for information about the characteristics, nature and long-term 
outcomes for people with multiple conditions. While the data collected in population 
surveys differ in their nature from those collected in primary care settings, which 
results in some notable differences between their prevalence estimates (as illustrated in 
Chapter 5), the wider availability and breadth of topics covered in this survey means 
that it has the potential to address important information gaps related to multiple 
conditions that the data analysed by Barnett et al. (2012) could not. For example, the 
extent to which multiple conditions cluster with known disease risks and other 
important contextual factors (such as individual-level measures of socio-economic 
status), or the extent of their variation across time. These outcomes are beyond the 
scope of this thesis, but serve to illustrate the wider analytical opportunities that would 
be afforded by having a comprehensive measure of multiple conditions. Similarly, 
their association with outcomes such as quality of life and, indeed, quantity of life (via 
the mortality records to which most participants’ data are linked) can also be explored 
(Chapters 5 and 6 present some results of such analyses). But, more than this, these 
data have the potential to identify potential mechanisms that could increase 
understanding of the ways in which having multiple conditions impact on people’s 
lives (some examples of these are provided in Chapter 6).  
In addition, the development of this new measure of multiple conditions drew on an 
extensive review of the conditions information collected in the survey (as reported in 
Chapter 5), from which a series of recommendations could also be made about 
potential improvements to the survey questions (outlined in Chapter 7). 
Finally, the approach adopted in this thesis is novel because, unlike traditional 
empirical analyses, the methodology adopted explicitly acknowledges the multiple, 
contested and constructed nature of health, illness and diagnosis; the limits of 
empirical enquiry; and the problems associated with conceptualising a phenomenon 
such as multimorbidity uncritically. The work presented here therefore also provides 
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an opportunity to explore the extent to which attempts to integrate different 
theoretical perspectives can add value to analyses of quantitative data.  
Terminology 
Before presenting an overview of the remaining contents of this thesis, a note on 
terminology is necessary. Most research and clinical practice on this topic employs the 
term multimorbidity to describe the state of having multiple conditions. The work 
presented in this thesis consciously departs from this terminology and instead uses the 
term multiple conditions rather than multimorbidity, wherever possible. There are a 
number of reasons for this. The overriding reason is my desire to reject this rather 
clinically-oriented label in favour of one that gets closer to a form of language that the 
majority of the population would be likely to identify with. A second reason is my wish 
to avoid turning the experience of living with multiple conditions into an artificially 
singular state of being. The language used to describe individual conditions can 
unhelpfully turn people into their illness (“an epileptic / a diabetic”), whereas 
terminology that describes conditions as entities that people have (“a person with 
epilepsy / with diabetes”) retains the agency of the person concerned. In much the 
same way, I would argue, the term “multimorbid” describes a state of being, whereas 
“multiple conditions” describes a state of having. To ask what is the prevalence of 
multimorbidity, or to ask what characterises the multimorbid, therefore implies a level 
of reductionism, abstraction from the particular, and perhaps even a level of certainty 
about the ontological status of multiple conditions, that I am uncomfortable with. It 
has proved impossible to avoid all uses of the term multimorbidity, and it has been 
retained in much of the discussion of existing literature because it is describing work 
that uses that term. However, in discussions of my work’s aims, methods and results, 
multiple conditions is the favoured term.  
This concern for language might seem unusual for a quantitatively-based analysis 
ultimately designed to yield numbers. However, as I hope to demonstrate, by using 
insights from the worlds of sociology to inform epidemiological practice - one aspect of 
which is a heightened attention to the power of language and labelling - it is possible 
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to bridge, in part, the gap that lies between the act of quantifying lived experiences and 
the reality of living them. 
Overview of this thesis 
The rest of this thesis is structured as follows: 
 Chapter 2 presents a review of the literature on multiple conditions, including a 
consideration of its historical emergence as well as a summary of the main points 
of consensus emerging from that body of work.  
 Chapter 3 outlines the methods and methodology adopted for this thesis. It 
begins with a detailed description of the data source (the Scottish Health 
Survey), the health conditions measures contained within it, and a review of its 
key strengths and weaknesses. Towards the end there is a more detailed 
discussion of the ontological and epistemological underpinnings of the overall 
approach, followed by an overview of how this was operationalised. 
 Chapter 4 provides a detailed review of the theoretical insights derived from the 
sociological literature that have been included in this work. As noted above, 
these include aspects related to the meaning, classification and diagnosis of 
conditions, medicalisation, overdiagnosis and illness experiences. It ends with 
two case studies (of obesity and psychological distress) that are intended to 
illustrate how these insights were used to guide decisions about what conditions 
to include in the measure of multiple conditions. 
 Chapter 5 presents the results of the various steps that were undertaken in order 
to derive the new measure of multiple conditions. For each set of considerations, 
the key issues needing to be resolved are outlined, the methods employed to 
resolve them are described and the results presented, with the resulting decision 
summarised before moving on. The new measure of multiple conditions arrived 
at via this process is then presented and its impact on overall prevalence 
estimates of multiple conditions, and on the social patterning of this outcome, 




 Chapter 6 takes the measure of multiple conditions arrived at in Chapter 5 and 
explores its association with low wellbeing. The chapter has two aims. The first is 
to extend some of the previous analyses of multiple conditions and wellbeing 
reported in the literature to uncover potential mechanisms that might help 
account for its patterning by age and deprivation level. Secondly, it considers the 
extent to which the experiences of people with multiple conditions are distinct 
from those with one condition or none, with a view to using this information to 
help inform the conceptualisation of this phenomenon.   
 Chapter 7 discusses the results presented in Chapters 5 and 6. It starts by 
focusing on the question of measurement, chiefly drawing on Chapter 5’s 
results, and ends with some recommendations for how the newly defined 
measure should be taken forward, and how the survey could be amended to 
make the data collected more effective and/or efficient. It then considers the 
arguably trickier issue of conceptualisation by taking the wellbeing results from 
Chapter 6 and asking in what ways does grouping people according to the 
number of conditions they have increase understanding of population wellbeing 
patterns? And, in what ways does analysing wellbeing increase understanding of 
the experiences of people with multiple conditions?  
 Chapter 8, the final chapter, concludes the thesis with a discussion of the overall 
strengths and weaknesses of the approach followed, including what value it 
added to the work presented. It then offers some thoughts about where this 
work could be taken next, with recommendations for potential new analyses as 
well as further ideas about ways in which the experiences of people with multiple 
conditions could be more comprehensively reflected in population health 









Chapter 2 Literature Review 
Introduction 
Aims of this review 
This literature review is deliberately broad and is designed to be representative of key 
themes in the field. In common with the main aims of the thesis, it has prioritised 
articles concerned with methodological/definitional matters, general population data 
(rather than those solely drawn from in-patient data), and with wellbeing (the outcome 
selected to elucidate the experiences of people with multiple conditions in this thesis). 
Despite being a relatively new field of research, it was still necessary to manage the 
breadth of this review’s scope. Therefore, the sections covering substantive outcomes 
largely focus on areas that can be described as nearing, or having reached, a consensus 
within the field. It starts by introducing the concept of multiple conditions, both as a 
status that people have and as a topic of interest in health research and clinical 
practice. Its historical emergence is then described, including a chronology of selected 
key articles, before moving on to the more methodological and substantive aspects of 
the literature. 
Methods 
A number of search strategies were used to identify the literature presented here. 
However, an important source of information was the library of articles maintained by 
The International Research Community on Multimorbidity (IRCM) (International Research 
Community on Multimorbidity 2015). The IRCM use the terms “multimorbidity”, 
“multi-morbidity” and “multiple chronic conditions” to conduct their searches and 
while acknowledging that this has the potential to miss articles, Fortin (2013) states 
that “we are sure that most publications on the subject are included in the list”. However, to 
avoid this review being wholly reliant on one source, additional steps were taken, such 
as: 
 A MedLine search for systematic reviews focusing on multimorbidity or 
comorbidity published from 2000 onwards (details in Appendix A); 
 Following up references in published papers; 
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 Conducting citation searches of key papers; 
 Conducting searches within key journals; 
 Consulting publication lists for key data sources, such as the Health Survey for 
England and English Longitudinal Study of Ageing, to identify “grey” literature.  
Although this is not a systematic review, a short quality assessment checklist was used 
to help appraise the systematic reviews identified (see Appendix A). In addition, to 
broaden this work beyond purely empirical epidemiological work, and to embed it 
within a more theoretically-focused approach, a parallel review of work in the sociology 
of illness literature was also conducted, which encompassed aspects such as disease 
conceptualisation, classification, illness experiences, diagnosis, medicalisation and 
overdiagnosis (interest in the last of these aspects spans both sociological and 
epidemiological research). The overarching approach to integrating this wider 
sociological literature with the empirical analysis conducted in this thesis is described 
in Chapter 3, while the insights gained from these areas are presented in Chapter 4.  
What is multimorbidity? 
As noted in the introduction, the majority of studies in this field use the term 
multimorbidity, whereas I have stated my preference for the term multiple conditions. 
However, as much of the work being considered in this review used the term 
multimorbidity, the discussion follows this usage where appropriate, but with a 
preference for using the term multiple conditions as far as is possible.  
While the meaning and measurement of multimorbidity is far from straightforward, 
something approaching a consensus appears to exist around the following two points, 
first described in detail by Akker et al. (1996):  
 comorbidity is used to describe a person with multiple concurrent health 
conditions, in addition to an index condition of interest; 
 multimorbidity is used for situations in which a person has more than one 




However, the absence of a firm consensus on this was illustrated in a review by Almirall 
and Fortin (2013). Similarly, the European General Practice Research Network (EGPRN) 
has been attempting to develop a single multimorbidity definition (Le Reste, Nabbe, 
Manceau, et al. 2013), as has the IRCM (International Research Community on 
Multimorbidity 2013).   
The nature of this on-going debate appears to be more oriented towards ontological 
than epistemological concerns, with the focus largely on which multiple conditions 
should be grouped, and how. More epistemologically-focused questions about whether 
such measurement is possible are certainly evident (see, for example, Diederichs et al. 
2011) but are relatively less common, and are themselves informed by ontological 
concerns about the nature of multimorbidity.  
Tracing the history of these concepts, Valderas et al (2011) describe multimorbidity as: 
“a modern alternative to ‘comorbidity’ … [a] more ‘democratic’ approach” (p1). In a similar 
vein, Boyd & Fortin (2010) describe multimorbidity as a person-centred concept, while 
Valderas et al. (2009) suggest it is most usefully applied in primary care settings where 
a generalist focus predominates, with comorbidity more relevant when a specialist 
approach is needed.  
What is meant by a chronic health condition is arguably one of the more complex 
elements of these definitions, and a considerable amount of space is devoted to 
considering this in greater detail in Chapter 4. However, it is worth highlighting that 
concurrency, and the threshold used to determine multiplicity, are both similarly 
problematic. Furthermore, while some conceptual clarity generally surrounds the 
distinction between multimorbidity and comorbidity, in practice they are often used 
interchangeably. Studies of comorbidity are considerably more prevalent in the 
literature (Valderas et al. 2011), while other descriptions, such as multiple chronic 
conditions, are used in some contexts either in preference to, or as well as, 
multimorbidity (for example Boyd & Fortin 2010; Walker 2012; Almirall & Fortin 
2013; Wallace & Salive 2013). The challenge of conceptualising multiple conditions 
lies at the heart of this thesis, and a significant proportion of the literature in this field 
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reflects this problem. However, before these issues are detailed more fully, it is useful 
to describe when - and why - the concept emerged in the first place. 
Historical emergence of multimorbidity 
Overview of the literature 
Le Reste et al. (2013) trace the origins of the term multimorbidity in the research 
literature to a German article published in 1976,2 and state that just 72 articles 
between that point and 1990 contained the term (the vast majority of which were also 
in German). A search of the MedLine database using the term “multimorbid$ OR 
multi-morbid$” (limited to humans) yields 1,601 results for the period January 1974 to 
December 2014. The number of articles published each year (illustrated in Figure 2.1) 
grew exponentially from the late-2000s onwards. To calibrate this growth against the 
overall increase in articles in recent times, the graph also shows the total number of 
citations within MedLine for the same period. It’s clear that the recent rate of growth 
in the number of multimorbidity articles is more than just a reflection of a general 
growth in publishing. 
                                                 
2 MedLine contains two articles using the term multimorbidity before this, but the 1976 article was the 
first to include it as a keyword.  
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Figure 2.1 Number of articles identified in MedLine search using search term 
“multimorbid$ OR multi-morbid$”,3 and total number of citations in MedLine,4 by year, 
1974-2014 
 
To help put this in context, Fortin et al. (2005) compared the number of articles 
identified in MedLine in the 1990-2002 period using the keyword multimorbidity or 
MeSH term comorbidity, with those related to a selection of single conditions. They 
found 38 articles on diabetes for every multi/comorbidity article, 74 on asthma and 94 
on hypertension. While the recent growth in multimorbidity articles is likely to have 
reduced the gap between these figures, a MedLine search using the family of diabetes 
MeSH terms (and excluding multimorbidity articles) yields over 72,000 results for the 
2005-2012 period alone, suggesting that the number of articles focused on single 
diseases still outstrips those for multimorbidity by some margin. While it is hard to 
identify a single article that fuelled the notable growth in multimorbidity articles from 
around 2007 onwards, this work by Fortin et al. (2005) was possibly a contributory 
factor. The volume of work now being produced certainly seems to support Tinetti & 
Basu’s (2014) suggestion that this field is “no longer in its infancy” (p.S5), though their 
qualifying point that “much remains to be learned and uncovered” (p.S5) underlines the 
                                                 
3 Search first conducted on 21 October 2013 and updated 21 November 2015. 
4 Source: http://www.nlm.nih.gov/bsd/index_stats_comp.html (accessed 21 November 2015). 
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extent to which an increased level of research output does not necessarily result in an 
increased depth of understanding of a topic. 
Bibliometric analyses such as these can be a useful mechanism for tracing the 
development of concepts. However, caution needs to be exercised when interpreting 
such results. The data in Figure 2.1 relates to the occurrence of keywords, so the 
explosion from the mid-2000s onwards could be as much to do with changes in the 
way that articles are coded in MedLine, rather than changes in their underlying 
content. This does not necessarily invalidate this approach, as changing practices 
around the use of particular keywords are reflective of an important research paradigm 
shift, but it is nevertheless important to temper claims about the growth of a field by 
recognising the limits of what simple keyword counts can reveal.  
Related to the previous point, it is also important to highlight that multimorbidity’s 
relatively recent emergence as a term does not, of course, mean that the fact people 
can have more than one concurrent condition is also a fairly novel discovery. For 
example, while death certificates are designed to capture a single cause of death, they 
have long had space to list additional contributory causes (Bowker & Star 1999). In 
addition, the burden of multiple conditions has long been a feature of the gerontology 
literature, as exemplified by a study reported in The Lancet in 1962 which examined 
200 patients admitted to the Aberdeen Geriatric Unit in 1957 and found them to 
have had 1168 diseases between them, an average of six each (Wilson et al. 1962). If 
replicated now, such research would undoubtedly use the term multimorbidity. 
Similarly, the psychiatric epidemiology literature has a long-standing interest in the co-
occurrence of conditions (see, for example, the references cited in Kraemer 1995).  
Chronology of key articles 
Despite the recent and rapid growth in research in this area, it is possible to identify a 
much smaller sub-sample of around 20 key references that have either helped to define 
the field, or are representative of major developments within it, based on the 
frequency of their citations or their presentation of work that helped to shift the 
direction of research in this field, for example by proposing approaches that have 
subsequently been more widely adopted. This list is neither definitive nor exhaustive, 
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rather it is intended to be illustrative of work that helps contextualise the historical 
development of research in this field. With this in mind, the following discussion 
highlights how these articles reflect key themes in the literature and other important 
developments in the field. The more thematic discussion that follows afterwards will 
consider their contents in more detail. 
Reflecting the historical development of the concept, the earliest articles that feature 
prominently in this field discuss the definition and measurement of comorbidity, as 
opposed to multimorbidity. Feinstein (1970) was the first to outline a clear definition 
of comorbidity and describe the negative consequences of failing to account for 
multiple conditions in both research and clinical practice. Kaplan and Feinsten 
(Kaplan & Feinstein 1974) proposed the first multimorbidity index, for a study of 
mortality in diabetes patients, which distinguished between types of comorbidity 
(vascular and non-vascular), as well as their severity. With the exception of Guralnik et 
al.’s (1989) study of comorbidity and disability in the older population in the USA, 
very little else was published in the 1970s and 1980s that arguably qualifies as seminal 
in this field. This changed in the 1990s, when some of the statistical challenges of 
comorbidity analysis were developed further by Kraemer (1995), and Akker et al. 
(1996), who were the first to draw a clear distinction between comorbidity and 
multimorbidity. A little later, Akker et al. (2001) discussed additional statistical and 
methodological challenges posed by multiple conditions research. This period was not 
solely devoted to methodological work; Akker et al.’s (1998) study of multimorbidity 
in the Dutch general population is a good example of an early and widely cited 
prevalence study (147 citations in PubMed as of December 20155). The early 2000s 
saw more work on the methodological aspects of research in this field, with de Groot 
et al. (2003) stating that consensus about the definition of comorbidity and 
multimorbidity had not yet been reached.  
Some key articles about the impact of multimorbidity on health outcomes and its 
implications for primary care also date from this period. These include Fortin et al.’s 
(2004) systematic review of multimorbidity and quality of life; Tinetti et al. (2004) and 
                                                 
5 http://www.ncbi.nlm.nih.gov/pubmed/9619963 [Accessed 27 December 2015]. 
18 
 
Boyd et al.’s (Boyd et al. 2005) work highlighting the problems of applying single-
disease clinical guidelines to people with multimorbidity (an approach that continues 
to be applied in other work, e.g. Hughes et al. (2013)); and Vogeli et al.’s (2007) wide-
ranging study of multimorbidity prevalence and its impact on health outcomes, service 
use and care delivery. Around the same time, Fortin et al. (2005) highlighted the lack 
of research on multimorbidity relative to single diseases (discussed previously), and the 
IRCM,6 coordinated by the University of Sherbrooke in Canada, was established as a 
virtual network of researchers in this field to try and address this and other concerns 
(Fortin et al. 2007).  
Methodological concerns were, however, ever present in this era – Valderas et al. 
(2009) highlighted ongoing problems with the lack of conceptual clarity surrounding 
comorbidity and multimorbidity research, and outlined some clear guiding principles 
to help standardise research practice in the field. Boyd and Fortin (2010) continued to 
promote the need for health systems and research to better meet the needs of people 
with multimorbidity, with a particular emphasis on the importance of patient-centred 
care, but also devoted time to the critically important issue of defining multimorbidity.  
2011 saw the founding of the Journal of Comorbidity, envisaged to be a platform for 
research about multiple conditions and their management (Valderas et al. 2011); its 
choice of title possibly reflecting continuing ambiguity around nomenclature in this 
field. The first edition included articles spanning most of the main themes highlighted 
in the above discussion: methodological challenges, health care implications, 
prevalence, and future research needs related to multiple conditions.  
The current decade has also started to see an increasing number of systematic reviews, 
concerning both the impact and measurement of multimorbidity. These include 
Marengoni et al.’s (2011) wide ranging review of multimorbidity in the ageing 
population, with its strikingly wide prevalence estimate range of 55-98% now highly 
cited. While a consensus that multimorbidity refers to multiple conditions within the 
same individual appears to be emerging, Diederichs et al.’s (2011) review of 




multimorbidity indices provided an invaluable insight into the huge variability in how 
this has been applied in the literature: the number of conditions used to define 
multimorbidity in the studies they reviewed ranged from four to 102. Fortin et al.’s 
(2012) systematic review of prevalence studies drew similar conclusions surrounding 
the problem of inconsistent definitions. They made recommendations about the ideal 
number of conditions to include (at least 12), and suggested reporting multimorbidity 
prevalence based on two thresholds (at least two conditions, and at least three), but did 
not make firm recommendations about which underlying conditions to include, 
though stated that high prevalence, impact and burden would be useful selection 
criteria. Subsequent to this, Huntley et al. (2012a) conducted a similar (but far wider-
ranging) review of multimorbidity measures for use in non-clinical settings. By arguing 
that “[i]t is important that measures are based on an underlying conceptualisation of why and 
how multimorbidity is expected to have an impact on other variables” (Huntley et al. 2012a, 
p.139) their work arguably demonstrated an important attempt to move the debate 
about multimorbidity definitions away from purely mechanistic issues, towards more 
theoretically-informed approaches.  
Moving away from methodological debates, two key articles of relevance to the UK 
setting provided the first nationally-representative estimates of multimorbidity 
prevalence using primary care data in England (Salisbury et al. 2011) and Scotland 
(Barnett et al. 2012). The latter article subsequently won the 2013 Royal College of 
General Practitioners prize for best research paper of the year (BBC 2013), and the 
data source has since been used to produce additional analyses (McLean et al. 2014; 
Smith et al. 2014; Cooper et al. 2015).  
The final papers to highlight here are a Cochrane Review of interventions for 
managing patients with multiple conditions outside hospital settings (Smith et al. 
2012), and an article outlining recommendations for the design and evaluation of such 
interventions (Smith et al. 2013). These arguably illustrate the distance travelled by 
research in this field over the past few decades, from a preoccupation with 
methodology towards an increasing emphasis on the consequences for individuals with 
multiple conditions. However, Smith et al. (2012) also illustrate ongoing deficiencies 
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in this field: just 10 studies were identified for inclusion in the review, with mixed 
results.  
The above discussion has presented an historical overview of the emergence of 
multiple conditions as a concept in the research literature. It has not, however, 
addressed the question of why this came about. Its emergence can be linked to a 
number of factors, including wider societal trends, such as population ageing, as well 
as to changes in the nature of healthcare delivery and the conceptualisation of disease, 
and also to transformations in the roles performed by, and the relationship between, 
clinicians and patients. Some of these are considered in more detail below, others are 
explored further in Chapters 4.  
The role of the epidemiologic transition and demographic change 
Some of the most significant drivers of the emergence of multiple conditions as a 
status of interest (and as a state of being) can be traced to the major demographic 
changes seen in most parts of the world across the twentieth century. These have 
dramatically changed the nature of the disease burden and the age profile of 
populations, a process described as the ‘epidemiologic transition’ (Omran 1971). The 
key features of this transition can be summarised as: the decline in infectious disease 
mortality coupled with a corresponding increase in chronic non-communicable disease 
(NCD) morbidity and mortality, increasing life expectancy, declining fertility and, as a 
consequence, an ageing population (Taylor & Bury 2007). Omran (1971) was very 
clear that the main drivers of this transition were linked to the processes of social and 
economic change prevailing as societies modernised, with the contribution of 
medicine “largely inadvertent until the twentieth century” (p.520).  
The scale of these changes is evident both globally and locally. To illustrate, as recently 
as 1970, the proportion of the world’s population aged under five was around three 
times higher than the proportion aged 65 and over. A decline in the former and an 
increase in the latter means estimates now suggest that, by 2020, the older age group 
will be larger than the younger (National Institutes of Health 2011). In 2012, the 
proportion of Scotland’s population aged under 16 exactly matched the proportion 
aged 65 and over (17%). However, these figures mask notable on-going changes in the 
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age structure and the fact that, between 2010 and 2035, the proportion of the 
population aged 65-74 is projected to increase by 46%, and by 82% for the 75 and 
over group, whereas the corresponding figures for the rest of the population range 
from just 3% for the under 16s to -3% for the 16-29 group (Registrar General for 
Scotland 2013).   
Increasing age is a key risk factor for chronic NCD onset. Multimorbidity is usually 
defined as the presence of multiple chronic conditions, so it is therefore unsurprising 
that many articles on this topic make reference to the trends outlined in the 
epidemiologic transition model (Caughey & Roughead 2011; Marengoni et al. 2011; 
Fortin et al. 2012; Diederichs et al. 2011; Salive 2013). However, studies are 
increasingly highlighting the prevalence of multiple conditions in younger age groups 
and challenging its status as an exclusively geriatric phenomenon (Taylor et al. 2010; 
Barnett et al. 2012). In addition, low and middle income countries are also seeing a 
different pattern emerge as a result of what Oni et al. (2014, p.2) describe as “colliding 
epidemics of NCD and ICD [infectious chronic disease]”. The multiple condition burden in 
these countries has a much younger age profile than that seen for NCDs in high 
income countries, due to the younger age of people with TB and HIV.  
The epidemiologic transition model is not universally accepted, though. As Hyde and 
Rosie (2012) argue, its critics mostly focus on the model’s applicability to settings 
beyond the developed world, or propose extensions to it, without necessarily 
questioning its original premise. Armstrong (2013), however, does just this, arguing 
that changes in mortality and morbidity patterns over the course of the twentieth 
century were largely driven by the pathologising of ageing wherein conditions and 
deaths previously attributed to old age are now given more clinical definitions, such as 
heart disease. While this thought-provoking account makes some valid points about 
the socio-contextual nature of disease and illness classification (which are developed 
further in Chapter 4), the fact remains that outwith Africa, life expectancy is rising, 
acute infectious diseases no longer cause deaths in the numbers they once did, and the 
WHO estimates that almost two-thirds of all deaths globally in 2008 were caused by 
NCDs (WHO 2011). Such patterns cannot reasonably be wholly attributed to changes 
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in the definitions used in death certificates. While critiques like Armstrong’s remain 
in the minority, more extensive debate surrounds the consequences and implications 
of these demographic changes, particularly for older age groups (Christensen et al. 
2009; Rechel et al. 2013), and significant resources are now devoted to the cross-
national study of ageing (National Institutes of Health 2011).  
Rechel et al. (2013) present evidence to help assess three potential morbidity patterns 
as a consequence of population ageing: compression (decreasing years spent in ill-
health as a proportion of total lifespan), expansion (increase in years spent in ill-health 
outstripping increases in total lifespan) and equilibrium (years of ill-health as a 
proportion of total lifespan staying broadly stable). The compression of morbidity 
model is of particular significance to public health because its successful realisation, as 
originally outlined by Fries (1980), is premised on four preventative interventions: 
primordial (risk factor prevention), primary (risk factor reduction), secondary (disease 
progression prevention), and tertiary (disease amelioration rather than elimination) 
(Fries et al. 2011, p.2). Rechel et al. (2013) suggest that the evidence in support of 
these models is mixed, while Fries et al. (2011) describe various sources of evidence as 
providing proof of concept that compression of morbidity is possible in certain 
circumstances, if not necessarily inevitable (for example, they demonstrated that older 
physically active people enjoyed more years of disability-free life than inactive controls). 
In contrast, analyses presented by Crimmins (2010) conclude: “…compression of 
morbidity may be as illusory as immortality.” (p.83).  
Huge variability in patterns and experiences of ageing exist, both within and between 
countries, related to markers of socio-economic status such as income, education and 
social class, as well as in access to health care, which arguably make attempts to identify 
distinct models of ageing rather problematic. For example, the fact that Rechel et al. 
(2013) describe the evidence in support of the various models as mixed could in part 
be due to there being different experiences operating simultaneously within the same 
population; the search for evidence to conclusively support a single model is therefore 
arguably misguided (Krieger (2011) critiques the epidemiologic transition model on 
similar grounds).  
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More recently, Chatterji et al. (2014) also concluded that variations exist between 
different countries in the extent to which they are experiencing compressions or 
expansions in morbidity but, along with Beard & Bloom (2014), argued that better 
and more consistently harmonised evidence is needed, including a move towards more 
emphasis on functional capacity as opposed to solely focusing on disease burden per se. 
Significantly, Beard & Bloom (2014) suggest that the rise of multiple conditions at 
older ages makes functional assessment a more important aspect to consider (clinically, 
in research, and in wider public health policy), arguing that “[f]unctional assessments of 
these syndromes [frailty, impaired cognition, continence, gait and balance] are better predictors of 
survival than the presence or number of specific diseases” (p.659).  
An important issue for this field of research is therefore whether to conceptualise 
multimorbidity as an inevitable consequence of the natural ageing process that needs 
to be actively monitored and managed. Or, instead, whether it is also (or alternatively) 
a consequence of the wider structural factors underlying both the increase in, and 
unequal distribution of, NCDs (Beaglehole et al. 2011), which potentially offers 
opportunities for preventative strategies, though only if the correct policies are 
implemented, which they rarely are (Frank et al. 2015; Douglas 2015). There isn’t 
space here for an exhaustive account of this issue, but the principal drivers of health 
inequalities, including those observed in NCD prevalence, are now widely accepted, 
within social epidemiology and public health circles at least, to originate in socio-
structural inequalities (e.g. Link & Phelan’s theory of fundamental causes (Phelan et 
al. 2010) and Wilkinson & Pickett’s work on income inequality (Wilkinson & Pickett 
2009; Pickett & Wilkinson 2015). Following on from this observation is the fact that 
the rising levels of inequality experienced in the UK in the past four decades (as in 
most of the world) have themselves been caused by the particular kinds of economic 
and political policies that have become predominant (Schrecker & Bambra 2015; 
Collins et al. 2015). These policies are typically labelled neoliberal, though 
neoliberalism is more appropriately conceived of as having multiple, context-
dependent, forms rather than as a single, specific entity (Collins et al. 2015). If the 
account suggested by Collins et al. (2015) that the connection between neoliberalism 
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and health inequality is “clear, well known and causal” (p.131) is accepted, then another 
potential explanation for the increasing prevalence and prominence of multiple 
chronic NCDs in recent decades is that they are an inevitable consequence of 
neoliberalism, as opposed to being an inevitability of ageing populations. 
The growth of concerns about health care costs and sustainability 
Rising attention to the fact that populations are ageing has led to concerns about the 
financial costs associated with growing numbers of chronically ill people, and the 
demands they place on health and social care systems. Thus the rise of multimorbidity 
as a concept can also be traced to debates such as these. However, tensions are evident 
in the wider ageing literature surrounding the issue of rising costs, with some arguing 
that other factors, such as end-of-life treatment (and hence, proximity to death), and 
new health technologies drive costs, rather than age per se (Lloyd-Sherlock 2000; 
Seshamani & Gray 2004; Felder et al. 2010). It is worth noting that recent accounts 
suggest that ageing and health technology demands interact, and caution against 
treating them as separate, unrelated cost drivers (Breyer et al. 2011; Meijer et al. 2013). 
Similarly, concerns have been raised about the negative characterisation of ageing 
evident in much of the literature and policy debates (Lloyd-Sherlock et al. 2012), and 
the potential fallacy of characterising all people above retirement-age as “dependent”, 
with those below it bearing their costs (Spijker & MacInnes, 2013). Irrespective of the 
nature of the relationship between ageing and healthcare costs, it is clear that much 
multimorbidity research has been motivated by concerns about the healthcare ‘burden’ 
associated with treating people with multiple conditions, with healthcare utilisation 
and costs a prominent feature of the literature (for example: Vogeli et al. 2007; Glynn 
et al. 2011; Huntley et al. 2012b; Steiner & Friedman 2013). All these studies have 
found multimorbidity to be associated with increased costs, and figures for the US 
suggest that two-thirds of healthcare expenditure is accounted for by people with 
multiple chronic conditions (Goodman et al. 2012) – a figure that is now routinely 
cited in US-based studies of this topic (for example, LeRoy et al. 2014). Few of these 
studies directly address what proportion of these costs can be attributed to inefficient 
healthcare delivery, unhelpful polypharmacy, overtreatment, or adverse consequences 
of conflicting treatments, all of which are known features of healthcare in the context 
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of multiple conditions, especially – though not exclusively – in the USA (Hitchcock 
Noël et al. 2007; Boyd & Fortin 2010; Nobili et al. 2011; Hughes et al. 2013). 
Furthermore, no clear indication is ever given as to whether the cost figures cited 
represent an appropriate level of resource utilization, or whether these kind of 
statements are intended to highlight “disproportionate” resource consumption. 
However, as this group is clearly comprised of people with the greatest health burdens, 
it is an almost banal point – shouldn’t the majority of healthcare costs be directed 
towards people with the worst health? Indeed, it might be more remarkable if this 
wasn’t the case, given how little most countries health systems spend on preventative 
and wider public health measures. This critique is not intended to deny the increasing 
complexity of healthcare, and therefore costs, associated with treating people with 
multiple conditions, but it is intended to highlight that the coupling of these two 
phenomena can be problematic – and potentially stigmatizing - if it is not 
accompanied by more nuanced accounts of the underlying dynamics.  
Multiple conditions as a challenge to the single disease model 
In addition to the macro-level trends outlined above, there have also been important 
developments in the delivery of healthcare that have contributed towards the 
recognition of multimorbidity. One such development is the rising use of clinical 
guidelines.  
Weisz et al. (2007) described the presence of clinical guidelines in modern medicine as 
“ubiquitous” (p.691). In the UK, for example, the National Institute for Health and 
Care Excellence (NICE) lists 165 clinical guidelines on its website (not including its 
various public health recommendations) (NICE 2015a), developed specifically for use 
in the UK, while the Scottish Intercollegiate Guidelines Network (SIGN) lists around 
50 (guidelines labelled “use with caution” or “withdrawn” have been excluded from 
this figure) (SIGN 2015). These figures do not include the very large number of 
additional guidelines issued by bodies such as the UK’s Royal Colleges, and 
organisations representing clinical specialities who, in the USA in particular, occupy a 
highly influential role in the healthcare system. The use of such guidelines is standard 
practice across the developed world, though their coordination is poor and 
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recommendations for the same conditions can vary widely, to the extent that bodies 
such as the Guidelines International Network have been established to try and better 
coordinate their development and use (GIN 2013).  
Various reasons have been cited for the growing use of guidelines, including concern 
about variations in practice leading to unnecessary costs, wasteful or inefficient care, or 
inequitable outcomes; professionals’ desire for self-regulation; the modern-era’s 
proliferation of medical research and the need to translate findings into practice 
recommendations; the need to standardise an increasingly complex and fragmented 
healthcare system; and a reining-in of clinical autonomy (Woolf et al. 1999; Harrison 
& Ahmad 2000; Weisz et al. 2007). The critical feature of clinical guidelines is that 
they almost exclusively adopt a single disease approach and focus on the diagnosis and 
management of one condition with scant reference to comorbidities. The rising use of 
such guidelines has, therefore, arguably made the challenges of treating people with 
multiple conditions much more apparent than might otherwise have been the case. 
This recognition has not only increased the prominence of multimorbidity, but it has 
also brought into question the practicality and desirability of the single-disease model 
and guideline-driven care (Tinetti et al. 2004; Boyd et al. 2005; Boyd & Fortin 2010; 
Lugtenberg et al. 2011; Reuben & Tinetti 2012; Guthrie, Payne, et al. 2012; Hughes 
et al. 2013; Wyatt et al. 2014).  
As noted above, one consequence of treating people with multimorbidity as if they 
were no more than the sum of each single condition can be polypharmacy – the 
prescribing of multiple medications – which brings with it the potential for harmful 
drug interactions, poor treatment adherence (linked to the complexity and burden of 
taking multiple drugs), high costs and the risk of developing further comorbidities. 
Both Boyd et al. (2005) and Hughes et al. (2013) outline the treatment regimes that a 
selection of hypothetical patients with multiple conditions would be subject to, and 
highlight the large number of drugs they could potentially be prescribed. This situation 
is particularly apparent in the older population, where additional problems arise from 
not just the potential for negative interactions between drugs, but also from the fact 
that the physical effects of ageing have consequences for prescribing that need to be 
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considered (Nobili et al. 2011). Polypharmacy is not in itself problematic, as Hughes et 
al. (2013) note, nor does the application of guidelines always result in the 
overtreatment of people with multiple conditions (Roland & Paddison 2013) – if the 
recommended drugs and other interventions are vital to maintaining a person’s health 
and quality of life, have no negative interactions and do not impose a treatment 
burden that outweighs their benefits. The critical point is that healthcare systems are 
widely acknowledged to be highly specialised, and therefore often fragmented, so not 
only do guidelines rarely cross-reference treatment recommendations, but the system 
delivering them is similarly ill-coordinated and not well-placed to effectively manage 
people with multimorbidities. Situations such as unhelpful polypharmacy and 
overtreatment therefore arise as a consequence of how healthcare is delivered, and not 
as a result of multimorbidity per se. This point applies in many countries (Nobili et al. 
2011), and has been identified as a specific cause of problems for people with multiple 
conditions for over a decade (Wright et al. 2003; Bayliss 2012).  
A further example of the failure of the single-disease model arises from the exclusion 
of people with multiple conditions from most of the clinical trials that are conducted 
in medical and public health research – many of which are used in the development of 
the drugs and clinical guidelines used in the treatment of people with multiple 
conditions (Fortin et al. 2006; Fortin et al. 2007). The extent that this occurs was 
illustrated in a study by Boyd et al. (2012) which reviewed the trials reported within 11 
Cochrane Reviews covering four chronic conditions. The study found that people with 
comorbidities were often excluded, and where they were not, the existence of effect 
modification for people with comorbidities was not often reported. Interestingly, the 
problem of clinical trials lacking external validity to multimorbid populations was 
highlighted over forty years ago by Feinstein (1970).  
Concerns about the sustainability of the single-disease model are also evident beyond 
the epidemiological and largely quantitative literature considered so far. As will be 
discussed further in Chapter 4, the many dimensions of people’s lived experiences of 
chronic illness has long been a central theme in the sociology of health and illness 
field (Gerhardt 1989; Bury 1991; Kelly & Field 2004; Taylor & Bury 2007; Bury 
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2010). However, most (if not all) of this work was grounded in research focusing on 
single conditions, and Kelly & Field (2004) also suggest that the field has been 
dominated by studies of “exotic” or “intractable” (p.257) conditions, rather than those 
more commonly seen by GPs, though attempts have been made to redress this single 
disease focus (Townsend et al. 2003; Townsend et al. 2006; Sells et al. 2009; Morris et 
al. 2011; Hurd Clarke & Bennett 2013; Ong et al. 2014; O’Brien et al. 2014). 
Similarly, representations of illness is a prominent field within health psychology 
research, and work has started to adapt and update this concept in the context of 
multiple conditions (Bower et al. 2012). However, compared with the growth of 
epidemiological research on multimorbidity, its presence in the sociology of health and 
illness and health psychology literature appears to be comparatively less well-
established.  
Multiple conditions as reflected in changing roles 
The decline of the single-disease model, and corresponding growing recognition of 
multiple conditions, can also be linked to wider changes within society and the 
practice of medicine, in which there has been a decline in clinical autonomy and 
deference to professionals, and an alteration to the roles occupied by clinicians and 
patients (Coulter 1999; Harrison & Ahmad 2000; Scambler 2002; Nettleton 2004; 
Stevenson & Scambler 2005). Many of the causes that have been attributed to this 
phenomenon are not directly relevant to this discussion, but those that are include the 
increasing prevalence of chronic illness, whose long duration affords people extended 
periods over which to gain knowledge about their conditions and their management; 
rising education levels; the widening of access to health information (accelerated by 
the advent of the internet) and its prominence in the media; and the role of social 
media as a forum for people to share their illness experiences (Stevenson & Scambler 
2005; Mazanderani et al. 2013).  
Amongst all these changes, a shift towards a more person-centred approach to health 
care can certainly be identified, including the rise of the so-called “expert patient”, 
though the motivations behind it and the genuine extent to which it has been realised 
have rightly been questioned (Bury 2010). The emergence of a concept such as 
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multimorbidity can, however, be seen as integral to trends such as these. 
Acknowledging – and taking seriously – the fact that people can and often do have 
multiple conditions, arguably reflects an approach that de-emphasises single diseases 
(around which much of the medical establishment is built), and better reflects the 
reality of people’s experiences of living with chronic conditions. Clearly it is not the 
sole reason why multimorbidity has become a matter of concern, but it is hard to 
imagine how it would have done so without there also having been changes to the way 
in which clinicians view and value their patients. However, as will be seen, the extent 
to which definitions of multimorbidity take into account the experiences and 
preferences of people with multiple conditions is rather limited. 
Having outlined some of the key factors that have contributed to the emergence of 
multimorbidity as a concept, the remainder of this review highlights the key points of 
consensus evident in the literature to date, and signals some of the more recent 
developments that are starting to feature more prominently. However, before doing 
this, a brief outline of some of the key measurement challenges facing this field is 
presented.  
Multiple conditions, multiple measures 
As the above discussion of the historical emergence of multimorbidity hopefully 
demonstrated, its measurement has long been, and continues to be, fraught with 
difficulties. Goodman et al. (2013) contrast the clarity and precision found in 
infectious disease classification with the many layers of heterogeneity associated with 
chronic disease and multiple conditions coding.  
As touched on previously, Almirall and Fortin (2013) conducted a bibliometric 
analysis of the following terms, all found in the literature in this field, covering the 
period from 1970 to 2012: comorbidity, multimorbidity, polymorbidity, 
polypathology, pluripathology, multipathology and multicondition. Additionally, they 
conducted a review of multimorbidity definitions. The key finding was that 
comorbidity was the most commonly used of these terms by some margin, followed by 
multimorbidity. The majority of articles using the term comorbidity adhered to 
Feinstein’s (1970) original definition and included an index condition, though 17% 
30 
 
did not. Most articles using the term multimorbidity did not define it, and that where 
it was defined, 13 different definitions could be identified (the issue of which 
conditions were included in the definition was not addressed). The authors stated that 
they hoped this work would help to develop a consensus on these definitional matters, 
and organised an online survey between December 2013 and January 2014, via the 
IRCM (International Research Community on Multimorbidity 2013). This gathered 
views on whether the definition of multimorbidity should stipulate that the conditions 
included are chronic/long-term (the key distinction between the two multimorbidity 
definitions that span 91% of the articles in their review). The majority (69%) of 
respondents favoured this definition:  
Multiple co-occurring chronic or long-term diseases or conditions, none 
considered as index disease. (International Research Community on 
Multimorbidity 2014). 
A further 17% wanted no reference to the chronicity / duration of conditions within 
the definition, 7% didn’t have a preference between these options, and 7% opted for 
another (unspecified) definition. However, clarity over the temporal nature of the 
conditions included is not, arguably, the only problem confronting the definition and 
measurement of multimorbidity. Additional challenging factors that need to be 
considered include how individual conditions have been defined and identified, how 
data have been collected, which populations the data apply to, how much granularity is 
possible, whether severity should be factored in, and what counts as multiplicity. It 
seems implicit in the definition above that multiple means more than one, however, 
the fact that this does not provide particularly good discrimination in older 
populations (most of whom have more than one condition) has resulted in some 
studies using a threshold of three or more (e.g. Bussche et al. 2011; Harrison et al. 
2014). Fortin et al. (2012) recommend reporting both thresholds (two or more and 
three or more), though this has not been widely followed, and Harrison et al. (2014) 
suggest that significant underestimation could arise from using a threshold of three or 
more unless datasets included all potential conditions (though they describe the lower 
threshold as insufficiently specific to be useful). 
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Arguably the two most fundamental issues appear to be: what conditions should be 
counted, and how this should be done. However, it appears that more of the literature 
has been devoted to the construction of weighting methods (Groot et al. 2003; 
Huntley et al. 2012a; Sharabiani et al. 2012; Diederichs et al. 2012), with the issue of 
what underlying conditions should comprise measures of multimorbidity rarely treated 
as important (Diederichs et al. 2011). To illustrate, the extensive review by Huntley et 
al. (2012a) considered 194 articles spanning 184 studies. They grouped them 
according to the counting method employed, with supplementary material providing 
an alternative typology grouping the studies according to their main research findings. 
Both these methods of presenting the findings provided valuable information in an 
accessible format, but the actual conditions included in the studies were not detailed, 
nor did they merit much discussion, which rather leaves the impression that this is 
unimportant. This approach was also true of the reviews by Fortin et al. (2012), 
Marengoni et al. (2011), and Salive (2013). Although Violan et al. (2014) did not 
document the conditions covered by their systematic review of prevalence, it included 
an analysis of condition clusters (an increasingly common line of inquiry in this field, 
as noted below), hence the question of what conditions had actually been included 
was a little more prominent in their work. However, the extent to which a measure has 
captured a partial or more comprehensive picture of people’s morbidity burden will 
surely affect the generalisability of any findings to the population, and it is striking 
how few studies in this field include mental health conditions (though, as subsequent 
chapters will demonstrate, there are numerous methodological and logistical reasons 
why this is not surprising). The impact of this inconsistency is most telling when 
reviews of prevalence are conducted, as they will invariably yield results with such wide 
variations that arguably the most appropriate conclusion that can be drawn is simply 
that different definitions generate different prevalence estimates – such as the 55-98% 
range presented by Marengoni et al. (2011) for the older population, and the 12.9% to 
95.1% cited by Violan et al. (2014).  
Diederichs et al.’s (2011) review is the only detailed examination that exists of the 
heterogeneity of conditions within multimorbidity indices, and its findings shed light 
on why underlying conditions tend to be absent from systematic reviews: 25 studies 
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were excluded from the review because the conditions used to define multimorbidity 
had not been specified, and of the 39 studies that were included, only 16 contained an 
explicit rationale for the chosen conditions. Pragmatism and expediency therefore 
appear to be the driving force behind the selection of conditions in much of the 
literature, with data availability the most common constraint, and opacity about this 
issue seems to be commonplace (Almirall & Fortin 2013).  
The direct experiences of people who actually have multiple conditions has received 
scant attention in the literature. For example, the process of establishing a multiple 
chronic conditions definition for use in US health research, as described by Goodman 
et al. (2013), used expert opinion from clinicians, epidemiologists and public health 
specialists to come up with 20 conditions based on their chronicity, prevalence and 
whether they were amenable to interventions. They do not mention involving patient 
groups, or whether patient views were considered in the process. Similarly, the attempt 
by the European General Practice Research Network (EGPRN) to devise an “exhaustive 
definition of multimorbidity drawn from scientific literature” (Le Reste, Nabbe, Lygidakis, et 
al. 2013, p.132) for use across studies in primary care settings to help standardise work 
in this field was informed by qualitative work with GPs, but not with people with 
multiple conditions. This work was also criticised for failing to consult with key 
members of the international multimorbidity research community (Almirall & Fortin 
2013).  
While Diederichs et al. (2011) recommend 11 high prevalence conditions that should 
be included in future indices, they also voice doubts about the utility of 
operationalising a complex concept such as multimorbidity using a simple definition 
based on two or more chronic conditions. Instead, they highlight the need for other 
dimensions to also be taken into consideration, such as the extent to which conditions 
impact on people’s quality of life and functioning, as Reuben & Tinetti (2012) also 
argue. In a similar vein, others suggest going further than this, for example by using 
complexity measures, or indicators of functional capability, that capture far more 
about a person’s situation than the sum of their conditions (Safford et al. 2007; 
Valderas et al. 2009; Mercer et al. 2009; Schaink et al. 2012; Grembowski et al. 2014; 
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Beard & Bloom 2014; Chrischilles et al. 2014; Koroukian et al. 2015). Analyses using 
techniques to cluster people according to their condition types have also become more 
common recently - Prados-Torres et al. (2014) identified 14 articles to include in a 
systematic review, only four of which had been published before 2010. These analyses 
attempt to identify common patterns of occurrence that could potentially yield 
insights about causal pathways between conditions, or identify combinations 
particularly likely to cause significant burdens for people. However, the value of 
identifying such patterns has, arguably, yet to be fully realised.    
The EGPRN’s attempt to develop a multimorbidity definition (Le Reste, Nabbe, 
Manceau, et al. 2013), the criticism it has faced (Almirall & Fortin 2013), and the 
counter attempt by the IRCM (International Research Community on Multimorbidity 
2013) to do the same (described above), further illustrates the possibility that 
multimorbidity might not be a concept to which a single definition can be applied. 
Following a systematic review, the EGPRN proposed the following (Le Reste, Nabbe, 
Manceau, et al. 2013): 
Multimorbidity is defined as any combination of chronic disease with at least 
one other disease (acute or chronic) or bio-psychosocial factor (associated or not) 
or somatic risk factor.  
Any biopsychosocial factor, any somatic risk factor, the social network, the 
burden of diseases, the health care consumption, and the patient’s coping 
strategies may function as modifiers (of the effects of multimorbidity). 
Multimorbidity may modify the health outcomes and lead to an increased 
disability or a decreased quality of life or frailty. 
This definition has also now been translated into 10 European languages (Le Reste et 
al. 2015). This bears little resemblance to the commonly used definitions identified in 
Almirall and Fortin’s (2013) review. This is partly understandable, as it was developed 
to bring clarity to this very muddled field, but it is arguably undermined by its length, 
by including terms that themselves need further clarification (e.g. bio-psychosocial), 
and by its breadth, particularly its inclusion of  acute disease and other risk factors. 
This definition has the potential to classify the vast majority of the population over 50 
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with a chronic condition as having multiple conditions, a situation that probably 
warrants a discussion far beyond the scope of the task the EGPRN originally set itself. 
The challenges raised by these definitional issues recur throughout this thesis. As 
noted in the introduction (Chapter 1), its title - Beyond a Boundary - was chosen to 
reflect the fact that many boundaries exist that require consideration in the process of 
identifying people with multiple conditions. For example, whether multiplicity is 
defined as more than one condition, or more than two; how to handle health states 
that straddle the boundaries between conditions and risks, normality and abnormality; 
and how the boundary between clinical and lay voices is best approached. But it is also 
intended as a challenge to the idea that the resolution of these boundary issues is 
merely a technical matter; that there exists a perfect measure of this status that just 
needs to be identified, and, indeed, that this status has a fixed form that is amenable 
to measurement in the first place.  
These kinds of considerations stray into the territory of some of the more 
fundamental, philosophical, questions surrounding the nature of health, illness and 
classification that are considered in more depth in Chapter 4. However, a more 
prosaic challenge must also be considered - that of actually sourcing the basic 
information necessary to create measures of multiple conditions. A key aspect of this is 
considered next. 
Multiple conditions, multiple sources 
It seems an obvious point, but the prevalence of people with multiple health 
conditions can only be established by ascertaining information about the single 
conditions people have. Health data come in many forms – the majority of the studies 
cited so far were derived from administrative data sources from primary care, or 
sometimes hospital, settings - but the question of what can be collected directly from 
people themselves, via population health surveys, is clearly of most relevance to the 
work presented in this thesis. Self-reported data are often omitted from reviews of 
conditions on the grounds of data quality (e.g. Violan et al. 2014). In contrast, 
Huntley et al. (2012a) make the point that self-reported data sources have the 
advantage of being able to incorporate direct reports from people about any functional 
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impairments, and are therefore critical for studies of quality of life. Fortin et al. (2012) 
concluded that self-reported data are best augmented by additional sources, such as 
medical records, but do make the point that medical records too have limitations that 
self-reports can help to address (such as missing or out of date information).  
The measurement of health spans a vast literature and identifying conditions 
(diagnosed or otherwise) occupies only a very small part of this (see, for example, 
Bowling 2001; Bowling 2005). Basing estimates on people’s own reports of what 
conditions they have received diagnoses of requires a number of criteria to be fulfilled: 
they need to have been told their diagnosis (this cannot be assumed in all cases), they 
need to have understood what they were told, remember having been told, agree with 
the diagnosis, and be prepared to volunteer that information to a third party (e.g. a 
survey interviewer). What is less often noted is that such diagnoses – if they are to truly 
reflect someone’s current state of health – also need to have been accurate in the first 
place, and they need to still be valid at the time the survey is undertaken. Any one of 
these criteria can fail and therefore result in the kinds of discrepancies that are 
commonly reported in the methodological literature on health measurement. For 
example, diabetes reporting is generally accurate (Kriegsman et al. 1996; Goldman 
2003; Okura et al. 2004; Pastorino et al. 2015), hypertension is much less so 
(Goldman 2003; Tolonen, Koponen, Mindell, Männistö, Giampaoli, et al. 2014), 
though not uniformly so (Okura et al. 2004). Cardiac events have been found to be 
both under and over-reported relative to medical records (Yasaitis et al. 2015). 
Kriegsman et al. (1996) also found the concordance between self-reported and medical 
record estimates of arthritis to be generally quite poor.  
Gooberman-Hill et al.’s (2003) qualitative study of the responses older people gave to a 
survey question intended to measure long-term conditions among the general 
population is of particular interest to the work in this thesis. In addition to the 
potential problems outlined above, this study highlighted the complexity of the 
judgements being made about what should, or should not, be reported, in part linked 
to people’s experiences of symptoms, their understandings of health and the nature of 
conditions, and the extent to which they identified with certain health conditions as 
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illnesses or as inevitabilities of the ageing process. Some of these were related to 
cultural and generational differences, and Gooberman-Hill et al. (2003, p.2556) raise 
the following possibility:  
While we would expect that some survey items may not capture the meaning of 
health and illness, this also implies that they may not capture the prevalence of 
chronic conditions among older people. 
 
Related to this, Hansen et al. (2014) highlighted differences between GP and patient 
reports of conditions among people with multiple conditions in Germany. This study 
didn’t use medical records as the comparative source of data, but instead used 
physician’s reports (which other studies have found to be fairly inaccurate (Merkin et 
al. 2007)). This had the advantage that they could use focus groups to explore reasons 
for some of the discrepancies between the patient and physician accounts (Hansen et 
al. 2015). Patients gave greater priority in their illness accounts to conditions with 
more invasive symptom burdens, whereas physicians gave greater weight to conditions 
with life-shortening prognoses, which suggests that another important aspect affecting 
people’s propensity to report conditions, especially when they have multiples of them, 
is the extent of their immediate impact on their daily lives. 
This thesis is specifically interested in estimating prevalence of multiple conditions 
using self-reported data so there is little to be gained from a more exhaustive 
consideration of its merits relative to other sources. However, the sources of the 
discrepancies that have been found to exist, the fact they vary by condition type, and 
the groups among whom they are most common (typically, but not exclusively, older 
people and those with lower levels of education) are all highly relevant and will recur 
throughout this thesis.  
Moving away from the methodological aspects of this work, the remaining sections of 
this chapter now describe what appear to be the main points of consensus that have 
emerged in relation to the impact of multiple conditions. The matter of how multiple 
conditions as a single status has been defined, and the potential consequences of the 
measurement heterogeneity outlined above are, therefore, largely absent from the 
remaining discussion, except where it is pertinent to the conclusions being drawn.  
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Emerging consensus around multimorbidity  
Demographic and socio-economic profile of multimorbidity 
Perhaps the most universally reported observation about multimorbidity patterning is 
that it increases with age. For example, systematic reviews of prevalence studies in both 
primary care settings and the general population show that the increase in 
multimorbidity prevalence with age generally follows an S-shaped curve (Fortin et al. 
2012). Huntley et al.’s (2012b) large-scale review of multimorbidity definitions shows 
that age is associated with increasing multimorbidity prevalence, across a number of 
different multimorbidity measures. Numerous other studies, not included in the 
Fortin et al. review (mainly due to their timing), support this finding (Taylor et al. 
2010; Salisbury et al. 2011; Barnett et al. 2012; Ward & Schiller 2013; Lochner & 
Cox 2013; Violan et al. 2014). Many of these studies also make a point of drawing 
attention to the multimorbidity burden in the population aged under 65 years to 
highlight the fact that, despite increasing with age, multimorbidity should not be 
treated as a topic of relevance solely to the older population (a point also made by 
Mercer et al. (2009)). Indeed, while studies of people’s experiences of living with 
multiple conditions have more commonly focused on older populations, recent 
qualitative work has attempted to redress this balance (e.g. O’Brien et al. 2014; 
Duguay et al. 2014), with the participants in Duguay et al. (2014) describing their 
illness experiences as a form of premature ageing. 
The majority of studies reviewed by Violan et al. (2014) report a higher prevalence of 
multimorbidity in women than men, as did the main UK-based studies (Barnett et al. 
2012; Salisbury et al. 2011) though this is not universal (Huntley et al. 2012b), and the 
magnitude of the difference varies depending on the study design, age range analysed, 
and multimorbidity definition used (see, for example: Ward & Schiller 2013). It is 
highly likely that gender differences in the underlying conditions included in 
multimorbidity definitions will contribute to such differences in outcomes between 
studies. 
Analyses using measures of socio-economic status appear to be less common in the 
literature than those reporting age or sex differences. This is likely to be due to the fact 
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that many studies are based on administrative data, such as health records, which 
often have limited access to socio-economic measures. The presence of socio-economic 
gradients in multimorbidity has, however, been clear from quite early on in the history 
of its reporting. For example, Akker et al. (1998) reported that multimorbidity in the 
Dutch population was associated with low educational attainment and having public 
(rather than private) health insurance. Huntley et al.’s (2012b) review found 11 studies 
that reported negative associations between multimorbidity prevalence and a wide 
range of socio-economic status measures, such as household income, unemployment 
and social class. All of the studies reported in Violan et al. (2014) that investigated SES 
gradients found multiple conditions prevalence increased as SES declined. In the UK, 
both Barnett et al. (2012) and Salisbury et al. (2011) used area-based measures of 
deprivation in their analyses and showed that multimorbidity prevalence increased 
with deprivation. To illustrate the deleterious effect of deprivation, Barnett et al. 
(2012) show how the prevalence of multimorbidity in the most deprived parts of 
Scotland matches that found among people aged 10-15 years older in the least 
deprived areas. Moving beyond simply describing its prevalence, two qualitative studies 
in Scotland have also explored the additional burdens incurred by people with 
multiple conditions who also face the additional contextual challenge of living in an 
area of high social deprivation. These studies highlighted both the difficult lives people 
lead (O’Brien et al. 2014) and the considerable complexity of their treatment needs 
(O’Brien et al. 2011). Taking a life-course approach, Tucker-Seeley et al. (2011) show 
how the cumulative impact of adverse socio-economic circumstances, such as financial 
hardship in childhood, and earnings during young-to-middle adulthood, demonstrate 
a negative association with multimorbidity onset. Similarly, Tomasdottir et al. (2015) 
demonstrated an association between retrospective measures of childhood adversity 
and multiple conditions in adulthood, with allostatic load cited as the possible 
pathway between these outcomes.  
Mortality 
The association between multiple conditions and mortality occupies a large portion of 
the literature, in part due to the links between this and the wider gerontology field. 
Indeed, a number of comorbidity/multimorbidity indices have been devised with the 
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specific aim of predicting mortality, such as the Charlson and Elixhauser indices 
(Sharabiani et al. 2012). Gijsen et al.’s (2001) systematic review showed that most 
studies using comorbidity indices demonstrated a negative association between 
comorbidity and mortality. Marengoni et al.’s (2011) systematic review of 
multimorbidity in the older population included mortality as one of its outcomes, and 
was similar to Gijsen et al.’s (2001) in terms of the breadth of outcomes investigated. 
Unlike Gijsen et al. (2001), Marengoni et al. (2011) concluded that the evidence in 
relation to multimorbidity and mortality was “controversial” (p434), with three studies 
showing a positive association and two finding no increased risk of mortality. 
However, based on a quality assessment of the reviews, adapted from two checklists 
(CEBM 2005; CASP 2013), Marengoni et al. (2011) can be shown to have more 
weaknesses than Gijsen et al. (2001), specifically relating to the search terms used and 
the number of searching techniques used (see Appendix A for the assessment criteria). 
For example, there were just five studies specifically reporting mortality outcomes in 
Marengoni et al. (2011) compared with 36 in Gijsen et al. (2001). Huntley et al. 
(2012c) reported findings more in line with Gijsen et al. (2001) – all 25 studies, 
spanning various types of multiple conditions measures, included in their review 
reported that mortality increased with increasing numbers of conditions. This 
accumulation of evidence, Marengoni et al. (2011) aside, therefore appears to suggest 
that the positive association between multiple conditions and mortality is a fairly well 
established point of consensus in the literature.  
Negative experience of health services 
In addition to the comparatively larger body of work examining health care utilization 
by people with multiple conditions – and the associated costs – the ways in which this 
group often experience sub-optimal health care is a further common area explored in 
the literature. As already noted, a number of studies have outlined various ways in 
which people with multiple conditions can be faced with services that are fragmented 
and time-consuming to use (Hitchcock Noël et al. 2007; Boyd & Fortin 2010; Nobili 
et al. 2011; Hughes et al. 2013). Salisbury et al. (2011) found that having multiple 
conditions was negatively associated with continuity of care (despite this being valued 
by such patients), and concluded that this was a result of the increased number of 
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consultations made by this group. Liddy et al.’s (2014) review of self-management in 
the context of multiple conditions also highlighted the difficulties that arise when 
multiple health care providers give conflicting or confusing advice, adding to the 
considerable work involved (illness work, as Corbin & Strauss (1985) framed it, is 
discussed further in Chapter 4). As with the example cited above of unhelpful 
polypharmacy resulting from systems poorly equipped to coordinate the needs of 
people with multiple conditions, the appointments systems used in many UK GP 
practices also appear to ill-serve this group by prioritising rapid access to any doctor, 
over continuity of personnel (Roland & Paddison 2013). Salisbury et al. (2011) also 
make the important point that attempts to improve mechanisms for sharing 
information about patients, which they describe as “‘management continuity’ and 
‘information continuity’” (pe17), do not in themselves help to meet people with multiple 
conditions’ preference for continuity of contact with clinicians. O’Brien et al.’s (2011) 
study of how GPs and practice nurses manage patients with multiple conditions in 
very deprived areas sheds further light on the inability of the UK primary care system – 
as it is currently structured and resourced – to adequately meet the needs of this very 
complex group; a process they describe in the title of their article as “an endless struggle”.  
The current mechanism for allocating primary care resources is based largely on the 
size of a local population rather than its actual healthcare needs. This results in the 
‘inverse care law’, a term first coined by Tudor Hart in 1971, whereby: “the availability 
of good medical care tends to vary inversely with the need for it in the population served” 
(Tudor Hart 1971, p.405). Mercer et al. (2012) argue that the inverse care law 
amplifies the problems faced by people with multiple conditions because they 
represent a group with some of the greatest care needs.  
Quality of life and wellbeing 
As set out in Chapter 1, the analysis presented in this thesis uses measures of wellbeing 
to elucidate how the experiences of people living with multiple conditions vary. 
Therefore, this topic is given greater weight in this literature review than is the case 
with the other areas of emerging consensus described above. 
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Despite its relatively recent appearance in the research literature, a sufficient number 
of studies had been conducted in the 1990-2003 period exploring the association 
between multimorbidity or comorbidity and quality of life for a systematic review to be 
carried out (Fortin et al. 2004). This widely cited review (86 citations in the PubMed 
database as of December 20157), found an inverse association between multimorbidity 
and quality of life in almost all studies that met their inclusion criteria. The study’s 
main limitations, as noted by its authors, included the lack of a consistent definition 
of multimorbidity, the use of self-reported measures, poor treatment of confounders in 
the analysis, and the absence of mental-health conditions from most of the studies’ 
multimorbidity definitions – a situation described as “simply unacceptable” (Fortin et al. 
2004, para. 35). The question of whether self-reported measures are inherently inferior 
to alternatives such as case-note reviews or administrative data, is less clear-cut than the 
authors suggest, though obviously has huge implications for the work presented in this 
thesis, which is based on self-reported conditions. This will be revisited in many of the 
following chapters.  
Similar findings are reported in Gijsen et al. (2001), which reviewed studies of 
comorbidity between 1993 and 1997. The condition combinations covered by the 
studies included in this review were generally narrower than was the case in the Fortin 
et al. (2004) review (as would be expected of a study of comorbidity as opposed to 
multimorbidity). However, the authors conclude that the majority of studies which 
utilised a comorbidity index (which is effectively a multimorbidity measure) showed a 
negative association between comorbidity and quality of life.  
More recent studies, many of which have addressed some of the limitations identified 
by Fortin et al. (2004), have confirmed the original – and expected – finding that 
multimorbidity is inversely associated with quality of life. For example, Huntley et al. 
(Huntley et al. 2012b) cite over 20 separate studies of multimorbidity and various 
measures of quality of life, almost all of which reported an association in the direction 
expected. Given the almost universal consistency of the findings, it is perhaps 
                                                 
7 See: http://www.ncbi.nlm.nih.gov/pubmed/15380021 [Accessed 25 December 2015]. 
42 
 
surprising that studies of multimorbidity and quality of life continue to be reported. 
Fortin et al. (2004) justified this body of research by arguing that:  
Although the existence of this association makes logical sense, it still has to be 
demonstrated and thoroughly studied to find ways of improving care for 
specially affected patients. Thus, the pressing question may not be whether there 
is an association but rather how strong is the association and what factors are 
responsible for it? (Fortin et al. 2004, para. 29). 
It is perhaps, therefore, more accurate to conclude that while consensus surrounds the 
matter of the association between multimorbidity and quality of life, the literature has 
yet to yield similar agreement on its subtler dimensions, with the question of which 
specific factors contribute to reduced quality of life so far unanswered. The main 
consequence of this, of course, is that practical recommendations to improve quality of 
life among this group of people are somewhat scant. There are, however, examples of 
work attempting to do more than simply confirm the existence of already established 
global associations. For example, Lawson et al. (2013) used the 2003 Scottish Health 
Survey to demonstrate that the negative association between multimorbidity and 
health-related quality of life (HRQoL) was more pronounced among younger age 
groups and in those living in the most deprived areas – and described their study as 
the first to attempt such analysis. Similarly, Mujica-Mota et al.’s (2015) analysis of 
HRQoL using a survey of GP patients in England also found that outcomes were 
better among people with multiple conditions at older ages relative to their younger 
counterparts. They also attempted to explore condition-specific patterns among people 
with multiple conditions and concluded that people with diabetes, arthritis, 
neurological or mental health conditions (in combination with other conditions) had 
the worst outcomes, thus moving the analysis away from the more general findings 
noted above, and contributing some insights about the potential sub-groups within all 
those with multiple conditions for whom quality of life might be particularly impaired. 
Though it should be noted that their data collection method (a postal survey 
supplemented by a small proportion of online and telephone interviews) yielded only a 
38% response rate which, when further item non-response was factored in, meant 
their final cases available for analysis represented just a 30% response rate. 
Furthermore, their ascertainment of conditions was fairly limited – based on 12 listed 
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long-term conditions and an “other” option. Therefore, while their findings are in line 
with much of the published literature, the likelihood that this study reflects only a 
partial picture of the overall association between the burden of multiple conditions 
and HRQoL is quite high.  
The literature in this field is, understandably, largely dominated by studies of HRQoL 
(see the studies included in Huntley et al. 2012b). However, broader, 
multidimensional conceptualisations of wellbeing exist (Schrank et al. 2013), including 
the Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) (Tennant et al. 2007), 
which has been included in the Scottish Health Survey since 2008. Terminology in 
this field can be inconsistent, with mental health and mental wellbeing often used as 
synonyms. However, when developing WEMWBS, Tennant et al. (2007) 
conceptualised wellbeing as:  
a complex construct, covering both affect and psychological functioning with 
two distinct perspectives:- the hedonic perspective, which focuses on the 
subjective experience of happiness and life satisfaction, and the eudaimonic 
perspective, focusing on psychological functioning and self realization. (para. 2). 
 
WEMWBS underpins one of the Scottish Government’s national performance 
framework indicators (Scottish Government 2015a), and is included in its long-term 
monitoring of health inequalities programme (Scottish Government 2014), though 
concerns have been raised about its potential to demonstrate change over time or 
show much differentiation between groups (Frank & Haw 2011). No analyses of 
wellbeing using WEMWBS have specifically investigated its association with multiple 
health conditions. Stewart-Brown et al.’s (2015) analysis of predictors of low and high 
wellbeing in England covered a range of potential factors but no measures of health, 
while Wilson et al.’s (2015) Scottish Government wellbeing report only looked at 
individual CVD and respiratory conditions. 
The inclusion of WEMWBS within the Scottish Government’s performance 
framework is illustrative of a wider increase in the significance of wellbeing in research 
and policy practice in recent years, in many countries. A pivotal stimulus for this was 
the Commission on the Measurement of Economic Performance and Social Progress, 
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chaired by the economist Joseph Stigltiz, which argued that measures of subjective 
wellbeing were important markers of a society’s functioning that should be collected by 
national statistics agencies as well as more traditional economic output measures such 
as GDP (Stiglitz et al. 2009).   
The HRQoL analyses discussed above found outcomes were worse for people with 
multiple conditions of working age. However, this will, in part, be a function of 
general age-related patterns in wellbeing. The existence of a U-shaped curve in 
wellbeing across the lifespan for all adults, with those in middle age showing the lowest 
levels of wellbeing and those at younger and older ages having the highest, has been 
widely reported in the wellbeing and happiness literature for some time now 
(Blanchflower & Oswald 2008). Debate still surrounds the possibility that this pattern 
might be explained by period or cohort-specific effects, as opposed to changes across 
the lifecycle that all people undergo regardless of context (Bell 2014). Similarly, Frijters 
& Beatton (2012) used fixed-effects modelling to argue that the U-shaped pattern is an 
artefact of reverse causality and selection bias in panel studies (which form the basis of 
many of reported the U-shaped curve results). Swift et al. (2014) suggest that GDP 
mediates the association between wellbeing and age (within Europe, at least) such that 
higher income countries are more likely to demonstrate this U-shaped curve than 
lower income countries. They argue that this is likely to be due to a wide range of 
policies that support older people in high income countries, rather than any specific 
intervention, but this general conclusion nevertheless highlights that external, country-
level factors, can be important correlates of older people’s wellbeing, rather than it 
simply being linked to their development of better coping skills over the lifecycle, or 
revising their views about what they hope to achieve in life’s later stages (alternative 
accounts suggested by Swift et al. (2014), but not tested empirically in their study). 
Steptoe et al.’s (2014) wider review of the wellbeing literature (focusing on health, 
ageing and mortality) also concluded that the U-shaped curve was a feature of English-
speaking high-income countries, with different patterns evident in all other regions 
studied (ex-Soviet bloc countries, the Caribbean, Latin America and sub-Saharan 
Africa). They also suggest that the relationship between health and wellbeing is bi-
directional, with poor health reducing wellbeing, and high wellbeing reducing the 
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impact of poor health. Additionally, they used survival analysis of the English 
Longitudinal Survey of Ageing to show that higher levels of eudaimonic wellbeing 
were associated with a higher likelihood of survival in older people, after controlling 
for obvious confounders such as baseline health status and chronic disease risk factors. 
Analysis of a German cohort of older adults with multiple conditions found that levels 
of self-rated health, quality of life and functional capacity were all socially-patterned, 
with the worst outcomes experienced by those with the lowest incomes; they 
concluded that differential disease burden could not explain this (von dem Knesebeck 
et al. 2015). 
Conclusion 
It is clear that the concept of multimorbidity has become an important research area 
and is starting to feature in debates about health care delivery and, in the context of 
policies to manage the burden of NCDs, public health as well. At its core is the 
recognition that diseases and conditions do not occur in isolation within individuals, 
and that this needs to be better reflected in how people are treated within healthcare 
settings, in the design of interventions to improve people’s health, and within research 
more generally. However, conceptual clarity still eludes this field and this hinders 
attempts to make comparisons of prevalence across time and across settings, and poses 
challenges for those designing interventions intended to improve outcomes for people 
with multiple conditions (Smith et al. 2013). This lack of clarity arises from at least 
two sources. The first, perhaps most fundamental issue, is that what it means to have 
multiple conditions is not clear-cut and, quite possibly, is not amenable to universal 
consensus. Whether it should be limited to chronic conditions or should also 
encompass acute illnesses, or risk factors and other vulnerabilities, are all indicative of 
the complexity associated with this concept.   
The second issue relates to the limits of what can meaningfully be measured. As 
previously mentioned, in many cases it appears that research in this field has been 
constrained by pragmatic considerations relating to what data exist, and that 
multimorbidity has tended to be defined according to what is available to be counted, 
rather than what would ideally be counted. Many existing data sources, especially those 
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based on administrative data, can yield only partial measures if multiple conditions is 
conceptualised very broadly, but if it is very narrowly defined, the availability of data 
sources expands. The corollary of the need for conceptual clarity about definitions is, 
therefore, the need for appropriate data to operationalise any such definitions. And if 
this doesn’t exist, then situations where definitions are constrained by data availability 
should always be made explicit.  
The following contrasting approaches to the classification of disease can be found in 
the diagnosis literature: 
Occam’s razor: “entities are not to be multiplied beyond necessity” (Mani et al. 
2011 , para. 4) 
Hickam’s dictum: “patients can have as many diseases as they damn well please” 
(Mani et al. 2011, para. 8) 
While these statements have not been linked to debates about multiple conditions per 
se, they seem particularly apposite in light of the preceding discussion of the 
definitional difficulties being debated in this field. They also capture, fairly succinctly, 
one of the key tensions in this field that the analysis presented in this thesis was 




Chapter 3 Methods, methodology and approach 
Introduction 
This chapter outlines the methods and approach that underpin the analysis of 
multiple conditions presented in this thesis. It starts by setting out the research 
questions, after which a broad overview of population health surveillance is then 
presented to help locate the quantitative analysis. The next part of the chapter 
describes the data source in detail, including the specific survey questions and other 
measures that could be used to identify people living with multiple conditions, with an 
accompanying commentary on their strengths and limitations. The ontological and 
epistemological positions that have been adopted for the work are then outlined. 
Finally, the approach taken to identify conditions for use in the multiple conditions 
definition is explained. 
Research questions 
The overarching aim of the work presented in this thesis is to: 
 Quantify the experiences of adults living with multiple conditions in Scotland 
using the Scottish Health Survey. 
To address this, the following questions must be answered: 
 Does the Scottish Health Survey correctly identify people with multiple 
conditions? 
o And if not, who is missing? 
 How do different definitions of multiple conditions affect its prevalence in the 
population, and across sub-groups? 
 How do experiences of people living with multiple conditions vary in the 
population? 
The quantitative surveillance of population health 
Introduction 
As the preceding discussions outlined, this analysis hopes to make a contribution to 
efforts to increase understanding of the nature and experience of the lives of people 
with multiple conditions in the adult population in Scotland. Its use of population 
surveillance data warrants a discussion that sites the analysis within this practice and 
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makes the case for its extension to cover phenomena such as multiple conditions. The 
following briefly outlines the main role that surveillance plays within public health 
practice and then places it within the context of Scotland and the rest of the UK.   
What is population health surveillance? 
The WHO defines population health surveillance as: “the continuous, systematic 
collection, analysis and interpretation of health-related data needed for the planning, 
implementation, and evaluation of public health practice” (World Health Organization 
2015b). As the definition suggests, without knowledge about the nature of a 
population’s disease burden, health service planning would be difficult, strategies to 
prevent disease (or ameliorate its impact) would be ill-informed and hard to evaluate, 
and social inequities in its distribution would be hidden. The analysis presented in 
this thesis uses data collected via a social survey – the Scottish Health Survey (SHeS) – 
based on interviews with people in their own homes, covering a range of topics 
including health outcomes and risk factors for poor health (specific details of the 
survey’s methods are presented below). Surveys such as SHeS are just one of a range of 
tools used to provide population health data; other sources include routine clinical 
data collected in primary care settings, hospital records, disease registers (such as 
cancer registries), communicable disease notification systems, Census data collected 
from whole populations, and general surveys that cover health alongside other topics 
(Sosin & Hopkins 2006). Many of these sources depend upon the existence of well-
developed information-system infrastructures, typical of health systems in the 
developed world. However, surveys can perform a useful function in countries that 
lack such systems, supplying the kinds of data that more developed countries would 
generally obtain from registries (Rothman et al. 2008). 
Health surveys are typically categorised as Health Interview Surveys (HIS) if the data 
collected is purely based on self-reported information from participants, while Health 
Examination Surveys (HES) also include the direct measurement of items such as 
height, weight and blood pressure, and can often collect blood, urine and saliva 
samples (Aromaa et al. 2003). While clinical data have the advantage of having greater 
validity for some areas of information, such as confirmed diagnoses of conditions, and 
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sometimes achieve universal coverage, HIS/HESs have the potential to provide a 
depth and breadth of information about people’s lives that could not feasibly be 
captured in routine clinical encounters (Tolonen, Koponen, Mindell, Männistö & 
Kuulasmaa 2014). For example, a health survey will typically collect detailed 
information about people’s educational attainment, occupational class, income, health 
behaviours and well-being, using a systematic approach to data collection and 
processing, and HESs can sometimes identify undiagnosed conditions or syndromes. 
An interview can take around an hour, or longer if a health examination is included, 
which is certainly more time than could feasibly be spent in a clinical setting collecting 
information from patients purely for research, as opposed to clinical, purposes.  
The use of HIS/HES data to track trends over time in health outcomes and risk 
factors, and to monitor sub-group differences, is widespread in European countries 
and North America, with their use dating back to the 1950s and 1960s, respectively 
(Tolonen, Koponen, Mindell, Männistö & Kuulasmaa 2014). In the UK, the multi-
topic General Household Survey was the main source of self-reported population-wide 
health data in the 1970s and 1980s, with data on topics such as long-term conditions, 
smoking and alcohol consumption collected annually (Office for National Statistics 
2013). However, by the early 1990s the need for more detailed information, including 
examination data, to help monitor and inform health policies led to the 
commissioning of HESs in England (1991), Scotland (1995), and Northern Ireland 
(1997) (White et al. 1993; Dong & Erens 1997a; Northern Ireland Statistics and 
Research Agency Central Survey Unit 2003). Wales has never had a HES, but 
intermittent HISs have been conducted, largely using postal questionnaires, from 1985 
onwards (Nicolaas et al. 2003).   
Population surveillance in Scotland 
Scotland has a global reputation for high quality, consistent routine health data aided 
by the long-standing use of a unique patient identifier, the Community Health Index 
(CHI), in all primary care and hospital encounters, enabling data to be linked and 
used in research (Health Informatics Research Advisory Group 2015). However, the 
need to supplement these kinds of sources with data from representative samples of 
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the public was reflected in the Scottish Office Home and Health Department8 
commissioning its first population health survey (the 1995 SHeS). Plans for SHeS had 
been set out in the 1992 strategy document Scotland’s Health: A Challenge to Us All, 
with the intention of monitoring targets set out in the 1991 Health Education in 
Scotland: A National Policy Statement, and the dietary targets published in 1994 (Dong 
& Erens 1997a). Although these targets span a broad range of health topics, the 
survey’s founding overarching purpose was the investigation of risk factors for 
cardiovascular disease, a major source of morbidity and mortality in Scotland. The 
survey was repeated in 1998 and 2003, before switching to a continuous format from 
2008 onwards. At present, it is the only source of regular population-wide data on: 
dietary habits, physical activity, alcohol consumption (as opposed to purchases), 
wellbeing, BMI, and long-term conditions. It is currently used to monitor progress 
towards more recently set targets such as those in the Obesity Route Map (Scottish 
Government 2010), the Scottish Government’s National Performance Framework 
(Scottish Government 2015b), and its Long-term Monitoring of Health Inequalities 
program (Scottish Government 2014).  
Population surveillance of multiple conditions 
Chapter 2 outlined the recent emergence of the concept of multiple conditions in 
research and practice, and noted the population prevalence study conducted in 
Scotland using primary care data from 314 GP practices in 2007 (Barnett et al. 2012). 
SHeS participants are asked to report information about long-term conditions and, as 
will be detailed further below, other aspects of their health and behaviours that can, 
collectively, be used to estimate the prevalence of multiple conditions. The current 
reporting of multiple conditions in SHeS is limited to the information solely collected 
at an unprompted question on long-term conditions, with no use made of the wider 
health and conditions data available. This omission served as the starting point for this 
analysis, with my concern to “improve” the measurement of multiple conditions 
fuelled in part by a desire to see more accurate reporting, but also a concern to make 
                                                 
8 Following devolution in 1999, responsibility for the survey lay with the new Scottish Executive Health 
Department, followed by the Scottish Government Health Directorate in 2007, and the Health and 
Social Care Directorate in 2010.  
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full use of the information that participants volunteer during the course of what is a 
fairly extensive data collection exercise.  
While disease prevalence estimation is an important element of health surveillance, 
self-reported measures have limitations (as detailed more below). Therefore, arguably 
the most useful contribution that a source such as SHeS can make to this field is to 
shed light on the wider life circumstances and experiences of people living with 
multiple conditions. One of the main strengths of a multi-topic population health 
survey is its ability to connect the dots between people’s health outcomes, risk factors 
and wider social circumstances. For example, work on multiple risk exposures reveals 
how many of the objects of public health interventions such as smoking, poor diet or 
low physical activity are in fact inter-connected and cluster within the same individuals 
(Lawder et al. 2010; Bromley 2011).  
While a survey can never capture the depth and complexity of experiences that 
qualitative studies such as those reviewed in Chapter 2 can (O’Brien et al. 2014), it can 
provide complementary information about the extent of particular configurations of 
experience, the nature of the social patterning of those experiences, and, in some 
cases, their change over time and link to later outcomes. To ignore the potential of 
such analyses to reflect the circumstances of a group (in this case people with multiple 
conditions) that is attracting increasing attention in policy and practice circles, and for 
whom interventions are being developed, would be remiss. It would also represent a 
failure to maximise the use of data that has been collected at considerable public 
expense – both in terms of its financial costs and time burden on participants. 
Furthermore, data such as this can also contribute to more critical debates about the 
utility of concepts such as multiple conditions, and challenge some of the orthodoxies 
that surround it.   
The following section describes the methods used in SHeS and expands on some of 
the strengths and weaknesses already highlighted.  
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The Scottish Health Survey 
Study overview 
The survey was first run in 1995 and was repeated on an intermittent basis, in 1998 
and 2003, before switching to a continuous mode from 2008 onwards. Although the 
core aims and design have remained broadly similar since its inception, notable 
changes were introduced in 2008 and 2012, hence the grouping of the following 
description around those periods. Children have been included in the survey from 
1998 onwards; however, as the analysis presented here is based only on adults, 
information about the sampling and data collection methods related to children has 
been omitted. The following discussion uses information from the published technical 
reports available for each survey year, as well as personal knowledge gained from my 
role as project manager, then director/principal investigator, from 2002 until 2012. 
The published sources are as follows: 
 1995: Dong & Erens (1997b). 
 1998: Shaw et al. (2000a). 
 2003: Bromley et al. (2005). 
 2008-2011: Bromley et al. (2009; 2010; 2011); Rutherford et al. (2012). 
 2012: Rutherford et al. (2013).  
1995-2003 
As noted above, SHeS was launched in 1995 as a study of the working-age population 
(16-64), living in non-institutional establishments in Scotland (typically referred to in 
UK survey sampling as the “household” population). It was initially intended to be 
repeated on a three-yearly basis (in contrast to the annual continuous survey 
conducted in England from 1993 onwards). When it was repeated in 1998 the upper 
age limit increased to 74. Following a five-year gap, it was next conducted in 2003, at 
which point the previous age-related sample restrictions were removed. The core 
features of the study were broadly similar in this period: interviewers conducted the 
main interview and measured height and weight, while nurses conducted the health 




The study underwent a major re-design prior to switching to a continuous format in 
2008. The sample population stayed the same (0+), but to save costs the nurse 
examination element was restricted to a sub-sample of around one in six adult 
participants (16+) (described as the “nurse sample” in subsequent discussions). The 
2008 to 2011 surveys were designed to enable pooling of multiple years’ data to 
provide more precise estimates for sub-groups, such as Health Boards and the 15% 
most deprived areas, after either two or four years had accrued. A modular structure 
was introduced to expand the range of topics covered in the interview, with certain 
topics asked in alternate years, rather than annually.  
2012 onwards 
Further modifications were introduced from 2012 onwards. Most of the design 
elements introduced in 2008 were retained, including the capacity to pool years of 
data (e.g. 2012-2013, 2012-2015, but not across the time periods before and after 
2012). The biggest change saw specially trained interviewers replace nurses to collect 
biomarker information, which resulted in some of the information and samples 
collected changing. Of most relevance to this work was the loss of blood samples and 
prescription medication coding.  
Sample design 
The sample source for all surveys was the Postcode Address File (PAF), a list of all UK 
addresses to which Royal Mail makes deliveries. Multi-stage random probability 
sampling was used, with regional stratification and clustering of addresses to make 
fieldwork more efficient. The stratification and clustering methods differed across the 
years, as explained below. Interviewers were issued with batches of addresses and 
tasked with identifying invalid ones, such as empty or derelict properties, businesses 
and communal accommodation (e.g. halls of residence, care homes). At addresses 
occupied by more than one household, interviewers made a random selection, using a 
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pre-supplied Kish grid.9 Again, while these core sampling features are common to all 
survey years, various changes have been introduced across the years.  
1995 and 1998 
The 1995 and 1998 sample was stratified by seven regions comprising pairs of NHS 
Health Boards (Greater Glasgow was its own region, Highlands was paired with all the 
Island boards), and by area deprivation (using the Carstairs Index (ISD Scotland 
2010b)). A sufficient number of addresses was selected in each of the regions to enable 
estimates to be made at this level.  
A multi-stage design was used to select households, with geographic localities selected 
as the primary sampling units (PSU) and batches of addresses then selected within 
each PSU (households were selected as described above). This method ensured that 
interviewers’ assignments could be covered more efficiently (without the first stage, 
addresses would have been scattered across regions often with very large distances 
between them). However, it introduced clustering to the sample whereby the 
participants could be more similar to each other in certain characteristics (for example, 
their socio-economic status) than would be the case if a simple random sample had 
been drawn. Clustering increases standard errors for estimates, but this can be taken 
account of in the analysis (Groves et al, 2009).  
One adult (16 years and over) per household was selected at random to take part, 
again using a Kish grid.  
2003 
The regional and deprivation stratification approach used in 1995 and 1998 was also 
used in 2003. However, to reduce the number of addresses at which interviews were 
conducted (and thus reduce costs), from 2003 onwards the selection of adults 
changed, so that all adults (up to a maximum of 10) in selected households were 
eligible to be interviewed. While this method introduces further clustering at the 
                                                 
9 A Kish grid is a randomly generated table of numbers. Interviewers list the elements to be sampled 
(households, adults or children) in a standardised format (e.g. adults in descending order of age, or in 
alphabetical order), and use the Kish grid to determine which of the listed elements should be selected. 
Kish grids minimise the potential for selection bias to be introduced. Quality control spot checks 
monitor the accuracy of their administration. 
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household level, it also enables the analysis of within-household health and behaviour 
patterns.  
2008-2011 
The sampling procedures introduced in 2003 remain in place to date, however the 
seven region stratification was replaced with a design that enables estimates to be made 
for each of Scotland’s 14 regional Health Boards, and the 15% most deprived areas. 
The deprivation-based stratification used the Scottish Index of Multiple Deprivation, 
which was launched in 2004 (ISD Scotland 2010c). The very small (and dispersed) 
populations in some of the Health Boards (e.g. ~23,000 in Shetland, ~27,000 in the 
Western Isles (ScotPHO 2015c)) would make it very expensive, and logistically 
challenging, to provide these estimates annually. Instead the sample was designed to be 
pooled across four years, with a target minimum achieved sample size in each board.  
As described above, the 1995-2003 sample used a clustered design, with batches of 
addresses grouped at the local level. The 2008-2011 sample was designed to provide 
geographically unclustered estimates using the pooled sample, though clustering was 
still present in the single years’ surveys (and household member clustering remained). 
The analysis of 2008-2011 data presented here has not, therefore, needed to take 
account of design effects due to geographic clustering. 
The pooled sample also enables analysis of subgroups that are typically small in the 
population; the majority of the analysis presented in this thesis uses the 2008-2011 
pooled sample and takes advantage of the large sample this provides.  
Data collection methods 
The data collection methods and record-linkage have been broadly similar in all 
surveys, in part due to the need to maintain comparable data for time series estimates. 
The majority of the data are collected via a face-to-face interview conducted in 
participants’ homes, using computer assisted personal interviewing (CAPI). From 2003 
onwards (when multiple household member sampling began) up to four people could 
be interviewed concurrently in one interview session. This has clear implications for 
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the health status and conditions questions, as participants could be reluctant to 
disclose diagnoses of some conditions in front of other household members.  
Some very sensitive topics, such as problem drinking, the General Health 
Questionnaire (GHQ 12) (Goldberg & Williams 1988) and, from 2008, the Warwick 
Edinburgh Mental Wellbeing Scale (WEMWBS) (Tennant et al. 2007) are included in 
a supplementary paper self-completion, administered during the interview. Young 
adults (aged 16-18 years, and in some cases, 18-19 years) answer questions about 
smoking and drinking via the self-completion, rather than face-to-face. 
Adults provided answers on their own behalf with no proxy interviewing permitted, 
for example in the case where someone did not have the capacity to consent to being 
interviewed, or if a selected participant was absent. This means that the survey under-
represents adults with mental incapacity, for example older people with dementia, 
which is a notable weakness of the methods used.  
Survey response 
Response rates for the surveys on which this analysis is based are shown in Table 3.1. 
Note that the change in sample design after 1998, described above, introduced 
additional levels of non-response and extended the population covered (age 75 and 
over), both of which reduced response rates, though also made them difficult to 
compare over time. 





Addresses sampled 15,332 32,830 
Total households in scope 11,836 29,580 
Households in which at least 1 
adult interviewed 
9047 (76%) 18,797 (63%) 
Households in which all 
eligible adults interviewed  
n/a 14,685 (50%) 
Total adult participants 9047 (76%) 28,785 (55%) 
Nurse sample   





Consent to link participants’ survey data with their NHS health records has been 
sought since the survey began. The 1995-2011 consent covers secondary care data 
(hospital episodes), cancer registrations and mortality (Gray et al. 2010); from 2012 
consent to link to primary care data has also been included (though such data are, at 
present, unavailable). The 1995 and 1998 surveys used verbal consent, from 2003 
signed consent was obtained. Rates of consent have been very high (92% in 1998). 
Table 3.2 shows that small, but statistically significant, differences in consent 
permission rates exist by age and area deprivation. However, while people with very 
bad self-assessed general health had the lowest consent rates, the difference was not 
significant (this group is very small). 
Table 3.2 Consent to NHS record linkage by age group, area deprivation and self-
assessed health, 1998 SHeS 
 Consent to linkagea 
Age (p<0.001)b % Sample size 
16-24 93 1385 
25-34 93 1894 
35-44 93 1817 
45-54 93 1578 
55-64 91 1268 
65-74 89 1053 
Area deprivation quintile (Carstair’s index) 
(p<0.001) 
  
1st most deprived 90 2445 
2nd 92 1967 
3rd  93 2083 
4th  92 2230 
5th least deprived 93 2405 
Self-assessed health (p=.147)   
Very good 92 4586 
Good 92 4353 
Fair 92 1670 
Bad 92 433 
Very bad 84 87 
aAll figures are unweighted. 
bp values are based on the chi-squared test for trend. 
The linked data are held by the Information Services Division (ISD) of NHS Scotland, 
who oversee applications for access to the data. A minimum dataset with general and 
mental health acute/in-patient day cases, cancer registrations and mortality records is 
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available for use with minimal restrictions. Other data items, such as maternity records 
or outpatient visits, require additional safeguards for their use. The analysis presented 
here uses the 1998 minimum linked dataset (the application for use is provided in 
Appendix C). 
Health condition questions and coding 
Long-term conditions - unprompted 
Question wording 
The question wording used in 2008-2011 to collect information on people’s long-term 
condition (LTC) status was as follows:  
Do you have a long-standing physical or mental condition or disability that has troubled 
you for at least 12 months, or that is likely to affect you for at least 12 months?  
 
[IF YES] 
What is the matter with you? {Free text entered by interviewers} 
 
Does [name of condition provided] limit your activities in any way? {Yes / No} 
 
It was intended to measure long-term conditions and disabilities, without any initial 
prompting about what conditions should be included, beyond the stipulation about 
their duration. Interviewers were tasked with recording the details of conditions 
mentioned, using probes where appropriate (as outlined in Figure 3.1). The same 
looped format and follow-up questions were used in 1998 and 2003, however the 
initial stem of the question differed: 
Do you have any long-standing illness, disability or infirmity? By long-standing I mean 
anything that has troubled you over a period of time, or that is likely to affect you over a 
period of time?  
 
The question wording was revised for the 2008-2011 survey due to concerns that the 
lack of a defined time period could lead to participants interpreting it inconsistently, 
and that mental health conditions were being under-reported. As a consequence, the 
estimates of long-term conditions based on these questions are not directly comparable 
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over time, but they are, however, sufficiently close to be deemed functionally 
equivalent for the purposes of the analysis presented here. 
At present, all published estimates of the prevalence (Given 2010) or impact (Lawson 
et al. 2013) of multiple conditions based on SHeS use the information collected at this 
question, and no other data. 
Before being asked the long-term conditions question, participants were asked to self-
assess their general health status, using a long-established measure common in health 
surveys: 
How is your health in general? Would you say it was ...very good, good, fair, bad, or very 
bad? 
 
While this question does not produce information about specific named conditions, it 
is a helpful benchmark of subjective health status and has been shown to be a good 
predictor of service use, morbidity and mortality, and is an important marker of health 
inequalities (Jylhä 2009; Au & Johnston 2014). It also likely to have helped frame 
people’s thinking when they responded to the question (and its associated follow-ups) 








The LTC question, as originally designed, was intended to measure the overall burden 
of long-term conditions in the population, and the relative contributions made by 
conditions related to specific body systems. It was not designed to be a measure of 
specific individual conditions or, therefore, multiples of them. The coding 
methodology therefore needs to be understood in terms of those original objectives.  
The free text data from the LTC question was processed by a centralised team of 
coders overseen by the NatCen Social Research Operations Department (see Figure 
3.2 for an overview of the process). A code frame with 40 categories was used (see 
Do you have a long-standing physical or mental condition 
or disability that has troubled you for at least 12 months, 
or that is likely to affect you for at least 12 months?
What is the matter 
with you?
Yes
Does (name of condition) limit 
your activities in any way?
(Can I check) do you have any 
other long-standing physical or 




PROBE FOR DETAIL. 
IF MORE THAN ONE 





FOR A MAX. OF 6 
CONDITIONS
END: MOVE TO 
NEXT SECTION




Appendix D for the coding instructions and the full codeframe). Some of the codes 
covered very specific conditions, such as diabetes (though no distinction was made 
between types 1 and 2), whereas others captured a very wide range of related 
conditions, such as neoplasms, lumps and cysts (malignant and benign). The 
codeframe was originally designed for use in the 1988 UK General Household Survey 
to enable the reporting of condition types based on a selection of 15 ICD chapters (see 
Table 3.3, ICD-9 was in use when it was developed, but the chapter structure is 
broadly similar for ICD-10, if not the numbering). The unprompted LTC question 
(and the specific CVD condition questions described below) were inherited from the 
1994 Health Survey for England (HSE), on which the first SHeS (in 1995) was largely 
based (Shaw et al. 2000b). In turn, the HSE long-term conditions question was taken 
from the UK-wide General Household Survey (GHS), conducted by the Office for 
National Statistics (ONS) since 1971 (White et al. 1993). Although the GHS 
interviewers recorded information about conditions in the same way as the HSE and 
SHeS, the data were not routinely coded (it was described as a “courtesy question” 
(White et al. 1993, p.212)). However, a long-term conditions codeframe was developed 
for the 1988 and 1989 GHS, as described above, and that methodology – largely 




Figure 3.2 Flowchart of long-term condition (LTC) coding process, SHeS 2008-2011 
 
ICD is designed primarily to capture information about causes, as opposed to 
symptoms, so certain accommodations had to be made to use it with this data. For 
example, some ICD chapters were omitted as they do not relate to long-term 
conditions (such as pregnancy, childbirth and the puerperium, ICD-10 chapter 15), or 
because they relate wholly to causes with no reference to body-systems (external causes 
of morbidity and mortality, ICD chapter 20). Similarly, congenital conditions were 
coded using the corresponding body-system chapter for the reported condition, rather 
than under a single code for all such conditions (as per ICD-10 chapter 17), because of 
Total number of participants aged 16+: 
n=28,785
No LTC to code: n=15,627
• No LTC reported: n=15,614
• Refused to answer: n=6
• Didn’t know: n=7




No valid code applied: n=112
• Complaint no longer present: n=9




• 1 code: n=13,064
• 2codes: n=6,228
• 3 codes: n=2,727
• 4 codes: n=1,084
• 5 codes: n=444
• 6 codes: n=163




the difficulty of establishing whether participants had their condition at birth or 
acquired it later (White et al. 1993). 
Table 3.3 Condition codes by ICD 10 chapter number (and sub-groups, where 
applicable), SHeS 2008-2011 
ICD 10 chapter number SHeS 
condition 
code 
1) Infectious disease  37 
2) Neoplasms and benign growths  1 
3) Blood & related organs  38 
4) Endocrine & metabolic 
 -Diabetes  




5) Mental disorders 
 -Mental illness/anxiety/depression/nerves  




6) Nervous system 
 -Epilepsy/fits/convulsions  
 -Migraine/headaches  





7) Eye complaints 
 -Cataract/poor eye sight/blindness  




8) Ear complaints 
 -Poor hearing/deafness 
 -Tinnitus/noises in the ear  
 -Meniere’s disease/ear complaints causing balance problems 






9) Heart, blood vessels & circulatory system 
 -Stroke/cerebral haemorrhage/cerebral thrombosis  
 -Heart attack/angina  
 -Hypertension/high blood pressure/blood pressure 
 -Other heart problems  
 -Piles/haemorrhoids 
 -Varicose veins/phlebitis in lower extremities 









10) Respiratory system 
 -Bronchitis/emphysema  
 -Asthma  
 -Hayfever 






11) Digestive system 
 -Stomach ulcer/ulcer/abdominal hernia/rupture  
 -Other digestive complaints (stomach, liver, pancreas, bile ducts, small intestine 
– duodenum, jejunum & ileum)  
 -Complaints of bowel/colon (large intestine, caecum, bowel, colon, rectum) 











Table 3:3 Condition codes by ICD 10 chapter number (and sub-groups, where 
applicable), SHeS 2008-2011 (continued) 
13) Musculoskeletal system 
 -Arthritis/rheumatism/fibrositis 
 -Back problems/slipped disc/spine/neck 





14) Genito-urinary system 
 -Kidney complaints  
 -Urinary tract infection 





18) Other complaints  40 
 
As can be seen, some conditions were assigned chapter-level codes (e.g. infectious 
disease, skin complaints), with no further distinctions made between the conditions 
reported (e.g. eczema, chronic acne). In the majority of cases, however, conditions were 
assigned sub-chapter level codes.  
Coders could allocate a maximum of six separate codes for LTCs (in accordance with 
the original questionnaire design that enabled interviewers to record six LTCs). If an 
interviewer had entered two conditions in one data entry field (rather than in two 
separate ones, as instructed), the editor could correct this and assign two codes, 
providing the maximum of six was not exceeded. Many of the codes cover a number of 
different conditions, so people could end up with the same code applied more than 
once. Code 4, “mental illness/ anxiety/ depression/ nerves”, was one of the most 
common to be applied more than once (e.g. someone reporting depression and 
alcoholism, or depression and anxiety, could receive two code 4s). The consequences 
of this aggregation are discussed further in Chapter 5. 
The data were then subject to two stages of aggregation when they were processed. The 
first combined the multiply coded conditions (such as depression and anxiety) so they 
were only counted as one condition. The second stage mapped the 40 condition codes 
onto their 15 corresponding ICD chapter headings. During this process, codes such as 
arthritis (34), back problems (35) and other muscle / joint conditions (36) were 
combined to form the group representing “Musculoskeletal system conditions”. This 
aggregation was carried out on the grounds that the conditions with the same codes, or 
within the same chapters, were very similar and, consequently, no guarantee could be 
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made that the information provided by participants and recorded by interviewers, was 
sufficiently detailed to enable them to be considered wholly accurate measures of 
distinct conditions. For example, given the nature of the way the data were collected, 
coding discrepancies could quite commonly occur within some chapters, such as 
within the musculoskeletal chapter, with arthritis in the neck coded 35 (back 
problems/ slipped disc/ spine/ neck) rather than 34 (arthritis), depending on how 
participants reported their condition and/or interviewers recorded it. In contrast, 
errors across chapters (e.g. arthritis being coded as a mental health condition) should 
be much less common, due to the training and supervision coders undergo, and the 
quality assurance checks employed. The designers of this process therefore decided 
that reporting at the level of ICD chapters, rather than individual reported conditions, 
would minimise the impact of these kinds of errors on prevalence estimates (White et 
al. 1993). 
The summary measure of the number of long-term conditions reported that is 
provided in the SHeS dataset (and other surveys that use this coding method, such as 
the HSE or GHS) is based on these grouped, chapter-level codes, rather than the 
underlying conditions people reported. Its adequacy as a measure of multiple 
conditions – as opposed to a measure of individual condition types – is therefore 
potentially impaired by these two stages of aggregation.  
Quality of the information collected 
The conditions reported could not be verified externally, for example by cross-checking 
primary care data. This, of course, raises questions about their accuracy, due to people 
under-reporting conditions (for various reasons), or mentioning symptoms that had 
never been formally diagnosed as a specific condition (see the discussion of potential 
resulting biases, and steps taken to minimise them, below). However, the anonymised 
free-text answers to the LTC question were made available to me for this analysis so 
the recorded information and coding applied could be assessed. Reviewing these 
answers revealed quite a high degree of variability in the extent of interviewers’ 
probing, as reflected in the depth of information provided. For example, some 
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interviewers probed10 to find out if a participant was taking medication for their 
condition, or the time since diagnosis, while others simply noted the names of the 
reported conditions (with a variety of interesting spellings), often in very broad terms, 
e.g. “mental health condition”. However, while variable, the quality of the information 
collected appears to have been sufficient for its intended purpose – just 112 LTC 
(<1%) answers were judged unclassifiable. This is perhaps unsurprising, given the 
breadth of some of the categories within the codeframe, which means that a very 
general description such as “mental health condition” provides sufficient information 
to enable the correct code to be assigned (a specific named condition, such as 
“schizophrenia”, is not necessary). This is arguably a clear example of the data being as 
good as it needed to be; the challenge comes when trying to put them to uses they were 
not originally intended to have – i.e. the identification of discrete conditions in order 
to estimate the extent of multiple conditions. 
Specific named conditions 
Question wording 
Ever since it began, the survey has also included a series of detailed questions about 
specific named cardiovascular system conditions (angina, heart attack, heart murmur, 
abnormal heart rhythm, other heart problems), stroke, hypertension and diabetes 
(from here on in described as the “CVD questions”, though stroke and diabetes are, of 
course, cerebrovascular and endocrine system conditions, respectively). If any of these 
conditions were reported, participants were asked whether a doctor (or nurse, in the 
case of hypertension) had diagnosed it. For CVD or stroke events/onset, participants 
were asked if these occurred within the previous 12 months or longer ago. Questions 
were also asked to identify gestational-only cases of diabetes and hypertension, while 
further questions established if these conditions were currently being treated (and 
how) (see example of hypertension in Figure 3.3 below).  
 
                                                 
10 Some interviewers, generally those with more years’ experience or advanced training, mark their text 
with // to indicate that they had probed further, and /- to signal the point at which that no further 
information was forthcoming from the participant. 
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Figure 3.3 Flowchart of questions intended to measure current hypertension 
prevalence, SHeS 1998, 2008-2011 
 
Other health problems 
Question wording and coding 
SHeS includes an additional question at the end of the section on cardiovascular 
conditions which asks:  
Can I check, do you have any other health problems that I have not asked you about? 
 
(If yes) 
Do you now have, or have you ever had high 
blood pressure (sometimes called hypertension)? 
You mentioned that you have had high 
blood pressure. Were you told by a doctor 
or nurse that you had high blood pressure?
Yes
Can I just check, were you 
pregnant when you were told 




END: MOVE TO 
NEXT SECTION
IF FEMALE:
Have you ever had high blood 
pressure apart from when you 
were pregnant?
Yes No
Are you currently taking medicines, 
tablets or pills for high blood pressure?
Yes* No





END: MOVE TO 
NEXT SECTION
END: MOVE TO 
NEXT SECTION
END: MOVE TO 
NEXT SECTION
*Meets definition of current HBP
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What are these health problems? 
 
The original justification for its inclusion in 1995 is unclear, the data do not appear to 
have ever been used, and neither the HSE nor GHS ask this. Interviewers recorded the 
details of any other health problems participants mentioned, but unlike the long-term 
conditions question, no further details about their impact on daily life were collected. 
The answers were coded in the same way as those given for the LTC question, using 
the same code-frame (see Figure 3.4 for details, and codeframe in Appendix D). These 
data were something of a mystery: a binary variable recording the presence of other 
health conditions is included in the public SHeS dataset every year, but the coding 
applied to the reported conditions is not, and, in common with the long-term 
conditions questions, the free-text information recorded by interviewers is not publicly 
available, because of its potentially disclosive nature. Therefore, the nature of the 
issues reported at this question, and whether they should be included in the multiple 
conditions measure, was unclear. They could be transient, short-term issues (e.g. a bout 
of the ‘flu); intermittent conditions but recurring, such as migraine or hay-fever; or 
perhaps conditions that participants had forgotten to mention, or had been reluctant 
to mention, earlier on in the interview when asked about long-term conditions. To 
help answer these questions, access to the free text data was granted alongside the 
information provided about long-term conditions.  
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Figure 3.4 Flowchart of other health problem (OHP) coding process, SHeS 2008-2011 
  
 
Biomarkers of underlying conditions 
Height and weight 
Interviewers measured height and weight following standardised protocols (see 
Appendix B of: Rutherford et al. 2012). Height was measured in centimetres (to the 
nearest even millimetre) using portable stadiometers. Weight was measured using 
electronic scales in kilograms (to the nearest 100g). Participants who weighed over 
130kg, those who couldn’t stand, pregnant women and those who did not wish to be 
measured, were excluded. Interviewers were asked to record if problems occurred 
during measurements and, if so, these data were excluded from the analysis. Scales 
Total number of participants aged 16+: 
n=28,785
No OHP to code: n=24,270
• No OHP reported: n=24,250
• Refused to answer: n=5
• Didn’t know: n=15




No valid code applied: n=282
• Complaint no longer present: n=19




• 1 code: n=4,222
• 2codes: n=367
• 3 codes: n=62




were calibrated on a regular basis throughout fieldwork, and measurement protocol 
adherence was monitored during fieldwork supervisions.  
The height and weight data were used to estimate participants’ body mass index (BMI) 
– height in cm / weight in kg2. The thresholds used to classify BMI were: underweight 
(<18.5 kg/m2); healthy weight (18.5-<25 kg/m2); overweight (>25-<30 kg/m2); obese 
(>30 kg/m2). 
Blood pressure 
Nurses measured blood pressure during a separate, follow-up interview, using Omron 
HEM207 devices. Three readings were taken at one minute intervals, following a five 
minute rest period. Pregnant women were excluded from the measurements. The 
analyses presented in this thesis are based on the average of the final two 
measurements (if all three were obtained). Readings from people who had eaten, 
drunk, exercised or smoked a cigarette in the 30 minutes prior to the readings were 
excluded.  
Blood samples 
Non-fasting blood samples were collected by nurses via venepuncture. People were 
excluded from providing a blood sample if they were pregnant, taking anti-coagulant 
drugs, or had a history of fitting. Samples were dispatched to the survey laboratory for 
analysis at the Royal Victoria Infirmary, Newcastle. The analyses presented in this 
thesis use the results of the glycated haemoglobin (HbA1C) and total cholesterol 
analytes. People who were known to be taking lipid-lowering drugs (e.g. statins) that 
reduce cholesterol were excluded from the analysis. The quality control procedures for 
the analytes are described in Roth et al. (2012).  
Prescription medication data 
Nurses collected the names of all prescribed medications participants reported taking 
(recording details directly from containers where available) and asked whether they 
had been taken within the previous 7 days. Nurses also applied British National 
Formulary (BNF) coding to the information collected (British National Formulary 
2009). Additional questions were asked about any drugs with BNF codes beginning 02 
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(cardiovascular system drugs) to establish if they were being taken to treat high blood 
pressure, heart problems or for other reasons. The prescription data and blood 
pressure readings were used in combination to establish the prevalence of untreated 
hypertension in the population. 
Psychological distress measures 
The General Health Questionnaire 12 (GHQ12) 
The 12-item GHQ has been included in every SHeS since it began. It was designed to 
measure symptoms of psychological distress in the form of deviations from usual 
functioning in the previous few weeks (the full questionnaire is in Appendix E). The 
areas covered include concentration; sleep; feelings of: usefulness, capability, strain, 
unhappiness, depression, worthlessness; the ability to overcome strain and overcome 
problems; enjoyment of normal activities; and self-confidence. Responses use a four 
point scale to which points are assigned. Scores range from 0 to 12, with a threshold of 
4 or more commonly used in population research to identify someone with a potential 
psychiatric condition (Goldberg & Williams 1988). The use of such measures in 
surveys is discussed in more detail in Chapter 4. As noted above, the GHQ12 was 
presented to participants as a paper self-completion during the main interview, due to 
the sensitive nature of its questions. 
The Revised Clinical Interview Schedule (CIS-R) 
A subset of items from the CIS-R was included in the 2008-2011 nurse interview 
(Lewis et al. 1992). Their fairly complex routing made them unsuitable for a paper 
questionnaire. It was decided that nurses were better placed to administer the 
questions as these interviews were conducted without other household members 
present (where possible) and nurses were judged to be better placed to handle any 
difficulties arising from their content. The questions covered symptoms of depression 
and anxiety, suicide attempts and self-harm. The full question text is contained in 
Appendix E. 
Survey limitations and biases 
A significant literature exists on the limitations and resulting biases associated with 
population surveys, some of which is referenced below. Rather than review the survey 
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method in its entirety, some key points have been selected that relate directly to the 
primary focus of the analysis presented – the measurement of multiple conditions and 
related experiences.  
A critical distinction can be made between the information this – and any – survey 
intends to collect and what, in reality, it succeeds in collecting. The main, but by no 
means only, causes of the gap between these two factors are error and bias. No survey 
avoids these; the key challenge is to minimise their impact and thus constrain the size 
of the gap between the survey’s intended and actual outcomes.  
There are at least two types of limitations and resultant biases that are useful for this 
discussion: firstly, those inherent to all surveys, and secondly, those specific to the data 
collected on health conditions – though the two often overlap or are interrelated. For 
example, excluding adults with mental incapacities is a problem inherent to all 
population surveys that rely on participants providing their own responses, rather than 
being “spoken for”. This limitation has particular resonance for health surveys as it 
effectively introduces a health-related exclusion bias, leading to an underestimation of 
a population’s illness burden. Similarly, participants’ reluctance to disclose sensitive 
information is a feature of any survey covering sensitive topics, however the fact that 
some conditions fall into this category will also lead to an underestimation of poor 
health in a population.  
The potential source of bias that tends to be most associated with surveys, and often 
provokes most concern, is non-participation. For example, Rothman, Greenland and 
Lash (2008) describe the maintenance of high response rates as “the single largest obstacle 
to high-quality epidemiologic research” (p.497). Survey response rates are generally 
declining in most countries, and health surveys, including SHeS (see Table 3.1), have 
not been immune to this trend (Aromaa et al. 2003; Galea & Tracy 2007; Rothman et 
al. 2008; Meyer et al. 2015). However, the relationship between response rates and 
bias is not completely straightforward: rates can decline without increasing bias, while 
it is also possible for increased response rates to produce more biased estimates if the 
additionally recruited participants are atypical (Groves 2006; Groves & Peytcheva 
2008; Davern 2013). Gorman et al. (2014) analysed the impact of non-response on 
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estimates of alcohol-related deaths and hospitalisations using the 1995-2010 SHeS. 
They found that rates of these outcomes were higher in the general population than 
among survey participants, confirming other studies that have showed non-participants 
to have worse health behaviours and poorer outcomes. However, they also found no 
evidence that the extent of the bias has increased over time, despite lower response 
rates (and declining record-linkage consent) in recent years. Similarly, Meyer et al.’s 
(2015) analysis of declining response in household surveys in the US concluded that 
non-participation, as a source of bias, actually contributes far less to errors in overall 
estimates than participants’ failure to answer items within surveys, or to answer them 
accurately, does (largely due to the corrective properties of unit nonresponse 
weighting). 
Response rates are just one potential source of bias in surveys. The Total Survey Error 
(TSE) framework (Biemer 2011) provides a comprehensive way of assessing a survey’s 
performance, encompassing multiple sources of errors related to: the study’s initial 
specification, measurements, frame (i.e. the sample frame coverage), nonresponse and 
data processing. The sources of such errors can be traced to the performance of the 
interviewers, participants and – in some cases – the coders who work with the data 
after they have been collected. Often (but certainly not always) such problems can be 
prevented, minimised or at least corrected for, post-hoc. The complete elimination of 
error is, however, a Sisyphean task, and Biemer (2011, p.821) instead suggests surveys 
should strive: “…to avoid the most egregious errors and control other errors to the extent that 
remaining errors are mostly inconsequential and tolerable.”  
Some examples of error sources that relate specifically to this analysis, and the TSE 
domain they occupy, are presented in Table 3.4 (frame error has already been 
mentioned above, in relation to the exclusion of adults without capacity to consent). 
Looking at the measurement of multiple conditions through the TSE lens suggests a 
number of ways in which the survey’s current measures might not paint a wholly 
comprehensive picture, and which warrant further investigation. These themes are 
therefore revisited in Chapter 5, which assesses the survey’s health questions and their 
suitability for inclusion in the multiple conditions measure. 
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Groves and Lyberg (2011) extend the TSE framework to include the issue of relevance 
and usefulness, pointing out that a statistic can be accurate but irrelevant, with 
relevance defined according to whether users’ needs have been met by the measure in 
question. This issue lies at the heart of much of the analysis presented in this thesis. It 
is not sufficient to improve the accuracy of a multiple conditions measure, the 
question of its usefulness should also be addressed. 
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Table 3.4 Assessment of selected limitations and biases within the Scottish Health Survey, and proposed remedial strategies, using a Total 
Survey Error (TSE) approach 
TSE domain and potential limitation  Potential bias Steps to reduce bias routinely taken 
as part of the survey’s conduct 
Additional strategies that could be 
taken (text in bold indicates the 
steps explored in this thesis) 
Response error: 
Some participants refuse to be 
interviewed  
Depends – if participating and non-
participating people have identical 
characteristics (age, sex, health 
status, SES) then no bias should arise. 
 
If response differs across groups, and 
is related to key survey measures 
(such as health) then estimates will 
be inaccurate. For example, response 
declines as deprivation increases 
(though is also low among the most 
affluent areas), and health is known 
to decline as deprivation increases. 
1998: non-response weighting at 
household level to adjust the profile 
of participants to better resemble the 
target population; additional sample 
issued in the final quarter of 
fieldwork (Shaw et al. 2000a). 
 
2008-2011: non-response weighting 
at household and individual level; 
participant incentives (£5 shopping 
voucher per participating household); 
additional sample issued in 2009-
2011 to address lower than expected 






TSE domain and potential limitation  Potential bias Steps to reduce bias routinely taken 
as part of the survey’s conduct 
Additional strategies that could be 
taken (text in bold indicates the 
steps explored in this thesis) 
Response error: 
Interview is more burdensome for 
people with health conditions than 
those without (more questions to 
answer, more risk factors to report). 
Non-response might be higher 
among people with very poor health 
(e.g. terminal conditions, those 
requiring frequent episodes of in-
patient stays), leading to biased 
estimates (see above). If they do 
participate, responses might be 
partial or less detailed, interviews 
might be incomplete, or consent to 
participate in further stages might be 
lower, due to fatigue during the 
initial interview. 
Fieldwork periods of at least a 
month, followed by a reissue stage to 
re-contact people not interviewed 
initially, increase the chance of 
people experiencing poor health 
participating (if they recover 
sufficiently in the extended period). 
Interviewers were encouraged to 
offer split visits if necessary, so that 
interviews did not have to be 
completed in one sitting. 
Tailor questions so that some topics 
are missed by people with lots of 
health conditions to report. Or give 
people the option to miss topics. 
Specification / Measurement error: 
Participants’ might not report 
conditions that the survey question 
was intended to measure (e.g. 
hypertension is not universally 
reported as a long-term condition), 
due to misunderstanding of the 
requirement, or mismatch in 
participants’ and survey designers’ 
beliefs about conditions. 
Prevalence of conditions will be 
under-estimated. 
Cognitive testing was used to help 
inform changes to the long-term 
conditions question in 2008. This 
process reveals insights about 
participants’ understanding of 
questions that traditional piloting 
methods do not (Collins 2015).  
Complicated or ambiguous medical 
terms are avoided where possible, or 
‘lay person’ terms are used as well.  
Augment estimates with other data 
from within the survey (e.g. 
questions on specific conditions, 
other health problems, or 
prescription data from nurse 
interview). 
 
Linked data can be used to identify 
historic hospital admissions 
associated with some specific 
conditions, but data on ongoing 




TSE domain and potential limitation  Potential bias Steps to reduce bias routinely taken 
as part of the survey’s conduct 
Additional strategies that could be 
taken (text in bold indicates the 
steps explored in this thesis) 
Measurement error:  
Potentially sensitive conditions are 
not disclosed (e.g. HIV, drug 
dependency, mental health 
conditions) 
Prevalence of conditions will be 
under-estimated. 
Data protection and confidentiality 
assurances were provided to 
participants in writing. 
Participants were told (broadly) what 
the survey topics would be (so could 
opt for a single rather than 
concurrent interview if they wished).  
 
Very sensitive data was collected in a 
self-completion. 
Augment estimates with other data 
from within the survey (e.g. 




Some participants will not know that 
they have a diagnosed condition (e.g. 
if a GP has withheld information, or if 
they have forgotten or not 
understood their diagnosis). 
Prevalence of conditions will be 
under-estimated. 
None. Some potential to use reported 
prescription medications to identify 
treated, but unknown conditions, 
though scope is limited by the multi-




TSE domain and potential limitation  Potential bias Steps to reduce bias routinely taken 
as part of the survey’s conduct 
Additional strategies that could be 
taken (text in bold indicates the 
steps explored in this thesis) 
Measurement error: 
Some participants might self-
diagnose conditions, or report minor 
conditions as more serious. 
Prevalence of conditions will be over-
estimated. 
Long-term conditions were defined 
for participants, other health 
problems were open for participants 
to interpret. 
 
Doctor-diagnoses were probed for 
some conditions (e.g. CVD, 
hypertension, diabetes, COPD, 
asthma). 
 
Limited treatment data collected on 
hypertension, pregnancy-related 
diabetes and hypertension can be 
identified, impact on daily activities 
recorded for all long-term conditions 
mentioned. 
Ask additional questions about 
circumstances, treatment and 
burden of conditions. 
 
Measurement error: 
Interviewers record multiple 
conditions as single entities. 
Prevalence of multiple conditions 
could be underestimated. 
Information about severity will be 
missed. 
Instructions and training make clear 
that each reported condition should 
be recorded separately (to ensure 
the correct follow-up questions are 
asked).  
 
Coders can assign multiple codes and 
correct the data entry post-hoc. 
CAPI could include in-built checks to 
remind interviewers to record 
information on each reported 
condition separately (e.g. a check 
could be triggered if the text entered 




TSE domain and potential limitation  Potential bias Steps to reduce bias routinely taken 
as part of the survey’s conduct 
Additional strategies that could be 
taken (text in bold indicates the 
steps explored in this thesis) 
Data processing error: 
Coders miscoding conditions / 
assigning single codes to multiple 
conditions. 
Bias could be minimal if random and 
non-systematic coding errors occur 
(e.g. transposition of digits), but more 
systematic errors relating to a 
misunderstanding of a specific 
condition would bias the estimate of 
its prevalence. 
Coders receive generic training and a 
tailored briefing for the project. 
 
Random checks of coders’ work are 
performed by supervisors. 
 
The computer has in-built checks to 
prevent entry of invalid codes. 
 
All cases where coders are uncertain 
are referred to the research team for 
guidance.  
 
Codes for similar conditions (e.g. 
musculoskeletal conditions) are 
grouped together and reported in 
aggregate, so that inconsistencies in 
assigning codes between very similar 
conditions are minimised (though see 
Chapter 5).  
Specific guidance could be provided 
for handling coding of multiple 








Despite the limitations and biases inherent in these (and all) survey data, there are also 
many notable strengths. They can be traced to two specific attributes: firstly, the kind 
of information that was collected in the survey, and secondly, the methodological 
rigour with which the data was collected and processed.  
In terms of measuring multiple conditions, while this source lacks external validation 
(i.e. medically confirmed diagnoses), it captures people’s own perceptions of their 
health condition burden, which can, for various reasons, differ from that contained in 
their medical records. SHeS is a particularly useful source in this respect as it contains 
a number of different measures of health conditions, rather than the just one or two 
questions which are typically asked in multi-topic population surveys with only limited 
information about health. However, the chief advantage of population health survey 
data is the breadth of information collected about other aspects of people’s lives and 
experiences, which few administrative sources will ever have the capacity to record.  
The survey methods described above, and the quality assurance steps discussed next, 
can all be said to be at the higher quality end of the population survey spectrum. For 
example, it uses a random probability sample, rather than a convenience or self-
selected sample, which means estimates can be extrapolated to the wider population 
with known levels of precision (Groves et al. 2009, p.102). Face-to-face interview 
surveys generally gain higher response rates than postal, telephone or internet surveys, 
largely due to the efforts made by interviewers to contact selected sample members 
(Groves et al. 2009, p.150, p.153). As discussed above, this is not in itself a guarantee 
of less biased estimates, but direct contact methods are typically better at reaching 
population sub-groups who need additional encouragement to participate. Using 
specially trained interviewers and nurses, and standardised protocols, helps to 
minimise measurement error, while CAPI reduces data entry errors and allows for real-
time checking of answers that interviewers have potentially mis-recorded (Groves et al. 
2009, p154, p.168). The large sample enables detailed analyses to be conducted of low 
prevalence phenomena, or of small population sub-groups of interest. 
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Quality assurance processes 
The quality assurance steps taken during the data collection and processing stages are 
documented in the technical reports for each year’s survey, as referenced above, and in 
a data quality document (ScotCen Social Research 2009). Briefly, a high level of 
training and on-going supervision is provided to interviewers and nurses, selected 
participants are contacted afterwards to check that interviews were conducted in the 
proper manner, the CAPI has many in-built checks that either prevent inaccurate data 
entry or query potentially implausible answers, self-completion data-entry uses strict 
accuracy checks, coders are trained and their work is checked, and data reconciliation 
checks take place as the data is moved from the data preparation team to the data 
analysis team.  
The data management conducted for this thesis was conducted in SPSS version 19 
(IBM n.d.) and all stages were documented using syntax. This enabled periodic reviews 
of the syntax to be conducted to identify any errors. Syntax also ensures that the steps 
taken (both in the data management and the analysis) can replicated by third parties. 
Once the foundations of the definitional work were complete, the syntax to create the 
variables was run on a new version of the dataset so that any problems with replicating 
the variables could be investigated.  
The various stages of the multiple conditions definition work resulted in the creation 
of well over 100 new derived variables, many of which were used to create the final 
measures reported in Chapter 5 (the syntax for which is provided in Appendix F). 
Errors at any point in this process would therefore have serious consequences so a 
multi-stage approach was used to quality assure each individual variable created for the 
analysis. Where possible, the syntax was adapted from existing code rather than 
written from scratch (this reduces some transcription errors). It was also read closely to 
identify inconsistencies. In most instances, errors in syntax will be flagged by SPSS and 
commands will not run. However, plenty of errors can still result in executable 
commands so further checks were run to ensure that cases had been correctly assigned. 
This often required numerous stages of checking, for example by running cross-
tabulations with variables that were used in the derivation, or by identifying specific 
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sub-groups and listing their values to ensure they had been assigned to the correct 
categories. For example, if a variable category was intended to only include people with 
a specific characteristic (e.g. BMI greater than or equal to 30), a check was run to 
confirm that everyone with BMI >30 had been assigned to that category (and only that 
one), and that no-one with a BMI below 30 had been mis-assigned to it. This process 
became critical as the definition of multiple conditions became more complex.  
The substantive analyses of outcomes and experiences were conducted using SPSS 19 
(IBM n.d.). The SPSS analyses were similarly documented using syntax files.  
Data access and ethical issues 
As already noted, access to the 1998 linked data was granted by ISD Scotland, 
following assurances about the intended use and storage of the data, and the datafile 
used in the analysis was supplied via a secure server. Two versions of the combined 
2008-2011 dataset were used. One was directly obtained from the survey contractors, 
ScotCen Social Research (see below), and supplied via a secure server. The other 
version was supplied by the UK Data Archive (who also supplied the 2012 and 2013 
datasets11) (ScotCen Social Research et al. 2013; ScotCen Social Research et al. 2014; 
ScotCen Social Research 2014). To help inform the multiple conditions definition 
process, permission to access the free-text conditions data collected in the 2008-2011 
surveys (but removed prior to Archiving) was sought from the Data Controllers, the 
Scottish Government. This is removed because reports of very rare conditions could, 
in combination with other items in the survey, potentially identify participants. Once 
approved, ScotCen Social Research supplied the data directly in a non-disclosive 
format – a new serial number was created that could not be linked to the main survey 
datasets, age was provided in 10 year bands rather than individual years, no geographic 
identifiers were included, and only the data items required for the task were provided 
(application for the special dataset is provided in Appendix C).  
Ethical approval for the conduct of each of the surveys was obtained from NHS 
research ethics committees (REC) prior to their conduct (1998: from the RECs for all 
                                                 
11 Two tables in Appendix J use data from the 2012-13 surveys. 
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Health Boards in Scotland; 2008 and 2009-2011: the REC for Wales, study reference 
numbers: 07/MRE09/55 and 08/MRE09/62, respectively).  
The analysis in this thesis met the University of Edinburgh Centre for Population 
Health Sciences Research Ethics Subgroup’s criteria for level 1 self-audit (absence of 
reasonably foreseeable ethical risks). See checklist in Appendix B. 
Methodology  
The discussion in this chapter has so far been concerned with methods, chiefly the 
data source used and its associated data-collection instruments. The question of the 
methodology adopted for this work – its ontological and epistemological foundations - 
has, however, been absent.  
The research aims and questions set out at the beginning explicitly locate this work 
within epidemiology (a wholly quantitative discipline), while its concern with the social 
patterning of the prevalence of multiple conditions places it within its sub-discipline 
social epidemiology. Social epidemiology’s philosophical underpinning and methods 
of inquiry are typically associated with the positivist tradition (Dunn 2012). Much of 
the existing literature on multiple conditions has little, if any, discussion of its 
philosophical underpinnings, or how disease/illness is conceptualised. However, the 
very clinically orientated field in which it has emerged most prominently as a concept 
(health service delivery settings and epidemiology), and the predominant use of 
quantitative tools to investigate it, also point to this being a field mainly associated 
with, or at least very heavily influenced by, positivism.  
The ontological underpinning (i.e. the conceptualisation of reality) aligned with 
positivism follows precepts much like these outlined by Law (2004, pp.24–5, emphasis 
in the original): 
Out-thereness: there is a reality that is out there beyond ourselves; 
Independence: reality is usually independent of our actions and especially of our 
perceptions; 
Anteriority: reality comes before us … it precedes us; 
Definiteness: reality has, or is composed of, a set of definite forms or relations; 
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Singularity: the world is shared, common, the same everywhere. 
Positivist ontology is accompanied by an epistemological position which “asserts that the 
only authentic knowledge is that which is based on sense, experience and positive verification” 
(Dunn 2012, p.26). Theorising about phenomena in the absence of empirical evidence 
does not, from this perspective, generate or constitute valid knowledge.  
As Chapter 4 expands in far more detail, this thesis has sought to challenge some of 
these precepts, in particular, for example, around the definiteness and singularity of 
medical classification and illness experiences. It has done this by drawing on 
theoretical perspectives from medical sociology, whose ontological and epistemological 
foundations tend to contrast quite starkly with those from the positivist-empiricist 
tradition. Therefore, in adopting this approach, I have sought to inform a typically 
positivist empirical exercise – the quantification of a social phenomenon – with 
strands of thought that use non-empirical, conceptually grounded approaches, as well 
as those informed by empirical but not quantitative data (e.g. interviews, ethnography). 
A desire to place the empirical analysis within a conceptual framework, and to 
critically engage with that conceptualisation, has been paramount throughout. As 
Porpora (2015, p.21) suggests “[w]e may successfully collect gobs of data, but if our concepts 
are awry, our data may be meaningless”. The following discussion outlines the 
foundations of this approach, while Chapter 4 contains a much more detailed 
discussion of its rationale and of the theoretical perspectives that have been 
influential. 
Rubinstein et al. (2000) present two contrasting characterisations of the status and 
function of sociomedical categories which provide a helpful framework for situating 
this work. Firstly, and in alignment with the positivist principles outlined above, they 
suggest these categories can be thought of as providing:  
the basis for the objective classification of human health behavioral activity and 
experience, thus allowing us to tell what functioning falls outside of the range of 
normal activity. (Rubinstein et al. 2000, p.41). 
And that they operate as “natural categories whose boundaries exist, only needing to be 
discovered” (Rubinstein et al. 2000, p.41).  
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In contrast, an alternative approach would view sociomedical categories as “culturally 
and socially grounded characterizations of human health behavioral activity and experience as 
healthy or unhealthy, normal or not” which are “always the result of consensual agreement and 
thus are to some degree socially constructed” (Rubinstein et al. 2000, p.41). Both 
approaches allow the possibility that all phenomena under investigation require some 
form of classification in order for them to be understood. However, they argue that 
whichever of these interpretations is followed determines the processes through which 
such identification takes place. For example, they suggest that the former position 
results in:  
a world view the hallmarks of which are reliance on technology for ‘objective’ 
problem assessment, an emphasis on the role of expert knowledge, and a limited 
acceptance of the authenticity of people's reports of their experience. 
(Rubinstein et al. 2000, p.42). 
Whereas the latter, more socially constructivist, position permits: 
a world view that sees technology as socially situated, expert knowledge as partial 
and tentative, and people's reports of their experience as authentic and 
important for problem construction. (Rubinstein et al. 2000, p.42). 
While they argue against seeing these as diametrically opposed processes, for example 
lay and expert knowledge are suggested to be complementary rather than conflicting 
sources of information, they conclude that: 
categories are reifications of processes and do not exist independently of the 
purposes for which they are developed. Sociomedical categories must always be 
treated as tentative and provisional. (Rubinstein et al. 2000, p.45). 
The latter of these two positions has been influential in the approach followed in this 
thesis – on at least two levels – with the above caution about reification providing a 
particularly useful heuristic. Firstly, the identification of people with multiple 
conditions initially requires individual single conditions to be classified. The data 
source used contains both technical / objective knowledge (biomarkers, mortality 
records), expert knowledge (the doctor-diagnosed conditions, albeit reported through 
the filter of participants’ accounts) and people’s reports of their health problems and 
subjective assessments of general health status. An attempt has been made to strike an 
appropriate balance between these accounts to avoid privileging one set over another. 
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Moreover, the ontological status of disease and illness that has guided the work rejects 
the traditional biomedical positivist approach to these concepts and has, instead, 
attempted to be open to other perspectives. Nijhus and Van Der Massen (1994) 
characterise the ontological underpinning of modern medicine (drawing from the 
traditions of the natural sciences), with its mechanistic orientation, viewing humans as: 
“a biophysiological and neurophysiological system … composed of an unlimited number of 
subsystems” (p.2), and defining disease, consequently, as: “disturbances in one or more 
subsystems, resulting in somatic, psychological, or social dysfunctions” (p.2).  
In stark contrast to the traditional biomedical model, Mol’s (2002) extensive account 
of the nature of ontology in the medical field used an ethnographic study of 
atherosclerosis (a condition that results in the hardening of the arteries and, 
consequently, restricted blood flow in the legs), based in a Dutch hospital. Her 
discussion of the experience of the anthropologist Pool, undertaking research in 
Cameroon about the nutritional deficiency disease kwashikor, and his initial surprise 
at finding that people’s accounts of this condition did not coincide with his Western 
construct of it as a fixed entity, provides a clear illustration of the problem that arises 
from viewing disease in this way. As she notes:  
Why would laypeople, let alone in Cameroon, delineate entities in their own 
talk that nicely parallel the categories of Western medicine? To presume this is 
to presume that the disease categories of Western medicine are “natural”. That 
they reflect a reality out there for everyone to stumble over before interpreting it 
in diverse ways. (Mol 2002, pp.23–4). 
Contra to such an approach, she argues that rather than being a singular entity, 
atherosclerosis too has multiple forms, suggesting that the atherosclerosis identified via 
pathological analysis differs to that revealed by sonogram investigation, or surgical 
intervention, or that reported by patients in the form of symptoms. Most critically, 
however, she argues that:  
there are different atheroscleroses in the hospital but despite the differences 
between them they are connected. Atherosclerosis enacted is more than one – 
but less than many. The body multiple is not fragmented. Even if it is multiple, it 
hangs together. (Mol 2002, p.55, emphasis in the original). 
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And while this kind of fragmented, non-singular, non-linear conceptualisation might 
feel alien at the more clinical end of medical practice, Law (2004) argues that:  
contradictions are important in the day-to-day practice of medicine. For though 
medical professionals usually work with a strong, perspectival version of out-
thereness, this is only a means to the more important end of intervening and 
helping the patient. Their major preoccupation is in working out what to do. ... 
medical professionals often have to work with multiple possible truths”. (Law 
2004, p.52, emphasis in the original).  
Following from this, if disease is understood as something with multiple 
manifestations, whose discovery will be mediated by this complexity, then some of the 
social, cultural and historical processes that have contributed to the ways in which 
disease and illness have come to be understood and experienced also need to be 
considered, and their implications for this work illuminated. Chapter 4 does this, 
while Chapter 5 presents the results of bringing together these different theoretical 
perspectives for the purposes of identifying people with multiple conditions.  
Secondly, and perhaps more fundamentally, ultimately, the analysis presented in 
Chapter 6 (of people’s lived experiences) is an attempt to extend these lines of 
thinking and critically challenge and problematise the act of framing multiple 
conditions as a singular entity.  
It is perhaps important to highlight here that, despite the approach adopted, this work 
remains, fundamentally, quantitative in nature. As such, there are methodological 
limits to the extent to which it can realise the principles laid out above. For example, 
the data were collected via mechanisms that are inherently reductive, losing 
information, nuance and context along the way. Similarly, coding and classificatory 
frameworks have been applied that further strip away the participants’ original 
accounts. And while social constructivist insights have been influential, their 
limitations are acknowledged in Chapter 4, and my willingness to engage with ideas 
about the multiple constructions of disease and illness has not led me to a adopt a 
wholly relativist position in which these concepts are no more than human 
constructions. A belief in the “reality” of illness, and the distress and disruption it can 
bring for the people who experience it, and those around them, remains central to the 
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endeavour. However, the intention was to explore the processes involved in their 
discovery, to question the limits of data and the uses to which they are put, and to 
subject the process of quantifying phenomena to a broader set of theoretically-
informed considerations than is usually the case. The overall objective was the creation 
of a measure of long-term conditions that was more aligned with how many people 
experience poor health and illness - as a constellation of multiple issues. 
While the creation of population estimates of phenomena originates from the 
tradition of positivism, the methodology followed here arguably moves this thesis 
closer to the realms of post-positivist approaches, such as critical realism (see 
Danermark et al. 2002; Porpora 2015). However, it would be an overstatement to 
present this work as a fully-developed attempt at a critical realist analysis of multiple 
conditions, their measurement and impact. Indeed, as Porpora (2015) argues, critical 
realism is a philosophy of science, and as such its key function is to provoke reflection 
about the methods chosen to approach a research question, as opposed to providing a 
wholly distinct method in itself:  
No one is asking you to do what might be called CR research. What you are 
being asked to do is what Bourdieu asks you to do: Pay at least some attention to 
the philosophical grounding of your research, to what ontology you assume, 
what views of causality you hold, and so on. And to continually reflect on those 
matters in a manner that might be described as fallibalist or open to correction. 
(Porpora, 2015, p.208). 
The core critical realist principle that, I believe, resonates in the approach I have 
followed is its attempt to marry the very fixed realities presupposed by positivism, and 
the potentially infinite realities of relativism; a process which Danermark et al. (2002) 
suggest is emblematic of critical realism’s core properties. As Archer et al. describe it: 
“critical realism claims to be able to combine and reconcile ontological realism, epistemological 
relativism and judgemental rationality” (Archer et al. 1998, p.xi, cited in Danermark et al. 
2002, p.10). Two additional key critical realist tenets have also influenced my 
approach. Firstly, its ontological position that “the world exists independently of our 
knowledge of it” (Dunn 2012, p.27) and secondly, its epistemological approach that “all 
knowledge is fallible and theory laden” which means, consequently, that “all knowledge is 
subject to review, change and correction” (Dunn 2012, p.27). Collectively, these principles 
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underlie my unease with wholly constructivist accounts of disease and illness which 
characterise these as “mere epiphenomena of human language” (Gorski 2013, p.662). 
Similarly, they have informed my critique of positions that conflate / reduce the 
underlying nature of disease and illness with what can be directly observed of them 
(Williams 1999) – committing what critical realists term the epistemic fallacy: “the 
reduction of all questions of being to questions of knowledge” (Porpora 2015, p.16).  
However, as noted above, my engagement with critical realism is far from 
comprehensive. This work would therefore be better characterised as marking the 
beginning of an exploration of its potential, sparked by an interest in other people’s 
uses of it, rather than being fully underpinned by a detailed understanding of the 
writings of key figures in this field such as Margaret Archer, Roy Bhaskar or Andrew 
Sayer. To illustrate, Pilgrim’s (2013) suggestion, in relation to the problems associated 
with psychiatric diagnosis, that critical realism provides a framework that “allows us to 
acknowledge the problem of conceptualization without reducing the whole matter under 
consideration to this (undoubted) problem” (Pilgrim 2013, p.350) has been a valuable 
insight. This mechanism for acknowledging but not being derailed by conceptually 
problematic phenomena provided a helpful framework for my thinking on the 
meanings of disease, classification and diagnosis. Similarly, Patterson & Johnston’s 
(2012) use of critical realism to underpin their conceptualization of obesity as a hybrid 
entity, simultaneously biophysical and social, provided a useful way of framing my 
thinking about individual conditions and the concept of multiple conditions as an 
entity in its own right.  
Moving beyond the problems of conceptualisation, the critical realist approach to 
investigating and understanding the patterns typically observed in social epidemiology, 
and the potentially causal relationships underpinning them, that Dunn (2012) 
outlines was also influential in the analysis of experiences presented in Chapter 6, and 
in the recommendations for where this work could go next outlined in Chapter 8. 
Dunn describes this approach as follows:  
Traditional approaches based on positivism (e.g., epidemiology) would suggest 
that more data is needed, with the expectation that eventually a regularity that 
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better explains the phenomenon, or one that gives more certainty to an 
empirical relationship, will be found. According to the realist view, however, this 
relationship is not self-explanatory, but must be explained with reference to what 
produces it. (Dunn 2012, p.29). 
As reflected on in Chapter 8, these attempts to identify mechanisms that might 
produce the patterns in wellbeing observed represent the beginnings of my 
engagement with this as an approach.   
The next section describes how the definition process unfolded. 
Measuring multiple conditions: outline of approach taken  
Introduction 
The preceding sections located the work within the broad field of population health 
surveillance, provided specific details of the data used for the analysis, and outlined 
the ontological and epistemological approaches adopted. This final section outlines 
the steps that were taken to address the first of the research questions stated in the 
introduction: 
 Does the Scottish Health Survey correctly identify people with multiple 
conditions? 
o And if not, who is missing? 
As the literature review in Chapter 2 outlined, debate exists about the definition of 
multiple conditions, particularly surrounding the issue of what types of conditions 
should count and what threshold should be applied (i.e. more than one, or more than 
two conditions). This work has adopted the definition adopted in most of the 
literature based on chronic (as opposed to transient) conditions, and has applied a 
threshold of more than one such condition to identify multiple conditions. Other 
approaches, such as La Reste et al.’s (Le Reste, Nabbe, Manceau, et al. 2013), which 
proposed a multidimensional definition that included social and economic 
vulnerabilities and disease risk factors in the condition count were explored, but 
rejected because it does not enable variations in the lives and circumstances of people 
with multiple conditions to be identified once these vulnerabilities become part of the 
definition process. On the surface these might seem like reasonably straightforward 
decisions. However, operationalising these decisions in the form of a variable in the 
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dataset that included all people with multiple conditions required a number of stages, 
and drew on multiple methods and sources to inform them:   
 A review of the conditions data. 
 The incorporation of evidence from medical sociology literature. 
 Analyses of the association between different definitions and outcomes. 
The results of each of these stages are reported in Chapter 5, while Chapter 4 
describes the sociological literature that informed this work in full. In reality, the 
separation of the process into these three stages is somewhat artificial – they 
overlapped and informed each other as part of an evolving and non-linear process. 
However, treating them as distinct stages is a helpful tool for the purpose of explaining 
how this work was conducted. 
Reviewing the conditions data 
This stage is self-explanatory; all the data recorded on conditions were assessed for 
their suitability for contributing to a multiple conditions measure. This involved a 
review of the questionnaire material as well as an in-depth analysis of the free-text data 
entered by interviewers. This stage used the 2008-2011 dataset, to take advantage of 
the large number of cases available (28,875). However, reviewing all the free-text 
answers to assess this would have been excessively time-consuming. Therefore, a 
random sub-sample of 1,000 cases with LTC free-text answers was selected from the 
2008-2011 SHeS dataset using the sampling command in SPSS v19 (the main datafile 
was stratified by year of interview, so an even spread of years was included, and the age-
sex profile of the sub-sample of cases matched that of the main dataset from which 
they were selected). The same approach was used to select a further 1,000 cases of 
OHP free-text answers. For each of the sub-samples, the text entered for the first 
reported condition was reviewed and coded using the code frame shown below. 
Answers such as “rheumatoid arthritis” were coded as a named diagnosis, while 
“backache” was coded as a symptom. Other codes captured scenarios that did not fall 
neatly into these two categories (a wider range of answers was given to the OHP 
questions than the LTC question, hence the longer code frame). 
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Table 3.5 LTC and OHP data entry codeframe 
Specific named condition  1 
Broad condition / body system  2 
Symptom  3 
Treatment 4 
Injury  5 
Mixture / other 6 
Still under investigation (OHP only) 7 
Historic / in remission (OHP only) 8 
 
The questions addressed in this stage were: 
 Were the conditions described in terms of symptoms or named conditions / 
illnesses? 
 Did participants report obesity / weight problems as long-term conditions or as 
other health problems? 
 How did the conditions reported as long-term and those described as “other health 
problems” differ?  
 What was the level of agreement between the reporting of long-term conditions 
without prompting and the reporting of doctor-confirmed diagnoses of specific 
conditions? 
 To what extent were conditions under-reported? 
 How much granularity can the data support? 
The information gathered at this stage in turn generated the following questions, 
which were addressed in the next two stages: 
 Should the long-term conditions coding be disaggregated to enable all mentioned 
conditions to be counted separately? 
 Should unprompted mentions of conditions such as hypertension be included in 
the definition? 
 How should conditions reported as “other health problems” be handled? 
 Should obesity be counted as a condition? 
 How should under-reported mental health conditions be handled? 
 Should undiagnosed conditions be included? 
Incorporating insights from medical sociology 
The set of questions arising from stage one were first addressed with reference to the 
insights that have been generated from sociological investigation of chronic illness 
experiences, disease classification frameworks, diagnoses and medicalisation (as 
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reviewed in Chapter 4). In some cases, an answer to the question was arrived at based 
on this literature alone, and no further analysis of outcomes was performed. In some 
cases, however, further analysis was warranted, as follows. 
Analyses of the association between different definitions and outcomes 
To complement the work carried out in the previous stages, in some cases survival 
analysis was also performed to see whether the inclusion or exclusion of a condition in 
the measure changed the association between multiple conditions and 15 year 
mortality rates (using the SHeS 1998-SMR linked data). To illustrate, using the 
example of obesity, Kaplan-Meier plots were produced to compare the outcomes of 
people who were defined as having multiple conditions only if obesity was included 
(i.e. they have one condition and BMI >30), with: a) people who had multiple 
conditions, and a BMI below 30; b) people with two or more conditions and BMI >30; 
c) people who had one condition and BMI <30; d) people with no conditions and 
BMI <30, e) people with BMI >30 and no reported conditions. Logistic regression 
models were then used to enable the role of potential confounders such as age and sex 
to be assessed. Similar analyses were conducted, this time using Cox-proportional 
Hazard Ratios, to compare the final definition chosen with the original one based 
solely on long-term conditions reported unprompted by participants.12 
The final multiple conditions definition was therefore selected on the basis of its 
alignment with principles garnered from the literature, and its association with 
mortality.  
  
                                                 
12 The Kaplan-Meier plots and further investigations suggested that the proportional hazards assumption 






Chapter 4 Theoretical perspectives on measuring health 
conditions 
Introduction 
This chapter describes how the theoretical perspectives offered by sociological 
approaches to the conceptualisation, classification and experience of health and illness 
were used to inform the decisions that needed to be taken to help define and measure 
the presence of multiple conditions in this thesis. The approach outlined here was 
heavily influenced by the following observation: 
If one allows that measurement in sociology is more than a glorified labelling 
process, and if one grants that the labelling process itself is but a part of the way 
in which social meanings are generated then one can transcend arguments about 
the stability, arbitrariness or otherwise of our definitions and variables. (Pawson 
1989, p.37) 
The act of defining a concept such as multiple conditions comprises many stages, each 
of which has numerous associated considerations and possibilities. At the very outset, 
a decision needs to be made as to what is meant by condition. As the discussion in this 
chapter will hopefully highlight, this is less straightforward than it might at first appear 
and definitive positions do not necessarily exist. Obesity and hypertension provide two 
concrete examples of how this complexity manifests, as their status as diseases - as 
opposed to risk factors - is not universally agreed upon, and where measurement and 
threshold controversies abound. Even if agreement can be reached about what 
conditions are of interest, this work is presented with the challenging issue of how to 
handle the high volume of information that has been collected. Population-based 
health surveys that do not have access to clinical records on diagnoses are always faced 
with the question of what might be missing: how can we be sure that the questions 
asked have fully tapped the extent of health conditions people live with? And what 
about the people who did not take part in the survey? Faced with these kinds of 
challenges, the question arises of whether it is appropriate to use information on 
prescription medications or symptoms that might identify conditions that have been 
under or misreported. However, given what will become clear about the complex and 
contested nature of illness experiences, diagnosis and classification, is it appropriate to 
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presume that clinical records would necessarily provide a more accurate picture of 
people’s health, or that such a thing as “an accurate picture” even exists? 
In addition to the difficulties associated with defining and measuring single 
morbidities, the issue of what is meant by multiple is equally challenging. Some 
conditions can affect multiple sites, such as arthritis, which raises the question of 
whether such cases should be considered singular or plural, for the purposes of 
defining multimorbidity. Similarly, depression and anxiety very commonly co-exist, 
with some arguing that they are symptoms of a single underlying condition, as opposed 
to discrete but simultaneously experienced problems (Horwitz 2011). As will be 
illustrated, the very nature of the classification system adopted can mask or reveal such 
granularities, and the question of what level of detail is helpful or most appropriate 
remains, at its core, a very human one.  
The above issues concern the individual decisions required to construct a measure of 
multiple conditions (the stages focusing on the “parts”), but considerations about the 
parts should not be regarded as distinct from questions about the overall purpose of 
the “sum”. For example, the ultimate utility and validity of any measure will, in part, 
be linked to how it is constituted, so any decisions need to be taken while facing in 
two directions: looking downwards at the detail of the data and upwards at the overall 
purpose of the measure.  
Clear parallels exist between the challenges associated with the conceptualisation and 
measurement of multiple conditions and those attending another, closely related, 
concept: disability. For example, Shakespeare and Watson (2010) caution that the 
huge diversity in, and high specificity of, individual disabled people’s experiences 
could result in the single term disability “missing the nuance through lumping a disparate 
group together” (p73). Indeed, in earlier work, they argue that an overarching 
understanding that reflects all disabled people’s experience is unobtainable 
(Shakespeare & Watson 2001). Their description of disability (below) raises interesting 
questions about the extent to which multiple conditions, as a concept, faces similar 
challenges in attempting to unify disparate experiences into a single entity: 
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For us, disability is the quintessential post-modern concept, because it is so 
complex, so variable, so contingent, so situated. It sits at the intersection of 
biology and society and of agency and structure. Disability cannot be reduced to 
a single entity: it is a multiplicity, a plurality. (Shakespeare & Watson 2001, 
p.19). 
Having outlined some of the key considerations that accompany the measurement of 
multiple conditions, the rest of this chapter describes the theoretical perspectives that 
were drawn on to inform these decisions in this thesis. A theory-informed approach 
was chosen, as opposed to one driven purely by the data. Before discussing the specific 
strands of sociological theory that were used to shape the work, the next section 
expands a little on what is meant by a theory-informed approach, and what value it 
adds. 
Why theory? 
This approach to the analysis of empirical epidemiological data is, arguably, quite 
distinctive. Epidemiology, the study of population health and its determinants, has 
attracted criticism from within its field for being under-theorised, or even atheoretical 
(Dunn 2012; Krieger 2011). In contrast, medical sociology’s use of theory has been 
characterised as uniquely distinctive, setting it apart from other health research 
disciplines (Cockerham 2013), though others have argued that this was not always 
necessarily so, especially when compared with the theoretical underpinnings and 
concerns of its parent discipline, sociology (Turner 1992). It is perhaps inevitable that 
such debates exist within and across many disciplines. In common with such debates, 
epidemiology has been described as genuinely underpinned by theory, but in a way 
that is “seldom made explicit” (Bhopal 2008, p.348).  
Theory can be described as “a statement that provides an explanation or coherent account of 
a group of ideas, facts, or observed phenomena” (Bhopal 2008, p.3). Krieger’s (2011, p.3) 
suggestion “that without theory, observation is blind and explanation is impossible” illustrates 
the pivotal contribution theory can make and the deficiencies its absence creates. The 
chart in Figure 4.1 provides a humorous but telling example of a real, observable 
correlation between two phenomena which, in the absence of any theoretical 
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framework, could be open to wild misinterpretation.13 And while it might seem 
implausible that anyone would draw flawed causal links between sociology doctorates 
and space exploration, it is worth noting that epidemiology is a discipline whose 
toolbox includes explicitly atheoretical data-mining approaches such as this, designed 
to simply detect patterns in large datasets with no prior hypotheses (see, for example: 
Hanauer et al. 2013).  
Figure 4.1 The correlation between worldwide non-commercial space launches and 
the award of sociology doctorates in the US, 1997-2009 
 
Source: Spurious Correlations (http://www.tylervigen.com/view_correlation?id=805, accessed 28 
April 2015). 
When applied to a research problem (in any field), theory can help to formulate 
hypotheses about possible associations between phenomena, or mechanisms behind 
them, and can also serve to make explicit the principles that underline the entire 
methodological approach within the discipline. Within epidemiology and public 
health, the multiple levels at which theory is applied span the micro to the macro, 
encompassing ideas about how individuals enact changes in their lives to how societies 
function and why this contributes to specific outcomes or the emergence of patterns 
(such as disease distributions). Key examples of theories relating to macro-level 
phenomena include Link and Phelan’s (1995; 2010) theory of fundamental causes (on 
the structural determinants of individual disease risks), Wilkinson and Pickett’s (2009; 
2015) spirit level hypothesis (on the association between income inequality and health 
                                                 
13 The example is taken from the website “Spurious Correlations”, which contains over 20,000 such 
examples, derived from a data mining programme written by a student at Harvard to illustrate the 
difference between causation and correlation. 
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outcomes), and Krieger’s (2001) ecosocial theory of disease distribution (a multi-level 
approach which combines ecological, social and biological perspectives on health, 
across both time and place). Within public health, numerous theory-based models of 
health promotion and/or health behaviour change within individuals have been 
developed (Lewis et al. 2015 list seven).  
The term “theory” can be used to describe a singular construct (a theory is…/a theory 
of…), but it arguably also has a status more akin to a collective noun, describing a body 
of work, or an overarching approach comprising multiple theories. It might therefore 
be more helpful to think of theory as a framework (rather than a statement) that offers 
(rather than provides) a means of thinking about (rather than explaining) phenomena. 
This approach acknowledges the contestable and uncertain ground that most theories 
occupy, as well as the possibility that multiple complementary (or contradictory) 
theories might be necessary to help build understanding. Furthermore, as the 
following argues, in the context of a discussion of the powerful influence of the French 
philosopher Foucault: “we should guard against dogmatism and the myth that there can be 
one, all-encompassing theory to explain the complexity of modern life” (Peterson 2012, p.17).  
The above examples illustrate how theory has been applied to thinking about patterns 
of distributions in populations or the behaviours of individuals, rather than what 
theory can contribute to how a concept such as multiple conditions is conceptualised 
and measured. Indeed, instances of this kind of approach are rare. This is largely 
because surveys tend to be aligned with positivist methodologies that are predicated on 
an understanding of the world in which entities are largely fixed and have an existence 
independent of observers that, with the right tools (e.g. questions or, in the case of 
health surveys, physical assessments), can be measured, ultimately yielding valid and 
generalizable results (Moses & Knutsen 2007). Williams (2003) describes the 
assumption underpinning the approach to measurement in many surveys as “there is a 
straightforward relationship between an object and its measurement” (Williams 2003, para. 
8.1). However, if it is accepted that illnesses and diseases are not fixed entities but 
instead have socially and spatially contingent properties, this clearly presents major 
challenges for any attempts to operationalise them for the purposes of quantification. 
100 
 
From some perspectives (hard constructivism, for example, as discussed below) this 
would represent an insurmountable barrier, with the very act of quantification 
considered pointless (Moses & Knutsen 2007).  
Analyses of survey data need not, however, be constrained by the tenets of positivism. 
Instead, theorisation can be used to apply prior thought to the very nature of what is 
being measured and move beyond a sole focus on what can be observed (Williams 
2003). The purpose of this chapter is to illustrate the ways in which I have attempted 
to do this, by using theoretical insights to construct a measure of multiple conditions. 
It is worth acknowledging from the outset that achieving a comprehensive theory-
informed approach would ideally have also involved applying prior thinking to the way 
in which the data were collected, and what it sought to measure, rather than solely at 
the analysis stage. Forbes & Wainwright’s (2001) critique of the use of survey data to 
try and understand health inequalities outlines a number of ways in which they suggest 
measures within official surveys such as SHeS fail to capture the complexity of the 
phenomena they attempt to explain. The data presented in this thesis had already been 
collected so the discussion of measurement implications for future surveys in Chapters 
7 and 8 is an attempt to address this gap. 
Why medical sociology? 
This work has drawn heavily on the theoretical insights contributed by the medical 
sociology field, which I was drawn to via its sub-discipline of work around chronic 
illness experiences (Scambler & Scambler 2010).14 I had initially sought out this 
literature to help fill what I felt was a gap in the “mainstream” literature on multiple 
conditions which, as described in Chapter 2, has been largely quantitative in its focus, 
with few insights into the lived experiences of people with multiple conditions (though 
more recent studies, such as O’Brien et al. (2014), have started to redress the balance). 
This exposure to sociological perspectives on chronic illness experiences led me to 
                                                 
14 Debate surrounds the terms “medical sociology” and the more recently adopted “sociology of health 
and illness”, with the former sometimes characterised as being too medically-focused and the latter as 
being more reflective of the broader considerations covered by the field (Timmermans & Haas 2008). 




explore other insights within this discipline, notably around the construction of 
health, illness and disease (Conrad & Barker 2010); classification (Bowker & Star 
1999); and finally, the concept of medicalisation (Conrad 2013), which has very strong 
links to current debates around overdiagnosis in the more clinically-oriented medical 
literature, exemplified by the British Medical Journal’s “Too Much Medicine” 
campaign (Moynihan, Heneghan, et al. 2013).  
A recent review of the unique contribution that medical sociology - or, more 
specifically, as the review termed it, qualitative health sociology - offers, outlined seven 
“warrants” that could be used to underpin it as a discipline:  
examining the constructed nature of prevailing health beliefs and knowledge, 
witnessing health’s beneficiaries and the collateral damage of a lack of health, 
examining the unfulfilled promises of health interventions, following financial 
incentives, following health across place and time, detecting causal mechanisms, 
and reframing dominant perspectives. (Timmermans 2013, p.6). 
These warrants could equally be thought of as purposes, or roles, many of which have 
the potential to inform all health research, including quantitative data analysis. While 
some of these warrants are not directly relevant to this thesis, two particular insights 
that this perspective offers - that “the current understanding of health is neither preordained 
nor natural” (p2) and that “[b]ehind the statistics lie countless individual and collective dramas 
that profoundly affect lives” (p3) - helped to shape the approach followed. 
It is important to note that although medical sociology undoubtedly offers valuable 
insights in the ways outlined above, it would be remiss to ignore some of the problems 
associated with its approach (while acknowledging that no approach could, of course, 
be uniformly flawless). Of particular relevance to this work is the charge that the 
preponderance of its studies have focused on single conditions - often those that could 
be described as “exotic” or “intractable” (Kelly & Field 1996, p.257) - from which 
generalisations have been made about experiences shared by all people with chronic 
illnesses (Timmermans & Haas 2008). Similarly, medical sociology’s approach to the 
biophysical / bodily aspects of illness experiences has arguably been problematic 
(Williams 2006), with one view suggesting that the body has typically been 
characterised as having “an ethereal quality forever gliding out of view” (Kelly & Field 
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1996, p.242). The latter issue has been a particular focus of (often contentious) debate 
between medical sociologists and disability theorists (Thomas 2010; Shakespeare & 
Watson 2010). Indeed, the question of why the concept of multiple conditions - with 
its focus on how people experience conditions simultaneously - emerged from the 
more clinically-oriented fields of epidemiology, primary care and gerontology, rather 
than from medical sociology, which has for many decades attempted to access and 
reflect experiences of people living with chronic conditions, warrants further 
exploration and critique.  
The point of highlighting the kinds of tensions illustrated above is not to diminish the 
contribution of the insights offered by sociological theory, but is instead intended to 
highlight, again, the contested nature of theory and rarity - or even absence - of 
definitive positions. This of course means that my attempt to use such insights to 
inform the kind of work pursued here involved degrees of subjectivity and 
experimentation that collectively resulted in a more complex and challenging approach 
than is typically adopted in the quantitative analysis of phenomena. However, since 
social epidemiology has been described as a ‘bridge science’, that “combines epidemiologic 
principles with social science research and methods” (Bayoumi & Guta 2012), it could be 
argued that attempting to inform epidemiological analysis with sociological insights is 
simply an extension of that bridge.  
Having established the motivation and rationale for integrating sociological theory 
into this work, the following sections consider the specific domains that were covered. 
It begins with the very root of what is and can be meant by health, illness and disease. 
The nature of health, illness and disease 
Medical sociology arguably offers the most notable critique of, and counterpoint to, 
the biomedical model of disease (Nettleton 2013). The philosophical tradition of 
social constructivism has provided the lens through which much - though by no means 
all - of this critique has been framed (Olafsdottir 2013). A full consideration of the 
origins and tenets of social constructivism, or, more broadly, the various other 
philosophical approaches within medical sociology, is beyond the scope of this thesis 
(but can be found within Gerhardt (1989)). However, to understand how its principles 
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have (and have not) contributed to this work a little space must be devoted to this 
topic. Conrad & Barker (2010, p.s67) define social constructivism as: “a conceptual 
framework that emphasizes the cultural and historical aspects of phenomena widely thought to 
be exclusively natural”. The critical aspect of this definition is that it highlights how 
social constructivism explicitly challenges existing orthodoxies, especially those that 
might - in some settings - be treated as incontestable. Social constructivism is a 
tradition whose core principles have been characterised as diametrically opposed to 
approaches which sit within the positivist tradition, which employ highly empirical 
methods, such as the population surveys common in social epidemiology (Dunn 
2012). The root of this tension is not simply a question of what methodologies are 
deemed appropriate, but how these traditions conceptualise reality (ontology) (Bryman 
2008). Constructivist approaches reject the notion of objective “truths”, lying dormant 
until their “discovery” that are independent of human or social involvement – the 
position at the core of positivism. Constructivism is instead associated with views such 
as this:  
…that which we take to be knowledge of the world and self finds its origins in 
human relationships. What we take to be true as opposed to false, objective as 
opposed to subjective, scientific as opposed to mythological, rational as opposed 
to irrational, moral as opposed to immoral, is brought into being through 
historically and culturally situated social processes. (Gergen & Gergen 2007, 
p.463). 
In the context of health and illness, Lupton (2000) points out that rejecting the 
existence of objective or universal truths is not the same as denying the reality of the 
suffering that can accompany disease, rather the key issue is that: “we can only ever 
know, think about, and experience these realities through our specific location in society and 
culture” (Lupton 2000, p.50).  
Even allowing for there to be “harder” and “softer” forms of constructivism (Blaxter 
2010; Lupton 2000), with the latter being somewhat less wedded to the absolute 
rejection of an objective reality, it is, understandably, a perspective that many find 
difficult to align wholesale with the study of health and illness, where seemingly fixed 
and timeless disease pathologies predominate (Turner 2000), and the proponents of 
scientific approaches yield great power (Lupton 2000). And yet, constructivism has 
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profoundly influenced the way that these concepts are thought about, and constructs 
such as medicalisation (discussed further below) have succeeded in gaining mainstream 
awareness beyond the confines of medical practice or sociological enquiry (for 
example, Orr 2015).  
The sustained challenge to the biomedical model of health, illness and disease is 
perhaps the clearest example of the contribution that constructivist approaches have 
made. They have facilitated a questioning of the notion that biological processes are 
the sole arbiters of what is and is not a disease (Bury 2004), and challenged an 
approach in which “the body is isolated from the person … and the subjective interpretations 
and meanings of health and illness are deemed irrelevant” (Nettleton 2013, p.2). The 
critiques offered by constructivist perspectives, typified by Freidson’s (1970) pivotal 
work, argue that illness can have an existence that is distinct from - or even absent of - 
any “biological reality” while acknowledging that illness “always has a foundation in social 
reality” (Freidson 1970, p.212).  
Much of the sociological literature on the nature and framing of health and illness 
highlights the ways in which these concepts have had different meanings over time, 
and continue to do so across social and cultural contexts, to highlight their negotiated, 
permeable and evolving nature (Rosenberg 1989; Blaxter 2010; Silverman & 
Rosenberg 2013). Kendall (1975, cited in Blaxter 2010, p.33) uses the analogy of 
furniture in a house to exemplify the historical development of how diseases are 
framed, with items from previous generations being supplemented with (rather than 
necessarily replaced by) new pieces, resulting in an assortment of seemingly ill-matched 
styles (e.g. modern plastic chairs alongside Tudor ones).  
Constructivist approaches can be identified in the attempts that have been made to 
clarify many of the key concepts in this field. For example, Radley (1994) suggests that 
disease is the pathological disruption occurring within the body, which in turn is 
treated by doctors, whereas illness describes the way in which a person experiences 
disease (this distinction echoes that offered by Kleinman 1988, cited in Nettleton 
2013, p.73). A third term, sickness, is the label that society then attaches to the person 
who is diseased or experiencing an illness (Radley 1994). This distinction has some 
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limitations, for example these terms are commonly conflated in people’s everyday 
language (e.g. the phrases “I’m sick” and “I’m ill” are regularly interchanged). Perhaps 
in response to this common conflation of such labels, another descriptor - condition - 
is now more typically used in clinical, research and policy settings. This tends to act as 
an umbrella term to describe disease or illness states. For example, NHS Scotland’s 
public information website has an A-Z listing of “conditions or treatments” (NHS 
Inform 2015), and the Scottish Government has a programme of work to improve 
outcomes for people with long-term conditions (Scottish Government 2009). This is 
worth noting because much of the data presented in this thesis was collected via a 
question that used the term “condition” (indeed, as described in Chapter 3, a 
conscious decision was taken to replace the terms “illness” and “infirmity” with the 
single term “condition” at one point in the survey series, though “illness” was 
reinstated at a later stage).  
The idea that disease can be understood solely in terms of pathological disruptions 
(and partitioned from more socially-framed illness experiences) underplays the role 
and complexity of the processes through which underlying pathologies come to be 
recognised as diseases in the first place, and the fact that this complexity has, arguably, 
been heightened by social and technological advancements from the 20th Century 
onwards (Rosenberg 2002). For example, type 2 diabetes and high blood pressure have 
underlying pathologies that can be traced to dysfunctions at the cellular level, but the 
point at which they become entities that warrant treatment requires the setting of 
thresholds whose determination involves many factors (and potentially vested interests 
e.g. Moynihan, Cooke, et al. 2013) and is not simply a neutral exercise in 
identification and labelling. Oliver (2004, p.282) offers a useful insight on this point: 
“defining impairment or disability or illness or anything else for that matter is not simply a 
matter of language, or science; it is also a matter of politics”.  
Freidson (1970) questioned (though did not wholly reject) the practice of accepting 
pathologically-framed medical constructs of disease as facts, based on the seeming 
ubiquity of consensus around their existence, and only applying sociological enquiry to 
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illness experiences and their social contexts. This consensus, he argued, was only made 
possible via human actions:  
Consensus among humans about what physical signs and symptoms are 
undesirable (and therefore deviant) is high for a great number of the cases 
labelled “illness” - they do not seem very arbitrary. But that the consensus is high 
does not make it any the less a social construction. (Freidson 1970, pp.214–
215). 
In a similar vein, the suggestion that it is possible to distinguish between clinical 
entities (the signs and symptoms doctors are confronted with) and disease entities (the 
understandings that flow from such interactions), as proposed by King (cited in Turner 
2000), also fails to resolve the question of what aspects of disease and illness can be 
said to be socially produced and which are not. As Turner (2000) argues, this is 
because clinical signs “are mediated through and by the experiences and training of physicians, 
and these physicians are the products of specific and local medical cultures” (Turner 2000, 
p.21).  
These philosophical issues manifest themselves in the context of health and illness via 
the classification and diagnostic processes that are applied to some (but not all) 
disruptions in people’s physical or mental functioning. Hence the previously 
mentioned variations that arise across places, time periods and social groups in how 
disease and illness are framed and understood are largely the consequences of 
variations in classification and diagnostic practices. It is these processes that have 
direct consequences, primarily for the people experiencing such disruptions, but also 
for those tasked with their treatment, and of critical importance here, to those 
attempting to measure their existence within a population.    
The processes of classification and diagnosis  
The challenges associated with defining and identifying illness and disease are replayed 
in attempts to classify and diagnose them. Although these are distinct acts, each of 
which has a particular significance for this work, they are intrinsically linked processes. 
Two other closely related concepts, overdiagnosis and medicalisation, are also 




Much of the information collected in the survey underwent some form of classification 
to transform the details participants reported into useable data items. Understanding 
more about such processes was therefore an essential part of this work. Bowker and 
Star (1999, p.10) distinguish between classification as an act: “a spatial, temporal or 
spatio-temporal segmentation of the world” and as a system: “a set of boxes (metaphorical or 
literal) into which things can be put to then do some kind of work”. In the health field, one of 
the key uses of classification is epidemiological analysis, such as monitoring causes of 
death or illness burdens within populations (Rosenberg 2002). Indeed, William Farr, 
who developed the world’s first national health surveillance system and whose work 
directly influenced the creation of the International Classification of Disease 
(Lilienfield 2007), suggested that disease classifications perform the function in 
medical statistics that weights and measures do for physical sciences (Rosenberg 2002).  
More formal definitions of classification, such as that offered by ISO 17115 (cited in 
Madden et al. n.d., p.7), suggest that the process involves: “an exhaustive set of mutually 
exclusive categories to aggregate data”. However, the extent to which any classification 
process can in reality be truly exhaustive, with sub-categories that are mutually 
exclusive, when faced with complex, socially-located information such as health states 
is doubtful. Bowker and Star (1999) instead describe such attributes as ideal 
properties, rarely (if ever) found in the classification systems humans use, and cite 
medicine as an example where achieving mutual exclusivity is particularly challenging 
(p12).   
Western medical classification’s origins lie in Sydenham’s attempt in the late 17th 
Century to classify diseases using the same approach that a biologist might use to 
classify plants, though Krieger (2011, p.65) points out that it took another two 
centuries before anything like a ““universal” nomenclature” for diseases was achieved. 
The medical world is now awash with classification systems. The WHO’s International 
Classification of Diseases, Injuries and Causes of Death (ICD) (World Health 
Organization 2015c) spans both physical and mental health conditions and is the 
oldest of the medical classificatory systems still in common use today. Initially devised 
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at the end of nineteenth century as a register of the causes of death, by the 1940s it 
had been expanded to cover non-fatal morbidity (Armstrong 2011). The first edition of 
the American Psychiatric Association’s Diagnostic and Statistical Manual (DSM) 
(American Psychiatric Association 2014b) was published in the 1950s (the fifth, most 
recent revision was published in 2013), but the origins of psychiatric classification have 
a longer history dating back to the work of Emil Kraepelin in Germany in the 1880s 
(Shorter 2013). Although the DSM ostensibly focuses solely on mental health 
conditions, Rose (2013, p.124) notes that the preface to its fourth edition specifically 
rejected the mind/body distinction that such a notion implies and described it as “a 
reductionist anachronism”. Other classificatory systems cover aspects such as functioning 
(WHO’s International Classification of Functioning, Disability and Health), or 
symptoms (International Classification of Primary Care) (World Health Organization 
2015d). Despite their different structures and purposes they all share the common 
function of attempting to assemble disparate information about health states and 
bring them into some sort of order. The very fact that multiple forms of such 
frameworks are required underlines the different manifestations of health that exist, 
and the contexts in which they are encountered. Another key common feature is that, 
like all classification systems, they are subject to negotiation, dispute and, over time, 
have both shaped and been shaped by, prevailing understandings of disease and 
illness. Armstrong (2011) describes the expansion of the ICD to cover non-fatal 
conditions and injuries (rather than solely causes of death), and its consequential 
application in hospital medicine, as a marker of “the success of the pathological system of 
medicine” (Armstrong 2011, p.802), but also highlights how ICD struggled when first 
confronted with the realities of how health problems are presented in primary care 
settings (in the form of symptoms rather than diseases). 
Technology has played a major part in the shaping of health classification systems. 
Bowker and Star (1999) cite the example of how, historically, technology imposed 
constraints on the ICD’s classificatory framework. The earliest version contained just 
200 categories because this was the limit to how much information could be recorded 
on the enumeration sheets used at the time, rather than because that was how many 
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causes of death were thought to exist. Thus the interaction between what disease or 
illness states exist “out there” and human ability to capture them can be seen to be 
highly contingent on available resources. The expansion of technological capabilities 
to identify disease processes and pathologies that had previously been hidden similarly 
impacts on classifications, as more finely grained details of conditions are gleaned 
(Rosenberg 2002; Silverman & Rosenberg 2013). For example, microscopy enables 
sickle-cell anaemia to be distinguished from other forms of anaemia (Jutel 2011), and 
genomic data can be used to identify highly specific sub-types of diseases, such as 
cancer, heralding what has come to be known as the era of ‘personalised medicine’ 
(Savard 2013). While such advances have clear benefits when they can help target 
treatments more effectively, Savard (2013) highlights how focusing conceptualisations 
of disease and illness on the cellular level alters disease ontology by replacing illness 
experiences with genetic disease potential, and side-lining the role of wider societal 
influences on disease onset and distributions. They also valorise clinical markers as 
classificatory or diagnostic tools over the information provided by people reporting 
symptoms. The ICD-9 classification of intractable migraine provides an interesting 
example of this. Jutel (2011) describes the suffix “so stated” which was attached to this 
condition as an example of medical dominance being ceded to patients (p.8). In 
contrast, Bowker and Star (1999) use the same example to highlight how the term “so 
stated” was used to assign a potentially questionable status to patient reports, and 
contrast it with intractable epilepsy which was afforded no additional qualifier because 
it had been determined via a clinician’s interpretation of laboratory information. It is 
worth noting that ICD-10 does not use these terms but, as Bowker and Star (1999) 
themselves state, the purpose of such critiques is not to condemn the terms used but 
to understand them in the context of how they reflect and reveal the principles 
encapsulated by classificatory systems when they were devised.   
The extent to which conditions can be distinguished from one another is, of course, 
critical to any study of multiple conditions. If the granularity with which information 
has been captured is not sufficiently fine then the presence of multiplicity will not be 
revealed. But if too much detail has been applied then distinctions between conditions 
that are meaningless for the person experiencing or treating them could potentially 
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over-inflate estimates of multiple condition prevalence. Developing more of an 
understanding that classification and diagnostic practice is not an exact or fixed 
process, and the ways in which such systems often privilege clinical information over 
that provided by human report, helped me to evaluate and critique the information 
collected in the survey about health conditions, especially in relation to its level of 
detail and also in terms of what information, if any, should be privileged. 
As noted above, classification is one way in which health information is organised and 
recorded. Diagnosis is another closely related process that requires consideration. 
Diagnosis 
Classification was important to consider because much of the survey data was subject 
to some form of it. In a similar vein, diagnosis is an important process to understand 
because, as will be seen, it plays such a powerful role in how people experience and 
ultimately report their health conditions. While Brown (1995) was the first to suggest 
treating the sociology of diagnosis as a distinct sub-discipline, and Jutel has arguably 
done the most to develop this idea (e.g. Jutel 2009; Jutel 2011; Jutel & Nettleton 
2011), diagnosis has long been the subject of sociological inquiry (Blaxter 1978; 
Rosenberg 2002; Armstrong 2011). 
In some instances, classification and diagnosis essentially perform the same function of 
conferring a name on a set of symptoms or behaviours deemed to be outwith an 
organism’s normal expected functioning. This blurring of the functions of the two 
processes is illustrated by Jutel’s (2009) initial description of diagnoses as: “the 
classification tools of medicine” (p.278). However, drawing on Blaxter, Jutel (2009) goes 
on to describe diagnosis as both “a process and a label” (p.280), with the process 
element relating to the act of assessing symptoms and other information, while the 
label is the outcome resulting from the process (so people both undergo and receive a 
diagnosis).  
In common with the constructivist approaches to disease discussed previously, 
sociological examinations of diagnosis have tended to apply similar frameworks to 
understand it as a process, as exemplified by this observation:   
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Diagnoses do capture reality, but the nature of that reality is fluid, situated, and 
social. Mirowsky and Ross (1989) compare diagnoses to constellations in the sky, 
made up of stars that are truly present but whose meaning comes from how we 
assemble them in recognisable patterns. (Jutel 2011, p.61) 
The act of assembling recognisable patterns from underlying signs and symptoms is 
not a static, one-off process, but one that is often subject to re-negotiation. Such re-
arrangements don’t necessarily result in the diagnosis or disease label changing per se, 
but the social or treatment implications of certain diagnoses can change. For example, 
the constellations made up from the stars underlying MS have been re-drawn over time 
as understanding about its biological mechanisms has changed. It couldn’t be 
understood (and therefore treated) as an immunological condition when it was first 
discovered as the concept of immune systems did not exist at the time, nor had myelin 
(the protective sheath encasing nerves that are damaged in MS) been discovered (Rolak 
2009). Similarly, the discovery that the Helicobactor pylori bacterium is implicated in 
most cases of gastric ulcer helped alter its framing (and treatment) away from being a 
“lifestyle” disease (with implied personal blame due to poor diet or drinking habits) to 
one with a distinct pathological cause (NHS Choices 2013b).15 
The power to diagnose lies almost exclusively with the medical profession who, as 
Brown (1995) describes, exercise significant powers in this respect:  
Diagnosis locates the parameters of normality and abnormality, demarcates the 
professional and institutional boundaries of the social control and treatment 
system, and authorizes medicine to label and deal with people on behalf of the 
society at large. (Brown 1995, p.39) 
The act of giving a set of symptoms the status of a diagnosis can be shown to be a 
profoundly transformative process for both the person making the diagnosis and, most 
significantly, the person receiving it. Diagnosis can empower individuals by giving 
them a framework to understand their health conditions  - Rosenberg (2002) talks of a 
“curtain [being] pulled aside” to reveal a “structured narrative” (p.255), which will, in some 
cases, also suggest a prognosis. Of particular importance, sociologically, is how 
                                                 
15 This is not to underplay the important interaction between the bacterial pathogen and associated 
risks, such as poor diet and high levels of stress, which contribute to poor outcomes - the point is that 
this discovery has changed social and cultural perceptions of ulcers. 
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diagnosis can legitimise illness behaviours by locating people’s experiences in the world 
of medicine, where a particular premium is placed on pathological as opposed to 
psychological roots of ill-health or poor functioning. Contested conditions, where 
symptoms receive the designation ‘medically unexplained’, exemplify this perfectly. 
People with such conditions often engage in significant struggles to have their 
symptoms recognised so they can move out of what Corbin and Straus described as 
“diagnostic limbo” (cited in Nettleton 2006, p.1168). In many instances this desire for a 
clear diagnosis is driven by a need for treatment – the two usually go hand-in-hand – 
but it is also the route through which people can avoid being labelled deviant and be 
given, as Nettleton’s (2006, p.1167) article title suggests, “permission to be ill”. This is an 
idea whose origins can be traced to Parsons’ notion of the ‘sick role’, developed in the 
1950s, in which he outlined the conditions under which people could be excused 
from performing the functions usually expected of adults within society (e.g. work) 
and, more importantly, be absolved from any blame for needing such an exemption 
(Nettleton 2013, p.66). However, the guarantee that a medical diagnosis will bring 
such absolution, or be a positive experience, is far from certain (Zola 1972). Stigma 
often accompanies many conditions, with wide ranging negative consequences for 
people’s health and self-esteem, and also their outcomes across a wide range of social 
domains (such as housing, employment and education) (Hatzenbuehler et al. 2013). 
This issue is expanded on below in the section on illness experiences.  
Despite the potential drawbacks noted above, for some people diagnosis clearly 
attaches a form of legitimacy to their experiences, hence the considerable efforts that 
are often made to achieve diagnostic clarity. However, medical diagnosis has also long 
been implicated in the labelling, control and sometimes suppression of individuals 
displaying behaviours deemed to be socially unacceptable, often involving debates 
about whether certain acts should be designated criminal, immoral or pathological 
(Freidson 1970; Zola 1972). One aspect of these debates focuses on the extent to 
which human behaviours and problems deemed socially deviant (such as alcoholism) 
are ‘medicalized’ by assigning them medical terms and applying approaches from the 
clinical world (such as diagnosis and treatment) (Conrad 1992). One notably 
outrageous historical example of the medicalisation of supposedly deviant behaviour is 
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drapetomania – a mental disorder that was ‘diagnosed’ in slaves with “an unconscionable 
desire to abscond from his or her owner” (Bynum 2000, p.1615). (The term medicalisation 
covers a wider territory beyond its application in the study of deviance; additional 
relevant examples of it are discussed further below). A more commonly cited example 
of disease labelling as an exercise of power is homosexuality’s inclusion in the DSM - 
in some form until as late as 1986 (Olafsdottir 2013).16 However, the origins of this 
were not necessarily intended to be malign; Conrad (2007, p.98) notes that 
homosexuality originally came under the ambit of medical diagnosis as a way of 
removing it from the more punitive jurisdiction of the penal system. Its removal from 
the DSM was in part due to pressure from the gay liberation movement, but also due 
to changes in the way psychiatric conditions were conceptualised as psychiatry 
underwent a shift towards a more pathologically-focused, biomedical approach 
(Conrad 2007; Rose & Abi-Rached 2013; Olafsdottir 2013). In many respects, 
homosexuality’s inclusion and then removal from the DSM, and indeed, some of the 
recent attempts to ‘re-medicalise’ it that Conrad (2007) describes, encapsulate much of 
the preceding discussion of the ways in which diagnostic and classificatory practices are 
highly contingent. Prevailing social norms and practices, and also changing 
conceptualisations of disease, each shape the nature and function of diagnoses. As 
Jutel (2011, p.34) suggests, the example of homosexuality illustrates: “[that] diagnoses are 
not prior, ontological entities but social categories that organise, direct, explain, and sometimes 
control our experience of health and illness” (emphasis in the original). Armstrong adopts a 
similar perspective to classification and diagnosis, suggesting that:  
Major changes in medical classification demonstrate that there are no diseases 
waiting in nature to be discovered; there are no diagnoses which capture an 
immutable illness state. Diseases and diagnoses only become apparent through 
the contemporary classification systems. (Armstrong 2011, p.806). 
 
                                                 
16 Although it was removed as a blanket disorder in 1973, a new diagnostic category was added, and 
remained in place until 1986, for homosexual people who wanted to be heterosexual, and therefore 
experienced distress as a consequence. 
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The above characterisation of the diagnostic process could inadvertently give the 
impression that a one-to-one correspondence exists between the presence of a set of 
symptoms and their recognition by a medical professional, and that the only 
sociologically interesting dynamics exist within those parameters. In reality, however, 
the likelihood of receiving a diagnosis is itself socially contingent and various processes 
contribute to the situation whereby the same set of symptoms are sometimes more 
readily recognised in some people than others. Aronowitz (Aronowitz 2008a) used the 
term “framing” to describe aspects of this process, though some questioned whether he 
was proposing anything new, as opposed to re-stating pre-existing analyses of the 
socially constructed nature of disease and illness (Kunitz 2008; Nathanson 2008). 
However, his approach to framing was novel because it described how certain 
tendencies of the diagnostic process could itself contribute (albeit partially) to the 
social patterns in health revealed in population studies (e.g. a higher prevalence of 
asthma among socially disadvantaged people), as distinct from factors such as 
underlying biological mechanisms or differences in risk factor burdens (such as 
smoking). In so doing, he was attempting “to emphasize the relevance of processes usually 
examined in one silo, the sociology of medicine, for another, sociology in medicine” (Aronowitz 
2008b, p.20, emphasis in the original) - an approach that has clearly been influential in 
this thesis. One mechanism he suggested drew on a US study that showed African 
Americans to have higher treatment rates for hypertension (i.e. they were more likely 
to be medicated) than their equally hypertensive European American counterparts 
(Hertz et al. 2005), though they didn’t achieve better hypertension management. 
Aronowitz (Aronowitz 2008a) attributed the higher treatment rate to the higher than 
average incidence of hypertension in African Americans leading to an increased focus 
on this high risk group, therefore framing hypertension as a condition particularly 
important to treat in that population. He used a similar example, initially outlined by 
Gergen (1996), in which disadvantaged children (e.g. from inner cities or African 
American populations) with wheezing symptoms were more likely to be diagnosed with 
asthma than more affluent children with the same clinical presentation, despite the 
prevalence of symptoms showing no social patterning. This situation, Aronowitz 
(Aronowitz 2008a) suggested, reflected the fact that: “Medical diagnosis is a necessarily 
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Bayesian exercise. The “prior probability” of disease shapes the diagnosis” (p.3) Therefore, by 
taking the social distribution of a disease into account when making a diagnosis, 
clinicians partly contribute to that higher prevalence. Gergen (1996) suggested this 
meant studies of asthma prevalence needed to distinguish between “predictors of the 
disease asthma, without regard to the diagnosis” and “predictors of the acquisition of the 
diagnostic label asthma” (p.1362). These insights have clear implications for all 
population studies of health and illness, especially those in which social inequalities 
are a key focus of the analysis. This is not to suggest that such analyses should not be 
performed, but that the act of doing so should be accompanied, in the very least, by 
some reflection on the extent to which any discernible patterns could be a function of, 
or contribute to, this kind of framing. 
A discussion of two closely-related topics now follows. Firstly, overdiagnosis, whereby 
diagnostic labels are attached to risks or pre-disease states, expanding and potentially 
blurring the boundaries of what is meant by disease (Welch et al. 2011). Secondly, 
medicalisation (as mentioned above), the process of assigning medical terms, or 
applying approaches from the medical world, to problems not previously treated as 
such (Conrad 2013). Some would not make such a clear distinction between the two 
processes, or would describe overdiagnosis as a form of medicalisation, however for the 
purpose of the discussion here, I feel it is useful to consider them as separate, but 
related topics. In both cases, specific examples of issues arising from the data that 
needed to be considered as part of the task of defining conditions for the multiple 
conditions measure will be highlighted.  
Overdiagnosis and the blurring of illness boundaries 
Welch et al. (2011, p.xiv) suggest overdiagnosis “occurs when individuals are diagnosed 
with conditions that will never cause symptoms or death”. Moynihan et al. (2012) offer two 
definitions, the first of which follows Welch et al. (2011), while a second, broader 
definition also encompasses: “the related problems of overmedicalisation and subsequent 
overtreatment, diagnosis creep, shifting thresholds, and disease mongering, all processes helping to 
reclassify healthy people with mild problems or at low risk as sick” (Moynihan et al. 2012, 
p.e3502). In part prompted by the BMJ’s ‘Too Much Medicine’ campaign (Moynihan, 
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Heneghan, et al. 2013), overdiagnosis has recently become an important heuristic for 
analysing and questioning diagnostic practice. Diabetes, hypertension, osteoporosis, 
high cholesterol, attention deficit hyperactivity disorder (ADHD), cognitive 
impairment, kidney disease, and thyroid, breast and prostate cancer are among the 
conditions typically cited in discussions of overdiagnosis – the breadth spanned 
arguably highlights how pervasive a phenomenon it has become, but also how widely 
the concept has been applied. At the individual level, concern about overdiagnosis 
arises from its potential to do harm - via drug side-effects, interactions with other 
medications, or through the stress or stigma of being labelled ‘sick’ (Greaves 2000; 
Welch et al. 2011). Overdiagnosis can also harm populations by diverting resources 
away from the sick towards the largely healthy (McCartney 2012), by shifting attention 
away from societal-level models of disease prevention (Conrad 2007), and by altering 
perceptions of conditions to make them seem less serious, with the consequence that 
the needs and experiences of people with the most severe presentations are neglected 
(Aronowitz 2009). 
The drivers of overdiagnosis are quite diverse. A simplistic account would focus solely 
on the commercial interests that are served when a change to diagnostic thresholds 
causes more people to become candidates for pharmaceutical treatments, though this 
is clearly an important driver, as is the role of industry-sponsored experts on the panels 
that make such decisions (Moynihan, Cooke, et al. 2013). Other drivers include the 
growth of diagnostic technology that can identify ever more refined disease 
presentations (as discussed above in relation to diagnosis more broadly), a risk-averse 
socio-medical framework that fears underdiagnosis more than overdiagnosis, and 
cultural expectations that more treatment and investigations is always a good thing 
(Moynihan et al. 2012).  
Although interest in overdiagnosis has grown in recent years, concern about the 
treatment of disease risk has a long history, perhaps best encapsulated by Armstrong’s 
(1995) coining of the term ‘surveillance medicine’ to describe the twentieth century 
phenomenon of population monitoring. Originally intended as a means of managing 
risk and preventing illness, it has led to what he suggests is the “the dissolution of the 
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distinct clinical categories of healthy and ill” and the “problematisation of the normal” 
(Armstrong 1995, p.395). Around the same time, and in a similar vein, Meador (1994, 
p.440) suggested that “well people are disappearing”. Drawing on Armstrong’s (1995) 
work, Greaves (2000) argued that surveillance medicine has contributed to the 
emergence of a new type of ‘partial patient’:  
people who do not feel themselves to be ill or disabled either most or all of the 
time but who have been informed medically that because of certain personal 
characteristics, they have or may have a disease or other medical condition or are 
at risk of acquiring such a disease or medical condition. (Greaves 2000, p.23). 
Among such partial patients, he suggests, are people with risks factors for disease (e.g. 
elevated cholesterol), asymptomatic conditions (e.g. essential hypertension), conditions 
in remission (e.g. cancer), and conditions that have stabilised due to treatment (e.g. 
diabetes or angina) (Greaves 2000, p.24). While some of these situations clearly extend 
beyond the narrower of the two definitions of overdiagnosis at the start of this section, 
and indeed the above description of the partial patient, they are all nevertheless 
indicative of a bigger picture in which the notion that fixed boundaries can be drawn 
between the sick and the well is undoubtedly redundant. This theme is also critical to 
Frank’s (1995) concept of the ‘remission society’, which he links to a shift in medical 
practice and illness experiences from pre-modern, to modern and then post-modern 
models of thinking and understanding:  
In modernist thought people are well or sick. Sickness and wellness shift 
definitively as to which is foreground and which is background at any given 
moment. In the remission society the foreground and background of sickness 
and health constantly shade into each other. (Frank 1995, p.9, emphasis in the 
original). 
These observations are important for this thesis because the measure of multiple 
conditions draws on information about conditions that people spontaneously report 
(as opposed to solely using pre-determined categories). I was therefore confronted with 
the challenge of how to reconcile the fact that many common conditions, such as 
hypertension, high cholesterol, cancer in remission and diabetes, occupy this uncertain 
terrain, so the extent to which people identify with them as reportable conditions 
varies. Consequently, I attempted in this work to develop an understanding of why 
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condition reporting varies that extends the explanations offered by traditional survey 
quality frameworks (as outlined in Chapter 3). By engaging with the kinds of themes 
discussed above, it has been possible to provide a more nuanced account of the 
challenges of measuring multiple conditions. It is not simply that our measurement 
tools have deficiencies (as all tools do), but also that the very concepts they are trying 
to capture have qualities that make the challenges of their measurement more than 
just a technical issue to be overcome. As Aronowitz (2009, p.419) outlines: 
“Distinguishing the disease experience from the risk experience is difficult because so many 
developments are obliterating this difference”.  
Medicalisation  
Measurement challenges also arise from the consequences of the expansion of 
medicine into many areas of life, an overarching process described by Zola (1972) as:  
an insidious and often undramatic phenomenon accomplished by ‘medicalizing’ 
much of daily living, by making medicine and the labels ‘healthy’ and ‘ill’ relevant 
to an ever increasing part of human existence. (Zola 1972, p.487, emphasis in 
the original). 
Obesity and mental distress are two aspects of human existence that have increasingly 
been framed as medical problems or diseases (Jutel 2006; Horwitz & Grob 2011). 
Understanding the processes that led to this situation might therefore help to guide 
any decisions about whether to include them in the multiple conditions measure. The 
following provides an overview of the concept of medicalisation, before turning to 
discuss these two specific examples. While much of the discussion draws heavily on 
Peter Conrad’s (1992; 2005; 2007; 2013) work, which reflects his large contribution to 
this field, this is not to imply that his analysis is definitive or exhaustive. Indeed, a 
wider range of sources is cited in the more focused discussions of obesity and mental 
distress. 
Much of the focus on overdiagnosis centres on diseases whose physiological 
manifestation involves a continuous spectrum ranging from normal to abnormal (e.g. 
blood sugar levels or blood pressure), with the key point of contention being where to 
set the threshold between these states. In contrast, while the factors typically described 
as being medicalised can also involve a continuous distribution and debates about 
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what constitutes abnormality, they also have the additional feature of being 
characteristics whose status as medical (as opposed to social or cultural) abnormalities 
can be questioned. For example, baldness, sexual dysfunction, hyperactivity, shyness 
and restricted height have all been subject to varying degrees of medicalisation in the 
form of targeted pharmaceutical treatments and, in the US at least, efforts to have 
their status as medical diagnoses recognised so that medical insurance will meet their 
treatment costs (Conrad 2007).  
As overdiagnosis is one aspect of medicalisation, many of the same societal drivers of 
overdiagnosis outlined above are also relevant to this discussion. However, the 
contribution of the pharmaceutical industry has arguably been even more pervasive in 
this process, especially in recent decades, due to its efforts to both create and cure 
conditions (Conrad 2005). For example, in the case of restricted growth, Conrad 
(2007, p.81) cites the following statement from a doctor: “Short stature became a disease 
when unlimited amounts of growth hormone became available”. Both Conrad (2007) and 
Horwitz (2010) devote significant critical attention to the way the pharmaceutical 
company GlaxoSmithKline invested heavily in campaigns to frame shyness and 
nervousness in social situations as a medical condition (social anxiety disorder) that 
could be treated by their anti-depressant Paxil (thus expanding its potential market).  
As the above should illustrate, medicalisation spans a broad range of topics and has 
clearly been an important theoretical framework for sociologically-informed analyses of 
medicine. However, critics of medicalisation as a concept (as opposed to as a process) 
have questioned its contribution. For example, Rose (2007, p.700) described it as “a 
cliché of critical social analysis” and criticised it for implying “passivity on the part of the 
medicalised” (p. 702), especially in relation to the kinds of drug company activities just 
described. Bury’s (1986) twin-pronged critique centred on its potential to overstate the 
extent to which people actually experience life as being medicalised and, more 
fundamentally, the social constructionist roots of medicalisation’s thesis which 
presents difficulties linked to its philosophical positions on knowledge and what can 
be known. In contrast, while Davis (2006) values the contribution of the 
medicalisation thesis as originally framed by Zola (and others), he argued that its reach 
120 
 
had been extended too far (e.g. in Conrad 1992) and, by losing its original coupling 
with medicine, it “encompasses too much and it stings too little” (Davis 2006, p.56). 
Conrad addressed some of these criticisms, for example by making clear that, far from 
being passive, members of the public can be active agents in the medicalisation of 
issues via patients’ advocacy movements (Conrad 2007). Moreover, he argues that the 
term medicalisation is not meant to be normative. Instead, the primary objective of its 
study should be the analysis of medicalisation’s roots and impact, with no automatic 
assumptions made as to the rights and wrongs of it as a process (Conrad 2007; Conrad 
2013). By way of balance, examples of benevolent medicalisation are provided, such as 
the transformation of epilepsy from a curse to a neurological condition with the 
possibility for treatment (Conrad 2013). Similarly, a distinction is made between 
“unreflective” and “extreme” forms of medicalisation in relation to pregnancy and 
childbirth (Conrad 2013, p.199), and the beneficial interventions that have reduced 
maternal and infant mortality and morbidity. Finally, Conrad rejects the charge that 
medicalisation is now too broad a concept to be meaningful, pointing out that 
conceptual tools need to evolve in line with social realities, with the changing role of 
medical professionals providing a clear example of this (Conrad 2013). 
The implications of the debates outlined above for this thesis are that simply 
establishing that a factor being considered for inclusion in the multiple conditions 
measure has been described in the literature as medicalised, and therefore subjected to 
the critiques provided by this lens, should not be the sole deciding factor in whether it 
is indeed included or rejected. The task instead requires looking beyond the 
medicalisation label and enquiring about the associated processes and consequences 
that have attended the factor in question, and whether these help shape the decision 
about whether to include them. To an extent, the same principles apply to the issue of 
the overdiagnosis of risk, even though the prefix “over” carries with it a normative 
judgement in a way that medicalisation does not (or, at least, claims to avoid). But, 
whereas the insights from the overdiagnosis literature provided a framework for 
understanding why variations might exist in how people report their health 
conditions, the answer to the question of whether such risks should be excluded from 
the multiple conditions measure requires additional insights. In contrast, the primary 
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consideration in relation to medicalised factors is whether they should be counted as 
conditions that contribute to the multiple conditions measure. Two key examples of 
factors that posed this challenge are outlined below: obesity and symptoms of mental 
distress. 
Illness experiences 
Strauss and Glaser’s 1975 work Chronic illness and the Quality of Life is widely 
acknowledged as the first sociological investigation of the lived experiences of people 
with long-term illness to recognise the importance of subjective accounts to 
understand the impact of illness (Conrad & Bury 1997; Charmaz 2010). While 
Parsons’ work on the sick role arguably established the first framework for 
understanding illness as a socially and culturally-mediated process, Strauss and Glaser’s 
work laid the foundations of a less medically-dominated approach and therefore 
helped to uncover the kinds of struggles and adjustments that people who live with 
illness on a permanent basis face in their daily lives (Conrad & Bury 1997). 
Subsequent to this, the 1980s onwards saw a huge growth in the study and 
understanding of long-term illness experiences, resulting in numerous, broadly 
complementary rather than conflicting, perspectives. For example, the impact of long-
term illness on people’s identity and sense of self is an important aspect of Bury’s 
concept of illness as biographical disruption, Charmaz’s work on the loss of self 
associated with long-term illness onset, and Williams’ (somewhat more positive) idea 
of narrative reconstruction and the way in which people make sense of their 
experiences following diagnosis (Lawton 2003). The longevity of this identity-oriented 
perspective is underlined by the fact that concepts such as biographical disruption still 
feature prominently in the research literature on long-term illness experiences today 
(see, for example, Bray et al. 2014). Corbin & Strauss’s (1985) article on the work 
associated with living with chronic illness – and in particular their emphasis on how 
this interacts with the work associated with people’s everyday lives - has been similarly 
influential.  
As discussed earlier, this body of work has attracted various criticisms (which don’t 
need to be repeated here), but a specific omission of relevance to this thesis, which has 
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not been raised in any literature I have found, is the fact that the predominance of 
studies based on single specific conditions leaves many questions unanswered about 
the illness experiences of people with multiple conditions (especially those experienced 
sequentially, rather than diagnosed simultaneously). For example, are biographical 
disruption and loss of self phenomena that people experience anew with each 
additional diagnosis, in a loop-like fashion? Or are new conditions less disruptive, less 
damaging to the self, for people who have already experienced one round of narrative 
reconstruction as a consequence of a long-term condition diagnosis? These questions 
have not been directly addressed in the sociological literature to date, but a number of 
qualitative studies looking at people’s experiences of living with multiple conditions 
have started to explore some aspects. For example, Hurd Clarke & Bennett (2013) 
explored the gendered experience of multiple conditions in older age and highlighted 
how both men and women accommodated and framed their illness experiences as 
inevitable consequences of ageing, which they describe as a form of ‘biographical flow’ 
as opposed to the biographical disruption as conceived by Bury. O’Brien et al. (2014) 
explored the illness and everyday life work associated with living with multiple 
conditions among people of working age, highlighting the considerable struggles 
people face, especially when deprivation and mental health problems were among the 
challenges they faced.  
In terms of people’s capacity to adjust to multiple conditions, Sells et al. (2009, p.99) 
suggest that Knudson’s (1971) “two-hit” theory, which sets out a mechanism whereby 
two independent factors collide and cause a negative health outcome (such as cancer) 
that would not have occurred had just one of the two factors been in place, might 
usefully be applied in this context. For example, they argue that the period of 
adjustment and reconciliation following the onset of a single disease can be 
experienced almost like a wake, featuring “a period of necessary grieving, entailing reflection 
and the testing of modified routines, roles and identities” (Sells et al. 2009, p.99) during 
which time the addition of further conditions:  
may conspire to flood time and attention with seemingly continual patient-
related concerns, engulfing any space of mindfulness one might use towards 
constructing more gainful identities. (Sells et al. 2009, p.99). 
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In contrast, Liddy et al. (2014) suggest that: 
repeated poor health and increasing suffering create a tipping point for patients, 
whereby they are able to take charge of their health more effectively, despite 
having multiple chronic conditions. (Liddy et al. 2014, p.1130). 
The nature of the work presented in this thesis cannot resolve such questions, but it is 
important to acknowledge the gaps in these theoretical approaches as well as to 
identify where they provide useful contributions. I believe they are still useful, despite 
such limitations, because they nevertheless highlight the extent to which living with 
long-term ill-health represents, for many, a serious encroachment on people’s lives, as 
Frank (1995, p.56) describes it: “[d]isease disrupts a life, and illness then means living with 
perpetual interruption”. As a consequence, there is an argument that health analysts have 
a duty to ensure that the data that have been collected reflect, as far as is possible, the 
full extent of these experiences. But also, in conjunction with insights above about the 
fluid nature of disease classification and medicalisation of risk, the fact that illness 
experiences can have such a profound impact on people’s lives means that any 
perceived “failures” to report health conditions need to be given some thought before 
being dismissed as participant errors. How people perceive health conditions and 
contextualise them in their lives will clearly shape how they answer survey questions. 
Lawton et al.’s (2005) study of people’s experience of type 2 diabetes illustrated this 
perfectly – those with no discernible symptoms (following treatment) often questioned 
their diagnosis, and clearly experienced their illness very differently to those for whom 
a health condition continues to involve significant symptoms following their diagnosis. 
Similarly, Duguay et al.’s (2014) participants drew clear distinctions between 
conditions with a direct bodily impact (e.g. pain) and those with no physical 
manifestations; as one interviewee (with nine conditions) stated: “Day-to-day my life is 
normal. The only time I think about having diseases is when I’ve just met with the doctors” 
(Duguay et al. 2014, p 15). Increasingly, however, these kinds of symptomless 
conditions (high blood pressure and high cholesterol could equally be included here) 
now bring with them treatment and monitoring regimes that can themselves bring 
about the kinds of shift in identity that are more typically associated with physically 
embodied illness experiences (hence some of the concerns noted above about 
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medicalisation and the creation of partial patients (Greaves 2000)). Furthermore, 
following from the discussion above of the significance of receiving a diagnosis, it is 
also the case that a diagnostic label in the absence of any symptoms can be harmful, as 
Scambler & Scambler (2010, p.3) suggest with reference to misdiagnosis: “a considerable 
psychosocial price can be paid in the absence of any underlying (psycho-)pathology: a label can in 
and of itself prove decisive for quality of life”. However, the following observation from one 
of Lawton et al.’s (2005) study participants, also provides a useful illustration of the 
extent to which illness experiences can be mediated by people’s wider beliefs about 
health, their confidence or trust in medical “authority”, and their direct experience of 
physical symptoms: 
I just wonder how many other people are like me cos they seem to go through 
five year- I call it the five year cycle. It was the cholesterol for five years, then it 
was the high blood pressure for five years and now it’s the diabetes, y’ know. So 
what’s going to be the next thing, y’know? (participant quote, cited in Lawton et 
al. 2005, p.1428). 
As the discussion of medicalisation and overdiagnosis above highlighted, the answer to 
this arguably prescient question could be any number of things, for example dementia 
(NHS England now incentivises GPs to identify cases (McCartney 2014)), or perhaps 
pre-diabetes (NICE is currently consulting on plans to identify people at risk of 
diabetes in England, despite concerns about its measurement (Yudkin & Montori 
2014)).  
Illness experiences are, therefore, clearly quite diverse, and can be profoundly 
disruptive of people’s routines and also their sense of self, and bring considerable 
work. However, potential clearly exists for people to frame their experiences with 
reference to both physically embodied symptoms and wider social and cultural 
expectations and responses to ill-health, a process Radley (1994) describes as 
adjustment. However, the extent to which the diagnostic distinctions drawn by 
medical nosology map onto people’s lived experiences of distinct conditions is also 
unclear, especially if multiple conditions yield similar functional impairments which 
“blend into one” (Ong et al. 2014, p.313). 
125 
 
Additional challenges arise when people have conditions associated with social stigma. 
Scambler (2009, p.441) defines stigma as:  
[..] typically a social process, experienced or anticipated, characterized by 
exclusion, rejection, blame or devaluation that results from experience, 
perception or reasonable anticipation of an adverse social judgement about a 
person or group. 
In the health context, stigma is especially associated with conditions linked to sexual 
behaviour (in particular HIV), neurological conditions (epilepsy has been the subject 
of much work around stigma), and mental illness (Pierret 2003; Corrigan et al. 2005; 
Pescosolido et al. 2008; Scambler 2009). Stigma operates in multiple forms, as the 
above quote reflects, with a particularly important feature being the way that it can be 
harmful not only as a result of the direct experience of stigmatising behaviours and 
attitudes, but also due to the anticipated fear of such responses (this aspect was first 
described by Scambler & Hopkins (1986) as “enacted” and “felt” stigma). 
Consequently, the stigmatisation of certain health conditions creates particular 
challenges for population studies based on self-reported information, due to people’s 
reluctance to disclose the existence of such conditions, partly fuelled by fear of a third 
party’s response, with the concealment of mental health conditions particularly 
common (Corrigan et al. 2013). Citing work by Link and Phelan, Scambler (2009) 
notes that stigma is not solely about the way that individuals treat each other, but that 
“stigma is entirely dependent on social, economic, and political power – it takes power to 
stigmatise” (Link and Phelan 2001, cited in Scambler 2009, p.450). Following this, 
stigma has also been conceptualised as a “central driver of morbidity and mortality at a 
population level” (Hatzenbuehler et al. 2013, p.e1). Others argue that neoliberalism 
actively requires the stigmatisation and shaming of socially marginalised people with 
poor health in order to underpin its tenets and reinforce its continued hegemony 
(Peacock et al. 2014; Bissell & Peacock 2015). The study of health and illness therefore 
also has an additional responsibility to ensure that it is not conducted in a manner 
that stigmatises, or reinforces the existing stigmatisation of, groups of people on the 
basis of their conditions or other health characteristics. This especially applies to 
studies that have some official status, such as those that generate population estimates 
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for public bodies (such as the data used in this thesis). Examples of how this could 
happen include the adoption of unnecessarily risk-averse approaches that exclude 
people with HIV or other blood-borne viruses from biological measurements (or 
mandating the use of surgical gloves in such cases, rather than for all participants). 
Health studies can also contribute to indirect stigmatisation via the way that issues 
such as obesity or alcohol and other substance misuse disorders are described and 
framed in subsequent analysis and reporting. For example, using pejorative rather than 
neutral language, or graphics that compound stigmatising attitudes, or failing to 
acknowledge that critical debate surrounds such constructs and instead presenting 
certain aspects as uncontested facts. The case study of obesity presented below in 
particular illustrates how its framing as a disease (and its measurement and 
classification) exemplifies these points. 
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Case studies: obesity and psychological distress 
Introduction 
The perspectives and insights on health, illness and its classification and impact on 
people’s lived experiences discussed in this chapter were not intended to simply 
provide some theoretical context to an otherwise wholly quantitative empirical analysis 
of the prevalence of multiple conditions in the adult population in Scotland. Instead, 
the point was to provide a framework for approaching the analysis in a more nuanced 
way, drawing on such insights to shape and, hopefully, enable the thesis to be more 
grounded in the experiences of people living with multiple conditions. The next 
chapter provides a fuller overview of how this has worked in practice for a series of 
decisions about how the data were handled. However, the topics of obesity and mental 
health problems and disorders stand out as having been particularly shaped by this 
approach. They are therefore considered in more detail here.  
Obesity 
Obesity is typically defined as excess body weight as a consequence of accumulating fat 
(Tremblay & Doucet 2000). The WHO’s definition also includes a quantification of 
this excess - a body mass index (BMI), derived from height and weight, of 30 or more17 
- and a reference to its consequences for health (World Health Organization 2015a). 
The measurement and classification of obesity is a controversial and complex topic 
and its standard metrics (BMI and waist circumference) and thresholds have all been 
the subject of criticism (Nicholls 2013). Nevertheless, obesity (BMI >30) has become 
an important public health issue and is the subject of clinical guidelines, population 
initiatives to reduce its prevalence (Foresight 2008; SIGN 2010; Scottish Government 
2010), and wildly varying estimates of its financial burden to health services and the 
wider economy - Castle (2015) cites a figure of £0.9 to £4.6 billion per year in 
Scotland. 
                                                 
17 BMI = height (cm) / weight squared (kg2). A BMI of below 18.5 is considered underweight; 18-5 to 
<25 normal weight; 25 to <30 overweight; 30 and over obese. Further distinctions are often made 
within the upper range to identify a more severe form of obesity of BMI 40 or more.  
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Obesity serves as an exemplar of many of the themes discussed above in relation to 
disease framing, classification, medicalisation and illness experiences. However, the 
most prominent issue of contention is arguably the extensive debate about its status as 
a disease, as opposed to a risk factor for poor health or marker of other pathologies 
(Tremblay & Doucet 2000; Heshka & Allison 2001; Kopelman & Finer 2001; Jutel 
2006; Allison et al. 2008; Chaput et al. 2012; Hurt et al. 2014). The impetus to 
designate it a disease was arguably a matter of pragmatism, linked to the US-based 
health insurance model that requires the treatments it funds to be associated with 
specific diseases – coupled with the rise of drug and surgical interventions for obesity - 
rather than the result of a scientific process to adjudicate its status (Chaput et al. 
2012). Though, as Chaput et al. (2012) acknowledge, and the preceding discussion in 
this chapter should have made clear, disease designation is always a multi-faceted, and 
ultimately human, process that doesn’t necessarily follow strict criteria, so the 
contested nature of its disease status should not be surprising. However, while 
unsurprising, the latest of The Lancet’s series on obesity also highlights how the 
question of its designation as a disease is just one of a much wider set of controversies 
surrounding the topic, which they characterise as:  
false and unhelpful dichotomies: individual blame versus an obesogenic society; 
obesity as a disease versus sequelae of unrestrained gluttony; obesity as a 
disability versus the new normal; lack of physical activity as a cause versus 
overconsumption of unhealthy food and beverages; prevention versus treatment; 
overnutrition versus undernutrition. (Kleinert & Horton 2015, p.2326). 
 
Whether or not to consider obesity a disease is clearly a key consideration in whether 
it should be included as a condition in the definition of multiple conditions, while 
measurement issues form the basis of secondary considerations about how to include 
it. Both of these issues, in part, explain why obesity is largely absent from the 
conditions reported in most of the published literature on multiple conditions. Five of 
the 39 multiple conditions measures reviewed by Diederichs et al. (2011) included 
obesity, though it is unclear whether its inclusion / exclusion from the measures was 
due to data availability (many administrative data sources lack robust or complete 
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measures of height and weight) or active choices about whether to include it (the 
review does not discuss this). Related to this, the publications library maintained by 
the International Research Community on Multimorbidity (2015) does not include 
any articles addressing this issue specifically, and where obesity is explicitly mentioned 
in an article title its focus tends to be on obesity as a risk factor for chronic conditions 
(not as a condition in itself). The question of obesity’s exclusion from Barnett et al.’s 
(2012) study of multiple conditions in Scotland was discussed in post-publication 
correspondence (Wang et al. 2012; Guthrie, Watt, et al. 2012). The original authors 
justified its exclusion by highlighting the relative scarcity of previous studies including 
obesity as a condition, and (most critically) the lack of obesity data in their study 
source, without making a definitive suggestion about whether it should, ideally, be 
included (though severe obesity was flagged as potentially having a similar status to 
uncomplicated hypertension) (Guthrie, Watt, et al. 2012). Similarly, the pre-
publication review comments on a study of obesity and chronic disease clustering 
largely centred on the issue of whether the estimates of multiple condition prevalence 
(and subsequent analysis) presented should include obesity in their definition 
(Agborsangaya et al. 2013a; Agborsangaya et al. 2013b). The authors justified doing so 
on the basis that the American Medical Association has, since 2013, defined it as a 
condition, but this discussion is confined to the pre-publication correspondence with 
reviewers. The main article itself is weak in this respect, simply stating that “Its inclusion 
in studies on multimorbidity is thought to be vital” (Agborsangaya et al. 2013a, para 2) with 
no evidence presented beyond the post-publication correspondence on Barnett et al. 
(2012) cited above (Wang et al. 2012; Guthrie, Watt, et al. 2012).  
Its disease status in clinical and research circles should not, however, be the sole 
consideration.  The lived experience of people with a BMI in the obese range also 
matters – if such people do not identify their weight as a health condition or disease 
then using their physical measurements to assign them a disease label arguably 
demotes their agency in the process. As this thesis is attempting to reflect, as far as is 
possible with the kind of data collected, the conditions that people live with, then the 
question of whether people need to actively identify with their condition status for it 
to be included is an issue to consider. However, another important aspect of the lived 
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experience of multiple conditions is how they impact on key outcomes, such as quality 
of life and, ultimately, mortality. If an additional negative association can be 
demonstrated between the existence of multiple conditions and lifespan when obesity 
is included as a condition, then arguably there are more grounds for its inclusion.  
In addition to the above points, the factors that make obesity’s disease designation and 
status as a public health issue of concern controversial, such as debates about the 
extent to which it genuinely represents a risk to health (Campos et al. 2006b; Kim & 
Popkin 2006; Orbach 2006; Blair & LaMonte 2006; Flegal 2006; Lobstein 2006; 
Stevens et al. 2006; Rigby 2006; Campos et al. 2006a; Gard 2011a), and the social, 
political and personal consequences of its framing as either a disease or a health risk 
(Gard 2011b; Patterson & Johnston 2012; Saguy 2013; Guthman 2013) also make the 
question of its inclusion in multiple conditions analyses similarly fraught. From a 
population health perspective, one of the problems with classifying obesity as a disease 
is the danger that this frames it as a medical problem within individuals, requiring 
clinical interventions such as bariatric surgery, drugs to aid weight loss and targeted 
weight-loss interventions (Saguy 2013), rather than as a problem of societies, requiring 
action to address the problematic social, political, economic and environmental 
circumstances that collectively contribute to weight gain in individuals (Moodie et al. 
2013; Schrecker & Bambra 2015).  
Whether it is included or excluded, the decision cannot (or, at least, should not) be 
separated from these wider debates surrounding obesity, nor those discussed in 
previous sections in relation to the medicalising of risk and overdiagnosis. Having 
considered these issues, it is clear that including obesity has the potential to reify its 
status as a disease and health risk (even if done tacitly), especially as other studies often 
look to previous practice to help frame definitional decisions. In contrast, excluding it 
could be framed as an explicit rejection of its disease status and associated health risk 
which, depending on the justification given, could be aligned with the arguments of 
those who question the existence of negative health consequences resulting from 
obesity, for example the Health at Every Size and Fat Acceptance movements discussed 
in Saguy (2013).  
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Mental health problems and disorders 
The themes discussed in this chapter have particular resonance in the context of 
problems and disorders that affect psychological functioning, such as thought 
processes and emotions, as distinct from those with only a physiological element. The 
former of these is often grouped under the umbrella term mental health, in 
juxtaposition to physical health, though the notion that such a binary distinction exists 
between these concepts is generally considered unhelpful (Rogers & Pilgrim 2005). 
The debates surrounding the nature and construction of disease are amplified in this 
domain, with the dividing line between being mentally well and mentally ill a much 
contested territory, not just historically but still also today (Leader 2011; Pietikainen 
2015). As with the discussion of obesity, the point of what follows is not to adjudicate 
on this and other controversies in this field. Rather, the point is to highlight the 
existence of such debates and draw out their implications for the study of ill-health in 
populations. The implications are somewhat wider ranging than was the case with 
obesity, hence the additional space devoted to this topic in the discussion that follows.  
Terminology is rarely neutral. For the purpose of this discussion, and for reasons that 
will hopefully become clear, I have chosen to use the term mental health problems to 
cover the broad range of psychological symptoms that can have a negative impact on 
people and which all people encounter at some point in their lives, and disorders to 
indicate a subset of those symptoms or collections of symptoms that represent rarer 
and more severe levels of dysfunction.  
Mental health problems and disorders occupy a pivotal position in debates about the 
social construction of health and illness (Rogers & Pilgrim 2005). This is largely 
(though not solely) because of the ongoing failure to definitively identify organic 
underpinnings for most disorders, despite many efforts to do so within the structure of 
the brain, its neurochemistry or, increasingly, within DNA (Rose & Abi-Rached 2013). 
Commenting on this failure, Paris (2013, pp.40–41) suggests: “[w]e are no closer to 
understanding the etiology and pathogenesis of mental disorders than 50 years ago”. The 
following observation reflects how this situation has shaped some people’s approach to 
mental disorders and their ontological status: 
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Biological psychiatry has failed to produce quick, convincing explanations for 
any of the mental disorders. This is because it has been unable to circumvent the 
fundamental and inherent flaw in the biological, “realist” approach—mental 
disorders don’t really live “out there” waiting to be explained. They are 
constructs we have made up—and often not very compelling ones at that. 
(Frances 2013, p.96). 
As a consequence, the identification of mental health problems is dependent on 
descriptions of symptoms which, as Pilgrim (2013) describes, brings problems because 
“they are negotiated intersubjectively in a culturally context-bound, and thus fluid or open-
textured, manner” (Pilgrim 2013, p.337). It is important to highlight that approaches 
such as those articulated in the preceding quotes do not necessarily deny the existence 
of mental disorders in humans, and the reality of the significant burdens and distress 
they can impose. Rather, their intention is to problematize their framing, origins and 
application. They are therefore quite distinct from perspectives that reject the notion 
of mental illness outright, such as the prominent anti-psychiatry figure Thomas Szasz’s 
view that mental illness was a “scientifically worthless and socially harmful” concept (Szasz, 
1974, cited in Pietikainen 2015, p.312). Although the critiques that had sympathy 
with this kind of view no longer have the influence they perhaps did in the 1960s and 
1970s, their contributions unquestionably helped shape the understandings of mental 
illness and forms of psychiatric practice that exist today (Horwitz 2011; Pietikainen 
2015). Though perhaps not in ways that they might have intended. Many cite the 
groundswell of criticisms of psychiatric practice in the 1970s (from academic circles 
and wider popular culture) as a driver of the concerted efforts that followed to develop 
a more bio-medically focussed model of psychiatry with an overt emphasis on reliable 
(i.e. replicable across time and context) classifications for conditions (Horwitz 2011; 
Kinghorn 2013). The outcome was the DSM-III, published in 1980, which radically 
moved the classification of mental disorders away from the previously dominant 
psychodynamic approaches (heavily influenced by Freud) towards symptom-oriented, 
purportedly more robust, diagnostic criteria (Shorter 2013). However, some argued 
that there was a danger inherent in this approach, namely a failure to address the 
question of validity: 
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The focus on reliability provided the justification for psychiatry to claim it was 
scientific without having to demonstrate why any of the classified entities ought 
to be considered instances of mental disorder. (Horwitz 2002, p.69).  
Another criticism of the DSM approach, from DSM-III onwards, has been its failure to 
demonstrate that its classified entities were genuinely distinct from one another, as 
opposed to being symptomatic of broader conditions or dysfunctions. For example, 
Horwitz argues that:  
…most nonpsychotic symptoms stem from general underlying vulnerabilities that 
may assume many different overt forms, depending on the cultural context in 
which they arise. Particular symptoms do not indicate underlying diseases; they 
are symbols that have a more arbitrary connection to what they represent. 
(Horwitz 2002, p.108).  
The DSM is therefore emblematic of the wider challenges associated with the 
development of classification frameworks discussed above. But those challenges are 
heightened by the lack of consensus about what constitutes mental disorder. 
Consequently, the ability to meaningfully delineate its various manifestations is 
similarly problematic. As Frances (2013, p.102) suggests: “Our classification of mental 
disorders will always necessarily be no more than a collection of fallible and limited constructs 
that seek but never find an elusive truth”. Similarly, Kinghorn argues:  
The DSM would appear to be an artifact of bricolage, a catalogue of conditions in 
which psychiatry happens to take some interest and which have historically been 
constructed as proper domains of psychiatry’s authority (Kinghorn 2013, p.59, 
emphasis in the original).  
At the crux of perhaps the most sustained critique of the post DSM-III approach to 
classification and diagnosis was its supposed lack of contextual grounding, as Horwitz 
and Wakefield have argued in relation to anxiety: “…pathology cannot be equated with the 
sheer presence of negative emotions, since bad feelings can often exist for good reasons and be 
normal” (Horwitz & Wakefield 2012, p.33). This failure to adequately address context, 
Horwitz and Wakefield argue, has been exploited by others and contributed to an 
increase in diagnoses; a process that has attracted the interest of analysts of 
medicalisation and overdiagnosis. At the heart of this problem, it is argued, is a failure 
to fully appreciate what is normal, in order to better understand and identify what is 
not (Horwitz & Wakefield 2012). Though it is worth highlighting that this critique 
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largely centres on the status of disorders with non-psychotic symptoms, such as 
depression and anxiety, where severe and dysfunctional sadness and fear exist at one 
end of a continuum that also includes less severe, arguably “normal” manifestations of 
these same emotions. Horwitz’s position is therefore based on the premise that 
psychotic symptoms, such as auditory and visual hallucinations or delusional thoughts, 
have a much less ambiguous status, though this partitioning is itself potentially 
contestable (Rogers & Pilgrim 2005).  
Conrad (2007) implicates pharmaceutical industry interests and activity in the rise in 
diagnoses of conditions such as social anxiety disorder, whereas, Horwitz (2011) argues 
that the association between such vested interests and the widespread growth of these 
types of conditions has been mediated by classificatory elasticity: 
…the DSM-III diagnostic criteria transformed a condition that was thought to be 
very serious and rare into one that was extremely common. A number of interest 
groups capitalized on this aspect of the MDD [major depressive disorder] 
diagnosis and shaped it to their own ends. (Horwitz 2011, p.42). 
In this context, therefore, a symbiotic relationship could be said to exist between the 
nature of the approach used to diagnose many mental disorders, and the potential this 
then opens up for various parties to exploit this feature for commercial or other forms 
of gain (e.g. the receipt of research funds, professional prestige) – and to further 
introduce new diagnostic labels, thus beginning the loop again.  
The DSM’s most recent, and certainly most controversial revision (Paris & Phillips 
2013), resulted in the release of DSM-5 in 2013 (American Psychiatric Association 
2014a). DSM-5 arguably now has the status of being the medical classification tool 
most widely known about beyond the confines of its own domain (see, for example: 
NHS Choices 2013a), following very public disagreements within the world of 
psychiatry. Perhaps the most notable criticism has been from Allen Frances - one of 
the architects of DSM-IV - who described DSM-5’s approval as “the saddest moment in 
my 45 year career of studying, practicing, and teaching psychiatry” (Frances 2012, para. 1), 
chiefly due to his concern that its further loosening of diagnostic criteria would lead to 
“diagnostic hyperinflation” (Frances 2012, para. 22). Such hyperinflation, he argues, 
diverts attention and resources away from very seriously ill people towards people “with 
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the everyday problems of life” (Frances 2012, para. 22), echoing the concerns outlined by 
Aronowitz (2009) in relation to the merging of risk and disease boundaries.    
But why do the above issues pose a challenge for the study of population health, and 
in particular, multiple conditions? A number of issues arise, chief of which is the fact 
that two simultaneous processes conspire to make the estimates of mental health 
disorders in population surveys quite problematic. Firstly, as noted in the main 
discussion, the stigma associated with these kinds of conditions can lead to under-
reporting of diagnoses to survey interviewers. Secondly, while much of the above 
discussion focused on the danger of medicalisation and overdiagnosis, underdiagnosis 
also occurs (Pierre 2013). So it would be possible for someone to be living with severe 
and impairing mental health problems in the absence of any “official” diagnosed 
disorder, which if detected by the survey might potentially warrant inclusion as a 
condition if the aim is to reflect as far as possible the true extent of people’s lived 
experience of illness – named or otherwise. Any study of multiple conditions is further 
challenged by the issue of where to set boundaries round diagnoses or symptoms; for 
example, should someone reporting a diagnosis of, or reporting symptoms of, 
depression and anxiety be counted as having two sets of problems, or just one? 
The critical challenges are therefore three-fold: how to address the issue of under-
reported psychological disorders, how to make a meaningful distinction between 
symptoms that reflect general problems and more severe disorders, and how to handle 
reported diagnoses of multiple disorders. Many general health surveys, SHeS included, 
include measures of psychological distress and / or mental wellbeing. In addition, 
studies with a specific focus on mental health symptoms and diagnoses also exist, such 
as the Adult Psychiatric Morbidity Survey in England (Mental Health Surveys 2012) 
and the National Comorbidity Survey in the USA (National Comorbidity Survey 
2005). While the aims and topic coverage of these studies may vary, they tend to share 
common methods, such as the use of validated measurement tools. The tools used in 
SHeS were intended to identify potential symptoms of non-psychotic psychiatric 
disorders and positive mental wellbeing. They were the: 
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 12-item self-completion General Health Questionnaire (GHQ-12) (Goldberg & 
Williams 1988);  
 14-item self-completion Warwick-Edinburgh Mental Wellbeing Scale 
(WEMWBS) (Tennant et al. 2007); and 
 a sub-set of items from the Revised Clinical Interview Schedule (CIS-R) (Lewis 
et al. 1992) to measure anxiety and depression symptoms, self-harm and suicide 
attempts for the sub-sample of adults interviewed by a nurse.18  
As discussed above, the most sustained criticisms levelled at survey measures of mental 
distress symptoms surround the question of whether they can, in themselves, be treated 
as proxies for psychiatric illnesses (Horwitz 2002; Horwitz 2010; Horwitz & Grob 
2011). Hence, when GHQ-12 results are presented, they are usually described as 
indicating “possible psychiatric morbidity” (Wilson et al. 2015, p.6). In clinical settings, 
diagnostic psychiatry is meant to draw on information about symptoms as well as their 
context, duration and impact (Horwitz & Grob 2011). The chief concern is that while 
population surveys cover symptoms, they rarely measure duration or impact (other 
than superficially), and in the case of the various measures included in SHeS, have no 
details about context. A person reporting symptoms of sleeplessness, sadness or anxiety 
due to a recent bereavement, or a stressful event such as an exam, job interview or 
relationship breakdown, might not, therefore, be distinguishable from someone with 
the same symptoms as a result of a serious disorder. The fact that such symptoms are 
reported with the caveats noted above about only reflecting possible conditions can 
easily be lost in subsequent citations. 
The use of surveys to identify psychiatric disorders is therefore highly problematic. The 
roots of this lie not only in the survey process itself, but in the wider difficulties 
associated with the contested ontological reality of mental health problems and 
disorders, and their labelling and diagnosis. However, simply disregarding the 
information that people have volunteered about their diagnoses and symptoms of 
                                                 
18 From 2012 onwards these questions moved to a computer-aided self-completion section of the 
interview and were asked as part of the biological module conducted by specially trained interviewers 
that replaced the nurse visit.  
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distress on these grounds would deny the reality of distressful and often disabling 
experiences. Instead, it is suggested that a critical realist approach can resolve this as it: 
“allows us to acknowledge the problem of conceptualization without reducing the whole matter 
under consideration to this (undoubted) problem” (Pilgrim 2013, p.350). Pilgrim goes on to 
argue that while the diagnostic labels of schizophrenia, personality disorder, major 
depression and anxiety disorder themselves might not add insights to the problems they 
describe, the underlying reality of what they describe remains, and that is what should 
draw our attention:  
whatever we opt to call variable experiential states of misery, many people really 
are miserable in many contexts. And so, tentatively, we might begin to trace the 
reasons why people are miserable at some times in their lives and not others. 





Implications for this work 
The various main strands of theoretical insights outlined above have influenced the 
analysis conducted in this thesis in a number of ways. Specific examples are provided 
in the next chapter, however the overarching principles that they generated can be 
summarised as follows. Quantitative analysis should:   
 explicitly acknowledge the limits of quantification and be clear that measuring 
and classification do not, in themselves, reify phenomena;  
 understand that complex human experiences, such as illness, cannot be neatly 
captured by single measures, and that some aspects of poor health or 
functioning might remain hidden to the measurement process; and 
 recognise that the act of measuring is, in itself, an exercise of power that 
potentially carries implications (for those being measured, and those doing the 
measuring) that reach beyond the confines of the discrete piece of analysis 
being conducted, and that power brings certain responsibilities.  
Therefore, deciding whether to classify someone’s reported symptoms of 
psychological distress, or their BMI above a certain threshold, or uncomplicated / 
non-symptomatic conditions such as hypertension, or even sub-clinical disease 
states such as pre-diabetes as health conditions is not simply a data processing task, 




Chapter 5 Identifying people with multiple conditions: 
integrating theory and data 
Introduction 
The previous chapters should, by now, have clearly illustrated that the definition and 
identification of conditions (and multiples of them) is not a straightforward process. 
This chapter presents the outcome of applying the theoretical insights reviewed in 
Chapter 4 to the data collected in the survey, in order to identify adults in Scotland 
living with multiple health conditions.  
Chapter 3 outlined the wide array of data that could potentially be used to identify 
health conditions. Figure 5.1 provides a summary of these. The purple boxes highlight 
questions that were asked directly of participants, the dark blue boxes illustrate 
additional information from which the presence of conditions could potentially be 
inferred (e.g. via biomarkers such as blood samples, BMI, or information on 
prescriptions). Each of these sets of data are considered in turn in this chapter. The 
issues that they present for the measurement of multiple conditions are outlined and 
the results of any further analysis conducted to inform the decision about their 
inclusion are presented. A summary of the decision made for each set of data is then 
provided. The last part of the chapter then presents the impact of the new definition 
arrived at on prevalence of multiple conditions, overall and for key sub-groups in the 
population. The next chapter then takes this definition and explores the life 
experiences of people with multiple conditions in more detail.  
In amongst the various conceptual and measurement challenges outlined in Chapter 
2, it was noted that Fortin et al. (2012) recommended that multiplicity be defined as 
both two or more, and three or more, conditions, in order to better delineate the 
experiences of older populations. However, in line with the majority of the literature 
in this field, and to enable comparisons to be more easily drawn between the estimates 
generated here and those published in other sources, a threshold of two or more has 










Long-term conditions: unprompted 
Summary of prevalence 
In 2008-2011, based on the question that asked people to report long-term conditions 
(LTC) without any prompting, 17.2% of adults aged 16 and over in Scotland reported 
two or more, 24.9% reported one condition, and 57.9% said they had none. 
Prevalence of multiple conditions was a little higher in women (18.8%) than men 
(15.5%). As Figure 5.2 illustrates, prevalence increased markedly with age, though at 
no point did a majority of any age group have multiple conditions. The extent to 
which this corresponds with prevalence estimates from other sources (e.g. in Barnett et 
al. (2012) or McLean et al. (2014)) is discussed at the end of the chapter.  
Figure 5.2 Prevalence of multiple long-term conditions (unprompted question) in 
adults aged 16 and over, by sex and age group, SHeS 2008-2011 
 
As noted in Chapter 3, the individual conditions reported were coded and then 
aggregated to correspond with ICD 10 chapters. The prevalence of condition types, 
based on this classification, is shown in Table 5.1. The two most commonly reported 




Table 5.1 Prevalence of conditions by ICD 10 chapter, adults aged 16 and over, by 
sex, SHeS 2008-2011 
 Men Women All adults 
(16+) 
ICD 10 chapter % % % 
I Infectious disease 0.2 0.2 0.2 
II Neoplasms & benign growths 1.8 2.0 1.9 
III Blood & related organs 0.5 1.3 0.9 
IV Endocrine & metabolic disorders 6.2 8.2 7.2 
V Mental health conditions 5.0 7.1 6.1 
VI Nervous system disorders 3.7 4.7 4.2 
VII Eye complaints 1.8 1.8 1.8 
VIII Ear complaints 1.8 1.8 1.8 
IX Heart & circulatory system 11.2 10.5 10.9 
X Respiratory system 7.6 7.6 7.6 
XI Digestive system 3.8 4.9 4.3 
XII Skin complaints 1.4 1.4 1.4 
XIII Musculoskeletal system 15.0 18.2 16.7 
XIV Genito-urinary system 1.7 1.9 1.8 
XVIII Other complaints 0.3 0.3 0.3 
Sample size 12,516 16,256 28,772 
Note: Percentages are weighted, sample sizes are unweighted 
Issues to be resolved 
The overview of the information collected at the unprompted LTC question, and the 
coding applied, presented in Chapter 3, revealed two key issues that needed to be 
resolved to ensure that the data reflected people’s condition status as accurately as 
possible: 
1. The aggregation of multiple conditions with the same code; and 
2. The aggregation of individual condition codes into ICD chapter-level groups. 
These acts transform the information collected directly from participants into data 
items for specific reporting purposes, but they clearly have the potential to lose some 
of the more finely grained information about people’s illness experiences. However, if 
the two reported conditions were more akin to two sets of symptoms related to one 
condition (e.g. pain and immobility as a consequence of arthritis), rather than two 
distinct, and therefore multiply experienced, conditions, removing the aggregation 
could add more noise than signal. For example, the discussion in Chapter 4 of 
problems associated with the diagnosis and classification of mental health problems 
highlighted the fact that dispute surrounds the distinction between anxiety and 
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depression. Horwitz (2011) describes them instead as symptoms of a single overarching 
syndrome or vulnerability. However, the collective insights discussed in Chapter 4 
surrounding illness classification and the experiences of people living with long-term 
conditions, and in particular the profound disruption to lives that can accompany 
diagnoses, coupled with a concern not to privilege one set of accounts over others, led 
me to be distinctly uncomfortable with the idea of aggregating conditions with the 
same codes, or within the same ICD chapters, and counting them only once, without 
first inspecting the answers and coding directly.  
To explore the impact of the two stages of aggregation, the data were re-processed to 
remove the aggregation (adapting the syntax documented in the derived variable 
specification supplied with the public dataset, see Appendix F). This, alongside access 
to the anonymised free-text data, enabled me to see what kinds of conditions ended up 
being aggregated, and what impact it made on overall population estimates. In total, 
26 of the 40 condition codes were used more than once for the same individual. A 
selection of the most common conditions for which multiple codes were applied is 
presented in Table 5.2. (Note that these figures relate to the raw frequencies in the 
dataset, not weighted population prevalence estimates, and therefore do not match the 
figures in Table 5.1 above). Unsurprisingly, the mental illness code (which, as already 
discussed, covers a broad range of conditions) was the most commonly applied on 
multiple occasions for the same individual: 6.2% of participants overall had a 
condition coded as a mental illness, just under 10% of whom had in fact mentioned 
more than one such condition (the majority of whom mentioned two). The next most 
commonly multiply-applied code was for “other problems of bones/joints/muscles”, 




Table 5.2 Prevalence of the same long-term condition codes being used more than 
once for same individual (selected conditions), SHeS 2008-2011 












 % n % n % n % n % n 
Total with 
condition 
6.2 1782 7.6 2169 4.3 1241 3.3 936 9.3 2665 
No. of codes 
applied 
          
One  90.3 1609 94.4 2056 95.2 1182 95.6 895 97.4 2596 
Two  8.3 148 5.1 112 4.7 58 4.3 40 2.6 69 
Three  1.2 22 0.4 0 0.1 1 0.1 1 - - 
Four  0.1 2 0.0 1 - - - - - - 
Five  - - - - - - - - - - 
Six  0.1 1 - - - - - - - - 
Note: Percentages and sample sizes are unweighted 
 
The most important points to note from Table 5.2 are that multiple uses of the same 
condition codes was generally rare, and that where it did happen to any great extent 
(e.g. in 5% of cases and above), the condition codes were themselves very broad and 
covered a number of distinct – though linked – conditions. Table 5.3 provides some 
examples from the free text data that help to illustrate the kinds of conditions that 
were coded multiple times, but which prior to the disaggregation process, would have 
originally only been counted as one condition. 
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Table 5.3 Examples of multiple conditions with the same code reported within the 
same individual, SHeS 2008-2011 
Sex / age group Conditions 
 Mental illness/anxiety/depression/nerves  
Male, 35-44 Schizophrenia + alcoholism 
Male, 45-54 Bipolar depression + obsessive compulsive disorder 
Male, 45-54 Alcoholism + agoraphobia  
Male, 35-44 Asperger’s syndrome + dyslexia + anxiety + depression 
Female, 35-44 Agoraphobia + paranoia + methadone treatment 
Female, 55-64 Depression + panic attacks + anxiety 
 Other problems of bones/joints/muscles 
Male, 55-64 Below knee amputation + other ankle needs surgery 
Female, 55-64 Right hip replaced twice + left hip requires surgery 
Female, 55-64 Osteoarthritis of knee + rheumatoid arthritis of hand 
Female, 75+ Arthritis + polymyalgia rheumatica 
 
With the number of multiply coded cases being so small numerically, the impact of 
this disaggregation on overall population prevalence would be limited. However, the 
fact that it occurred most commonly for the codes that were quite broad, and the 
examples highlighted in Table 5.3 show that people were indeed mentioning illness 
experiences that could appropriately be described as multiple rather than singular, 
suggests that disaggregating the data in this way reveals additional insights that have 
been lost as part of the data processing. Even if the impact was minimal, following the 
principle that the data should reflect, as closely as possible, people’s illness experiences 
meant that I decided this was an important step to take.  
Having made the decision to count all conditions with identical codes as discrete 
entities, the same logic was then applied to the chapter-level disaggregation. Table 5.4 
shows the prevalence of reporting multiple conditions under the same ICD chapter 
headings, for the four most common chapters with four or more associated codes. 
Prevalence of reporting multiple conditions within these chapters ranged from 13% 




Table 5.4 Number of conditions reported within selected ICD 10 chapter codes, 
adults aged 16 and over, SHeS 2008-2011 
 ICD 10 Chapter 
 Musculo-
skeletal 
Circulatory Respiratory Digestive 
Number of conditions reported  % N % N % N % N 
One 87.0 4745 88.2 3226 94.1 2110 93.6 1238 
Two 12.4 679 11.0 403 5.6 126 6.3 83 
Three or more 0.6 33 0.9 30 0.3 6 0.2 2 
Sample size 5457 3659 2242 1323 
Note: Percentages and sample sizes are unweighted 
Comparing the figures in Tables 5.4 and 5.3 shows that many more people “lost” an 
additional condition in the process of aggregating codes into chapters than did so 
when multiple identical codes were aggregated. This is reflected in the net change 
figures presented in Table 5.5 which show that ungrouping the chapters, and therefore 
counting conditions based on the 40 underlying codes, not the 15 grouped chapters, 
had more of an impact on the prevalence of multiple conditions than did the 
disaggregation of duplicate codes. As the final rows in the table show, together they 
result in around an additional 2% of people being classified as having multiple 
conditions (10% of all those with conditions).  
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Table 5.5 Impact of disaggregating the long-term conditions data on estimates of 
numbers of conditions (all adults), SHeS 2008-2011 
All adults 

















% n % n % n B-A C-B C-A 
0 57.9 15,617 57.9 15,617 57.9 15,617 n/a n/a n/a 
1 24.9 7,546 23.5 7,090 23.0 6,923 -1.4 -0.5 -1.9 
2 11.2 3,593 10.9 3,520 10.9 3,506 -0.3 0 -0.3 
3 4.3 1,445 4.9 1,605 5.0 1,644 0.6 0.1 0.7 
4 1.3 447 1.8 600 1.9 641 0.5 0.1 0.6 
5 0.3 113 0.7 248 0.8 279 0.4 0.1 0.5 
6 0.0 11 0.3 92 0.5 162 0.3 0.2 0.5 
2+ 17.2 5,609 18.5 6,065 19.1 6,232 1.3 0.6 1.9 
Mean 
conditionsa 
1.6 13,155 1.7 13,155 1.8 13,155 0.1 0.1 0.2 
Median 1.0  1.0  1.0  n/a n/a n/a 
Note: Percentages are weighted, sample sizes are unweighted. 
aMean and median conditions numbers are based on all those with a condition. 
 
Overall, 6% of people were identified as having an additional long-term condition 
once the data were completely disaggregated. Of these people, most (83%) had just 
one additional condition, while 15% had two, and the remaining 2% had up to five 
more. Perhaps more critically, a third (33%) were newly classified as having two or 
more conditions as a result of this process, while the remaining two-thirds already had 
two or more conditions before the disaggregation. This means that the process more 
often added information about the extent of conditions among people who already had 
multiple conditions, rather than uncovering evidence of multiple conditions that was 
masked by the aggregation process.  
Summary of outcome 
All conditions mentioned, whether they attracted the same codes, or were grouped 
within the same ICD chapter, were counted as discrete entities for the purpose of 
identifying people with multiple conditions. 
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Table 5.6 Impact on multiple conditions prevalence of ungrouping chapters and 
counting all conditions, SHeS 2008-2011 




Number of conditions % % 
None 57.9 57.9 
One 24.9 23.0 
Two or more 
 -No change 










Mean no. of conditionsa 1.6 1.8 
Median 1.0 1.0 
Sample size 
All adults 16+: 28,772 
All with conditions: 13,155 
Note: Percentages are weighted, sample sizes are unweighted. 
aMean and median conditions numbers are based on all those with a condition. 
 
Specific named conditions 
Summary of prevalence 
The prevalence of directly reported, doctor-confirmed, CVD conditions is shown in 
Table 5.7. Hypertension was by far the most commonly reported condition. The 
figures here are for those defined as currently having hypertension, based either on 
their receipt of treatment or reported hypertension status, not the lifetime prevalence 
of ever having been diagnosed with this. As described in Chapter 3, recent incidence 
of stroke, heart attack and angina was established as well as lifetime prevalence.  
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Table 5.7 Prevalence of doctor-diagnosed named CVD conditions, adults aged 16 and 
over, by sex, SHeS 2008-2011 
 Men Women All adults 
(16+) 
CVD condition % % % 
Hypertension (current) 17.6 19.0 18.3 
Diabetes 6.0 4.5 5.2 
Angina    
 Ever 5.1 4.4 4.8 
 In past 12 months 2.8 2.7 2.8 
Myocardial infarction    
 Ever 4.5 2.3 3.3 
 In past 12 months 0.6 0.3 0.4 
Stroke    
 Ever 2.9 2.6 2.7 







Note: Percentages are weighted, sample sizes are unweighted 
aSample sizes vary due to different levels of non-response for each question, figures shown are the 
lowest and highest of the range. 
 
Concordance between unprompted LTC and CVD condition reporting 
Given the nature of the conditions covered by the CVD questions it might be 
reasonable to expect there to be a high degree of overlap between the answers given to 
these and the previous, unprompted, LTC question. However, analysis of the answers 
given revealed a significant degree of discordance between responses which, in 
common with previous studies (Johnston et al. 2009), suggest that relying solely on the 
initial LTC question leads to a significant underestimate of the conditions people live 
with. To illustrate, 5.3% of adults reported hypertension at the LTC question but 
18.3% were classified as having current hypertension based on the directly asked 
questions set out in Figure 3.3 (Chapter 3).  
The results presented in Table 5.8 highlight the extent of the discordance between the 
reporting for a selection of the conditions. It shows that while the majority of people 
who reported a condition at the LTC question also mentioned it when asked about it 
directly; the reverse was not the case. The kappa statistic, reported in the final column, 
provides a numeric summary of the degree of agreement between the two sets of data: 
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0 would indicate none, 1 would be perfect agreement (Kirkwood & Sterne 2003). As 
outlined in Figure 3.3 (Chapter 3), historic (no longer present) conditions have been 
excluded, as far as possible, from the directly-reported hypertension and diabetes 
definitions by excluding women who only reported these conditions during pregnancy, 
while for hypertension, people were only included in this analysis if they said they were 
currently being treated for it, or who reported still having high blood pressure without 
treatment. Results for stroke and MI/angina are presented separately for those with 
events in the previous 12 months and those occurring longer ago.  
Table 5.8 Correspondence between unprompted and directly reported conditions, 
SHeS 2008-2011 
 Proportion of those 
who mentioned a long-
term condition, who 
also directly-reported a 
doctor diagnosis of it 
Proportion of those 
with directly-reported 
doctor-diagnosed 
conditions, who also 





Condition % %  
Hypertension 98 28 Moderate-poor 
(0.39) 
Diabetes 97 73 Excellent (0.83) 
Stroke ever 92 31 Fair-good (0.46) 
 Within past yeara  49 n/a 
 Over a year ago  28 n/a 
Heart attack or angina 97 31 Fair-good (0.45) 
 Within past year  46 n/a 
 Over a year ago  17 n/a 
aThe LTC question did not record when stroke, heart attack or angina had occurred so Kappa values 
can’t be estimated for these separately.  
Note: Appendix J, Table J1 provides a comparison of 2008-2011 and 2012-2013 results for 
hypertension and diabetes (for the discussion in Chapter 7). 
Clearly there will be many reasons underlying such discrepancies, some of which could 
indicate that people’s understanding of the LTC question did not match the 
intentions of the survey designers’ (a rationale aligned with the Total Survey Quality 
framework discussed in Chapter 3). In contrast, the fact that the discrepancy reduced 
somewhat for stroke, MI and angina when cases occurring more than a year ago were 
excluded, suggests that some of these reported diagnoses related to experiences that 
had perhaps ceased to have immediate consequences for people. However, much of 
the discussion in Chapter 4 of the nature and meaning of disease, classification, 
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medicalisation, overdiagnosis and illness experiences, instead highlights an alternative 
set of factors, beyond simple comprehension of survey instruments, that might lead to 
people’s interpretation of questions about their health varying in the ways illustrated 
here. Hypertension is perhaps the most telling example of this. Most epidemiological 
studies of multiple conditions in the literature include hypertension in their 
definition, but the results here suggest that while people acknowledge they have raised 
blood pressure, they don’t necessarily identify with it as a long-term condition in the 
way it tends to be framed clinically. However, the fact that someone doesn’t report a 
condition in these terms does not, of course, mean it has no consequences for their 
lives, either in terms of how they engage with the work of being treated for a condition 
(e.g. by taking medication, making lifestyle changes and undergoing frequent 
monitoring), or more seriously in terms of the long-term consequences for their 
health.  
Issues to be resolved 
The key issue arising from the discrepancies described above is whether to add these 
directly reported conditions to the measure based on the LTC question (thus 
increasing the number of conditions included). My initial concern with taking this 
approach was whether it could be seen as privileging clinical definitions over people’s 
self-reported, unprompted illness experiences. The LTC question does, after all, ask 
people to report conditions that “trouble” or “affect” them, so it might well be 
appropriate to exclude uncomplicated hypertension and diabetes from a measure of 
multiple conditions that is attempting to reflect lived experiences. However, it is also 
true that the conditions included under this heading can be associated with significant 
treatment burdens and adjustments to life (including to people’s identities), following 
their onset. Another concern lies with the potential for overdiagnosing people at the 
less severe end of the disease spectrum, especially in relation to hypertension, thereby 
adding significant additional heterogeneity to the multiple conditions measure, 
resulting in a definition that has much less potential to reflect the experiences of 
people with more severe needs (as Aronowitz (2009) cautioned against). Of the 
conditions under scrutiny here, hypertension arguably was the one with the most 
problematic status as it showed the largest reporting discrepancy. It therefore 
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warranted further investigation via survival analysis using the 1998 survey data linked 
to mortality records. 
Longitudinal analysis of undeclared hypertension  
The following six groups were identified from among adults aged 16-74 and over who 
participated in the 1998 survey and agreed to their data being linked to NHS and 
mortality records. People classified as having undeclared hypertension (UDH) in this 
analysis obviously hadn’t mentioned hypertension as an LTC, while some of the 
people with conditions and no UDH will have done:  
1. One long-term condition, and undeclared hypertension (UDH) 
2. One long-term condition, no undeclared hypertension (no UDH) 
3. Two or more long-term conditions, and undeclared hypertension (UDH) 
4. Two or more long-term conditions, no undeclared hypertension (no UDH) 
5. No long-term conditions, and undeclared hypertension (UDH) 
6. No long-term conditions, no undeclared hypertension (no UDH) 
These groups’ mortality risk (all-cause) over 14 years and 9 months of follow-up was 
assessed using survival analysis in the form of Kaplan-Meier plots and Cox 
proportional hazard modelling. Group 1 was clearly of most interest in this analysis as 
they represent the people who would be newly counted as having multiple conditions 
if their undeclared hypertension was included in the definition. If their mortality risk 
was akin to that seen for the existing two groups of people with multiple conditions 
(groups 3 and 4) this would suggest that it could be justified to re-classify them as 
having multiple conditions on the grounds of their shared health consequences / 
experiences. In addition, if survival was demonstrably lower among people already 
identified as having multiple conditions but who also had undeclared hypertension 
this would suggest that its addition to the overall measure would better capture their 
overall health status and disease burden. If, however, the people in group 1 had a 
survival profile more similar to people with one condition or none (groups 2, 5 and 6), 
it might suggest that re-classifying them would potentially diminish the multiple 




The Kaplan-Meier survival plot in Figure 5.3 shows the cumulative survival trajectories 
for each of the six groups (the key group of interest, 1, has a dotted green line). The 
first point to note is that mortality risk increased in line with increasing condition 
numbers, but that undeclared hypertension was also strongly associated with increased 
risk of mortality. The people who reported no conditions at all had the highest 
probability of survival, while the group with multiple long-term conditions and 
undeclared hypertension (group 3) had the lowest. At the beginning of the follow-up 
period, up to around 50 months, group 1’s survival curve was indistinguishable from 
those of the two groups with multiple conditions (groups 3 and 4). From around 50 
months onwards survival became progressively less likely for groups 1 and 3. These 
patterns clearly demonstrate that people with undeclared hypertension have a higher 
risk of death, particularly if other conditions are also present. 
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Figure 5.3 Kaplan-Meier plot of survival among adults aged 16-74, for the six long-
term condition and undeclared hypertension (UDH) status groups (14.9 years’ follow-up), 
SHeS 1998-SMR linked data  
 
An obvious explanation for these patterns would, of course, be confounding by age – if 
group 1’s age profile was older than the other groups’ then this increased risk of 
mortality could simply be a function of that. To explore this, additional analysis was 
required that could take account of these potential confounders. The obvious choice 
would be to estimate Cox proportional hazards ratios (CPHR) for groups 1-5, with 
their risk of mortality compared to group 6’s (no conditions, no hypertension), first 
with no adjustments and secondly following adjustment for age and sex. However, the 
lines in the Kaplan-Meier plot above, and in the log-log plots shown in Appendix G, 
indicate that the proportional hazards assumption has not been met with these data 
(the lines cross at different points over time). Therefore, instead of estimating CPHRs, 
0 conditions & no UDH (6) 
1 condition & no UDH (2) 
0 conditions & UDH (5) 
>1 conditions & no UDH (4) 
1 condition & UDH (1) 
>1 condition & UDH (3) 
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odds ratios (OR) were estimated with death as the outcome, using binary logistic 
regression. An OR lacks the additional sophistication of factoring in time to events, as 
a CPHR does, so would not be the ideal choice of measure if the primary focus of this 
thesis was to explore the association between multiple conditions and mortality. 
However, as a mechanism for exploring whether the different groups identified above 
have different mortality risks, in order to help inform decisions about how to define 
multiple conditions, the odds ratios presented in Table 5.9 meet this purpose. They 
show that while this adjustment did indeed reduce the risk of mortality for group 1 
notably, their OR remained closer to those for the two groups already defined as 
having multiple conditions.19  
Table 5.9 Unadjusted and adjusted ORs for mortality in adults aged 16-74 at baseline, 
by condition number and undeclared hypertension status, SHeS 1998-SMR linked data 




(reference group: no 




95% CIa  Adjusted OR 
(sex and age) 
95% CIa 
(1) One long-term condition, 
and undeclared 
hypertension 
10.7 7.7-14.8 2.9 2.0-4.2 
(2) One long-term condition, 
no undeclared hypertension 
2.5 2.1-3.0 1.6 1.3-1.9 
(3) Two or more long-term 
conditions, and undeclared 
hypertension 
12.8 9.3-17.6 3.5 2.5-5.0 
(4) Two or more long-term 
conditions, no undeclared 
hypertension 
6.4 5.3-7.8 2.6 2.1-3.2 
(5) No long-term conditions, 
and undeclared 
hypertension 
5.0 3.5-7.2 1.3 0.9-2.0 [n.s.] 
ap value for all ORs <0.001, unless otherwise stated. 
 
These analyses were conducted to help inform the decision about whether to include 
these additional cases of hypertension in the multiple conditions measure. Viewed 
                                                 
19 CPHRs were also estimated and, despite the problem with the non-proportional risks, these results 
showed almost identical overall patterns. 
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solely through a clinical lens this additional analysis could be seen as unnecessary: 
hypertension is a known risk factor for cardio-vascular events and mortality, as 
reflected by the fact its identification and treatment is incentivised through the Quality 
Outcomes Framework (QOF) which currently generates part of the income for GP 
practices (ISD Scotland 2010a). However, the additional insights provided by the 
sociological perspectives outlined in Chapter 4 raised sufficient questions about its 
status to warrant it first being subject to this further scrutiny.  
Diabetes, stroke, MI and angina were also subject to varying degrees of under-reporting 
(as shown in Table 5.8). Overall, however, the numbers of cases were too small to 
enable the survival analysis presented above to be replicated for these conditions. 
Instead, the decision to include these conditions was taken on the basis of their likely 
treatment and life burden.  
Summary of outcome 
The following reported doctor-diagnosed conditions that had not been mentioned 
unprompted as long-term conditions were included in the definition of multiple 
conditions:  
 hypertension (if currently treated, or if untreated, still high; excluding 
pregnancy-related cases); 
 diabetes (excluding pregnancy-related); 
 MI, angina or stroke if occurred within the past 12 months. 
The timing stipulation was included for MI, stroke and angina due to the possibility 
that people not mentioning these if they occurred more than 12 months ago had 
reached a point of recovery where they no longer imposed a significant burden on the 
participants (either physically or psychologically). 
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Table 5.10 Impact on multiple conditions prevalence of adding previously 
unmentioned doctor-diagnoses of diabetes, hypertension, stroke/MI/angina (in past 12 
months), SHeS 2008-2011 
 Original Addition of: diabetes, 
hypertension, 
stroke/MI/angina (in 
past 12 months)  
Number of conditions % % 
None 57.9 52.7 
One 24.9 23.8 
Two or more 
 -No change 










Mean no. of conditionsa 1.6 1.9 
Median 1.0 1.0 
Sample size 
All adults 16+: 28,772 
All with conditions: 13,155 
aMean & median no. of conditions is based only on those with conditions. 
Note: Percentages are weighted, sample sizes are unweighted. 
 
Other health problems 
Summary of prevalence 
Other health problems (OHP) were reported by 14.7% of adults aged 16 and over (in 
contrast, 42.1% of adults reported at least one LTC). A total of 4,651 OHPs were 
assigned a valid code, with 6% judged unclassifiable, suggesting a broader range of 
issues were mentioned than was the case for LTCs where <1% could not be coded. 
Table 5.11 presents the prevalence of conditions reported grouped by ICD 10 chapter, 
for those who reported having an OHP. Problems related to the musculoskeletal 
system were by far the most commonly reported (20.7%), followed by respiratory 
(13.6%), digestive (13.4%) and endocrine / metabolic (10.4%) system problems. Note 
that these groupings have been used for summary reporting purposes only; the data 
were used in their disaggregated form for all the analyses presented below and for the 
purposes of identifying people with multiple conditions. 
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Table 5.11 Prevalence of other health problems reported by ICD 10 chapter, adults 
aged 16 and over who reported an additional health problem, by sex, SHeS 2008-2011 
 Men Women All adults 
(16+) 
ICD 10 chapter % % % 
I Infectious disease 0.4 0.3 0.3 
II Neoplasms & benign growths 4.0 6.0 5.1 
III Blood & related organs 1.1 3.3 2.3 
IV Endocrine & metabolic disorders 6.6 13.4 10.4 
V Mental health conditions 5.4 6.0 5.8 
VI Nervous system disorders 4.3 6.0 5.2 
VII Eye complaints 5.0 3.5 4.2 
VIII Ear complaints 5.0 3.2 4.0 
IX Heart & circulatory system 4.2 3.8 4.0 
X Respiratory system 15.0 12.4 13.6 
XI Digestive system 13.8 13.0 13.4 
XII Skin complaints 6.8 4.7 5.7 
XIII Musculoskeletal system 23.7 18.3 20.7 
XIV Genito-urinary system 6.1 9.1 7.8 
XVIII Other complaints 1.0 0.7 0.8 
Sample size 1826 2590 4416 
Note: Percentages are weighted, sample sizes are unweighted. 
Issues to be resolved 
A cross-sectional survey, by its very nature, captures a picture of people’s health at one 
point in time, though it can, of course, ask people to provide answers bounded by 
specific time periods, as the LTC question does. The OHP question wording provided 
no cues about the duration or severity of the problems that participants were expected 
to report, so there is a danger that some people would report transient issues with 
minimal impact. These might well have had a significant impact on people’s lives while 
they were happening, but they are not necessarily representative of a person’s longer 
term state of health and the challenges they may face as a consequence of living with 
multiple conditions on a permanent basis. Therefore, including acute episodes of ill-
health, or issues that have a very low burden, would detract from this purpose. 
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However, it was clear from reading through the free-text answers that mentioning 
short-term, self-limiting health problems such as coughs, colds and ‘flu was very rare – 
in part this would have been due to people with short-term illnesses delaying their 
interview until they had recovered, or not participating at all. And while some arguably 
less burdensome conditions were reported (for example, in one case, dandruff) this 
was the exception, not the rule. It is highly likely that the series of questions about 
specific CVD conditions, and the long-term conditions question, framed the responses 
provided about “other health problems” by priming participants to focus more on 
ongoing health issues, rather than brief episodes of ill-health. Bradburn (2004) 
provides a detailed account of the question-answering process in surveys and describes 
how priming:  
activates thoughts or ‘schemata’, that is, organized thoughts about objects or 
concepts, so that they are more accessible to consciousness and thus more easily 
come into play in interpreting the questions. (Bradburn 2004, p.8). 
Similarly, he argues that certain kinds of information are more readily retrieved by 
participants if they relate to “well rehearsed topics” that have an existing narrative to 
draw on, describing them as “chronically accessible” (Bradburn 2004, p.10). Although he 
cites birth dates and marital status as examples of these kinds of topics, enduring 
health and illness problems can – as the discussion in Chapter 4 illustrated – become 
similarly integral to people’s narratives and are therefore likely to also fall into the 
category of “chronically accessible” information.  
The chronic accessibility of more burdensome health problems might help explain 
why transient and very low burden issues tended not to be reported, but it doesn’t 
explain why some people with the same conditions – that by their nature are long-term 
– reported them as such while others reported them as an “other health problem”. The 
key issue to be resolved was therefore the fact that some of the problems reported at 
this question clearly represented long-term and potentially burdensome conditions 
which, if left out of the multiple conditions measure would underrepresent the extent 
of people’s condition burden, but some did not really meet this criteria. Excluding this 
information would therefore under-represent some people’s illness burden; however, 
including all the information would afford too much status and equivalence to some 
160 
 
very minor health issues, thus diminishing the overall measure’s ability to identify a 
meaningfully coherent sub-group in the population living with multiple conditions.  
Comparison of conditions reported as long-term and as other health problems 
Symptoms or diagnoses? 
One way of assessing the information provided across the two questions was to 
examine the nature of the descriptions people gave. The LTC question was framed 
around specific conditions whereas the OHP question, in asking about “problems” 
could be open to interpretation and perhaps generate more information about 
underlying symptoms than about diagnoses. While symptoms might more closely 
reflect people’s lived experiences of health problems, converting these into meaningful 
information about the extent of people’s multiple condition burden would be 
difficult. For example, someone might have reported arthritis as a long-term health 
condition, but then talked about its pain and associated complications as another 
health problem – so these two distinct sets of information would not represent two 
discrete conditions. 
As detailed in Chapter 3, random sub-samples of 1,000 cases with LTC and OHP free-
text answers were selected to enable detailed analysis of their contents to be 
conducted. The first reported condition was reviewed and coded using the code frames 
shown in Table 5.12.  
Information about LTCs was recorded using specific named conditions 75% of the 
time, rather than descriptions of symptoms. A slightly lower proportion, 67%, of 
OHPs involved named conditions, though still clearly a majority. In contrast, 10% of 
LTC and 14% of OHP information related to symptoms. The concern that the OHP 
information provided was universally insufficiently specific (or distinct from the LTC 
information) for the purposes of identifying additional conditions could therefore be 
largely rejected on the grounds that the nature of the information reported was broadly 
similar across the two questions.  
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Table 5.12 Classification of free-text answers on LTCs and OHPs, SHeS 2008-2011 
 LTC OHP 
Classification of condition description % % 
Specific named condition  75 67 
Broad condition / body system  10 7 
Symptom  10 14 
Treatment 2 3 
Injury  2 2 
Mixture / other 1 1 
Still under investigation n/a 3 
Historic / in remission n/a 1 
Sample size 1,000 1,000 
Note: Percentages and sample sizes are unweighted. 
Comparison of LTC and OHP reporting 
The balance of condition reporting across the two question types was explored by 
creating combined measures of conditions based on the data from both sources and 
then assessing what proportion of cases had been reported as LTC or OHP, or both. 
Table 5.13 presents the results for a selection of conditions. Note that where codes 
covered specific single conditions (rather than broader groupings), duplicate reporting 
was prevented at the coding stage, but where the code covered a broad range, then it 
was plausible for someone to have the same condition code recorded at the LTC and 
OHP questions, but related to different conditions. The figures presented are clearly 
not exhaustive in terms of all the possible conditions covered in the survey, but it 
provides sufficient evidence of the fact that the LTC question alone did not capture 
the full extent of people’s on-going ill-health burden.  
Interesting variations existed across the condition types, for example around 90% of 
arthritis and mental health conditions were reported as long-term, compared with just 
60% in the case of high cholesterol.20 The neoplasms category is perhaps the most 
                                                 
20 High cholesterol and thyroid problems are covered by the same “other endocrine/ metabolic” 
conditions code. The relatively high proportion of cases with this code among the OHP cases led to a re-
coding exercise to distinguish between high cholesterol, thyroid problems (under or over activity) and 
other problems. The analysis in Table 5-13 is based on this new variable.  
162 
 
interesting; reviewing the free-text answers suggested that some of the cases reported as 
other health problems (as opposed to long-term conditions) were in fact cancers in 
remission (with varying lengths of time since treatment stopped), while others were 
benign cysts or lumps currently under investigation. However, there were also clear 
cases of non-benign cancer currently undergoing treatment. This analysis cannot reveal 
why some people did not report cancer that was being treated when asked about long-
term conditions, but the significance of a cancer diagnosis, and the typical burden of 
the treatment required, makes it unlikely that participants had forgotten about their 
condition when asked the earlier question. It is possible that stipulating a 12 month or 
longer duration perhaps implied a degree of permanency that some people with cancer 
did not want to acknowledge, or it could simply have been a failure of the question 
wording – note that it did not include the term “illness” – which led to participants 
not reporting such conditions.  
Table 5.13 Whether conditions were reported as long-term or other health problems, 
for a selection of conditions, SHeS 2008-2011 
 What condition was reported as  
Condition type  LTC OHP Both Sample 
size 
Arthritis % 90 9 0.4 2938 
Mental health conditions % 88 10 1 1987 
Asthma % 82 19 n/aa 1800 
Thyroid problems % 75 25 n/aa 1097 
Neoplasms, lumps, cysts % 72 27 1 860 
High cholesterol % 60 40 n/ab 540 
Note: Percentages and sample sizes are unweighted. 
aSingle-coded condition, couldn’t be included in both categories. 
 
High cholesterol provides another interesting example. The LTC question asked 
people to report conditions that had “troubled” them for at least 12 months, or would 
be likely to affect them for that duration. The fact that four in ten people with high 
cholesterol mentioned these as other problems, rather than long-term conditions, will 
very likely reflect the fact that high cholesterol is something people can only experience 
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via its treatment and testing regime rather than via the symptoms the condition 
generates. Blood pressure (as discussed above) has similar features. The inclusion of 
this kind of health condition in a multiple conditions measure therefore poses a 
challenge: its impact is arguably low, if considered in terms of its consequences for 
activities of daily living, pain or treatment burden, therefore it is questionable to 
include it alongside considerably more intrusive conditions. However, people taking 
daily lipid-lowering medication, or taking steps to control it via diet or exercise, do 
have their life encroached upon, especially if they experience drug side-effects. In such 
circumstances, then, high cholesterol arguably contributes to the cumulative health 
burden of people faced with managing other conditions.  
Longitudinal analysis of other health problems  
As the above should have highlighted, the OHP data included a diverse range of 
conditions and symptoms, with varying degrees of likely severity and impact. A blanket 
exclusion of these additional insights on people’s health would explicitly privilege the 
more medically-framed questions (on LTCs and doctor-confirmed CVD conditions), at 
the expense of the voice of the participants themselves. A potential method of 
resolving the issue of how to discount less serious health problems without silencing 
people’s experiences presented itself: by integrating the insights provided by people’s 
global self-assessments of their health. As self-rated health has been found to be good 
predictor of mortality, it therefore taps an underlying reality of people’s illness 
experiences, while its social patterning reflects morbidity and mortality gradients seen 
in official data (Jylhä 2009; Au & Johnston 2014).  
The following approach was adopted: to help assess the longer-term impact of OHPs, 
and to potentially uncover the extent of their impact when compared to the long-term 
conditions people reported, survival analysis was conducted using the same approach 
undertaken for the additional hypertension data described above. This was done in 
two stages. Initially, the following six groups were identified from among the 




1. One long-term condition, and other health problem/s 
2. One long-term condition, no other health problem/s 
3. Two or more long-term conditions, and other health problem/s 
4. Two or more long-term conditions, no other health problem/s 
5. No long-term conditions, and other health problem/s 
6. No long-term conditions, no other health problem/s 
As before, group 1 (dotted green line) was of most interest – these people would be 
added to the multiple condition measure if all OHPs were included.  
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Figure 5.4 Kaplan-Meier plot of survival among adults aged 16-74 at baseline, for the 
six long-term condition and other health problem status groups (14.9 years’ follow-up), 
SHeS 1998-SMR linked data 
 
The survival plot suggests that mortality risk largely clustered around the number of 
long-term conditions people reported, with some additional effect evident for people 
who also reported other health problems, but not enough to move group 1’s mortality 
risk closer to that seen for the people already defined as having multiple conditions. 
Again, due to the non-proportional hazards, logistic regression was used to quantify 
these risks with and without adjustment for age and sex (Table 5.14).  
0 conditions & no OHP (6) 
0 conditions & OHP (5) 
1 condition & no OHP (2) 
1 condition & OHP (1) 
>1 condition & no OHP (4) 
>1 condition & OHP (3) 
166 
 
Table 5.14 Unadjusted and adjusted ORs for mortality in adults aged 16-74 at baseline, 
by long-term condition number and other health problems status, SHeS 1998-SMR linked 
data 
Condition / other health 
problem status 
 
(reference group: no 




95% CIa Adjusted OR 
(sex and age) 
95% CIa 
(1) One long-term condition, 
and other health problem/s 
3.9 2.8-5.4 2.1 1.5-3.1 
(2) One long-term condition, 
no other health problem/s 
2.7 2.2-3.2 1.6 1.4-1.9 
(3) Two or more long-term 
conditions, and other health 
problem/s 
7.8 5.6-10.8 2.6 1.8-3.7 
(4) Two or more long-term 
conditions, no other health 
problem/s 
6.6 5.5-8.0 2.7 2.2-3.4 
(5) No long-term conditions, 
and other health problem/s 
1.5 1.1-2.0  1.1 0.8-1.5 [n.s.] 
ap value for all ORs <0.01, unless otherwise stated. 
 
These results confirm the concern noted throughout that adding all the OHP data 
would provide both signal and noise, potentially diminishing the usefulness of the 
overall multiple conditions measure. Therefore a second stage of the analysis was 
conducted. This time, a person’s OHP information was only included if they also 
reported their general health to be less than good. In this way, people who reported 
additional health problems but otherwise said their health was very good, or good, did 
not have an extra condition added to the multiple condition measure. As Figure 5.5 
illustrates, as a result of this adjustment, the survival trajectory of the people who 
would be newly classified as having multiple conditions was much more similar to 
those of the other two groups with multiple conditions. The ORs presented in Table 
5.15 confirm this pattern.  
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Figure 5.5 Kaplan-Meier plot of survival among adults aged 16-74 at baseline, for the 
six long-term condition and other health problem status groups – adjusted for self-rated 
health (14.9 years’ follow-up), SHeS 1998-SMR linked data  
 
0 conditions & no OHP (6) 
0 conditions & OHP (5) 
1 condition & no OHP (2) 
 
1 condition & OHP (1) 
>1 condition & no OHP (4) 
>1 condition & OHP (3) 
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Table 5.15 Unadjusted and adjusted ORs for mortality in adults aged 16-74 at baseline, 
by long-term condition number and other health problems status (adjusted for self-rated 
health), SHeS 1998-SMR linked data 
Condition / other health 
problem status 
 
(reference group: no 




95% CIa Adjusted OR 
(sex and age) 
95% CIa 
(1) One long-term condition, 
and other health problem/s 
if general health <good 
7.0 4.7-10.5 3.7 2.3-5.8 
(2) One long-term condition, 
no other health problem/s 
2.5 2.1-3.0 1.6 1.4-1.9 
(3) Two or more long-term 
conditions, and other health 
problem/s if general health 
<good 
8.1 5.6-11.7 2.9 1.9-4.4 
(4) Two or more long-term 
conditions, no other health 
problem/s 
6.4 5.3-7.6 2.7 2.2-3.3 
(5) No long-term conditions, 
and other health problem/s if 
general health <good 
2.2 1.1-4.2  2.0 0.9-4.3 [n.s.] 
ap value for all ORs <0.02, unless otherwise stated. 
 
Summary of outcome 
Other health problems were included in the multiple conditions measure only if they 
were reported by people with less than good self-reported health. The impact on 
prevalence was as follows. 
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Table 5.16 Impact on multiple conditions prevalence of adding other reported health 
problems, SHeS 2008-2011 
 Original All other health 
problems 
added  




less than good 
Number of conditions % % % 
None 57.9 49.8 56.9 
One 24.9 27.3 22.6 
Two or more 
 -No change 














Mean no. of conditionsa 1.6 1.8 1.8 
Median 1.0 1.0 1.0 
Sample size 
All adults 16+: 28,772 
All with conditions (original): 13,155 
All with conditions (all problems added): 15,524 
All with conditions (problems added if health <good): 13,492 
Note: Percentages are weighted, sample sizes are unweighted. 
aMean & median no. of conditions is based only on those with conditions. 
Obesity 
Summary of prevalence 
Table 5.17 shows that the overall prevalence of obesity (BMI >30 kg/m2) in adults was 
27.4%, and that the vast majority of people who fell into this category had a BMI 
below the more severe threshold of 40 or more.  
Table 5.17 BMI groups and prevalence of obesity, adults aged 16 and over by, sex, 
SHeS 2008-2011 
 Men Women All adults 
BMI (kg/m2) groupa % % % 
Underweight (<18.5) 1.6 2.1 1.9 
Healthy (18.5-<25) 30.1 36.8 33.5 
Overweight (25-<30) 41.2 33.3 37.2 
Obese I (30-<40) 25.6 24.3 24.9 
Obese II (>40) 1.4 3.5 2.5 
    
All obese (>30) 27.0 27.8 27.4 
    
Sample size 10,691 13,185 23,876 
Note: Percentages are weighted, sample sizes are unweighted. 




Issues to be resolved 
The previous sections focused on all the conditions data collected in the survey via 
questions asked of participants. This section approaches the data from a new angle by 
addressing the issue of whether one specific condition or health state – obesity – 
should be included as part of the multiple conditions count. Including obesity would 
make use of the survey’s direct measurements of height and weight, from which BMI 
can be derived, and people in the obese range identified.  
As discussed in the case study in Chapter 4, obesity has a contested status as a disease 
or health condition, and its inclusion in studies of multiple conditions tends to be 
based on its availability to analysts rather than due to a priori decisions about whether 
it should be. SHeS included direct measurements of height and weight (conducted 
using a standardised protocol and calibrated equipment) from which the obesity status 
could be derived for participants who agreed to be weighted and measured. However, 
as the discussion in Chapter 4 should have highlighted, including it as a condition 
simply because it was measured bypasses any considerations as to whether it should be. 
While its status as a condition is increasingly common in US clinical and research 
practice, in the UK it is still more commonly regarded as a health risk – though often 
still requiring clinical management – so its inclusion here as a condition would stray 
into the territory of medicalisation of risk. Based on this, and other uncertainties 
related to the adequacy of the specific measure of obesity in the survey (BMI), 
discussed below and in Chapter 4, obesity was subjected to additional levels of scrutiny 
before a decision was taken on its inclusion.  
Approach taken 
Using the principle that people’s own accounts of their health experiences should be 
afforded a significant voice in this process, the first step taken was an assessment of the 
extent to which participants themselves mentioned obesity or weight problems when 
asked about long-term or other health problems. Secondly, survival analysis (of the 
same kind used in the hypertension and OHP examples above) was conducted to see if 
a negative association with mortality risk existed. If so, it could be argued that obesity 
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should be included by virtue of its impact on people’s lived experiences, regardless of 
any wider consensus surrounding its disease or risk status.  
Did people mention obesity or weight problems when asked about their health? 
Weight problems, such as obesity, did not have a distinct code within the codeframe, 
but if mentioned they should have been coded using the “other endocrine and 
metabolic conditions” code (in this context, “other” is used to distinguish this code 
from diabetes, the other condition code within this ICD chapter). As noted above, 
27.4% of adults aged 16 and over could be classified as obese (>30 kg/m2). In contrast, 
just 5.1% of adults had either a long-term condition or other health problem assigned 
the “other endocrine and metabolic condition” code (3.7% LTC, 1.4% OHP). 
However, as this code covers a number of conditions, including hyper/hypo-
thyroidism and high cholesterol, further coding was required to identify cases where 
weight was specifically mentioned as a health condition. Of the 1,240 long-term 
conditions coded as “other endocrine or metabolic” just 2.0% (n=25) were the result 
of obesity or weight being mentioned, as were 2.4% (n=13) of the 532 other health 
problems with this code – which represents 0.1% of the population overall. On the 
basis of these figures, obesity is clearly not something that participants identified with 
as either a long-term condition or health problem.  
The diagnostic specificity of BMI at the individual level is far from perfect, for example 
it cannot distinguish between muscle and fat, so a person with very developed muscles 
and very little body fat would have the same BMI as someone of the same height and 
weight who had very little muscle mass and a lot of fat. Therefore, the discrepancy 
between the prevalence of obesity (27%) and its very rare reporting as a health 
condition (0.1%), could in part be due to BMI misclassifying people’s obesity status. 
However, this is a very large discrepancy and BMI is not that imperfect a measure. The 
Scottish Intercollegiate Guidelines Network (SIGN) classification of obesity-related 
disease risk recommends that waist circumference is used in conjunction with BMI to 
assess risk in those with a BMI of 25 to <35, but a BMI of 35 and above is considered 
sufficient on its own to act as a marker of disease risk (SIGN 2010).  
172 
 
An alternative explanation could be that participants did not know their BMI was in 
the obese range. This can be assessed empirically. In 2008-2011, a random sub-sample 
of participants was asked to assess their weight and it is evident from their answers that 
most people with BMI >30 did recognise that they were at the very least overweight: 
just 6% thought their weight was about right, 69% said they were overweight and 24% 
said very overweight.21 We can therefore reject the idea that obesity was not reported 
as a health condition because people did not recognise their weight was outside the 
typically defined “healthy range” (BMI 18.5-<25).   
Longitudinal analysis of obesity  
Having looked at obesity from the perspective of participants’ reported conditions, this 
section now looks at its association with mortality, again using the 1998 SMR-linked 
dataset. The following six groups were identified:  
1. One long-term condition, and BMI >30 
2. One long-term condition, BMI <30 
3. Two or more long-term conditions, and BMI >30  
4. Two or more long-term conditions, BMI <30  
5. No long-term conditions, and BMI >30 
6. No long-term conditions, BMI <30 
As before, group 1 was of most interest, as they would be newly classified as having 
multiple conditions if obesity was counted as a condition. Both the Kaplan-Meier plot 
(Figure 5.6) and the ORs (Table 5.18) show that the risk of death was largely 
unaffected by people’s BMI status and was instead quite closely clustered according to 
their condition count.  
                                                 
21 These results come from the Knowledge, Attitudes and Behaviours module of the survey, unweighted 
sample size for the group with BMI in the obese (>30) range: 2,160. 
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Figure 5.6 Kaplan-Meier plot of survival among adults aged 16-74 at baseline, for the 
six long-term condition and BMI status groups (14.9 years’ follow-up), SHeS 1998-SMR 
linked data  
 
0 conditions & BMI <30 
0 conditions & BMI >30 
1 condition & BMI <30 
1 condition & BMI >30 
>1 condition & BMI <30 
>1 condition & BMI >30 
Note: the dotted lines 




Table 5.18 Unadjusted and adjusted ORs for mortality in adults aged 16-74 at baseline, 
by long-term condition number and BMI status, SHeS 1998-SMR linked data 
Condition / other health 
problem status 
 
(reference group: no 
conditions, and BMI <30) 
Unadjusted 
OR 
95% CIa Adjusted OR 
(sex and age) 
95% CIa 
(1) One long-term 
condition, and BMI >30 
2.6 1.9-3.5 1.3 0.9-1.8 [n.s.] 
(2) One long-term condition, 
BMI <30 
2.7 2.2-3.3 1.6 1.3-1.9 
(3) Two or more long-term 
conditions, and BMI >30  
6.8 5.2-8.9 2.3 1.7-3.1 
(4) Two or more long-term 
conditions, BMI <30 
6.5 5.2-8.1 2.7 2.1-3.4 
(5) No long-term conditions, 
and BMI >30 
1.4 1.0-1.8  0.9 0.7-1.3 [n.s.] 
ap value for all CPHRs <0.04, unless otherwise stated. 
 
Summary of outcome 
On the basis that people did not themselves identify with obesity as something that 
should be characterised as a health condition or problem (note that this does not 
mean people thought obesity was not problematic for their health, it simply means they 
didn’t classify it as a health problem), and it did not appear to confer any additional 
mortality risk over and above their underlying long-term condition count, obesity was 
not included in the measurement of multiple conditions in this thesis. 
Mental health problems and disorders 
Issues to be resolved 
Two sets of measurement issues were highlighted in the case study in Chapter 4 of 
mental health problems and disorders. Firstly, it is known that mental health 
conditions attract stigma which, in the context of a face-to-face survey interview, might 
lead to people under-reporting such issues. Secondly, the burden of mental ill-health is 
under-diagnosed such that more people are estimated to live with life-impacting 
symptoms than ever receive a formal diagnosis of them. The survey presents a number 
of options for resolving these issues. Firstly, it collected information about prescription 
medication use (for a sub-sample of participants) which could be used to identify 
people taking psychoactive drugs, which could act as a proxy for having been 
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diagnosed with a mental health condition, even if they did not report it. Secondly, it 
contained a number of measures of mental health symptoms and distress which could 
help to identify people with diagnosed conditions (based on their symptoms), or to 
identify people living with symptoms but without a diagnosis. As the discussion in 
Chapter 4 highlighted, however, the reported symptom data is particularly problematic 
as it lacks sufficient contextual information to meet the diagnostic requirements that 
would (or should) be applied in a clinical setting.  
Psychoactive prescription medication use and under-reporting of mental health 
conditions 
The following British National Formulary (BNF) (2009) codes were used to identify 
people taking medications that could be considered a proxy for having received a 
diagnosis of a mental health condition (prevalence in brackets, N=4,273): 
• 4.1.2 Benzodiazepines (anxiolytics) (0.7%) 
• 4.2.1-4.2.3 Anti-psychotics and anti-manics (0.8%) 
• 4.3.1-4.3.4 Anti-depressants (tricyclic, monoamine oxidase inhibitors (MAOI) 
& selective serotonin reuptake inhibitors (SSRI)) (8.5%) 
• 4.4.0 Stimulants used in the treatment of ADHD (0.0%) 
• 4.10.1-4.10.3 Drugs used in substance dependence (0.2%) 
Hypnotic drugs (sleeping tablets) were also identified (1.2%), but not used as a proxy 
for a mental health condition diagnosis as these can often be used on a short-term 
basis for insomnia with no connection to a long-term psychological condition.  
In total, 9.4% of adults were taking a prescription medication that potentially 
indicated an underlying mental health condition. Within this group (N=466), less 
than half (39.7%) reported a mental health condition as either a long-term condition 
or other health problem. This suggests that a substantial degree of condition under-
reporting occurred in the survey – as illustrated by the fact that the prevalence of any 
mental health condition increased from 6.2% to 11.9% after the medication data had 
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been taken into account. This raises two important questions: how much of this 
discrepancy was caused by under-reporting, and, more challengingly, why did it occur?  
Not all of the discrepancy will be due to under-reporting of conditions. For example, 
some of the people taking the older tricyclic antidepressant drugs could have been 
prescribed these for pain management or migraine prophylaxis (the nurses were not 
asked to probe this in order to identify these unlicensed uses). It is also plausible that 
in the intervening gap between the first interview and the nurse visit (in which the 
medications were recorded) some people had been newly diagnosed and prescribed 
their medication. Similarly, some of the discrepancy will be accounted for by people 
whose symptoms had reached a point (via the medication, or other mechanisms) that 
they no longer considered themselves to have the condition for which the drugs were 
originally prescribed. In which case, their lived experience and non-identification with 
the condition should arguably count for more than their medication use, though the 
illness work associated with adhering to their medications will likely still impose a 
burden in much the same way that taking blood pressure medication in the absence of 
hypertensive symptoms can. In addition, there are potential ethical issues with 
imputing information about conditions that participants choose not to disclose. 
However, it remains the case that the experiences of some people living with mental 
health conditions were not adequately captured by the survey’s data collection 
method, and therefore an important aspect of their illness experience is missing. This 
failure of the method might have occurred due to people’s unease at disclosing their 
condition to the interviewer, regardless of the circumstances, or in the case of 
interviews conducted in the presence of family members (i.e. partners, children, 
parents) it might have been their presence that led to the non-disclosure.  
Table 5.19 below compares the age and sex profiles of people who reported a mental 
health condition and those who were taking psychoactive medications but had not 
reported a mental health condition. It also presents their levels of psychological 
distress (measured by GHQ12) and low wellbeing (measured by WEMWBS). Although 
the sample available for this analysis is small, two aspects stand out very clearly: the 
people with undeclared mental health conditions were notably older, and had lower 
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levels of poor psychosocial functioning, than the people who had reported a mental 
health condition. The association between age and psychosocial functioning is 
examined in detail in Chapter 6, so will not be commented on here. However, the 
older age profile of the people with undeclared conditions raises the possibility that 
some of the under-reporting might have been caused by generational differences in 
people’s willingness to disclose information about mental health, as well as the 
possibility that some of the older people taking psychoactive medications had been 
prescribed them without being aware of an associated diagnosis.  
Table 5.19 Sex, age group, GHQ12 score of >4 and low wellbeing (>1 SD below mean) 
among people with a reported mental health condition, and people taking psychoactive 
drugs with no reported mental health condition, SHeS 2008-2011 (nurse sample) 
 All with a reported 
mental health condition 
No reported mental 
health condition but 
taking psychoactive 
medication 
Sex % % 
Men 36.9 30.9 
Women 63.1 69.1 
   
Age group   
16-24 7.9 1.2 
25-34 17.6 7.6 
35-44 23.0 13.0 
45-54 20.7 22.8 
55-64 17.9 24.0 
65-74 8.4 17.7 
75+ 4.5 13.8 
   
GHQ12 score >4 45.8 29.3 
   
Low wellbeing 46.5 34.8 
   
Sample size    
Sex / age 290 279 
GHQ12 / wellbeing 279 / 275 262 
Note: these data are based only on people who had a nurse visit. 
 
Using these un-reported cases to augment the definition of multiple conditions 
increases their overall prevalence by two percentage points, from 24.9% to 26.9% 
(using the definition arrived at based on the stages outlined above as the baseline). Of 
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those people taking psychoactive drugs but with no declared mental health condition 
(N=278), just over half (55.3%) already met the definition of having multiple 
conditions. A quarter (24.0%) had one already recorded condition so were therefore 
newly identified as having multiple conditions as a result of this imputation, while a 
fifth (20.7%) had no other reported conditions.  
The number of cases in this category was too small to enable the kind of survival 
analysis presented above to be conducted to help the question of whether this 
imputation should take place. However, a larger issue presented itself: the availability of 
the prescription data. The 2008-2011 surveys only collected prescription medication 
data from the sub-sample of adults who had a nurse visit, so while it can be used to 
answer the first aim of this work to identify people with multiple conditions, the 
limited sample size means there is only very limited scope to extend the analysis 
further to investigate their lives and circumstances. Furthermore, from 2012 onwards, 
only very limited prescription information was collected (to identify people taking anti-
hypertensive medications) so this method of imputing mental health conditions from 
prescription data is no longer possible in Scotland.  
Psychological distress symptoms 
Reported symptoms of psychological distress can sometimes be used to identify people 
with mental health conditions (both under-reported ones, and those without a formal 
diagnosis). While the information that was collected about symptoms of psychological 
distress avoided some of the problems associated with the stigma of disclosing such 
issues (the GHQ-12 questionnaire is administered via a paper self-completion while 
the CIS-R is conducted on a one-to-one basis by a nurse), the case study in Chapter 4 
highlighted a number of problems with conflating symptoms of mental distress with 
diagnoses of mental health disorders. Chief among these is the absence of contextual 
information about possible explanations for the symptoms reported that would help to 
distinguish between “normal” responses to difficult life events and ones that might 
indicate a diagnosable disorder (while acknowledging that there are difficulties 
associated with the construction of psychiatric diagnoses as well).  
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Summary of outcome 
The prescription medication data provides evidence of under-reported mental health 
conditions. However, its availability is limited and therefore its use would limit other 
analytical opportunities. In an ideal world there is an argument for carrying out the 
kind of imputation described above (for example, the Health Survey for England could 
use this approach as prescription data is collected for the majority of its participants). 
But in this context, while it serves as a useful illustration of a limitation of self-reported 
conditions, the prescription data was not used as part of the final multiple condition 
definition. In contrast, while the data on psychological distress symptoms was more 
comprehensive (for GHQ-12 at least, CISR was similarly restricted to the nurse 
sample), it was not sufficiently specific for the purposes of identifying people with 
conditions. In the analysis that follows of the lives of people with multiple conditions 
GHQ-12 has instead been used as an indicator of the contextual challenges people 
face. 
Biomarkers of possible undiagnosed conditions 
The biomarkers of hypertension, blood sugar (glycated haemoglobin – HbA1C) and 
total cholesterol collected in the nurse visit provide the final potential data source for 
identifying conditions from within the survey. Unlike the discussion in the preceding 
section, these largely serve the purpose of identifying undiagnosed conditions that 
participants were unaware of having, rather than conditions they had actively chosen 
not to disclose (though such cases are not improbable, the relative lack of stigma 
associated with these three particular conditions makes them less likely candidates for 
non-disclosure, and if they had been, they would need to be poorly controlled for this 
analysis to identify them). The prevalence of these potential undiagnosed conditions is 
shown in Table 5.20. The first point to note is that, diabetes aside, there appears to be 
reasonably high levels of potentially undiagnosed conditions, with 17% of the adult 
population without a hypertension diagnosis having elevated blood pressure, and 54% 
of the adult population having untreated high cholesterol. Integrating this information 
into the measure of multiple conditions could, therefore, have a notable impact on the 
overall prevalence and the composition of the group.  
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Table 5.20 Potential undiagnosed diabetes, hypertension, and high cholesterol in 
adults aged 16 and over, SHeS 2008-2011 (nurse sample) 
 Men  Women All adults 
Condition  % % % 
Undiagnosed diabetes: 
HbA1C >6.5% and no declared diabetes 
2.6 2.1 2.4 
Undiagnosed hypertension:  
SBP >140 mmHg or DBP >90mmHg and no 
declared hypertension  
18.8 15.1 16.9 
Undiagnosed high cholesterol:  
Total cholesterol >5.0 mmol/l and not 
taking lipid lowering drugs 
51.9 56.2 54.1 
















Note: Percentages are weighted, sample sizes are unweighted 
These prevalence figures underlie one of the key objections to using this kind of 
information for the definition being developed in this analysis: the potential for 
overdiagnosis. Allocating an additional condition status to half the population in the 
case of high cholesterol, and nearly a fifth in the case of hypertension, on the basis of 
measures taken at a single point in time, clearly crosses a diagnostic boundary for 
which surveys are not intended. While these levels of potential undiagnosed 
conditions might provide useful population health data for public health policy 
purposes, using them to diagnose conditions at the individual level is inadvisable. 
Secondly, as the intended ultimate purpose of the multiple conditions measure is to 
try and provide contextual information about the lives of people living with multiple 
conditions, using information about conditions people are unaware they have is a very 
clear departure from the person-centred approach that has been favoured throughout.  
Summary of outcome 
Biomarkers provide useful information about health risks in the population but are 
inappropriate for the purpose of identifying people with conditions.  
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New definition of multiple conditions 
Overview 
The overall outcome of the stages presented above was the development of a new 
measure of multiple conditions in the population, based on the following sources of 
information: 
 All conditions people reported when asked about long-term conditions, with 
no aggregation of identical codes and no grouping at the level of ICD chapters. 
 Additional reports of doctor-diagnosed (and still treated / symptomatic) 
hypertension. 
 Additional reports of doctor-diagnosed diabetes. 
 Additional reports of stroke, MI and angina if they occurred within the 
previous 12 months. 
 Other health problems, if people also reported their general health to be less 
than good. 
The following potential sources of information were not used in the definition: BMI 
>30; psychoactive medication use; psychological distress symptoms; biomarkers of 
potentially undiagnosed hypertension, diabetes, and high cholesterol. 
This section presents the prevalence of multiple conditions using the original and new 
definitions. It then compares various demographic characteristics of the group 
originally defined as having multiple conditions at the start of the process with the 
group identified by the end of it. This is further explored by looking at the 
characteristics of the people within the new definition based on whether their 
inclusion was a result of the definition change. The mortality risks associated with the 
two definitions are also presented. Finally, the estimates based on these definitions are 
compared with those derived from analyses of primary care data published in McLean 
et al. (2014). To aid the interpretation of proportions being compared between the 




Prevalence of multiple conditions using the original and new definitions 
Based on the new definition, 24.9% of adults aged 16 and over in Scotland had 
multiple conditions in the 2008-2011 period. This represents an increase of 7.7 
percentage points compared with the survey’s original measure of 17.2%. The 
breakdown of the nature of the change in overall prevalence in Table 5.21 shows that 
around a third of those identified as having multiple conditions were unaffected by 
the definition change, a third were newly identified as a result, and a further third had 
their number of conditions extended. 
Table 5.21 Prevalence of multiple conditions in adults in Scotland, original and new 
definitions compared, SHeS 2008-2011 
 Original New definition  
Number of conditions % (CI) % (CI) 








Two or more 
 
 -No change 












Mean no. of conditionsa 1.6  2.0  
Standard error of mean 0.008 0.011 
Median 1.0 2.0 
Sample size  
All adults 16+: 28,772 
All with conditions (original): 13,155 
All with conditions (final): 15,161 
Note: Percentages are weighted, sample sizes are unweighted. 
aMean & median no. of conditions is based only on those with conditions. 
 
Impact of the definition change on population sub-groups 
Table 5.22 compares the age, sex, area deprivation and self-rated health profile of the 
group with multiple conditions, based on the original and new definitions. People 
aged 65 and over, and those in less than good health were, in absolute terms, the 
groups most affected by the change in definition (in terms of having the largest 
increases in the proportion identified as having multiple conditions). Men and women 
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were equally affected, while the percentage point difference in prevalence increased 
gradually as deprivation increased.  
Table 5.22 Prevalence of multiple conditions by sex, age, SIMD quintile and self-rated 
health, original and new definitions compared, SHeS 2008-2011 





Total % 17.2 24.9 7.7 28,772 
      
Sex      
Men % 15.3 23.0 7.7 21,516 
Women % 18.8 26.7 7.9 16,256 
      
Age group      
16-24 % 4.0 5.4 1.4 2,553 
25-34 % 5.7 8.5 2.8 3,702 
35-44 % 10.3 14.1 3.8 4,825 
45-54 % 16.3 22.8 6.5 5,233 
55-64 % 25.6 37.0 11.4 5,064 
65-74 % 32.2 48.4 16.2 4,206 
75+ % 39.4 59.0 19.6 3,789 
      
SIMD quintile      
5th least deprived % 12.5 18.7 6.2 5,079 
4th  % 14.3 20.9 6.6 6,489 
3rd % 17.3 25.5 8.2 6,102 
2nd  % 19.0 27.8 8.8 5,484 
1st most deprived % 23.0 32.0 9.0 5,618 
      
Self-rated health      
Very good / good % 7.6 11.6 4.0 21,105 
Fair % 38.4 58.8 20.4 5,323 
Bad / very bad % 66.9 84.9 18.0 2,339 
Note: Percentages are weighted, sample sizes are unweighted 
 
The association between multiple conditions and deprivation is well established, 
particularly in Scotland (Barnett et al. 2012; McLean et al. 2014), with a key feature 
being the much earlier onset of conditions in people living in deprived areas. Figure 
5.7 illustrates this pattern: prevalence of multiple conditions among adults aged under 
65 living in the most deprived SIMD quintile reaches levels not experienced by those 
in the least deprived quintile areas for another 20 years. The absolute percentage point 
(p.p.) difference in multiple condition prevalence between the least and most deprived 
SIMD quintiles is also illustrated. It increases markedly from 5 p.p. for those aged 16-
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34, to as much as 30 p.p. for those aged 55-64, before declining again to just over 15 
p.p. in the two oldest age groups.  
Figure 5.7 Prevalence of multiple conditions (new definition) in least and most 
deprived SIMD quintiles, and percentage-point gap size, by age group, SHeS 2008-2011 
 
 
Figure 5.8 below extends this analysis and illustrates how the gap in prevalence 
between the least and most deprived areas varied according to the different definitions 
applied. When compared with the original definition, the new definition resulted in 
an increase in the absolute difference for all age groups, though the impact was much 
less notable at older ages. Most of the intervening stages also increased the gap relative 
to the original definition. This illustrates the extent to which the original definition 




Figure 5.8 Percentage point difference in multiple condition prevalence between most and least deprived SIMD quintiles, by age group and 




A key concern throughout this process was to ensure that the changes to the definition 
did not result in making the composition of the group with multiple conditions 
unhelpfully diverse in terms of their overall health status. Two pieces of evidence can 
be presented to illustrate how the new definition managed to avoid this. Firstly, Table 
5.23 compares the composition of the three sub-groups of people with multiple 
conditions highlighted in Table 5.21 above: those unaffected by the definition change, 
those newly identified as having multiple conditions, and those already identified but 
whose condition number was extended. The sex profile of the three groups was 
broadly similar, whereas the age profile of the newly identified group was more similar 
to the group with extended conditions than the group unaffected by the definition 
change. In contrast, the deprivation and health status measures were more similar for 
the unaffected and newly identified groups, with the extended conditions group 
standing out as having notably worse health, higher levels of psychological distress and 
more outpatient service use. The overriding point from this analysis is, however, that 
while the newly identified group was certainly healthier than the group whose 
conditions were extended, they were very similar to the group unaffected by the 
definition change, and hence did not constitute a group with a wholly different – 
healthier - profile.  
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Table 5.23 Multiple condition status by sex, age, SIMD quintile, self-rated health, GHQ 
12, and outpatient use, SHeS 2008-2011 
 Multiple condition status  
within the new definition  




added – newly 
identified 
Condition/s 
added – newly 
extended 
 % % % 
Total 8.8 7.8 8.3 
    
Sex    
Men 42 47 45 
Women 58 53 56 
    
Age group    
16-34 13 8 3 
35-54 32 24 21 
55-74 39 46 49 
75+ 15 23 27 
    
1st most deprived SIMD quintile 25 23 28 
    
Bad / very bad self-rated health 18 17 40 
    
GHQ12 >4 24 22 32 
    
Hospital outpatient in past 12 months 54 54 65 
    
Sample sizes    
Age, sex, SIMD 2806 2565 2804 
GHQ12 2522 2251 2467 
Outpatient in past 12 months 2802 2560 2796 
Note: Percentages are weighted, sample sizes are unweighted 
The second piece of evidence supporting this conclusion comes from longitudinal 
analysis of mortality, based on the 1998 survey. Table 5.24 presents the unadjusted 
and sex, age and deprivation adjusted CPHRs for mortality risk using the original and 
new definitions, as applied to the 1998 survey data, while Figures 5.9 and 5.10 present 
the survival plots.22 The unadjusted CPHR associated with multiple conditions was 
higher using the new definition (5.8) compared with the original (4.9), reflecting the 
older profile of the new group. After adjustment, the mortality risk associated with 
multiple conditions was similar across the two definitions (2.1 and 2.2, respectively). 
                                                 
22 The proportional hazards assumption was met for these analyses, as demonstrated by the log-log plots 
in Figures G2 and G3 in Appendix G. 
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This suggests that changing the definition did not result in creating a group with a 
healthier profile. 
Figure 5.9 Kaplan-Meier plot of survival among adults aged 16-74, using the original 





>1 condition  
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Figure 5.10 Kaplan-Meier plot of survival among adults aged 16-74, using the new 
definition of multiple conditions (14.9 years’ follow-up), SHeS 1998-SMR linked data  
 
 
Table 5.24 CPHRs for mortality in adults aged 16-74 at baseline, by multiple conditions 
– original and new definitions compared, SHeS 1998-SMR linked data 










Original definition     
One condition 2.4 2.1-2.7 1.5 1.3-1.7 
Two or more 4.9 4.2-5.6 2.1 1.4-1.7 
     
New definition     
One condition 2.1 1.8-2.5 1.3 1.1-1.5 
Two or more 5.8 5.1-6.6 2.2 1.9-2.6 
ap value for all CPHRs <0.01, unless otherwise stated. 




>1 condition  
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Comparison with estimates based on primary care data  
As noted in Chapter 2, a database of primary care data covering around a third of 
Scotland’s population in 2007 has been used to estimate prevalence of multiple 
conditions. McLean et al.’s (2014) analysis of this data source focused specifically on 
patterns by area deprivation in adults aged 25 and over, and provided prevalence 
estimates using ten-year age groups that can be easily compared with the SHeS 
estimates (the figures in Barnett et al. (2012) use larger age groups). There are four 
important points to note in Table 5.25. Firstly, the SHeS estimate based on the new 
definition for adults aged 25 and over (28.1%) is much closer to the primary care 
figure of 31.1%, than the original SHeS estimate (19.3%). Secondly, both sources had 
similar estimates for those aged 25-64 (no more than a 2 p.p. difference). However, the 
new definition still underestimates prevalence in people aged 65 and over – quite 
markedly – with the biggest difference between the sources as large as 17.1 p.p. (and 
twice this size when using the original definition). Finally, and partly explaining some 
of these figures, the SHeS figures overestimate the prevalence of people with one 
condition, relative to the primary care results, particularly for the oldest age groups. 




Table 5.25 Prevalence of multiple and single conditions in adults aged 25 and over by 
age group, SHeS 2008-2011 compared with figures in McLean et al. (2014) 






McLean et al. 
2014, Table 1 
(2007 data) 
Difference 
(SHeS new – 
McLean) 
Multiple conditions      
Age group      
25-34 % 5.7 8.5 8.1 0.4 
35-44 % 10.3 14.1 13.9 0.2 
45-54 % 16.3 22.8 23.0 -0.2 
55-64 % 25.6 37.0 38.9 -1.9 
65-74 % 32.2 48.4 59.0 -10.6 
75+ % 39.4 59.0 76.1 -17.1 









      
One condition      
Age group      
25-34 % 19.2 18.1 17.9 0.2 
35-44 % 22.8 21.6 21.8 -0.2 
45-54 % 26.1 25.4 25.0 0.4 
55-64 % 30.4 28.4 26.5 1.9 
65-74 % 31.0 27.8 22.6 5.2 
75+ % 31.8 25.8 15.2 10.6 









aThe total figures for the McLean data were estimated from the data provided in the published table 
for each age group. 
 
The above results suggest that the overall prevalence estimates in SHeS quite closely 
mirror those provided by analyses of primary care data, although with notable 
underestimates for older age groups. However, the figures presented in Table 5.26 
provide some potentially worrying information about the nature of the information 
contained within the SHeS estimates. The figures are based on adults aged 25 and over 
with multiple conditions and show what proportion of this group had any mental 
health conditions. The primary care data suggest that 43.7% of people with multiple 
conditions have at least one mental health condition, whereas the equivalent SHeS 
estimate was just 16.4%. Prevalence of mental health conditions declined with age in 
both sources, with an almost identically-sized absolute gap between the youngest and 
oldest groups. The level of underestimation within each age group was also fairly 
similar (around 25 to 32 p.p.). The concerns raised about the under-reporting of 
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mental health conditions discussed above are clearly evidenced here. Potential causes 
of this, and their broader implications, are discussed in Chapter 7. 
Table 5.26 Proportion of multiple conditions which include a mental health diagnosis 
in adults aged 25 and over with multiple conditions, SHeS 2008-2011 compared with figures 
in McLean et al. (2014)  
Mental only or mixed 
physical-mental as % of 
all those with multiple 
conditions 
 SHeS 2008-2011 
(new definition) 
McLean et al. 
2014, Table 2 
(2007 data) 
Difference (p.p.) 
SHeS new – 
McLean 
Age group     
25-34 % 40.3 72.7 -32.4 
35-44 % 36.5 66.0 -29.5 
45-54 % 26.8 54.4 -27.6 
55-64 % 15.8 41.7 -25.9 
65-74 % 6.3 31.7 -25.4 
75 and over % 4.1 36.3 -32.2 
Total 25+ % 16.4 43.7 -27.3 
     
Difference (p.p.)  
25-34 - 75 and over 
 36.2 36.4  
aThe total figures for the McLean data were estimated from the data provided in the published table 
for each age group. 
 
Conclusion 
The findings presented in this chapter illustrated the processes through which the new 
definition of multiple conditions was developed, as well as some of the implications 
for the prevalence and social patterning of multiple conditions that arose from the 
changes made. The theoretical perspectives outlined in Chapter 4, and the additional 
empirical information outlined here, were brought together to help determine what 
should and should not be included in the multiple conditions definition. This form of 
methodological triangulation reflected the wider aim to bring together different 
perspectives on people’s health conditions in an attempt to capture a more rounded 
picture of their experiences. The resulting definition was, however, something of a 
bricolage, drawing on the information to hand, rather than being able to augment this 
with any newly collected data. It therefore exposed a number of potential problems 
with the conditions data, as originally collected, and as subsequently processed; these 
are considered in more detail in the discussion in Chapter 7. Recommendations for 
how these problems might be resolved, either via changes to the way the questions are 
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asked, or changes to the way the data are used, are also provided in Chapter 7. Before 
these aspects are pursued, however, Chapter 6 takes this new definition and uses it to 
explore the wider life experiences of people with multiple conditions, principally 
through the lens of their psychological wellbeing. In doing so, it attempts to not only 
explore how multiple conditions are associated with other outcomes, but also to reflect 






Chapter 6 Living with multiple conditions 
Introduction 
Chapter 5 described the process used to arrive at a definition of people with multiple 
conditions, and illustrated the impact that decisions about its definition had on 
prevalence estimates and the composition of the group. This chapter takes this 
definition and uses it to explore aspects of the day-to-day experiences of people with 
multiple conditions, primarily using measures of psychological wellbeing. Before 
considering the detailed wellbeing results, there is a brief overview of some other 
aspects of people’s lives that are known to impact on, and be impacted by, health 
status which is intended to help contextualise the wellbeing analysis. The wellbeing 
results are then presented in three stages. Firstly, the association between the survey’s 
individual measures of wellbeing and condition status is explored using the summary 
measure introduced in Chapter 5 (no conditions, one condition and two or more). An 
extended and more finely grained measure of conditions is also used to illustrate the 
extent to which each additional condition is associated with outcomes (distinguishing 
between those with one, two, three, four and five or more conditions). Secondly, 
variations in wellbeing by conditions are explored by age group, area deprivation, and 
condition severity, with these factors explored both individually and collectively. 
Finally, the analysis explores some potential mechanisms that might help to account 
for the observed variations in wellbeing.  
Throughout these stages, careful attention is paid to the question of whether the 
experiences of people with multiple conditions are distinctive when compared with 
people with one or no conditions - either in terms of their overall level of wellbeing, or 
in the ways in which any variations in aspects of their wellbeing manifest. In addition, 
where patterns emerge that appear to be distinctive of people with multiple conditions, 
further consideration is paid to whether further sub-groups can be identified whose 
experiences stand-out from their counterparts.    
The previous chapter was focused on bringing together people with multiple 
conditions under one definition, with particular attention paid to avoiding making the 
group more heterogeneous in terms of their health status and mortality risk than was 
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the case with the original definition. In contrast, this chapter aims to explore the 
extent to which the experiences of people with multiple conditions can be highly 
heterogeneous and, most critically, socially stratified. As described in Chapter 2, much 
is already known about the association between condition numbers and outcomes 
such as psycho-social functioning. While the approach followed here replicates many 
of these analyses, it does so with the intention of using the insights gained to spur 
further thinking about their underlying mechanisms, and what they mean for the 
construction of categories such as “people with multiple conditions”.  
Selection of outcomes and rationale for analysis approach 
Just as the definition decisions taken in Chapter 5 were informed by theoretically-
grounded insights, the selection of outcomes and analysis approach chosen for this 
chapter was similarly guided. The intention is to provide more detailed insights about 
the lives of people living with multiple conditions, beyond the descriptive socio-
demographic analyses (of age, sex and deprivation status) presented in the previous 
chapter (and in the wider literature). The survey’s positive wellbeing instrument – 
WEMWBS - was selected for this purpose. The individual items within WEMWBS 
span a number of important functions central to people’s daily lives, many of which 
reflect the kinds of challenges highlighted in the illness experiences literature discussed 
in Chapter 4. Impairments in any one of these functions can be indicative of specific 
problems people face, while the cumulative experience of multiple functional 
impairments signifies a burden that is likely to have significant consequences for 
people’s quality of life.  
These data are cross-sectional so the identification of negative (or positive) associations 
between wellbeing and condition numbers cannot be used to draw conclusions about 
causation. However, uncovering the extent to which living with multiple conditions 
coincides with low wellbeing provides insights into the wider experiences and 
challenges that this group faces. Whether their experiences are a unique feature of 
their condition status is an additional important issue to consider because it might 
help to shape further thinking about the potential mechanisms operating between 
these sets of outcomes. In addition to this, however, and perhaps more challengingly, 
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their distinctiveness – or lack thereof – opens up questions about the utility of creating 
groupings of people based solely on their condition numbers and effectively assigning 
them a singular status.     
Epidemiological analysis is often concerned with ensuring that any demonstrated 
associations between risks and outcomes are, as far as is possible, not simply artefacts 
of confounding by other related factors, such as age and socio-economic status. 
Wellbeing has well established associations with both of these factors; however, the 
decision to illustrate the social stratification of these outcomes by condition number 
was guided by a concern to highlight these as important contextual factors, and not to 
treat them simply as measures whose effects need to be “controlled” for. As Charmaz 
(2010) points out, it is important that analyses of chronic illness experiences address 
contextual aspects such as these, rather than just emphasising “the relative intrusiveness 
of illness and effects on identity” (Charmaz 2010, p.8). In addition, the concern to 
highlight the heterogeneity of experiences among people with multiple conditions was 
influenced by Lofters & O’Campo’s (2012) discussion of the dangers of essentialism, 
that is, treating a socially defined group as if it had fixed characteristics and ignoring 
the sub-groups and associated dynamics that exist within it.  
Overview of measures 
Chapters 4 and 5 contained discussion of the role of symptom-based measures of 
psychological distress in identifying potentially under-reported or undiagnosed 
disorders in the general population. For the reasons outlined there, the main 
psychological distress measure contained in the survey – the GHQ12 – was not used to 
identify conditions by proxy. It is not the main focus of this chapter, either. However, 
it has been used below in the introduction to wellbeing, and later on in the chapter in 
the analysis looking at the impact of psychological distress in conjunction with 
multiple conditions on mortality. GHQ12 scores of 4 or more are generally used as a 
marker of a potential medically diagnosable psychological disorder, so this threshold is 
used here. However, as noted in Chapters 4 and 5, the absence of wider contextual 
information on people’s circumstances makes it a problematic measure of diagnosable 
disorders, so it has been conceptualised here to instead signal the presence of a level of 
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distress likely to be significantly burdensome to the person experiencing it, while 
remaining neutral on the question of whether they have a diagnosable condition.  
WEMWBS was selected because of its potential to provide a broader level of 
information about people’s social and psychological functioning, beyond the 
somewhat more symptom-focussed indicators of distress contained in the GHQ12 (for 
example, all WEMWBS questions are positively worded). WEMWBS is usually 
reported as an overall mean score (it was developed in Scotland and designed to yield a 
mean of 50.0 in the adult population). WEMWBS is not designed to be used to 
identify specific thresholds indicating particular levels of wellbeing. However, scores of 
more than one standard deviation below and above the mean have been used to 
identify people with very low and high levels of wellbeing, respectively (see, for 
example, Stewart-Brown et al. 2015). This is the approach adopted here. However, the 
14 item scale has been shown to have measurement problems, for example, when 
scaled, the 14 items do not collectively represent a single underlying dimension 
(Stewart-Brown et al. 2009). Principal components factor analysis of this dataset 
confirmed this finding (results not shown). In addition, Stewart-Brown et al. (2009) 
showed that a number of the items displayed differential item functioning (DIF), by 
age and gender – but not by long-term illness – which meant that men and women, 
and people of different age groups, with the same level of wellbeing give different 
responses to items, which introduces measurement bias. The important point is that 
DIF analysis is not designed to identify differences between men and women’s 
responses (which would be expected), but to identify where men and women with the 
same level of functioning give different answers to items. To address this, Stewart-
Brown et al. (2009) identified a shorter, seven-item scale (short WEMWBS), that did 
not have these problems, and which represented a unidimensional construct, largely 
focusing on functioning (again, the unidimensional structure of the alternative scale 
was confirmed in this dataset, results not shown). For this reason, the analysis of 
summary wellbeing in this chapter uses the short WEWMBS measure, called 
SWEMWBS hereafter (the full scale is presented in Appendix E).  
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These summary measures are helpful ways of describing population patterns, and 
facilitate making comparisons across sub-groups; however, their individual 
components are also valuable sources of contextual information about people’s lives 
and the kinds of difficulties they face. This chapter therefore presents the responses to 
the individual items (see Tables 6.1 and 6.2 below) before going on to focus on the 
summary measures. As noted in the introduction, however, it starts by contextualising 
the experience of low wellbeing by comparing it to other challenges and risks people 
face. 
Wellbeing in context 
One of the main advantages of population health surveys (such as SHeS) is the breadth 
of additional information they provide about people’s lives that is generally absent 
from clinical sources, such as GP records. Much of the contextual information 
reported in epidemiological studies centres on factors that have a negative impact on 
health, or which poor health itself contributes to, such as smoking, poor diet, high 
BMI or low activity levels. To help place this discussion of wellbeing into the broader 
context of people’s lives, this section briefly presents the association between condition 
numbers and a selection of such challenges, stratified by area deprivation, before doing 
the same for low wellbeing (>1 SD below the mean) and high psychological distress 
(GHQ12 >4). The selected aspects are: 
 Being a current or ex-smoker; 
 Having a BMI in the overweight, or the obese, range; 
 Eating fewer than two daily portions of fruit and vegetables;  
 Being physically active for fewer than 30 minutes per week.  
Rather than framing these as “behavioural” or “lifestyle” risks, they are presented here 
as examples of health “challenges” in an attempt to reflect the fact that while they 
capture aspects of people’s lives that have been measured at the individual level, they 
are also markers of much more distal, sometimes historic, and often multi-layered, 
risks and challenges. For example, some confer specific health consequences, such as 
the illnesses or symptom exacerbations linked to smoking (either now or in the past); 
others bring social stigma or attract a level of blame that can, in clinical settings, 
200 
 
negatively affect the treatment people receive or the way it is delivered (e.g. high BMI, 
current or past smoking). Others are markers of limitations on people’s personal 
opportunities (e.g. very low activity levels as a consequence of poor health); or reflect 
structural constraints, such as those imposed by income or availability on food choices.  
The challenges have been grouped to illustrate four distinct patterns that are 
identifiable. The first pattern, in Figure 6.1, reflects challenges (being overweight or an 
ex-smoker) that follow a gradient such that people in more deprived areas are at lower 
risk, though not consistently or markedly so. A BMI in the overweight range does not 
appear to be strongly related to condition numbers, whereas being an ex-smoker is 
highest among those with multiple conditions. This latter pattern will, of course, be 
additionally confounded by the different age profiles of the three condition groups, 
and historic patterns in the prevalence of smoking. The reason for the lower 
prevalence of both these challenges among the most deprived areas is explained, in 
part, by the patterns in current smoking and obesity shown below.  
Figure 6.1 Prevalence of a BMI in the overweight range, and prevalence of being an 
ex-smoker, by condition number (0, 1, 2 or more) and SIMD quintile, SHeS 2008-2011 
 
The second pattern shows that having a poor diet or being a current cigarette smoker 
are strongly related to area deprivation, but not to condition number. While at least 
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40% of people with multiple conditions living in the most deprived SIMD quintile 
face these considerable challenges, the same is also true for people with one or no 
conditions. 
Figure 6.2 Prevalence of eating <2 portions of fruit and vegetables per day, and 
prevalence of current smoking, by condition number (0, 1, 2 or more) and SIMD quintile, 
SHeS 2008-2011 
 
The next pattern is different again. Figure 6.3 shows that prevalence of having a BMI 
in the obese range, and of low activity levels, increases in a linear fashion with 
increasing deprivation, and with increasing condition numbers. The gradients follow a 
largely stepwise increasing pattern, running from those with no conditions in the least 
deprived areas through to those with multiple conditions in the most deprived areas.   
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Figure 6.3 Prevalence of being active for <30 minutes per week, and prevalence of a 
BMI in the obese range, by condition number (0, 1, 2 or more) and SIMD quintile, SHeS 
2008-2011 
 
The final pattern, displayed by the measures of distress and low wellbeing in Figure 
6.4, is quite distinct. Here the increase in prevalence with deprivation and condition 
number is curvilinear, and is particularly so for low wellbeing. The increase in low 
wellbeing with condition number is mediated by deprivation, with the result that 
people living in the least deprived areas have better outcomes than those in the most 
deprived areas, even if they have a higher condition burden (as highlighted by the 
circles in the chart). This contrasts sharply with the pattern for low activity in Figure 
6.3, where outcomes were always progressively worse for people within each SIMD 
quintile as condition numbers increased. In both sets of patterns, however, the worst 
outcomes of all are experienced by people with multiple conditions living in the most 
deprived areas.  
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Figure 6.4 Prevalence of GHQ12 score >4 and low wellbeing (SWEWMBS >1 SD below 
mean), by condition number (0, 1, 2 or more) and SIMD quintile, SHeS 2008-2011 
 
The relative strengths of the association between these factors and the likelihood of 
having multiple conditions are illustrated by the odds ratios presented below in 
Figures 6.5 (for men) and 6.6 (for women), after adjusting for age and SIMD.23 With 
the exception of overweight in men, they all conferred a significantly increased risk of 
having multiple conditions. However, the effect sizes for smoking, overweight (in 
women) and poor diet were fairly small, and could be the result of residual 
unmeasured factors. In contrast, low wellbeing stands out, having the highest odds 
ratios (4.2 for men and 3.5 for women) of all the challenges presented.  
                                                 
23 The selection of these measures, and the manner of their presentation, was deliberately modelled on 
the approach in Fortin et al. (2014). 
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Figure 6.5 Forest plot of risks associated with having multiple conditions (2 or more 
versus 0 or 1) in men, adjusted for age and SIMD, SHeS 2008-2011 
 
 
Figure 6.6 Forest plot of risks associated with having multiple conditions (2 or more 
versus 0 or 1) in women, adjusted for age and SIMD, SHeS 2008-2011 
 
Having demonstrated how low wellbeing is placed in relation to other challenges 
people with multiple conditions experience, both in terms of the nature of its social 
patterning and how it contributes to the overall risk of having multiple conditions, the 
rest of this chapter now focuses on patterns in low wellbeing and attempts to 
understand some of the mechanisms behind them. 
Current / ex-smoker 
Overweight 
Obese 
<2 Fruit & veg / day 
<30 mins activity / wk 
Low wellbeing 
Multiple conditions more likely   
Current / ex-smoker 
Overweight 
Obese 
<2 Fruit & veg / day 
<30 mins activity / wk 
Low wellbeing 
Multiple conditions more likely   
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Individual indicators of low wellbeing 
Table 6.1 presents the prevalence of responses to the individual WEMWBS items that 
indicate low wellbeing (the negative responses) so that these experiences are not 
completely lost in the analytic process (the items are presented in descending order of 
prevalence among those with multiple conditions). The analysis of outcomes presented 
in the rest of the chapter is based on the seven item summary SWEMWBS measure, 
whose items are indicated with asterisks in Table 6.1 and Figure 6.7. Figure 6.7 
supplements Table 6.1 by showing the prevalence of negative responses for each scale 
item using a finer breakdown of the number of conditions (0-5 or more). 
Both sets of results show that responses indicating low wellbeing are far higher among 
people with multiple conditions than those with just one or no conditions, while the 
results in Figure 6.7 show how low wellbeing becomes increasingly more common as 
the number of conditions increases to as many as five or more (though a couple of the 
lower prevalence indicators show some degree of plateauing). The most commonly 
reported indicator of low wellbeing  - having spare energy rarely or none of the time – 
was reported by 27.1% of all adults (this item was included in the scale as a measure of 
personal functioning). Of all the aspects covered in the scale, this item was a notable 
outlier among adults with multiple conditions, almost half of whom (47.6%) reported 
this, and which represented a 30 percentage point (p.p.) absolute difference compared 
with those with no conditions (17.7%). In contrast, the equivalent absolute differences 
between these two groups for the remaining scale items were much smaller (ranging 
from 6-14 p.p.). The results in Figure 6.7 are even more striking – over 60% of those 
with four conditions, and 70% of those with five or more reported having little energy. 
This is completely understandable, given the energy-consuming or draining nature of 
many of the conditions that people will have, and the fact that this is often a symptom 
that accompanies or signals depression. This item therefore has the potential to reveal 
insights about the experiences of people with multiple conditions over and above the 
information provided by the other individual items and illustrates the value of 
considering individual indicators as well as overall summary measures when trying to 
understand something of the lives of people with multiple health conditions.  
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The next two most commonly reported indicators of low wellbeing (having little 
optimism about the future or interest in new things) were also notable for their high 
prevalence among adults with multiple conditions, though even among those with the 
highest number of conditions the proportion reporting these two items was half that 
seen for having little energy. These items were intended to measure different 
dimensions of wellbeing (positive affect and personal development, respectively), but 
they are also both symptomatic of depression. They certainly highlight the extent to 
which people living with significant health burdens have constrained hopes about, and 
interest in, their future prospects. 
Differences in wellbeing between men and women were generally small, and where 
differences were evident, there was no consistent pattern. For example, men were more 
likely than women to say they had little interest in other people, whereas women were 
more likely than men to say they had been lacking confidence.  
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Table 6.1 Individual WEMWBS items by number of conditions (0, 1, 2 or more) and 
sex, SHeS 2008-2011 
 Number of conditions 
WEMWBS items “rarely / none of the 
time” responses 
None One Two or 
more 
Total 
 % % % % 
Men     
Energy to spare  14.0 23.8 46.3 23.6 
Feeling optimistic about the future* 16.2 21.0 30.5 20.6 
Interested in new things 8.2 13.1 24.1 12.9 
Feeling relaxed* 8.7 10.9 17.9 11.3 
Feeling useful* 6.6 9.2 19.6 10.1 
Feeling confident  4.3 7.8 16.7 7.9 
Interested in other people  8.5 11.5 19.4 11.7 
Feeling good about myself  4.3 7.1 16.6 7.8 
Feeling close to other people* 6.3 10.1 17.2 9.6 
Dealing with problems well* 4.5 6.0 13.8 6.9 
Feeling cheerful 4.0 6.2 12.6 6.5 
Feeling loved 4.5 6.7 11.2 6.5 
Thinking clearly* 2.5 4.7 9.5 4.6 
Able to make up own mind about things* 2.0 3.1 6.9 3.4 
     
Women     
Energy to spare  21.4 29.1 48.6 30.3 
Feeling optimistic about the future* 13.2 17.5 27.1 17.8 
Interested in new things 8.2 12.0 21.4 12.5 
Feeling relaxed* 10.8 13.5 20.3 13.9 
Feeling useful* 7.1 10.0 17.9 10.6 
Feeling confident  7.9 12.0 21.1 12.3 
Interested in other people  6.4 7.2 13.3 8.4 
Feeling good about myself  6.6 10.6 19.4 10.9 
Feeling close to other people* 4.8 7.0 13.2 7.5 
Dealing with problems well* 4.5 7.6 13.3 7.5 
Feeling cheerful 3.3 6.6 12.4 6.4 
Feeling loved 3.3 5.6 9.5 5.5 
Thinking clearly* 2.7 5.2 9.3 5.0 
Able to make up own mind about things* 2.1 4.3 8.2 4.2 
     
Sample sizes     
Men  5520 2794 3135 11,449 
Women  7150 3650 4240 15,040 
Notes:  
Percentages are weighted, sample sizes are unweighted;  
Sample sizes vary for each item, figures shown are the lowest of the range; 








Note: *short WEWMBS items 
 
The final results presented here compare the mean scores for each SWEMWBS scale 
item by condition number, using the extended measure (in Figure 6.8) and the 
summary measure (in Figure 6.9). It is clear from the charts above, and from Figure 
6.8, that in many instances, the experiences of people with two conditions are closer to 
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those reported by people with one condition rather than those with three, and are 
certainly very distinct from the experiences reported by people with the highest 
condition burdens. Indeed, no clear threshold presents itself as demonstrating a 
consistent point beyond which experiences differ markedly. Consequently, although 
Figure 6.9 shows that collectively the experiences of people with two or more 
conditions are notably different – in terms of their overall levels of impaired 
functioning – when compared with people with one or no conditions, the two 
conditions or more threshold is largely arbitrary when viewed purely empirically (for 
this particular outcome at least).     
Figure 6.8 Individual SWEMWBS item mean scores by number of conditions (0-5 or 
more), SHeS 2008-2011 
 
Note: scale has been truncated for clarity, items were scored from 1-5 
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Figure 6.9 Individual SWEMWBS item mean scores by number of conditions (0, 1, 2 or 
more), SHeS 2008-2011 
 
Note: scale has been truncated for clarity, items were scored from 1-5 
 
Variations in summary wellbeing  
Condition number 
Having considered the individual aspects covered by WEMWBS/SWEMWBS, Table 
6.2 and Figure 6.10 now present the SWEMWBS mean and median scores, and the 
percentage with low wellbeing (scores >1 SD below the mean). For comparison, the 
percentage with high wellbeing (>1 SD above the mean) is also shown.  
Mean SWEMWBS scores showed a statistically significant (though not necessarily 
substantively significant) decline from 25.9 for those with no conditions, to 25.2 for 
those with one, and to 23.7 for those with multiple conditions. Similarly, the 
prevalence of low wellbeing trebled between the group with no conditions (6.5%) and 
the group with multiple conditions (23.1%). In contrast, high wellbeing was only very 
weakly associated with condition numbers, with the difference between groups 
relatively small (14.0% for those with no conditions, 10.0% for those with two or 
more). The different patterns found for men and women’s individual wellbeing 
indicators balanced out across the whole population such that mean scores were 
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identical for men and women with multiple conditions, and levels of low or high 
wellbeing were also similar.  
Table 6.2 SWEMWBS summary measures by number of conditions and sex, SHeS 
2008-2011 
 Number of conditions 
 None One Two or more Total 
 % % % % 
Men     
Mean score 25.9 25.2 23.7 25.3 
Standard deviation 3.7 4.2 4.8 4.2 
Standard error 0.05 0.08 0.09 0.04 
>1 SD below mean (%) 6.5 11.5 23.1 11.4 
>1 SD above mean (%) 14.7 13.4 10.3 13.4 
     
Women     
Mean score 25.7 25.0 23.6 25.0 
Standard deviation 3.8 4.3 4.7 4.3 
Standard error 0.05 0.08 0.08 0.04 
>1 SD below mean (%) 8.4 12.7 23.9 13.4 
>1 SD above mean (%) 13.4 13.0 9.7 12.4 
     
All adults     
Mean score 25.8 25.1 23.7 25.1 
Standard deviation 3.8 4.3 4.8 4.2 
Standard error 0.03 0.05 0.06 0.03 
>1 SD below mean (%) 7.5 12.1 23.5 12.5 
>1 SD above mean (%) 14.0 13.2 10.0 12.9 
     
Sample sizes     
Men  5487 2762 3096 11,345 
Women  7084 3618 4186 14,888 
All adults  12,571 6380 7282 26,233 
Note: Percentages are weighted, sample sizes are unweighted. 
Figure 6.10 shows that both measures increased with increasing numbers of conditions 
to the point where over a third of people with five or more conditions had a 
SWEMWBS score >1 SD below the mean. In contrast, there was considerably less 
variation in scores >1 SD above the mean, with only very small declines as condition 
numbers increased. Clearly, an absence of conditions does not equate to very high 
levels of wellbeing in the same way that the presence of multiple conditions is 
accompanied by low levels of wellbeing. High wellbeing prevalence is not explored any 
further in this chapter. 
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Figure 6.10 Prevalence of SWEMWBS >1 SD below mean, and >1 SD above mean, by 
condition number (0-5 or more), SHeS 2008-2011 
 
Condition number and age group 
The headline figures reported in the previous section are now explored further to 
illustrate the way in which wellbeing differs quite markedly across the generations, and 
interacts with the number of conditions people have. Figure 6.11 shows that within 
each age group, low levels of wellbeing increase with the number of conditions 
reported, and those with multiple conditions always have the highest burden. But 
when the age groups are compared, it is clear that the absolute burden of low 
wellbeing is greatest for those with multiple conditions aged 16-64, while the 
prevalence among those aged 65 and over with multiple conditions is much lower than 
for their younger counterparts, and is in fact often closer to the levels experienced by 
those with one condition in the 16-54 age group. Therefore, it appears that adults with 
multiple conditions aged under 65 have a quite distinctive profile in terms of the 
burden of their low wellbeing, whereas those aged 65 and over share some experiences 




Figure 6.11 Prevalence of SWEMWBS >1 SD below mean, by age group and condition 
number (0, 1, 2 or more), SHeS 2008-2011 
 
 
Figure 6.12 extends the number of conditions shown and confirms that even for those 
with the highest burden of conditions, age is a critical factor shaping levels of psycho-
social functioning. Although it isn’t possible to show the age groups with the finer 
detail used previously (due to sample size limitations), people aged 65 and over with 
five or more conditions had levels of psychosocial functioning that were similar to, or 
better than, those seen among people aged 16-44 with two or more conditions, and 
people aged 45-64 with three or more conditions.  
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Figure 6.12 Prevalence of SWEMWBS score >1 SD below mean by age group and 
condition number (0-5 or more), SHeS 2008-2011 
 
Note: small sample sizes for 16-44 age group with 4 conditions (81) and 5+ conditions (69). 
 
Additional analyses of variations by age group for the individual SWEMWBS items 
showed that they follow very similar patterns regardless of condition numbers, in 
terms of the items that showed the largest and smallest differences between the age 
groups. So while the overall scores differ (as already demonstrated above) with people 
with multiple conditions typically having lower scores for each item than those with 
one condition, the underlying nature of the two groups’ wellbeing patterns are actually 
very similar (data not shown). 
Condition number and area deprivation 
Figure 6.4 at the start of the chapter showed the association between low wellbeing 
and condition number for each SIMD quintile; Figure 6.13 below replicates this. The 
progressive increase in low wellbeing by condition number is evident within each 
SIMD quintile. Furthermore, the size of the gap between people with multiple 
conditions and people with none increases markedly as deprivation increases, 
doubling between the least and most deprived quintiles. These patterns illustrate the 
way in which deprivation interacts with condition status to result in worsening 
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outcomes as deprivation increases. Another dynamic is also evident, as the impact of 
deprivation differs across the condition status groups, such that the absolute increase 
in low wellbeing related to deprivation is larger for those with multiple conditions 
than for the two other groups.  
Figure 6.13 Prevalence of SWEMWBS >1 SD below mean, by condition number (0, 1, 2 
or more) and SIMD quintile, SHeS 2008-2011 
 
 
The combination of deprivation and ill-heath therefore appears to be particularly toxic 
for people’s wellbeing: 33.5% of people with multiple conditions living in the most 
deprived areas have low wellbeing, compared with 13.5% of those with multiple 
conditions living in the least deprived areas. Conversely, and as seen with the results 
for different age groups, there are also some groups of people with multiple conditions 
who have better – or at least not notably worse – wellbeing than people with one or no 
conditions. The wellbeing of people living in the most deprived quintile who have no 
conditions, and those in the most and second most deprived quintiles who have one 
condition, is generally worse or matches that of people living in the least deprived 
areas who have multiple conditions. 
Figures 6.14 and 6.15 show the individual SWEMWBS items’ mean scores by SIMD 
quintile for people with multiple conditions, and one condition, respectively. Unlike 
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the equivalent analyses of age and SWEMWBS items discussed above, it is clear that 
both the absolute levels of low wellbeing and the nature of the variations in responses 
to items, differed by SIMD between those with multiple conditions and those with just 
one. This therefore illustrates that deprivation is not only associated with differences 
in absolute levels of wellbeing, regardless of condition number, but that it also shapes 
the way in which the individual measures underlying these summary patterns vary for 
people with multiple conditions compared to those with just one.   
Figure 6.14 Individual SWEMWBS item mean scores by SIMD quintile – among people 
with multiple conditions, SHeS 2008-2011 
 




Figure 6.15 Individual SWEMWBS item mean scores by SIMD quintile – among people 
with one condition, SHeS 2008-2011 
 
Note: scale has been truncated for clarity, items were scored from 1-5. 
 
Condition number, age and area deprivation  
The previous two sections explored the stratification of outcomes by age, a non-
modifiable risk factor, and deprivation, which is potentially modifiable, but rarely 
successfully. This section now explores the interplay of these two factors on the 
association between condition numbers and wellbeing. The aim is to better identify 
which specific groups in the population are most likely to experience impaired low 
wellbeing, and how this relates to their condition burden.  
Figure 6.16 shows the association between low wellbeing and SIMD quintile separately 
for three age groups (16-44, 45-64, 65 and over). Within each age group, low wellbeing 
increases with deprivation, and with condition number, with the highest levels of low 
wellbeing experienced by people with multiple conditions living in the most deprived 
areas. The only notable exception is the pattern seen for people aged 65 and over with 
one condition (who represent a relatively small group overall). However, the gradients 
are less steep in the 65 and over age group, which echoes the flattening with age of the 
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SIMD gradient in the overall prevalence of multiple conditions illustrated in Chapter 
5 (Figure 5.7).  
Overall, the highest levels of low wellbeing among adults with multiple conditions are 
for those aged 16-44 and 45-64 living in the most deprived SIMD quintile, and those 
aged 16-44 living in the second most deprived SIMD quintile, with around four in ten 
of these groups experiencing this. Again, as the results presented so far have shown, 
the wellbeing of people aged 16-64 who do not have multiple conditions but who live 
in the most deprived areas is often worse than the wellbeing of people with multiple 
conditions living in the least deprived areas.   
Figure 6.16 Prevalence of SWEMWBS score >1 SD below mean by condition number (0, 
1 2 or more), age group and SIMD quintile, SHeS 2008-2011 
 
The results of the final piece of analysis in this section are shown in Table 6.3, which 
presents the odds ratios (ORs) for having low wellbeing, unadjusted and adjusted for 
sex, age, deprivation and partnership status.24 For each measure, the ORs are 
presented using the two condition number summary measures (0-5 or more; 0-2 or 
more). People with one condition were used as the reference category. In this way, it is 
possible to illustrate each additional condition’s association with low wellbeing. 
                                                 
24 Partnership status was included in the model because previous studies have consistently shown it to 
be associated with wellbeing, with marriage / cohabitation positively associated with higher wellbeing.  
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Compared with people with one condition, the unadjusted odds of having low 
wellbeing increased to being as much as 4.3 times higher for those with five or more 
conditions, and were 2.2 times higher for all those with multiple conditions. After 
adjustment, these ORs changed remarkably little, to 5.2 and 2.4, respectively, and the 
four adjustment factors all remained significantly associated with having low wellbeing, 
independent of condition status. This therefore confirms that the association between 
condition numbers and wellbeing is not confounded by these additional factors (if 
they had been, the ORs would be expected to decrease).  
Table 6.3 Unadjusted and adjusted odds ratios for low wellbeing by condition 
number (0-5 or more; 0, 1, 2 or more), SHeS 2008-2011 
SWEMWBS Score >1 SD 
below mean  
Unadjusted 
OR 
95% CIa Adjustedb OR 





Number of conditions 
(p<0.001) 
    
No conditions 0.6 0.5-0.6 0.5 0.4-0.6 
One condition (reference 
category) 
1.0    
Two  1.6 1.5-1.8 1.8 1.6-2.0 
Three 2.4 2.1-2.7 2.8 2.4-3.2 
Four 3.0 2.5-3.5 3.4 2.8-4.1 
Five or more 4.3 3.6-5.1 5.2 4.3-6.2 
     
Two or more 2.2 2.0-2.5 2.4 2.2-2.7 
ap value for all ORs <0.001, unless stated otherwise. 
bOR estimates for adjustment factors are shown in Table I3, Appendix I. 
 
Condition number, severity, age and area deprivation 
This section adds a further dimension to the analyses presented above by examining 
whether the patterns seen so far are related to having a condition that limits daily 
activities.  
Conditions that limit daily activities are typically considered to be more severe, both in 
terms of their potential to shorten people’s lives, and their potential to reduce the 
quality of those lives, via the symptom burdens imposed, which are often the cause of 
the limitations that people report. A measure of activity limitations therefore captures 
aspects of both the physiological severity of a condition as well as its wider psycho-
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social consequences. The analyses presented below explore the extent to which the 
psycho-social functioning patterns outlined above are related to people’s experiences of 
limitations on their activities. A note of caution on how this was measured is necessary 
before proceeding. As Chapter 3 outlined, everyone who mentioned a long-term 
condition at the unprompted question was further probed to see if they felt that it 
limited their daily activities. No such information was collected in follow-up to the 
questions about additional CVD conditions or other health problems (which, in some 
circumstances, contributed to the multiple condition measure, as set out in Chapter 
5). This measure of limitations is therefore likely to be an underestimate, on the 
assumption that at least some of the people who mentioned other conditions or health 
problems will also have experienced some resulting limitations. This is reflected in the 
fact that 62.0% of people newly defined as having multiple conditions (via the stages 
outlined in Chapter 5) had a limiting condition, compared with 73.9% of those whose 
status did not change and 89.9% of those whose condition number was extended. For 
this reason a count of the number of limiting conditions has not been integrated into 
this analysis; it instead uses a binary measure of whether any limiting conditions were 
reported or not.  
Before looking at the role that activity limitations play in shaping people’s experiences, 
it is useful to look at the population prevalence of conditions with and without such 
limitations. In total, 26.7% of adults reported at least one activity limiting condition 
and 21.3% had at least one condition without limitations. Table 6.4 shows these 
figures split by condition number, as well as their distributions by age group and 
SIMD quintile. The most striking age-related pattern is found among people with 
multiple conditions, at least one of which is limiting, where prevalence increases from 
7.4% in the 16-44 age group to 21.7% for those aged 45-64 and to 40.5% for those 
aged 65 and over. The steepest SIMD gradient is also evident for people with multiple 
conditions and activity limitations, with prevalence just over doubling from 12.0% to 
26.4% between the least and most deprived quintiles. In contrast, differences by age 
were much less notable, and differences by SIMD were negligible or non-existent, for 
the groups with one condition (regardless of limitations), or with multiple conditions 
but no limitations. The absence of gradients for these outcomes is not typical of the 
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results usually seen in most chronic disease epidemiology and their implications are 
considered further in the discussion in Chapter 7. Focusing just on those with 
conditions, over half (55.6%) reported activity limitations, and this was very much 
linked to the overall number of conditions reported: 75.6% of adults with multiple 
conditions reported activity limitations, compared with 32.8% of those with one 
condition.  
Table 6.4 Prevalence of limiting and non-limiting conditions by age group and SIMD 
quintile, SHeS 2008-2011 




1 limiting 2 or more, 
none 
limiting 
2 or more, 




All adults % 51.9 15.2 7.9 6.1 18.8 28,772 
        
Age group        
16-44 % 71.4 11.3 7.6 2.2 7.4 11,080 
45-64 % 43.9 18.2 8.6 7.6 21.7 10,297 
65+ % 19.9 19.4 7.5 12.6 40.5 7395 
        
SIMD quintile       
5th least 
deprived 
% 58.3 16.4 6.7 6.6 12.0 5079 
4th  % 54.5 17.0 7.6 5.6 15.4 6489 
3rd  % 51.3 15.3 7.9 6.5 18.9 6102 
2nd  % 49.9 14.3 7.9 6.2 21.6 5484 
1st most 
deprived 
% 45.5 13.0 9.5 5.6 26.4 5618 
 
Table 6.5 below shows that levels of low wellbeing were broadly similar (7.5-9.6%) for 
people with multiple conditions, but no reported limitations, and those with one non-
limiting condition or no conditions at all. In contrast, both groups of people with a 
limiting condition had higher levels of low wellbeing, with the burden felt most by 
those with multiple conditions - at least one of which imposes activity limitations.  






1 limiting 2 or more, 
none 
limiting 
2 or more, 
at least 1 
limiting 
 % % % % % 
Low wellbeing 7.5 8.6 19.0 9.6 28.2 




Figure 6.17 illustrates how the age gradients in wellbeing seen above are more 
apparent among people with activity limitations, particular in the presence of multiple 
conditions. Similarly, Figure 6.18 shows how the SIMD gradients in wellbeing are far 
steeper for those with activity limitations. In both cases, the experiences of people with 
non-limiting conditions are very similar regardless of condition number. And, echoing 
the patterns seen previously (e.g. in Figure 6.16), the results in Figure 6.18 show how 
the wellbeing of people with one limiting condition living in the three most deprived 
quintiles was equal to, or worse than, the levels experienced by people with multiple 
conditions (including limitations) living the three least deprived quintiles.  
Figure 6.17 Prevalence of SWEMWBS >1 SD below mean by condition number (1, 2 or 





Figure 6.18 Prevalence of SWEMWBS >1 SD below mean by condition number (1, 2 or 
more), presence of a limiting condition and SIMD quintile, SHeS 2008-2011 
 
 
The odds ratios in Table 6.6 confirm the importance of activity limitations in 
explaining the association between condition status and low wellbeing. Looking first at 
the unadjusted results, compared with people with one non-limiting condition, people 
with one limiting condition have higher odds of low wellbeing (OR 2.5) than people 
with multiple conditions but no reported activity limitations (non-significant OR of 
1.1). Those with multiple conditions and activity limitations had the highest odds of 
low wellbeing (OR 4.2). After adjusting for age, sex, area deprivation and partnership 
status these figures changed a little, to 2.1, 1.3 and 4.3, respectively, and the OR for 
people with multiple conditions but no limitations (1.3) tips into being statistically 
significantly higher, but only marginally so. The sustained significance of factors such 
as age and area deprivation (with low wellbeing less common in older age groups, and 
more common as deprivation increases) confirm the patterns evident in the above 
graphs which showed how these factors were associated with outcomes when the 
analyses were stratified by limiting condition status (results shown in Table I4, 
Appendix I).  
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Table 6.6 Unadjusted and adjusted odds ratios for low wellbeing by limiting condition 
status, SHeS 2008-2011 




95% CIa Adjusted ORb 





Condition status     
One non-limiting condition 
(reference category) 
1.0  1.0  
No conditions 0.9 0.8-1.0 0.7 0.6-0.8 
One limiting condition  2.5 2.1-2.9 2.1 1.8-2.5 
Two or more conditions, no 







Two or more conditions, at 
least one limiting  
4.2 3.7-4.7 4.3 3.7-4.9 
ap value for all ORs <0.001, unless stated otherwise. 
bOR estimates for adjustment factors are shown in Table I4, Appendix I.  
 
Potential mechanisms behind variations in wellbeing  
Introduction 
The results presented in the chapter so far help to signpost the groups in the 
population most likely to be at risk of low wellbeing. However, they offer little by way 
of explanation, both in terms of the mechanisms explaining the overall association 
between conditions and functioning, or the age and deprivation-related patterns 
behind this. This section explores a number of possible explanations. The first is a 
function of the survey process itself and concerns the fact that using a paper self-
completion to measure wellbeing might have biased the results. Around one in ten 
participants did not complete these questions. If those who did not complete them 
had lower levels of wellbeing that those who did this would results in bias if they were 
found to be concentrated in particular sub-groups. Beyond the survey process, another 
possible mechanism that can be explored is whether there is a differential burden by 
age or deprivation group in the experience of limiting conditions – which was shown 
to be strongly associated with wellbeing. Different experiences of illness is also 
explored, briefly, by looking at some of the wider socio-economic characteristics of 
people with multiple conditions across the age spectrum. Finally, the issue of 
survivorship bias is examined to see whether the oldest age group with multiple 
conditions included in the survey in 2008-11 were comprised of healthy survivors, with 
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better health than would be expected as a result of premature mortality among their 
less healthy peers.  
Non-response bias 
The discussion here concerns the way wellbeing was measured within the survey. The 
broader issue of non-response bias as a consequence of non-participation in the survey 
at any stage is considered in the discussion chapter. As Chapter 3 outlined, to preserve 
participants’ confidentiality around the potentially sensitive topics covered by 
WEMWBS (and GHQ12) the questions were asked as part of a paper self-completion, 
offered during the main interview stage. Around one in ten adults (9.5%) did not 
complete the WEMWBS questions. In the majority of cases (around three-quarters) 
this was due to refusing the whole self-completion, rather than missing those items in 
particular. Table 6.7 below shows how levels of missing WEMWBS data differed by 
age, SIMD, condition status (using the definition which incorporates severity) and life 
satisfaction (measured on a scale from 0 to 10). Table 6.8 extends this by showing how 
the variations by condition status and life satisfaction differed by age group. The life 
satisfaction measure is useful here because it is the only measure of wellbeing included 
in the main interview so has virtually no missing data. So while it lacks the insights 
about experiences that underpin WEMWBS, it can serve as an additional indicator of 
wellbeing to help establish the consequences, if any, of the missing data for the other 
measures. It is a fairly basic measure, with a very skewed distribution (the modal 
answer is 8); results are presented here for scores of 0-5 and 6-10 (covering 13.7% of 
the population, scores of 0-5 were the closest fit with the low wellbeing measure). 
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Table 6.7 Prevalence of missing WEMWBS data by age group, SIMD quintile, 
condition status and life satisfaction, SHeS 2008-2011 
  WEMWBS 
missing 
Sample size 
Age group    
16-24 % 8.3 2556 
25-34 % 7.3 3702 
35-44 % 7.4 4829 
45-54 % 7.3 5236 
55-64 % 8.0 5064 
65-74 % 10.8 4207 
75+ % 20.1 3191 
    
SIMD quintile    
5th least deprived % 8.1 5082 
4th  % 8.7 6490 
3rd  % 8.8 6106 
2nd  % 9.8 5486 
1st most deprived % 12.1 5621 
    
Condition status    
0 conditions % 8.1 13,611 
1 non-limiting condition % 8.8 4593 
1 limiting condition % 10.1 2376 
2 conditions, non-limiting % 9.0 1967 
2 conditions, at least 1 limiting % 12.8 6225 
    
Life satisfaction score    
0-5 % 13.1 3917 
6-10 % 8.7 24,774 
Note: all figures are unweighted. 
The key points are that missing data increases with age and area deprivation and is 
highest among those with limiting conditions and low life satisfaction. Stratifying by 
age reveals that these patterns were all more pronounced for the oldest age group; for 
example, just over a fifth of those aged 65 and over with low life satisfaction had no 
WEMWBS data. The data cannot, on the basis of these patterns, be considered to be 
missing completely at random (formal tests of this confirmed this, see the additional 
information in Appendix I). 
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Table 6.8 Non-response to WEMWBS by condition status and life satisfaction by age 
group, SHeS 2008-2011 
 Age group 
 16-44 45-54 65+ 
Condition status % % % 
0 conditions 7.7 7.1 13.0 
1 non-limiting condition 6.4 6.9 13.3 
1 limiting condition 7.9 6.6 19.8 
2 conditions, non-limiting 4.9 8.5 10.6 
2 conditions, at least 1 limiting 8.4 9.5 16.8 
    
Life satisfaction score    
0-5 9.1 10.7 22.8 
6-10 7.2 7.0 13.3 
    
Sample sizes    
0 conditions 7714 4402 1495 
1 non-limiting condition 1258 1885 1450 
1 limiting condition 902 924 550 
2 conditions, non-limiting 265 769 933 
2 conditions, at least 1 limiting 941 2317 2967 
Life satisfaction 0-5 1277 1674 966 
Life satisfaction 6-10 9780 8601 6393 
Note: all figures are unweighted. 
These patterns of missing data mean that the possibility that the lower levels of 
impaired wellbeing found among older people with multiple conditions could, in part, 
be a consequence of non-response bias (because older people with low wellbeing are 
disproportionately missing from the data). Two pieces of evidence can be offered to 
discount this as major source of bias. The first is the fact that the distribution of low 
levels of life satisfaction (scores of 0-5) by age group and condition number broadly 
follows the same patterns seen for SWEMWBS (see Figure 6.19). Sensitivity analysis 
using different life satisfaction score thresholds generated the same patterns (data not 
shown). The second is that using multiple imputation (Sterne et al. 2009) to assign 
values to the missing SWEMWBS cases does not yield a notably different set of results 
compared with the original, based on a complete case analysis (see Figures 6.20 and 
6.21 below; full data is contained in Table I1, Appendix I). To further assess this, the 
regression reported in Table 6.6 above was replicated using life satisfaction scores of 0-
5 as the outcome of interest, and this resulted in almost identical results to the original 
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SWEMWBS analysis (full details of the imputation methods used, and the results of 
these additional analyses, are in Appendix I).  
Figure 6.19 Prevalence of low levels of life satisfaction (scores of 0-5) by condition 
number (0, 1, 2 or more) and age group, SHeS 2008-2011 
 
Figure 6.20 Prevalence of SWEMWBS >1 SD below mean, by age group and condition 





Figure 6.21 Prevalence of SWEMWBS >1 SD below mean, by age group and condition 
number (0, 1, 2 or more), SHeS 2008-2011 - following multiple imputation of missing data  
 
Missing data is a perennial problem in population survey research so their potential to 
bias results must always be considered. However, as the results here demonstrate, the 
characteristics of the people who do not provide complete information need to be 
consistently and notably different in order for their absence to exert a significant 
degree of bias. While older people with low levels of life satisfaction were overly 
represented among those with missing data when compared with other age groups, the 
overall composition of this group was sufficiently diverse to ensure that the age-related 
patterns in wellbeing by condition status were not an artefact of missing self-
completion data. The extent to which other forms of missing data, due to overall 
survey non-response, might have biased these results, and the extent to which 
household surveys underrepresent the experiences of older populations, are discussed 
further in Chapter 7. 
Differential burdens in condition severity  
As already noted, the majority of people with multiple conditions have activity 
limitations, whereas only a minority of those with one condition do. This is therefore 
likely to help account for the overall difference in wellbeing evident between those 
with and without multiple conditions. In contrast, as Figure 6.22 illustrates, the lack of 
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an association between age and the presence of limitations, among those with multiple 
conditions, means that their age-related patterns in wellbeing cannot be attributed to a 
differential burden of activity limiting conditions by age group (though this might be 
case for younger people with single conditions). However, although the prevalence of 
activity limitations among those with multiple conditions does not vary by age group, 
it is still possible that the experience and consequences of living with such limitations 
differs markedly between younger and older people. And it is these experiences that 
explain why having multiple conditions, a high proportion of which are deemed 
limiting, is accompanied by notably low levels of wellbeing in people under 65. This is 
explored, a little, in the next section; though clearly these kinds of insights stretch the 
possibilities of quantitative data.  
Figure 6.22 Prevalence of limiting and non-limiting conditions among people with 
conditions, by age group and condition number (1, 2 or more), SHeS 2008-2011 
 
 
The results in Figure 6.23 apply a similar approach, but this time with area 
deprivation. The proportion of those with conditions who report activity limitations 
increases in line with deprivation. However, the level of limitations found among 
people with one condition living in the most deprived areas is still lower than the level 
seen in people with multiple conditions in the least deprived areas. The social 
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patterning of the prevalence of activity limitations would also appear to be an unlikely 
source of the differences seen in wellbeing. Again, however, the possibility that 
differences exist in how these are experienced cannot be discounted.  
Figure 6.23 Prevalence of limiting and non-limiting conditions among people with 
conditions, by SIMD quintile and condition number (1, 2 or more), SHeS 2008-2011 
  
Differential illness experiences 
Many, if not most, of the explanatory mechanisms behind these patterns will lie 
beyond the reach of the data to hand. For example, one possible explanation for the 
increased levels of impaired psycho-social functioning among younger adults with 
multiple conditions is that the consequences of living with activity limitations are 
worse for younger people than older age groups, resulting in greater impairments to 
psycho-social functioning. It is clearly far rarer for younger people to have multiple 
limiting conditions than it is for older people, hence the sense of difference and 
exclusion felt by younger people relative to their peers will be more acute. This kind of 
explanation therefore moves beyond simply the quantitative identification of whether 
someone has a limiting condition, and instead attempts to unpick why that status 
might have different impacts for different types of people. These questions are more 
typically explored using qualitative methods, and have been, as the literature review in 
Chapter 2 outlined (see, for example, O’Brien et al. 2014; Duguay et al. 2014). 
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However, some of these possible mechanisms or contextual experiences can be 
explored quantitatively. For example, the societal implications of poor health during 
working age will mean, for many, absence from the labour market and exposure to the 
welfare benefit system, which has become increasingly punitive towards those claiming 
disability or sickness-related benefits in recent years. This status could therefore result 
in psychological distress by virtue of the associated stigma of occupying a marginalised 
position in the labour market, but also through the stress involved with interacting 
with a stressful welfare system. In contrast, older people’s income sources are largely 
seen as earnt entitlements, are less stigmatised, and typically involve fewer direct 
interactions with the apparatus of the welfare state. Half (47.9%) of adults aged 16-64 
with multiple conditions were economically25 active compared with 72.6% of those 
with one condition and 79.3% of those with none. Following from this, 27.7% of 
adults with multiple conditions of working age were classified as permanently unable 
to work due to sickness compared with 5.2% and 0.2% of those with one and no 
conditions, respectively. Another measure of economic capital, and also of relative 
residential stability – home ownership (with or without a mortgage) – was also clearly 
associated with condition status, as shown in Figure 6.24. At every age, people with 
multiple conditions were the least likely to live in a household that owned their 
property,26 but more importantly, the gap between this group and those with no 
conditions reduced as age increased. The limitations placed on access to credit 
following the financial crisis of 2008, coupled with a more precarious labour market, 
will likely have exacerbated these patterns. And while home ownership is now 
becoming less common than in the past, the continued political salience of affordable 
housing, and of initiatives to support first time buyers, underline its status as an 
important social aspiration in the UK.   
                                                 
25 In paid work, self-employed, on a government training scheme, waiting to take up paid work, or 
actively seeking paid work. 
26 Note that this is a measure of the tenure status of the household, hence the relatively high levels of 
ownership reported by younger people, many of whom were living in their parents’ homes. 
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Figure 6.24 Prevalence of living in owner-occupied housing by condition number (0, 1, 
2 or more) and age group, SHeS 2008-2011 
 
These economic measures can be supplemented with examples from other aspects of 
people’s social life experiences, such as forming relationships. Partnership status was 
included in the regression models presented above which identified its independent 
association with low wellbeing, and showed it was more common in single (never 
married), divorced, separated and widowed people than in married / cohabiting 
people. The positive benefits of having a co-resident partner will include an increased 
likelihood of access to social, practical and emotional support, which could all 
contribute to better psycho-social outcomes for someone living with poor health. In 
addition, the emotional trauma that accompanies divorce, separation and widowhood 
could confer additional assaults on people’s wellbeing, over and above the experience 
of living without a co-resident partner. Moreover, forming a long-term partnership is a 
social norm that, based on the evidence in Figure 6.25, appears to be less commonly 
experienced by people with multiple conditions than those with none, especially in the 
under 65 age group (with the gap around 20 p.p. for those between the ages of 25-34 
and 45-54).  
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Figure 6.25 Proportion of adults who were married or cohabiting, by condition number 
(0, 1, 2 or more) and age group, SHeS 2008-2011 
 
Similarly, people with multiple conditions aged between 35-44 and 55-64 were twice as 
likely to be living alone following divorce or separation than their counterparts with 
no conditions (although absolute rates were quite low, 8-15% of people with multiple 
conditions in these age groups fell into this category). In contrast, rates of widowhood 
were broadly similar between the condition groups at all ages. 
These measures of partnership status were taken at one point in time and only 
recorded information about people’s living arrangements at the time of the survey. 
Many of the people without a co-resident partner will nevertheless have had a non-
resident partner (conferring some of the advantages listed above), while some of those 
married or cohabiting will have previously experienced a divorce or separation or 
death of a partner. But, imperfect as they are, they do provide – in conjunction with 
above results about housing tenure and employment status - further evidence that the 
lives of working-age people with multiple conditions are both more economically 
challenging, and more divergent from, the social norms enjoyed by their same aged 
peers, than is the case for those in retirement. The potential for the identification of 
such mechanisms to help understand the wellbeing patterns presented here is 




Another possibility is that the older group represents a cohort of “healthy” survivors, 
their less healthy counterparts having already succumbed to premature mortality. 
Linked to this is the duration of people’s symptoms. Developing multiple conditions 
at an older age, having previously been relatively healthy, is likely to result in a very 
different set of life experiences and psycho-social consequences, than developing 
multiple conditions at a younger age, and living with them across the lifecourse. 
Similarly, the combined experience of deprivation and poor health, which confers a 
particular toll in terms of people’s wellbeing, has long been known to account for 
socio-economic differentials in life expectancy. Finally, it is also possible that higher 
levels of psycho-social impairment at younger ages itself contributes to a higher risk of 
premature mortality, which would be another potential mechanism for a healthy 
survivor effect being evident at older ages.  
Cross-sectional data cannot unpick these kinds of dynamics; however, survival analysis 
using the 1998 data can shed some light on them, to a limited extent. These three 
factors are obviously related in the ways already described in this chapter. Similarly, 
reverse causation needs to be considered - someone’s deprivation status could be a 
function of their health (via downward social mobility), and whether psychological 
distress is a cause, consequence or unhappy coincidence of poor physical health is a 
subject of debate. However, the point of the analysis presented below is not to try and 
explain differential mortality outcomes by condition number. It is designed to see 
whether higher levels of mortality among working age people with multiple conditions 
might help explain why low wellbeing is subsequently less common among the older 
population with multiple conditions.  
Severity 
The survival curves in Figure 6.26 show the association between condition number 
and activity limitations before the age of 55, and subsequent survival. Deaths in this 
age group were relatively rare in the follow-up period (248/5659), so note that the 
cumulative risk of death scale (y-axis) has been truncated to run from 0.5-1 to aid the 
interpretation of the graph. The upper age cut-off of 55 was chosen because, having 
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been interviewed in 1998/9, any deaths among these people in the follow-up period 
would have occurred before a maximum age of 68, and they are therefore the closest 
equivalent to the 65 and over age group within the 2008-11 survey – the group for 
whom the possibility of survivorship bias is being investigated. A cut-off point of 50 
would have been more accurate, but age is included in the 1998 linked dataset in 
aggregate ten year groups, rather than in single years (to help preserve participant 
anonymity), so 54 was the closest that could be reached. However, as the point of this 
analysis is to look for potential mechanisms to spur further thinking, rather than to 
come to definitive conclusions, this approximation seems adequate for the task 
required.  
The group with activity limitations and multiple conditions had the lowest survival 
rates, while those with one limiting condition had worse survival than those with one 
non-limiting condition, and, for most of the period, a very similar risk of death as 
those with two conditions with no reported limitations. This would lend some 
evidence to the suggestion that people with multiple conditions and activity 
limitations before retirement age - who have already been shown to have the lowest 
wellbeing – are disproportionately absent from older age groups as a result of 
premature death.   
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Figure 6.26 Kaplan-Meier plot of survival among adults aged 16-54, for the five long-
term and limiting condition status groups (14.9 years’ follow-up), SHeS 1998-SMR linked 
data 
 
Note: scale has been truncated to aid interpretation (full scale runs from 0-1). 
Deprivation 
The next set of survival curves show the risks of death separately for the three 
condition groups, split between those living in the bottom 25% most deprived areas, 
as measured by the Carstairs index (the deprivation measure in common use at the 
time of 1998 survey). Having one or multiple conditions and living in a deprived area 
was clearly associated with an increased risk of dying, relative to their non-deprived 
counterparts with the same condition number. Though people with multiple 
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1 limiting cond 
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conditions who did not live in a deprived area had worse survival than those with 
single conditions living in deprived areas.  
Figure 6.27 Kaplan-Meier plot of survival among adults aged 16-54, for the six long-
term condition and Carstairs deprivation status groups (14.9 years’ follow-up), SHeS 1998-
SMR linked data 
 
Note: scale has been truncated to aid interpretation (full scale runs from 0-1). 
Psychological distress 
The third of the mechanisms described above, that impaired psycho-social functioning 
could itself shorten life, is examined in the next set of survival plots. Using the same 
approach as above, the association between condition status, GHQ12 score of >4 and 
survival in those aged 16-54 is shown. GHQ12 was the only psycho-social functioning 
measure included in the 1998 survey; however, its closer association with directly 
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experienced symptoms of distress arguably makes it the better measure to use in this 
analysis.  
There is a clear additional risk of death associated with having a GHQ12 score of >4, 
evident for those with one condition, and even more so for those with multiple 
conditions. However, as before, the absolute number of deaths was small overall (most 
of the group at greatest risk do, after all, survive), so this evidence can only signpost the 
existence of one possible mechanism among many that accounts for the lower burden 
of low wellbeing experienced by adults with multiple conditions of retirement age 
(relative to the working-age counterparts).  
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Figure 6.28 Kaplan-Meier plot of survival among adults aged 16-54, for the six long-
term condition and GHQ12 status groups (14.9 years’ follow-up), SHeS 1998-SMR linked 
data 
 
Note: scale has been truncated to aid interpretation (full scale runs from 0-1). 
Conclusion 
Collectively these analyses have attempted to reflect, albeit only very partially, some of 
the ways that living with conditions can be accompanied by psychological, social and 
physical encroachments of the kinds drawn out extensively in the literature on chronic 
illness experiences described in Chapter 4. 
People with multiple health conditions live with many additional challenges. Some 
appear to be a distinctive feature of their health status, such as having very low activity 
levels, high levels of obesity, or low wellbeing, compared to people with fewer 
0 cond’s, GHQ12 <4 (grey) 
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1 cond, GHQ12 <4 (green) 
1 cond, GHQ12 >4 
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conditions or none. However, when investigated further, it is clear that these 
challenges are often exacerbated by social deprivation, or vary between age groups, 
sometimes resulting in a fragmentation of experiences among people with multiple 
conditions. Low wellbeing functions in this way, so people who experience the 
combination of both high levels of deprivation and multiple conditions suffer the 
worst outcomes of all. In contrast, people with multiple conditions living in the least 
deprived areas fare much better than their more deprived counterparts, and, moreover, 
they also tend to have better outcomes than people with one condition who live in 
areas of high deprivation. This pattern is particularly apparent among those aged 
under 65.  
While a quantitative analysis such as this can barely begin to uncover the complexity of 
experiences that might underpin patterns such as these, a number of mechanisms were 
tentatively explored. Differential non-response to the wellbeing questions does not 
appear to have been a factor, nor do variations in the absolute burden of limiting 
conditions by age group or area deprivation. However, attempts to unpick these 
experiences suggest that the illness experiences of younger people with multiple 
conditions are quite distinctive, and feature higher levels of economic insecurity and 
exclusion from potentially protective social norms, such as home ownership and long-
term partnerships. In addition, the experience of living with multiple conditions in 
conjunction with activity limitations, or social deprivation, or psychological distress at 
a threshold that might be indicative of a disorder, are all associated with a higher risk 
of premature mortality. This suggests that, for some people, living with multiple 
conditions and low wellbeing not only impairs quality of life, it also reduces quantity 









Chapter 7 Discussion 
Introduction 
This thesis set out to: 
 Quantify the experiences of adults living with multiple conditions in Scotland 
using the Scottish Health Survey. 
By answering the following questions: 
 Does the Scottish Health Survey correctly identify people with multiple 
conditions? 
o And if not, who is missing? 
 How do different definitions of multiple conditions affect its prevalence in the 
population, and across sub-groups? 
 How do experiences of people living with multiple conditions vary in the 
population? 
Scotland arguably has some of the most comprehensive estimates of the prevalence of 
multiple conditions, and of condition-specific patterns within that overall prevalence, 
of any developed country (e.g. those found in Barnett et al. (2012), McLean et al. 
(2014), Smith et al. (2014) and Cooper et al. (2015)). And while those data relate to 
2007, and did not include west-central Scotland, where some of Scotland’s highest 
levels of poor health are found, the primary aim of this work was not to simply 
replicate the task of establishing the prevalence of this increasingly important health 
phenomena with a new dataset. Instead, the aim was to ensure that Scotland’s main 
source of population health data was equipped to make a contribution to this field via 
its unique potential to provide additional information about the wider life experiences 
and circumstances of people with multiple conditions, and thereby widen and deepen 
current knowledge of these aspects, beyond the more biomedical and disease-focused 
analyses that currently exist. To do this it was necessary to ensure that the survey was 
correctly identifying people with multiple conditions. Hence the considerable 
attention paid to this matter in Chapter 5. However, as the approach outlined in 
Chapter 3 explained, and Chapter 4 demonstrated, I was keen to establish a 
theoretical grounding for this work, and in doing so, came to understand the 
problematic nature of what constitutes “correct” or “incorrect” when attempting to 
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identify health conditions. In a field dominated by very empirically driven analyses 
(e.g. where availability of data is the predominant criteria used to determine what 
conditions are included in definitions), I also hoped to make a wider contribution to 
the way that analyses of quantitative data are approached, by illustrating the potential 
for plural theoretical perspectives to help shape this process.  
This discussion chapter is structured around three themes: measurement, experiences 
and overall approach (though elements of each feature in all parts). The measurement 
theme starts by briefly drawing out the headline prevalence figures from Chapter 5 and 
how they relate to the existing studies of multiple conditions reviewed in Chapter 2. It 
then reflects more intensely on the process through which the definition arrived at 
here was developed, drawing on the wider theoretical insights provided in Chapter 4, 
to outline the key issues that emerged as a consequence. Each stage of the definition 
process was described in Chapter 5 in some detail. Rather than revisiting the rationale 
for each decision taken (which are already described in Chapter 5), the intention here 
is to focus on what might lie behind the information reporting patterns and potential 
discrepancies that posed the most significant challenges for this work. Finally, their 
wider implications for the measurement of health in populations are considered.  
The experiences theme then considers the results in Chapter 6, again by relating them 
to the literature in Chapters 2 and 4. When triangulated with the growing, though still 
somewhat limited, qualitative literature in this field, results such as these have the 
potential to increase understanding of the mechanisms that might explain why having 
multiple conditions is associated with such negative outcomes, and why this is 
particularly the case for some groups. However, Chapter 2 argued that much of the 
drive to frame analyses and, increasingly, health services and interventions, around the 
needs of people with multiple conditions has been spurred by the recognition that ill-
health is not always a singular experience. The next part of the discussion therefore 
raises the question of whether the complexities and challenges that accompany the 
experience of having multiple conditions are in danger of being under-appreciated by 
treating this set of circumstances as singular concept. In this way, the analysis 
presented in Chapter 6 is not only a means of illustrating how life experiences are 
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potentially affected by having multiple conditions, but is also a tool to help critically 
evaluate the utility of identifying people with multiple conditions in order to explore 
their outcomes and experiences as distinct from other groups. The final part of the 
chapter reflects on the approach taken; what it added and what challenges it brought.  
How many adults in Scotland have multiple conditions?  
Putting the SHeS results in context 
This section considers the SHeS results in the context of the broader literature on 
multiple condition prevalence patterns, based on the systematic reviews by Fortin et al. 
(2012) and Violan et al. (2014), and the UK prevalence estimates provided by 
Salisbury et al. (2011) and Barnett et al. (2012). The implications of the comparative 
results presented in Chapter 5 (comparing SHeS with McLean et al. (2014)) are 
discussed further below. 
Using the definition arrived at in Chapter 5, 24.9% of adults aged 16 and over in the 
2008-2011 period had multiple conditions (Chapter 5, Table 5.20). Understandably, 
every prevalence figure quoted in the literature varies, depending not only on the 
population studied, but also on the data source and definitions used (of both 
conditions and of multiplicity). For example, the headline SHeS results were fairly 
close to the most closely comparable domestic prevalence estimate available (as 
discussed in Chapter 5), and to the figure cited in Mujica-Mota et al. (2015), derived 
from the English General Practice Patient Survey (based on self-reported conditions). 
However, other UK sources, such as Salisbury et al. (2011), cite figures for the 
population in England aged 18 and over of either 16% or 58%, depending on the 
conditions included in the definition, thus complicating the extent to which any 
external comparison of absolute figures can usefully be made.  
However, although absolute levels cannot be reliably compared because fundamental 
differences exist between their sources (Violan et al.’s (2014) systematic review 
concluded they certainly shouldn’t be pooled), a fairly common set of patterns of 
relative differences between key sub-groups have been identified across sources. 
Establishing whether the SHeS results follow these established relative patterns is an 
important step in assessing their likely validity. For example, a very notable rise in 
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prevalence with increasing age is universally reported in general population studies 
(Fortin et al. 2012) – with an S-shaped curve typically evident as prevalence at older 
ages plateaus due to ceiling effects, and selective mortality (especially past the age of 
75). The SHeS results showed that prevalence increased from 5.4% at age 16-24 to 
59.0% for those aged 75 and over (Chapter 5, Table 5.21). The figures for the older 
age groups presented in Chapter 5 do not have enough granularity to show this S-
shape, but additional analyses (data not shown) show that prevalence for those aged 
75-84 and 85 and over was indeed very similar (59.5% and 61.1%, respectively), so the 
plateau reported in the literature was reached here too.  
Violan et al. (2014) reported that nine of 14 studies in their review found a higher 
prevalence of multiple conditions in women than men, and this was the case with the 
SHeS results: 26.7% in women, 23.0% in men, OR of 1.2 (1.2-1.3) (see Chapter 5, 
Table 5.21 and ORs in Appendix H Table H5). All of the studies reported in Violan et 
al. (2014) that investigated SES gradients found multiple conditions prevalence 
increased as SES declined; again the SHeS results reported in Chapter 5 fit that 
pattern. And, as Barnett et al. (2012) noted, the deprivation gradient was somewhat 
confounded by the younger age profile of people living in the most deprived areas, 
such that the OR associated with having multiple conditions for those in the most 
deprived SIMD quintile, relative to those in the least, increased from 2.1 (1.9-2.2) to 
2.8 (2.5-3.1) after adjustment for age (Appendix H, Table H5). The fact that the SHeS 
results yield patterns that are also found in analyses derived from systematic reviews, or 
large-scale UK-based secondary analyses, suggest they have some degree of validity. 
However, as Chapter 5 suggested, issues still surround certain aspects of their 
underlying composition and their ability to reflect the experiences of particular sub-
groups. The rest of this part of the discussion therefore returns to the very foundations 
of the definition process adopted – looking at both the approach followed and the 
outcomes it yielded - and considers the causes and implications of the challenges 
identified along the way. 
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Overview of measurement challenges 
The results in Chapter 5 confirm what was abundantly clear from the literature 
covered in Chapter 2 - the number of conditions people have is, of course, entirely 
dependent on what is counted and the way that counting is done. And this will, in 
turn, affect the prevalence of multiple conditions within single individuals. The various 
attempts to standardise definitions in this field have focused on aspects such as the 
duration or chronicity of the conditions being counted, the nature of the data sources 
used to arrive at such estimates (including how many conditions they need to cover to 
be sufficient and who provided the information), and the most appropriate thresholds 
for defining multiplicity. All these aspects needed to be considered for this work, but 
little of what was explored in this thesis can be said to contribute to their resolution - 
because they are, in many instances, irresolvable in any definitive way. For example, 
the kind of all-encompassing measure suggested by Le Reste, Nabbe, Manceau et al. 
(2013) that includes conditions, social vulnerabilities and disease risks might well suit 
some needs; they clearly think it meets theirs and can transfer across settings (Le Reste 
et al. 2015). However, for my purposes, this kind of multi-factorial conceptualisation 
of multiple conditions would have made it impossible to conduct the kind of stratified 
analyses of experiences presented in Chapter 6. Any attempt to measure multiple 
conditions must therefore not only address the question “how should it be done?” but 
also “what is it for?”, as Huntley et al. (2012a) suggest, but which is very often absent 
from much of the literature in this field. 
The results in Chapter 5 showed how a number of approaches helped to identify more 
conditions than the survey’s single measure of long-term conditions originally 
suggested people experience, and from these, identify those with two or more. This 
process therefore revealed a number of problems with the original data which, as shall 
be discussed further below, relate not only to the more mechanical aspects of the 
survey process itself, but also to the complex and contested nature of the underlying 




The identification of conditions to include in the measure of multiple conditions 
formed the core of this work. Chapter 2 ended with two contrasting approaches to 
disease classification described in Mani et al (2011): 
Hickam’s dictum: “patients can have as many diseases as they damn well please” 
(para. 8)  
Occam’s razor: “entities are not to be multiplied beyond necessity” (para. 4) 
The methodological approach outlined in Chapter 3, and the theoretical insights 
provided in Chapter 4, about the socially and temporally contextual nature of disease 
meanings and classifications helped to explain why different approaches such as these 
might be necessary, and why there isn’t a pre-determined and universally applicable set 
of criteria to resolve this issue. However, those insights also illustrated how the balance 
of power between the people generally tasked with diagnosing or classifying disease, 
and those living with it, is rarely even. Therefore, the capacity for patients to do as they 
please and make these kinds of “choices” – in the way Hickam’s dictum suggests - is 
clearly constrained. In addition to this, and perhaps more importantly, Chapter 4 also 
described how the various factors that contribute to the framing of disease – and, 
increasingly, risk of disease – collectively undermine the extent to which such matters 
could genuinely be seen as choices that any individual (clinicians included) freely 
makes. In contrast, the simplicity suggested by Occam’s razor belies a much bigger 
challenge, namely what constitutes the necessity beyond which entities should not be 
multiplied, and who should make that decision?  
The key principles adopted in this work attempted to address both these issues while 
also steering a way through two seemingly irreconcilable ontological positions on 
disease and illness offered by social constructivism and positivism. A wholly 
constructivist approach would arguably see the question of how many people have 
multiple conditions as entirely artefactual, or so open to limitless possibilities, that its 
ascertainment is therefore of questionable value. Viewed through a purely positivist / 
biomedical lens, arriving at an answer to this is a wholly technical exercise in 
identifying the appropriate information and enumerating it. The appropriate 
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information (e.g. the presence of conditions) would be adjudicated largely on the basis 
of recorded diagnoses, arrived at by an expert’s interpretation of directly observable 
physical signs and diagnostic tests, and where this isn’t possible, symptom reporting 
(preferably supported by external verifications or expert consensus on their 
significance). In this model, the role for the person actually experiencing a condition is 
relegated to that of passive recipient of tests and potentially unreliable reporter of 
symptoms for someone else to interpret. In essence, a condition is what clinicians code 
and treat as conditions, with no space in that circularity for reflection about why and 
how such classifications emerge. The very common rejection of studies based on self-
reported measures of health status (rather than clinical records) chimes with this 
approach. On the other hand, as is clear from the literature, and from the results in 
Chapter 5, self-reported measures do have numerous problems. This discussion must 
therefore also address these problems, and consider whether they justify the 
widespread critique, or rejection, of self-reported population health data. 
Having sketched out some of the more fundamental issues at stake in this work, the 
following now looks at specific aspects of the process from which the final definition 
of multiple conditions emerged. 
How much detail about conditions is required? 
Chapter 5 already described how the process of aggregating condition codes adopted 
in the survey was thought insufficiently reflective of the health experiences people 
reported, with too much potential for the existence of multiple conditions to be 
obscured. Similarly, it established that many conditions had not been mentioned 
when people were asked to simply report everything they thought of as a long-term 
condition, and concluded that it was important to incorporate additional information 
in order to better reflect people’s experiences.  
However, there remained a concern to avoid adding conditions that were much less 
serious than those typically already reported, either in terms of their likely prognosis or 
their impact on quality of life, because of the potential to overinflate the measure of 
multiple conditions (which has parallels with the notion of breaching a necessity 
boundary, suggested in Occam’s razor). This concern was further underlined by the 
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literature on medicalisation (including that related to psychological distress) and 
overdiagnosis (of disease risk, in particular) which highlighted the need to be wary of 
an approach that counted every possible disease marker. The wider validity of the 
approach was also a concern. In a field dominated by analyses of disease registers or 
primary care data, and the widespread application of rubrics such as the O’Halloran 
criteria (O’Halloran et al. 2004) to define chronicity or weighted indices to reflect 
severity (Diederichs et al. 2012), it would be naïve to assume that the steps I took 
would not require additional justification in the form of empirical evidence of their 
impact. In this way, then, the act of constructing the multiple conditions measure was 
conducted with a dual recognition that while all socio-medical constructions are 
“tentative and provisional” (Rubinstein et al. 2000, p.45), the final measure was also 
intended to relate to, as far as possible, a set of external realities that, however framed 
or labeled, have important consequences for the people concerned. 
Many of the decisions taken were seemingly uncontroversial. For example, 
disaggregating the ICD chapters resulted in distinguishing conditions that most 
analyses of multiple conditions also routinely consider to be separate entities (such as 
heart conditions and hypertension), albeit with shared aetiologies and, often, 
treatment protocols. However, the disaggregation also resulted in single 
musculoskeletal conditions affecting multiple sites (e.g. arthritis in more than one 
joint) being counted multiply if that was how the participants chose to report them (or 
the interviewers chose to record them). This level of granularity certainly goes beyond 
what most clinical data sources reflect, and represents a reframing of – and perhaps 
challenge to - the traditional bio-medical classification of this kind of condition, by 
using aspects of its experiential manifestation and not just its underlying pathology. 
But the reality is that when conditions such as osteoarthritis affect multiple sites in the 
body, it tends to happen progressively over time, rather than with a sudden, 
simultaneous onset. Consequently, people’s experience of living with the onset of 
symptoms, the limitations they bring, and the receipt of a diagnosis, is multiple, 
despite the condition having a singular status in a strict pathological sense. Surgical 
specialisation also means that someone needing a hip and shoulder replacement will 
end up seeing different surgeons, so their experience of medical care will also be 
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multiple rather than singular. However, this approach also represents a level of 
compromise about data consistency that is not usually well tolerated in survey analyses. 
As described in Chapter 3, the aggregation was originally implemented, in part, to 
diminish the impact of variations in participants’ reporting styles and interviewers’ 
recording practices, with the data therefore designed to represent the prevalence of 
conditions at ICD chapter level with a degree of confidence, but with no such 
guarantee at the level of individual conditions. The way I handled the data therefore 
resulted in the final measures being able to identify the existence of conditions, and 
multiples of them, but with much less certainty that the nature of those conditions 
had been recorded in a consistent manner. In their transformed state, these data are 
not, therefore, well suited to analyses designed to explore specific condition-related 
patterns within them, such as the kinds of concordant / discordant analyses that are 
increasingly common in this field (as described in Chapter 2). However, this deficit is, 
arguably, counterbalanced by the fact that this data source is far better placed to 
identify the kinds of experience-related patterns presented in Chapter 6, that are 
absent from most clinical sources. Furthermore, as these adjustments were taken after 
the data were collected, there is nothing to stop other analysts re-instating the 
aggregation if that suits their purposes.  
It is also worth noting that decisions about granularity beset many analyses, especially 
so in relation to conditions affecting the same body system or with the same 
underlying biological pathways, and compromises always have to be made. For 
example, Barnett et al.’s (2012) analysis of Scottish primary care data did not 
enumerate specific musculoskeletal conditions but instead had a single category of 
pain disorders based solely on the issue of more than four prescription-only pain 
medications in the past year. This therefore misses anyone using non-prescription 
medications to manage a painful condition (e.g. ibuprofen perhaps in conjunction 
with physiotherapy), while people whose medication covers more than one painful 
condition (of different causes) cannot be identified. On the other hand, this approach 
prioritises the symptomatic consequences of conditions that cause pain, which is 
arguably of greater experiential relevance to the people concerned. These examples 
illustrate how the kinds of decisions commonly taken with regards to data handling 
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can sometimes compromise – and sometimes enhance - the data’s potential to reflect 
people’s experiences.  
The challenge of measuring complex concepts  
The overarching, if sometimes unstated, principle of all research that is designed to 
quantify phenomena (be they social, physical or psychological) is that a sufficiently 
close fit can be established between what the measures used are intended to capture and 
what they actually succeed in capturing. In the absence of this, the whole venture stands 
on fairly shaky ground, and the different epistemological traditions adopted within 
and across different disciplinary boundaries clearly reflect the varying degree to which 
this premise is accepted. The discordance between the prevalence rates based on the 
unprompted conditions question and the questions that asked directly about named 
conditions such as hypertension and diabetes, or the variations between people in 
whether conditions were reported as long-term or as other health problems, perhaps 
provide examples of measures not yielding the outcomes intended of them.  
Most of the analyses of the accuracy of self-reported conditions data discussed in 
Chapter 2 looked at the agreement between answers to directly prompted survey 
questions and data from clinical records. However, many of the processes that generate 
discordances between people’s self-reported conditions and their clinical records could 
not have contributed to the patterns shown in Chapter 5. For example, a commonly 
voiced concern about self-reported data is that people aren’t always told what 
conditions they have, or haven’t understood or don’t remember what conditions 
they’ve been told about. The discordance patterns uncovered in this analysis could not 
be blamed on these factors because people did report conditions when asked directly 
about them, so the problem lay with their needing to be prompted to do so, rather 
than them simply having no knowledge. The root of the problem is likely to be 
twofold: firstly, the complexity of the question wording (see below), opening up wide 
scope for people to interpret what was required of them quite variably; and secondly, 
the fact that the health conditions being asked about themselves have quite fluid 
meanings or contested statuses. As a reminder, the long-term conditions question in 
the 2008-2011 surveys asked: 
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Do you have a long-standing physical or mental condition or disability that has troubled 
you for at least 12 months, or that is likely to affect you for at least 12 months?  
 
Many of the terms used could have been open to interpretation (as Gooberman-Hill et 
al. (2003) clearly demonstrated), but I have underlined two (troubled and affect) that 
can be singled out as particularly problematic. For example, it is unclear whether 
something that has an intermittent but permanently recurring pattern, such as 
migraines, should be included, or how a condition that has few symptoms but requires 
permanent medication should be handled, such as well-controlled diabetes, or indeed 
a disability whose associated trouble or affect is felt largely as a result of societal 
constraints, as opposed to any physiologically embodied consequences. The emphasis 
this question placed on participants’ own perceptions of the troubling nature of their 
conditions is in some ways very welcome, but it will also have contributed to the fact 
that conditions with few symptoms, such as hypertension or high cholesterol, were the 
ones found to have the greatest discordance between answers. Hansen et al.’s (2015) 
work definitely resonates here, especially their finding that patients gave greater 
priority in their illness accounts to conditions with more invasive symptom burdens, 
while their doctors gave greater weight to conditions with life-shortening prognoses, 
highlighting a contrast, perhaps, between the embodied experiences that weigh on the 
minds of the people living with them, and the negative future consequences associated 
with illnesses that preoccupy the clinicians charged with their management.  
In a similar vein, conditions that straddle the disease / risk boundary, such as high 
cholesterol, showed quite varied reporting patterns, with the additional complication 
in this instance that many people don’t realise that cholesterol-lowering treatment is 
long-term rather than temporary, hence the high proportion of people reporting this as 
an other problem and not as a long-term condition. These results also tie in with the 
discussion of health experiences in Chapter 4, specifically the quote highlighted from 
the participant in Lawton et al.’s (2005) study of lay beliefs who voiced suspicions that 
hypertension was just the latest in a line of fads for doctors to treat. In some cases, 
variations in condition reporting could also have resulted from decisions people made 
about their severity, or impact, which led them to not mention conditions like arthritis 
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or asthma when asked about long-term conditions, but to do so when asked about 
other problems.  
However, the analysis of the nature of people’s answers also showed that the 
overwhelming preponderance of information reported related to named diagnoses, 
and not to symptoms – and this also applied to the answers to the general question 
that asked about “problems” as opposed to conditions. It would therefore be too 
simplistic to characterise the lay-person / clinician divide as one that demarcates these 
two sets of phenomena as solely relating to what people feel, and what doctors name, 
or to suggest this is wholly responsible for the reporting patterns seen. Turner’s (1987) 
account of how people relate to their health is instructive here: 
The way in which an individual interprets or understands their disorders will 
depend, not upon individual whim or fancy, but significantly upon the 
classifications of illness which are available within a culture and by reference to 
general cultural values concerning appropriate behaviour. (Turner 1987, p.215). 
Furthermore, the idea that simply “improving” the wording, for example by removing 
some of these more ambiguous terms, would resolve all these issues can be shown to 
be misplaced. From 2012 onwards the long-term condition question was simplified by 
removing references to conditions that troubled or affected people, while the term 
illness was reinstated as well (it had been removed between the 2003 and 2008 
surveys). This change only resulted in a two percentage point increase in the 
proportion reporting a long-term condition and an equal sized decrease in reporting 
other problems, which is small enough to be within normal sampling variation 
(Appendix K, Table K1). Similarly, while the proportion of people with doctor 
diagnosed hypertension who reported it as a long-term condition increased from 28% 
in 2008-11 to 35% in 2012-2013, signifying some improvement in the question’s 
performance, this still left the majority of cases unreported, and levels of 
underreported diabetes did not change (see Appendix K, Table K2).  
The critical issue attending all these competing perspectives and interpretations is not, 
therefore, which of them is “correct”; indeed, Gooberman-Hill et al. (2003) suggest 
that such data should be assessed on the basis of its trustworthiness rather than its 
truthfulness. Aligned with this approach, arguably what matters is recognising the 
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plurality of possible interpretations and responses, and appreciating that they have 
corresponding implications for the collection of information about health. Viewed this 
way, the results suggest that the wording of the original (and indeed more recently 
revised) long-term conditions question fails to reflect the fact that perceptions (and 
consequently, answers) vary because the very concepts being measured do not 
themselves have fixed, universal meanings. The increasing move to actively treat 
disease risks will further complicate matters and undermine measures of health 
conditions that rely on narrowly-formulated questions and ignore the reality of - and 
variability in - how people experience and understand the conditions they receive 
diagnoses of, or are treated for. This distinction matters when attempts are made to 
improve the way such information is collected, otherwise the wrong remedy could be 
put in place. This is discussed further below.  
Contested conditions 
Moving away from the difficulties associated with how people interpreted the 
questions put to them, decisions also had to be made about factors such as obesity, 
whose status as a condition is highly contested. The results in Chapter 5, in 
conjunction with the arguments outlined in the case study in Chapter 4, made a 
strong case for excluding obesity from the condition count. People did not relate to it 
as a condition, including it did not alter survival trajectories, and significant debate 
still surrounds its status as a condition versus a risk factor. However, the results in 
Chapter 6 certainly illustrate the extent to which obesity is a distinctive feature of the 
lives of people with multiple conditions, and growing evidence (outlined in Chapter 2) 
suggests it contributes to the risk of acquiring multiple conditions over the lifecourse. 
Even though the survival analysis of mortality risk showed that obesity was not 
associated with that particular outcome, it still has the potential to negatively affect the 
quality of people’s lives. For example, as noted in Chapter 6, obesity is strongly 
associated with shame, with corresponding harmful psychological consequences. It can 
also negatively affect experiences of health services, if treatments are rationed for 
people with a BMI above a certain threshold, despite the considerable barriers to 
weight loss that people with co-existing conditions often face. It is also possible that 
the nature of the association between obesity and survival has changed over time as its 
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prevalence has altered (e.g. with onset occurring at earlier points in the lifecourse, or 
with the higher prevalence of very high BMI now occurring), so these analyses based 
on outcomes following the 1998 survey might not be replicated with later cohorts. All 
these possibilities underline the importance of being able to continue monitoring the 
ways in which people with multiple conditions experience obesity, and whether their 
outcomes differ notably from those with fewer or no health conditions. These kinds of 
issues are harder to explore if obesity is included as a condition within overall 
measures. This underlines the point made above that any measure of multiple 
conditions needs to take into account its purposes when deciding about its 
composition. 
What conditions are missing? 
The discussion so far has focused on what information was collected and how it was 
incorporated into the multiple conditions measure. A more complex, and arguably 
more important, issue concerns what was absent. The comparison of the SHeS results 
with those in McLean et al. (2014) at the end of Chapter 5 suggested the former had 
two key gaps relating to conditions in older people and mental health conditions. 
Furthermore, the comparison underlined the considerable extent to which the 
original, unadjusted multiple conditions measure had under represented people’s 
experiences at all ages, but particularly so for those aged 55-64 and above. However, 
before considering these issues it is worth reflecting on the nature of the comparison 
being made. There is always a danger when survey estimates are compared against 
estimates from other sources, such as clinical data, that the external source is held up 
to be a gold-standard, presumably free of flaws. Of course, as the above (and Chapter 
4) should have demonstrated, the very notion of a gold-standard data source on health 
conditions is highly questionable, given the highly contextualised nature of the 
information it could ever contain. While the notion that a single, “true”, prevalence of 
multiple conditions exists in the population is similarly problematic. The primary care 
data on which the McLean et al. estimates are based only capture the existence of 
conditions that can be identified via recorded diagnoses or inferred from specific 
prescription patterns (e.g. the pain medications noted above, or prescriptions for 
antidepressants). This is an important measure to have, given its direct implications for 
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GP care demands and likely patterning of demand for secondary care services as well. 
But it isn’t necessarily a complete measure of all the health conditions and burdens 
people live with (by virtue of it being based on a database of diagnosed or treated 
conditions), nor is it a measure that would necessarily correspond with how people 
themselves experience their conditions – because there is little space for patients’ 
voices to be reflected in the kinds of routine GP data utilised in epidemiological 
studies.  
Surveys are often promoted as tools for assessing unmet health needs in populations, 
for example by identifying undiagnosed conditions, thus providing them with a 
unique potential to provide additional information beyond what is available in 
primary-care data. As discussed in Chapter 5, this approach is not without its 
problems. For the most part, problems arise because a survey’s capacity to identify 
undiagnosed conditions is largely limited to those with potentially diagnostic 
biomarkers that are relatively easy to collect (e.g. by blood pressure readings or blood 
samples), rather than those requiring more detailed, contextual information and 
symptom reporting. The biomarker results can be problematic because their clinical 
significance often occupies contested territory on the risk / disease boundary, 
especially when there is no wider contextual information available, or repeated 
measures (hypertension diagnosis in primary care is based on repeated measures, 
ideally including some taken away from the clinic, rather than on the basis of one set 
of elevated readings, unless someone has severely raised readings (NICE 2015b)). 
Chapter 5 showed a prevalence of high cholesterol (using a 5.0 m/mol threshold) 
suggesting that as much as half the adult population in Scotland could require statins; 
this isn’t a failing of the biomarker or survey per se, but of the way in which its 
information is interpreted. Similarly, mental health disorders are commonly described 
as hugely under-diagnosed but the potential for surveys to overestimate the extent of 
this, as discussed in Chapter 4, is very real. Though it must be remembered that, 
unlike the biomarker data, there is no question that the answers indicating distress 
highlight troubling and quality of life diminishing symptoms that need to be 
addressed; the contested issue is whether they are indicative of disorders, as opposed to 
understandable distress. This potential role for the survey to identify the possible 
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burden of disease beneath the tip of the iceberg was not, therefore, incorporated into 
this analysis. Its ability to capture the kinds of information available in primary care 
sources must therefore be evaluated. 
It is possible that comparing the SHeS and the primary care results is akin to 
comparing apples and pears; they’re both measures of population health, but of 
different populations and of different kinds of health. However, two aspects in which 
the two sources can be seen to differ most (prevalence of conditions in older people, 
and of mental health conditions) have very plausible external explanations that do 
point to significant deficiencies in the survey estimates. Or, at least, suggest that 
specific caveats need to be placed around their interpretation. Firstly, SHeS is a survey 
of the household population in Scotland which therefore excludes people in 
residential care, whose health will in most cases be worse than adults living in their 
own homes. The primary care data, on the other hand, includes all patients registered 
with practices, so is better at reflecting the health of all adults, regardless of where they 
live. Secondly, SHeS only interviews people with full mental capacity to consent to 
participate and answer on their own account, so this key exclusion will also have 
contributed to the discrepancies in prevalence for older adults living at home but with 
impaired cognitive functioning. Similarly, adults of all ages with more than mild 
learning disabilities would have been excluded from the survey for these same reasons. 
These two factors, in combination with older survey participants potentially 
underreporting the extent of their health conditions, make the much higher multiple 
conditions prevalence in those aged 65 and over provided by McLean et al. perfectly 
understandable.   
Perhaps more worrisome, however, is the survey’s underestimation of mental health 
conditions. Based on the interview data alone, 6.2% of adults had a mental health 
condition, which increased to 11.9% once people taking psychoactive drugs were 
included in the measure. Analysis of the prescription data suggested that people taking 
psychoactive drugs who did not report any mental health conditions were older, on 
average, than people who reported such conditions. Hence this situation contributes 
both to the overall lower level of reported mental health conditions, and the 
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underestimation of conditions among older people. The majority of the psychoactive 
medications reported were antidepressants, and the majority of mental health 
conditions reported were depression or anxiety (based on visual inspection of the free-
text data - though a wide range of other conditions were also mentioned, such as 
combat-related PTSD, bipolar disorder, schizophrenia, alcoholism and other 
addictions). Smith et al. (2014) report a prevalence of depression in adults aged 18 and 
over in Scotland, based solely on prescription data, of 10.1%. This suggests that, as 
might be expected, the underestimation of mental health conditions is highly 
condition specific, with diagnosed depression and anxiety possibly much less affected 
than other psychiatric diagnoses. For example, dementia was classified as a mental 
health condition in the McLean et al. analysis, but the sample-frame issues and 
exclusion criteria described above will have contributed to this being underestimated 
in SHeS, relative to the primary care data. The sample frame will also have excluded 
people living in hostels or other types of supported social housing, many of whom 
have mental health conditions at the more severe end of the diagnostic spectrum, 
and/or alcohol and other substance abuse disorders (these were also included in the 
McLean et al. definition). But another important source of the underestimation is 
likely to be due to non-response to the survey being higher among eligible participants 
with the poorest health, and especially among those with severe mental distress. 
Interviewers report that a time-consuming survey involving a stranger coming into the 
home is often deemed too burdensome a prospect for those with the most extensive 
health problems, while the sometimes chaotic nature of the lives of people with severe 
mental distress is an additional factor that makes them harder to find at home and 
schedule a suitable time to be interviewed. Establishing who doesn’t take part in 
surveys is, by definition, quite difficult. But, data linkage is increasingly being used to 
compare the health and mortality profiles of survey participants with the general 
population to aid our understanding of non-response biases. The most appropriate 
example here is Gorman et al.’s (2014) analysis of alcohol-related hospitalization and 
mortality, which established that these outcomes were significantly less likely among 
SHeS participants than the population as a whole, with the gap in outcomes largest for 
those living in more deprived areas.  
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The evident discrepancies between SHeS and the primary care data, and their most 
likely sources, suggest that while it is problematic to treat the primary care data as if it 
contained the “true” measure of multiple conditions, it certainly appears to contain a 
more complete measure. The critical issue is what to do with this information. The 
first obvious point is to ensure that any results based on SHeS clearly highlight what 
they do and do not represent. That means making explicit the fact that the picture of 
older people’s health presented is only partial, and that the nature of the conditions 
reflected in the estimates is similarly incomplete. The steps taken to develop the 
multiple conditions measure in this thesis are also linked to this. This process 
explicitly acknowledges the complexities of people’s health and illness experiences, and 
the need to consider health from multiple angles, and resulted in a measure of the 
population’s condition burden that was, overall, far closer to that suggested by the 
primary care data than was initially the case. It is therefore possible to gain a better 
picture of people’s health if additional thought is devoted to the process. The final 
important point to note is that, despite the fact that some conditions and people are 
missing from the survey estimates, the information that has been provided still has 
enormous value. For example, the analyses in Chapter 6, which will be discussed in 
more detail below, sheds light on just one aspect of the differential experiences of 
people living with significant health burdens that primary care data could simply never 
yield. Furthermore, huge potential exists for other analyses to be performed using the 
survey data, some of which are described in the Conclusion in Chapter 8. In an era of 
increasing use of routine “big” data it is also incumbent on funders of population 
surveys to continue to question the value of what they get from such sources and 
ensure that their full potential is being maximised. As the concluding thoughts in 
Chapter 8 will touch on, I’m not convinced sufficient attention has been paid to this 
in recent years, largely due to the heavy demands placed on SHeS to measure 
“lifestyle” risks and population outcomes. In sum, then, the efforts of the people who 
contribute their experiences to population surveys – as noted above, often revealing 
deeply personal information to strangers - should not be diminished or devalued by 
the presence of known deficiencies in survey processes. Otherwise the collection of 
that information would, arguably, be unethical.  
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What changes could be made to improve survey estimates? 
Law’s (2004) description of the problems associated with the methods utilised in social 
science research provides a potentially helpful way of framing the challenges revealed 
by the results presented here: “while standard methods are extremely good at what they do, 
they are badly adapted to the study of the ephemeral, the indefinite and the irregular” (Law 
2004, p.4). Long-term conditions are clearly not, by their enduring nature, ephemeral; 
but I would argue that disease and illness are concepts, or states of being, that certainly 
have indefinite and irregular characteristics, for all the reasons outlined in Chapter 4. 
These characteristics, therefore, arguably contribute to the reasons why the 
identification of health conditions using standardised questionnaires is a particularly 
problematic venture which requires the kind of multi-stranded approach followed 
here. This is perhaps especially so because the information is derived from the general 
population whose myriad different understandings and experiences have to be 
considered alongside the ontological complexities associated with these concepts. 
However, it would be remiss to suggest this is a problem solely characteristic of self-
reported health data – Bowker and Star’s (1999) work on the ICD provides a counter 
case in point.  
One possible conclusion from the suggestion that the diverse meanings and 
experiences of having health conditions are associated with such complexity is that 
they will always confound attempts to measure them. However, the unique 
opportunity that SHeS provides by having disparate sets of information about people’s 
health shows that the potential does exist to bring this together in a demonstrably 
meaningful way to more fully reflect people’s experiences. This is not to say that the 
questions could not be improved, or the whole process streamlined a little. The small 
changes introduced from 2012 certainly appear to have made some difference. 
However, the key conclusion from the work in this thesis must be that people’s 
experience of living with long-term health conditions cannot be fully reflected in a 
single question, even when it uses a format that gives people space to report their 
experiences in their own words, as SHeS does, and especially not when it uses a more 
closed format (for example, the UK’s four Censuses ask similar, closed formatted 
questions (NRS 2015; NISRA 2015; ONS n.d.)).  
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The most commonly used alternative way of measuring long-term conditions in 
population surveys is to select a list of conditions thought to be the most relevant or 
important, based either on their population prevalence, costs or consequences, and to 
ask people whether they have them, or have been diagnosed by a doctor as having 
them. The Labour Force Survey (UK Data Service 2015a) and Welsh Health Survey 
(UK Data Service 2015b) use these methods. This question format saves the 
considerable cost of collecting and coding free-text information, and effectively 
resolves the issue of people underreporting conditions like hypertension (if it is 
included in the list of conditions asked about). However, the main drawback is that 
the list of conditions needs to be fairly short, otherwise participants will omit 
information due to the burdensome nature of the task, so its capacity to cover all 
conditions will be constrained. Switching to use this format in SHeS would require 
extensive prior consultation about conditions to be included, and concerns would 
probably have to be allayed if users raised concern that the approach currently in place 
provides better information. Also, a situation could easily arise where the conditions 
included solely reflected the priorities of policy makers or service planners, which 
moves the framing of the information collected even further away from the 
experiences of people living with conditions. Similarly, careful thought would need to 
be paid to whether the information sought related only to conditions diagnosed by a 
clinician (as the SHeS CVD questions currently do), or whether space would also be 
made for other health problems or symptoms to be reflected. The SHeS other health 
problems question was perhaps intended to do this, though the evidence presented in 
Chapter 5 suggests that people’s answers were still largely framed in terms of named 
conditions.  
Decisions about surveys’ contents obviously have to be made with reference to their 
key purposes. In effect, SHeS’s purposes are twofold. Firstly, its repeated collection of 
cross-sectional population health data is used to monitor change over time in key 
health indicators, and social and regional variations in these. As such, its questions 
must strike the appropriate balance between suiting the needs of the day, and 
providing continuity of measurement, so changes to key measures have to be very 
carefully considered. Hopefully the information presented in this thesis can help to 
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inform such discussions. However, its function as a source of longitudinal data on 
health outcomes, derived from its use of NHS record linkage, also means that each 
round of the survey remains a “live”, continually evolving, information source, with a 
shelf-life beyond what is typical for a one-off, cross-sectional survey. The analyses 
presented here do not, therefore, simply perform the function of highlighting where 
changes to future questionnaires might be helpful. They also provide examples of 
retrospective data adjustments that could be applied to the surveys that have already 
taken place, in order to better reflect people’s health experiences and enhance their 
ongoing potential.  
At a minimum, I therefore suggest that the role of the long-term conditions data is 
examined by the survey’s commissioners in Scottish Government, with options for 
alternative collection formats piloted, following consultations with key data users. The 
SHeS information, as currently collected, yields a very rich picture of people’s health, 
if used accordingly. But, it’s not a hugely efficient method of data collection, both in 
terms of cost and the time required to collect it, and the question lurks in my mind of 
whether there is more information than is really necessary. Some of the adjustments 
made to the multiple conditions estimate were quite marginal, often because the 
additional information provided related to people who already had multiple 
conditions. While that information exists it is unethical not to use it. But public 
money funds this data collection, and a large amount of time is given up by the people 
who participate. These factors have to be borne in mind when considering what might 
be lost if some information wasn’t collected in the first place. The “other health 
problems” data pose a particular conundrum. I’m torn between thinking they should 
be retained, at least until the whole approach to measuring long-term conditions is 
reviewed, because they clearly provide insights about people’s health that are otherwise 
missing. On the other hand, unless the way that I have used these data in this thesis is 
more widely adopted (or some other use is identified), it seems very questionable 
practice to continue collecting this information. The method of handling the “other 
health problems” data that I developed is probably the most likely to be disputed by 
more clinically-focused users of the data (because the chronicity or nature of the 
conditions is less certain than is the case with the other conditions questions). 
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However, while the survey retains its current format, these data should at least be 
provided for others to use (they aren’t presently in the public dataset, largely because 
they have never been used - until this thesis - and not because of any concerns for 
confidentiality). Similarly, the individual condition codes relating to the long-term 
conditions question should be provided in both their original and aggregated forms. 
The case for routinely integrating the additional information from the CVD questions 
into the long-terms conditions measure is compelling, based on the evidence presented 
in Chapter 5. At the very minimum, the data should be simplified to make their 
integration by secondary analysts more straightforward. Finally, feedback on some of 
the coding discrepancies identified in this process has been provided to the survey 
contractors, for example to highlight the need for editors to be consistent in assigning 
separate codes to depression and anxiety (this was not always the case). Further 
briefing of interviewers about how to input data when people mention multiple 
conditions was also recommended, as was the possibility of introducing a programme 
prompt so that any instances of the word “and” being inputted trigger a flag to check 
that multiple conditions are being correctly recorded.  
What is the value of identifying people with multiple conditions?  
Introduction 
The discussion has so far focused on the measurement of the individual conditions 
that underpinned the measure of multiple conditions, rather than on the value of 
conceptualising multiple conditions as a collective status of interest. These concepts 
are, of course, related, because the degree of granularity that exists in the underlying 
data will affect the prevalence of multiple conditions (as the ungrouping of conditions 
grouped under ICD chapter headings demonstrated). Hence the decisions about how 
much granularity was appropriate were also taken with the ultimate purpose – to 
identify people with multiple conditions – in mind. However, the question of how to 
conceptualise this phenomenon is far more complex, as reflected in the large volume 
of literature devoted to this topic (outlined in Chapter 2).  
As noted in the introduction, the discussion that now follows of the analyses of 
experiences presented in Chapter 6 is primarily intended to serve as a framework for 
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assessing the value of identifying a group of people with multiple conditions. Valderas 
et al. (2009, p.357) suggest the following criteria could be used to evaluate the utility of 
definitions or measures of multiple conditions:  
the value of a given construct lies in its ability to explain a particular 
phenomenon of interest within the domains of (1) clinical care, (2) 
epidemiology, or (3) health services planning and financing. 
Leaving aside the issue of whether any single measure can fully explain a phenomenon 
without recourse to other sources of evidence, these criteria could provide a useful 
framework for assessing the measure arrived at in Chapter 5, but with the term 
“explain” perhaps better replaced by “increase understanding of”. Applied in this way, 
then, the question would be: in what ways does grouping people according to the 
number of conditions they have increase understanding of population wellbeing 
patterns? With wellbeing treated as a phenomenon of interest in epidemiology and in 
wider public policy. However, a more challenging – but potentially more pertinent - 
framing would be: in what ways does analysing wellbeing increase understanding of the 
experiences of people with multiple conditions? This reversal of the assessment criteria 
opens the potential for the value of the construct to be challenged not because it 
reveals little about an outcome of interest, but because what it reveals presents a 
challenge to the very construct itself. The following discussion of the wellbeing 
patterns in Chapter 6 therefore attempts to address both these questions. This 
approach reflects the aspiration set out in the methodology section of Chapter 3 - to 
treat all such constructs as potentially fallible, without necessarily undermining their 
value to a point that they are no longer deemed useful.  
What do the experiences of people with multiple conditions reveal about 
wellbeing in the population? 
The results in Chapter 6 represent the most comprehensive analysis of the association 
between wellbeing (measured via WEMWBS) and multiple conditions conducted to 
date. However, as the literature in Chapter 2 made clear, the association between 
having multiple conditions and poor psycho-social functioning, using measures such as 
health-related quality of life (HRQoL), has been explored previously (Fortin et al. 
2004; Huntley et al. 2012b; Mujita-Moja et al. 2015), including in Scotland, using the 
266 
 
2003 SHeS (Lawson et al. 2013). While wellbeing and HRQoL are different constructs 
(Schrank et al. 2015), the key finding that outcomes were worst for people with 
multiple conditions of working-age living in deprived areas was common to both this 
analysis of wellbeing and Lawson et al.’s (2013) analysis of HRQoL. Similarly, the 
finding that the association between condition status and wellbeing was much less 
pronounced among older adults replicates the patterns seen in Lawson et al.’s (2013) 
and Mujita-Moja’s (2015) HRQoL analyses, with the latter concluding that this might 
be explained by “lower expectations of health in older age or a greater ability to adapt to 
lifestyle changes imposed by adverse health events” (p.915). In contrast, the deprivation 
gradient in HRQoL reported in Lawson et al.’s (2013) results did not follow a uniform 
pattern (the two most deprived quintiles had similar results, as did the two least), 
whereas the increase in levels of low wellbeing shown in Chapter 6 (Figure 6.13) 
followed a stepwise pattern across each quintile. This difference might have resulted 
from the differences in the underlying multiple condition measures used (Lawson et 
al. used the grouped SHeS long-term conditions measure which, as demonstrated in 
this thesis, disproportionately underestimates multiple conditions among the working-
age population in deprived areas), though it is also possible that wellbeing and HRQoL 
have different social distributions in relation to condition status (unfortunately SHeS 
has never measured both simultaneously). Mujica-Moja et al. (2015) adjusted for area 
deprivation in their analyses but did not present any stratified results or discussion of 
the impact of socio-economic context on HRQoL.  
Moving beyond what has already been demonstrated in the literature, the size of the 
sample available for the analyses conducted in this thesis made it possible to explore 
some of the patterns identified in Lawson et al. (2013) with greater precision, and to 
investigate some of the potential mechanisms they suggested might account for those 
patterns, such as greater levels of functional impairment among younger adults. 
Lawson et al. stated that the survey did not measure severity. However, the analysis of 
activity limitations presented in Chapter 6, which captures an aspect of severity, 
demonstrated that integrating this aspect adds important insights. Principally, it 
showed that the very clear differences in wellbeing by condition number were only 
really evident among people living with multiple conditions that included activity-
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limitations. Similarly, the deprivation gradient in low wellbeing was much more 
pronounced among people with activity limitations than those with non-limiting 
conditions. Finally, the social inequality in the prevalence of multiple conditions 
illustrated in Chapter 5 is also, on closer inspection, accounted for by inequalities in 
the distribution of multiple conditions in the presence of activity limitations. These 
patterns suggest that it is not the sheer fact of having more than one condition that 
shapes wellbeing, but that what matters is the much higher likelihood that having 
multiple conditions is accompanied by activity limitations (three-quarters of people 
with multiple conditions also reported activity limitations compared with a third of 
those with one condition). This was also supported by the results of the additional 
analyses of survival in Chapter 6. The challenges wrought by having multiple 
conditions are not, therefore, simply due to the complexity of managing or living with 
more than one condition, but due to the increasing extent to which they encroach on 
people’s functional capabilities.  
However, activity limitations alone clearly cannot account for the very notable 
variations in wellbeing by age and by deprivation among those with multiple 
conditions, because the results in Figure 6.22 showed that activity limitations were as 
likely to be reported by younger people with multiple conditions (who had the highest 
levels of low wellbeing) as they were by older people (with the lowest levels). As 
Chapter 6 has already noted, it seems likely that the psycho-social meanings and 
consequences of having activity limitations while still of working-age are worse than 
they are when experienced at an older age, so this simple measure of their existence 
has failed to capture that aspect. Identifying some of the ways in which the 
consequences of having multiple conditions differed between those still of working-age 
and those of post-retirement age helped to provide some evidence that this is indeed 
the case. One example of this is the greater extent to which the lives of people with 
multiple conditions aged under 65 differed from those of their counterparts with 
fewer or no health conditions in terms of their increased level of contact with the 
welfare state, and lower levels of home ownership and partnership formation. The 
possibility of a healthier survivor effect, illustrated by the survival analysis that showed 
how the contextual factors of severity, distress and deprivation - when combined with 
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living with multiple conditions - were all associated with higher mortality risks, will 
also be a factor.  
It is important to note, though, that the outcomes for older people with multiple 
conditions were not uniformly positive, and they were still socially patterned, with the 
most deprived adults in this group having higher levels of low wellbeing than their 
least deprived counterparts (as was found by von dem Knesebeck et al. (2015)). 
Similarly, Ong et al.’s (2014) study of resilience and multiple conditions, which was 
conducted almost exclusively among people aged 65 and over, described how couple 
relationships and wider social and family networks were put under strain (including 
physical separation following one partner’s move to a care home) as a consequence of 
worsening health. So the results presented in Chapter 6 must not give the impression 
that low wellbeing is not a feature of the lives of older people with multiple conditions. 
The point is that as a group, in relative terms, people aged 65 and over with multiple 
conditions had better outcomes than those aged 16-64 with multiple conditions.  
The insights offered by Hurd Clarke & Bennett (2013) are useful here. As noted in 
Chapter 4, their participants often accommodated and framed their illness experiences 
as inevitable consequences of ageing, sometimes drawing active comparisons with their 
less healthy counterparts in order to contextualise their own experiences (a 
phenomenon described as a “poor dear hierarchy” (p.354)). At their age, most of their 
friends and other social contacts had some degree of ill-health so the comparisons they 
made drew on a spectrum of similar experiences. In contrast, the extended social 
networks of younger people with multiple conditions will be far more likely to include 
a majority of people with few or no health problems, even if social sorting has resulted 
in their closest contacts having similarly poor levels of health. The people with 
multiple conditions interviewed by Duguay et al. (2014) – who were aged 37-66 years – 
described their deteriorating health as a form of premature ageing, which supports this 
notion that having multiple conditions in younger adulthood is a socially distinctive, 
and indeed isolating, experience.  
People with multiple conditions, especially those aged under 65, and those living in 
areas of high deprivation, clearly experience a high burden of low wellbeing. It is 
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possible that this is simply indicative of the high burden of mental health conditions 
experienced by people with multiple conditions of working-age that sources such as 
McLean et al. (2014) have revealed, but that population survey data struggle to reflect. 
Low wellbeing does, after all, appear to have a close correlation with diagnosable 
mental illness (Stewart-Brown et al. 2015), and many of the aspects covered by the 
WEMWBS items are potential symptoms of depression. Regardless of its designation, 
the arguably more challenging issue is how to improve the wellbeing of people within 
this group. It is clear from sources such as O’Brien et al. (2011 & 2014) that the scope 
to do this lies almost exclusively beyond the realms of what health services can deliver. 
For example, both studies illustrate how the boundaries between what constitutes a 
health problem and what might more appropriately be seen as a social or economic 
issue are very unclear for people who live with the complex combination of multiple 
health conditions and deprivation, especially if mental health problems are also 
present. These kinds of insights, when coupled with the results of this analysis of 
wellbeing suggest that people with multiple conditions display highly heterogeneous 
patterns of outcomes and experiences, with deprivation a fundamentally important 
determinant of these. This, therefore, leads to the question of what such patterns 
suggest about the value of grouping people solely on the basis of their condition count.  
What do wellbeing patterns reveal about the experiences of people with multiple 
conditions? 
A number of aspects of the findings in Chapter 6 suggest that the group of people with 
multiple conditions has highly heterogeneous characteristics. Firstly, the individual 
components of the scale that reflect low wellbeing, and the overall summary measure, 
both showed a graded relationship with condition numbers, with increasingly worse 
outcomes evident as condition numbers increased (when grouped from none to five or 
more; Figures 6.7, 6.8 and 6.10). No individual item (or the summary measure) 
demonstrated a pattern which clearly demarcated a particular threshold above which 
outcomes were notably worse than they had been for the previous group (though the 
overall pattern was curvilinear due to a slight upturn in negative outcomes evident 
when reaching the five or more group, which is itself a composite group including 
people with up to nine identified conditions). Therefore, the fact that low wellbeing 
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was notably higher among people with multiple conditions than those with one or no 
conditions was simply an arithmetic function of the much lower levels of wellbeing 
among people with the highest number of conditions, rather than the breaching of a 
critical threshold beyond which experiences were markedly different. The grouping of 
people according to whether they have more than one condition could, for this 
outcome at least, be said to be somewhat arbitrary, if this empirical aspect of the 
measure was the sole criterion determining its conceptualisation. And it could 
certainly be argued that the very negative experiences of those with the highest number 
of conditions are underrepresented in subsequent analyses using this threshold. 
However, while it is clear that outcomes continue to deteriorate as conditions numbers 
increase, the population prevalence of having higher numbers of conditions also drops 
markedly, which creates analytic challenges due to small sample sizes. Creating a 
summary measure that aggregates all those with more than one condition might 
therefore be blunt, but it is clearly expedient; the other complexities and increased 
illness work (of the kind described by Corbin & Strauss (1985) and discussed in 
Chapter 4) that are clearly associated with having more than one condition are also 
important considerations when determining how this status should be conceptualised, 
beyond the empirical patterns demonstrated here. As Chapter 4 illustrated, few 
concepts in this field can be genuinely demonstrated to be free of arbitrary, or at least, 
contingent, considerations. The important point is to recognise that all such 
constructs have these characteristics, and to use this recognition to avoid them 
becoming overly reified. 
Secondly, however, integrating a measure of severity revealed how the combined 
presence of activity limitations and multiple conditions appeared to be a key factor 
differentiating wellbeing outcomes, rather than just multiplicity per se. The literature 
review in Chapter 2 noted a number of sources that drew similar conclusions about 
the limitations of measures that solely focus on the number of conditions people have, 
without also taking into account their wider impact on people’s lives, with functional 
limitations often cited as an important factor to consider (Valderas et al. 2009; Mercer 
et al. 2009; Diederichs et al. 2011; Beard & Bloom 2014; Chrischilles et al. 2014). The 
strength of the data source used in this thesis is that it enabled people to make their 
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own judgements about the extent of their limitations, though the main weakness, as 
already noted in Chapter 6, is that this was only asked about in relation to long-term 
conditions that were reported without prompting. A more fundamental weakness is 
the absence of further details about these limitations, for example in what domains of 
people’s lives they were most acutely felt, or how many limitations people faced. 
Furthermore, in light of the very different outcomes experienced by younger people 
with multiple conditions, there would also be value in attempting to measure the 
extent to which people’s aspirations are constrained, as well as their daily functional 
capacities.  
Thirdly, the age-related patterns in wellbeing, and also the age by deprivation-related 
patterns in overall prevalence of multiple conditions, suggest the possibility that this is 
a construct whose meaning, and certainly whose consequences, vary over the 
lifecourse. As noted in Chapter 2, Fortin et al. (2012) suggest that a different threshold 
might be of value to better differentiate the experiences of older people (most of whom 
have at least two conditions). However, when it comes to differentiating between 
outcomes among people with multiple conditions, using a threshold of three or more 
(across the board or just for those aged 65 and over) adds little value. As Figure J1 in 
Appendix J shows, levels of low wellbeing are even higher among those aged 35-64 
when this higher condition threshold is applied, while the figures for those aged 65 
and above differ only marginally, and the sample size for those aged 16-34 becomes too 
small to be meaningfully representative.  
Finally, it was clearly the case that within each area deprivation quintile, low wellbeing 
was far higher among people with multiple conditions than among those with one or 
none. However, when the quintiles were compared, people with multiple conditions 
living in the least deprived areas had better outcomes than their more deprived 
counterparts with lower reported condition burdens. This of course raises the 
possibility that some people with one condition living in the most deprived areas had 
their condition burden underestimated, perhaps due to undisclosed or undiagnosed 
mental health conditions. However, the twofold increase in low wellbeing seen 
between people with one conditions and those with multiple conditions living in the 
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most deprived areas suggests that misclassification was probably not responsible 
(outcomes would be more similar if the one condition group contained a lot of people 
who actually had multiple conditions).  
The conceptual implications of heterogeneous experiences 
As noted above, questioning the conceptualisation of multiple conditions in this way 
does not necessarily need to yield the conclusion that it is a meaningless 
categorisation. Rather, the point is to identify more clearly what it does and does not 
mean, where it adds value and where it does not, and to use these insights to further 
shape both its conceptualisation and its application. Viewed from a critical realist 
perspective, multiple conditions is clearly a socio-medical categorisation that now 
exists, as evidenced by its proliferation as a research subject, its increasing use in policy 
circles, and in clinical practice. But it is also, for many people, a social reality that they 
experience directly, either via their understanding or interpretation of the multiple 
diagnostic labels they have been given, or through their different symptomatic 
manifestations, or via the increasing treatment burdens and clinical encounters they 
impose. They might rarely (if ever) use a term like multimorbidity, but they definitely 
inhabit a world in which poor health is experienced as a multiple rather than singular 
phenomenon. Simply highlighting the more socially constructed and contingent 
aspects of a concept such as multiple conditions without also recognising the extent to 
which it can help illuminate aspects of the lived realities of the challenges people face 
when confronted with increasing numbers of conditions, and the functional 
limitations that they bring, arguably devalues those very experiences.  
Collectively, the four aspects outlined in the preceding section highlight the fact that a 
narrow, biomedically-focused measure of health conditions can never fully reflect the 
entirety of the life experiences and challenges that are relevant to understanding 
people’s wider outcomes. Put more simply, health-related outcomes cannot be 
understood solely in terms of health-related inputs. The social context also matters, 
and in fact, in some circumstances, arguably matters more, especially if social context is 
taken to mean not only the socio-structural environments in which people live, but 
also the social functions they have the capacity to enjoy. However, as an organising 
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heuristic, identifying people with multiple conditions could at the very least be viewed 
as a useful starting point from which to further explore experiences and outcomes. 
This is because, regardless of how people choose to frame and interpret their health 
experiences, living with poor health is an important reality of many people’s lives and 
it confers significant negative consequences. The key is remembering that it is not the 
only important reality of people’s lives. Viewed like this, its limitations as a 
categorisation are therefore most acute when conditions are viewed as the sole 
characteristic of interest, with no further considerations paid to other key contextual 
information. This point could be criticised as obvious or platitudinous, were it not for 
the fact that a large amount of the published research in this field uses sources that 
have little or no information about the socio-economic context of its subjects, or of the 
ways in which conditions impinge on their activities, and many are based on very 
partial data about health conditions – with mental health conditions often completely 
absent.  
Conclusion 
This discussion has attempted to address the issues of both measurement and 
conceptualisation in relation to the phenomenon of having multiple long-term health 
conditions. It reflected the distinctive approach taken in the thesis to use a broad set 
of theoretical insights to help guide measurement decisions, underlined by a concern 
to follow a critical realist-informed approach that treated all constructs as fallible, but 
not necessarily flawed beyond utility. The strengths and limitations of this approach 
are considered further in the next chapter, which provides the overall conclusion to 
this thesis, and also includes suggestions for where this work could be taken next. 
With their focus on the individual building blocks that underlie the multiple 
conditions measure, the problems identified with, and recommendations made for 
improving, the measurement of individual conditions could be seen as distinct from 
those relating to the issues associated with measuring conditions in aggregate. 
However, as already noted, the inter-relationships and boundaries between conditions 
and how people experience them, and the questions relating to where risks end and 
conditions begin, are important issues that have consequences for the way that 
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conditions are conceptualised both individually and collectively. In much the same 
way, measurement and conceptualisation should not really be seen as entirely distinct 
exercises, but are, of course, two linked dimensions of one much broader activity. For 
example, the decision about whether to conceptualise multimorbidity as an entity 
relating solely to health conditions, or to follow the more expansive definitions offered 
by some in this field – such as Le Reste et al.’s (2013), or Mercer et al.’s (2009) 
suggestion to consider “existential and spiritual distress” (p.79) as morbidities - has 
obvious associated measurement consequences.  
However, decisions about conceptualisation clearly have more than just measurement 
consequences; the analytic potential offered by different conceptualisations of multiple 
conditions is also an important consideration. The literature review in Chapter 2 
devoted considerable attention to the definitional wrangling that has accompanied 
research in this field to date, and noted studies that highlighted the need to draw clear 
connections between the nature of how measures are defined and the ultimate 
purposes to which they are put (e.g. Valderas et al. 2009; Diederichs et al. 2011; 
Hughes et al. 2012). One aspect of the conceptualisation of multiple conditions that 
has been somewhat under-developed in this thesis is the question of what the measure 
is intended for (beyond just descriptive epidemiology of this phenomenon). 
Furthermore, three distinct trends in the literature suggest that the work presented 
here, and its creation of a single measure of multiple conditions, could be criticised for 
being too conceptually narrow. These are: the increasing use of more complex 
analytical and conceptual frameworks in this field (e.g. Schaink et al. 2012; 
Grembowski et al. 2014); the move towards using data reduction techniques to 
identify clusters of patterns in conditions among those with multiple conditions 
(Prados-Torres et al. 2014); and the recognition that factors such as functional capacity 
are a critically important aspect of people’s illness experiences and ultimate outcomes 
(Beard & Bloom 2014; Chrischilles et al. 2014). This issue is explored further as part 




Chapter 8 Conclusion 
Introduction 
The book from which the title for this thesis was borrowed – C. L. R. James’s Beyond a 
Boundary – is prefaced with the following observation: 
What do they know of cricket who only cricket know? To answer involves ideas as well 
as facts. (James 1963, p.n.p., emphasis in the original). 
Although clearly relating to a different field (figuratively and literally), the approach it 
suggests has a number of resonances with the work presented in this thesis. For 
example, its concern to integrate theory and data, and its use of perspectives that lie 
beyond the boundaries typically occupied by epidemiological analyses. This concluding 
chapter starts by drawing out some of the main strengths and limitations of this 
approach. This is followed by a discussion of potential new avenues that could be 
explored to address some of the limitations raised, and to further increase 
understanding of the lives of people with multiple conditions. It includes, for example, 
suggestions for new ways of analysing the existing data, or for collecting new data on 
aspects that could potentially be collected in future studies, either using population 
surveys, or via other, more methodologically diverse, study designs.  
Strengths and limitations of the approach followed 
Introduction 
This section will not repeat the discussions of the strengths and limitations of the data 
source that were covered in Chapter 3. Similarly, the well-rehearsed sources of bias 
that attend all population health surveys were already discussed in Chapter 7 in 
relation to the kinds of information and people that were likely to be missing due to 
non-response to the survey as a whole, or parts of it. Finally, the various problems 
identified with measuring people’s conditions, also outlined in Chapter 7, do not need 
further discussion here. Instead the focus now turns to the strengths and weaknesses 
associated with the overarching methodological approach adopted in this thesis - its 
attempt to integrate theory and data and, in so doing, expose the process of measuring 
and conceptualising multiple conditions to a level of scrutiny not always typical of 
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quantitative epidemiological analyses. The discussion of the value of what the 
approach added has been integrated into the consideration of its strengths. 
Strengths 
One way to evaluate the strengths of an approach is to identify examples where it 
resulted in beneficial outcomes that might otherwise not have occurred, or helped to 
avoid problems that might have arisen. In this way, the value added by an approach 
can be identified. In this case, for example, the insights gained from reviewing the 
literature on psychiatric nosology and the problems associated with population survey 
measures of distress, coupled with the wider literature on medicalisation and 
overdiagnosis, helped to avoid creating a measure of multiple conditions that was over-
inflated by disease risks of questionable value and markers of transient, everyday 
stresses of life. I know that previous analyses I have conducted of SHeS (and other 
similar data) have paid much less attention to these issues, and that my approach will, 
in future, be far more cautious as a result of what I learned through this process.  
This approach provided a framework for thinking more broadly about the 
measurement of health conditions in terms that didn’t presume a definitive “correct” 
answer was out there waiting to be captured using a standardised format that could be 
applied to all people. Instead, it accepted that people’s interpretations of questions 
about their health will differ for a variety of reasons, not all of which were the 
consequence of defective survey measures that could be addressed by small changes to 
wording. This didn’t mean that recommendations for improvements to the survey 
questions were deemed irrelevant, but rather the emphasis was placed on ways to re-
design the questions to better reflect the diversity of understandings and experiences 
that exist in the population.  
The approach also provided a space for the accounts provided directly by the people 
interviewed to be more fully integrated into the analysis. This had practical benefits in 
terms of helping to create a more comprehensive measure, but it was also, arguably, a 
more ethical approach given that it drew on a considerable amount of information 
that had been provided over the years but never used. It did this by working from the 
presumption that all the additional information provided was potentially of value, 
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rather than treating it as inconvenient noise within the data (the use of the 
disaggregated conditions is an illustration of this). The term potentially of value is 
important here as there was also an explicit acknowledgement that some of the 
information provided would not be valuable and could, in fact, cause harm if it were 
to result in diluting the experiences of people whose health burdens were at the more 
severe end of the spectrum (a caution raised by Aronowitz (2009)). The value of illness 
accounts, as eloquently illustrated by Frank (1995) in The Wounded Story Teller, was 
influential in the decision to use the assessments of self-rated health to help determine 
whether the “other” health problems people reported should be included in the 
multiple conditions measure (Turner’s (1987) work was also valuable in this respect). 
However, a balance clearly needed to be struck between being overly inclusive and too 
restrictive when identifying conditions to be included. Coupling these accounts with 
survival analysis to give it some grounding in a directly observable outcome (death) 
therefore provided a useful means to help arbitrate on such matters and to 
demonstrate the wider validity of the measurement decisions.  
Moving on from the measurement and conceptualisation aspects of this work, another 
strength was, arguably, its attempt to move beyond the mere identification of patterns 
in outcomes by condition number. The discussion of critical realism in Chapter 3 
described the ways in which it had influenced the work presented in this thesis, and 
outlined its arguments about the need to identify mechanisms potentially underlying 
associations between phenomena. As Sayer suggests: “patterns of events, be they regular or 
irregular, are not self-explanatory, but must be explained by reference to what produces 
them” (Sayer 1992, cited in Dunn 2012 p.29, emphasis added by Dunn). The 
identification of potential mechanisms to explain the different patterns in wellbeing 
among people with multiple conditions across different age groups, and by extension, 
to understand why low wellbeing was much more a feature of having multiple 
conditions while of working age was, therefore, my attempt to engage with this 
approach. Citing Sayer, Dunn (2012) described this process as follows: 
The “mode of inference” by which “events are explained by postulating (and 
identifying) mechanisms which are capable of producing them is called 
‘retroduction’” (Sayer 1992, cited in Dunn 2012, p.30, emphasis in original). 
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The mechanisms explored were quite broadly drawn. They included the potential that 
people whose lives feature both multiple conditions and additional contextual 
challenges (such as activity limitations, deprivation or psychological distress) die sooner 
than those who don’t experience these additional challenges, thus contributing to a 
healthier survivor effect. Another was the potential that the higher levels of low 
wellbeing found among people living with multiple conditions while still of working 
age were related to their greater likelihood of economic marginalisation (only half of 
this group were economically active) and exclusion from other social norms, such as 
long-term partnerships and home ownership. The process of identifying mechanisms is 
akin to peeling an onion, and the layers explored here represent only a small snapshot 
of the kinds of dynamics that might have produced the patterns observed. The point 
was to explore the potential to use the data to think in this way. There are, of course, 
major limitations in using cross-sectional data to draw conclusions about the nature of 
associations between phenomena (some of which are discussed further below). 
However, the identification of mechanisms such as these is not meant to be a 
definitive exercise, but should instead lay the foundations for further investigations 
using approaches better suited to this purpose (as also discussed below).  
Limitations 
The decision to use wellbeing as a marker of the wider contextual challenges that 
people with multiple conditions experience, and to reject the use of GHQ12 to 
identify psychiatric morbidity ‘caseness’, has limitations as well as the strengths noted 
above. For example, it is possible that it created an artificial partition between 
conditions and wellbeing that, based on the work reported in O’Brien (2014), has little 
grounding in terms of the way that people live with these experiences, and missed an 
opportunity to address the underestimation of mental distress that was clearly evident 
in the data. The question of what should be counted as “normal” and “abnormal” 
distress lies at the heart of the tensions that have run through psychiatric nosology for 
decades, as discussed in Chapter 4. This analysis could not, therefore, reasonably have 
been expected to resolve it in a way that avoided all limitations. Indeed, in an editorial 
discussing the results of Smith et al.’s (2014) analysis of the co-occurrence of 
depression and multimorbidity (based on the same source as Barnett et al. (2012)), 
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O’Dowd (2014) describes the difficulties associated with establishing whether 
symptoms of “unhappiness, pain, and impaired function” reported by people with physical 
conditions warrant an additional diagnosis of depression, or whether they instead 
reflect “a form of grief over the progressive loss of function that chronic illness brings about” 
(p.e1319). The discussion then goes on to describe the association between deprivation 
and the increased prevalence of these conditions and symptoms, suggesting that 
“Summoning the personal resources required for daily living in deprived areas takes its toll and is 
expressed as a more painful existence than for those living in better circumstances” (p.e1319). 
An obvious solution to the issue of whether to classify low wellbeing or high 
psychological distress as conditions that could contribute to the multiple conditions 
definition would have been to create two measures and assess their utility. This could 
form the basis of future work.  
Another potential limitation was the fact that the analysis of wellbeing patterns, and 
the attempt to identify potential mechanisms underlying them, focused on very 
proximally-located phenomena. This is partly a function of the nature of the available 
data, though as the discussion of risks at the start of Chapter 6 illustrated, only having 
access to proximal measures (such as smoking prevalence) does not necessarily mean 
that these have to be framed or interpreted solely in those terms. However, as the 
literature review in Chapter 2 briefly touched on, the rise of multiple conditions can, 
in part, be attributed to the global drivers of NCD prevalence, and these are largely (or 
even wholly) a consequence of mechanisms operating within the political and 
economic spheres. Much further thought (and analysis) is therefore required to 
elucidate the pathways operating between these highly distal (and complex) factors and 
the chain of intervening objects that result in their ultimate manifestations in the lives 
of people with multiple conditions. Some question the value of approaches that 
attempt to identify such pathways, for example, Collins et al. (2015) suggest it draws 
attention away from the fundamental political drivers of health inequalities and risks 
misidentifying the appropriate actions to address them. However, acknowledging the 
fact that the drivers are very distally located doesn’t have to be incompatible with 
attempts to further understanding of how these chains of complex interrelated 
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phenomena ultimately come to result in physical and psychological damage to people 
(Macintyre 2007). These kinds of insights could then be used to identify and 
implement at least mitigating, if not necessarily preventative, actions (Douglas 2015).  
No analysis of health inequality is complete without a critique of its measures of social 
position and the problems associated with adequately capturing this aspect of people’s 
lives (Galobardes et al. 2007). The measure used in this thesis, the Scottish Index of 
Multiple Deprivation, is an area-based, as opposed to individual-level, measure of 
socio-economic context. Consequently, it is only a proxy measure of a person’s social 
position (though area is an important context too (Pearce et al. 2015)). Not all of the 
people living in the most deprived areas will themselves be socially disadvantaged by 
any other standard measures, while many socially disadvantaged people do not live in 
an area with these characteristics (this is a particular problem in rural parts of Scotland 
Fischbacher (2012)). The choice to use SIMD was quite deliberate. It has no missing 
data, unlike the survey’s measures of household income and occupation-based social 
class, and is the most used measure of disadvantage in Scotland for both research and 
policy. As Fischbacher (2012) outlines, all of the main initiatives to reduce health 
inequalities or improve outcomes among the most disadvantaged people use this 
measure to target resources. However, the potentially negative consequences of this 
can be illustrated by the fact that the majority of people with multiple conditions and 
low wellbeing did not live in the most deprived SIMD quintile (data not shown), 
hence targeting this group solely by means of their geographic location will not be 
effective. Hence these limitations must be aired, and the recommendations for future 
work include suggestions for incorporating some of the survey’s other measures of 
disadvantage into analyses, as well as ideas for other measures that could be useful. 
The final limitation to note relates less to the approach that was followed and is more 
to do with the overall balance achieved between aspects relating to measurement and 
those relating to conceptualisation. Ultimately, more consideration was devoted to 
what conditions to include than to the more fundamental question of what the 
measure was ultimately for. However, the outline of potential future developments 
presented below is an attempt to address this by suggesting applications to which the 
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new measure could be put as well as refinements to its construction that might 
sharpen its purpose.  
Where can this research go next? 
The above discussion of strengths highlighted its use of theoretically diverse 
approaches to conceptualising disease and illness to help guide the definition process. 
However, as the discussion in Chapter 7 touched on, a measure of health constructed 
around conditions (as opposed to symptoms or functional limitations) is still, 
ultimately, a very biomedically-focused conceptualisation of health experiences. There 
are clear reasons why knowing how many people in a population live with multiple 
conditions is of value, how this varies by social group, and what negative consequences 
this status brings. This is so even if the criteria used to determine whether someone 
has a condition, or multiples of them, are fallible (so long as this fallibility is 
acknowledged). Such reasons include not just the sheer volume of illness work and 
cascade of symptoms that can result from multiple diagnoses, and the fact that people 
do not necessarily experience their conditions as discrete entities. There is also the 
consideration that having multiple conditions will bring challenges above and beyond 
the sheer fact of their aggregation, such as unhelpful drug interactions, unrelated 
symptoms that exacerbate each other, or the stress of managing conflicting or 
contradictory treatment advice. However, there remains a value in ensuring that 
groupings such as these do not become essentialised (i.e. treated as if they had singular, 
fixed characteristics), resulting in the heterogeneity of their composition and 
experiences being lost in the process. Population data have a unique advantage over 
clinical sources in that they can draw out these heterogeneities far more expansively by 
drawing on wider characteristics that capture aspects of people’s lived experiences and 
social, economic and cultural circumstances. Chapter 6 opened by briefly locating 
wellbeing within the wider context of other challenges that are often linked with 
health outcomes, such as smoking, high BMI, low activity levels and poor diet. As 
discussed then, these kinds of challenges can often acquire additional significance in 
the context of existing health problems, either because they exacerbate symptoms, or 
because failing to address them (either in the past or the present) can provoke stressful 
feelings of shame or failure, or result in the withholding of care (e.g. BMI restrictions 
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on surgery). Hence their significance as potentially important markers of other 
complexities that people with multiple conditions might face, sometimes 
disproportionately so, relative to people with better health.   
The literature reviewed in Chapter 2 included a number of studies containing 
proposals for frameworks for approaching this topic that better reflect the complexity 
of circumstances people with multiple conditions face (e.g. Schaink et al. 2012; 
Grembowski et al. 2014), or suggestions of definitions that encompass many of these 
aspects (Le Reste, Nabbe, Manceau, et al. 2013), or analyses that cluster people 
according to condition patterns (Prados-Torres et al. 2014). However, similar analyses 
of people’s wider circumstances were not identified, so an important extension of the 
work presented here would be to investigate such patterns using data reduction 
techniques such as latent class analysis (Collins & Lanza 2010) to identify patterns that 
go beyond the more biomedically-focussed disease clustering analyses in this field.27 
This would not only serve the purpose of challenging more essentialist 
conceptualisations. This kind of more comprehensive contextual information would 
also demonstrate the full extent of the challenges that some people with multiple 
conditions face. Such insights could then inform practice, such as the work being done 
to re-formulate guidelines and deliver more ‘patient-centred’ care (as noted in Chapter 
2). As Wyatt et al. (2014) suggest, attempts to implement guidelines without 
appreciating the complex context of multiple conditions results in “an absurd 
accumulation of work and complexity to which clinicians and patients can only respond with 
noncompliance” (p.s99). 
From a population health perspective, these kinds of analyses could help to shift the 
focus of interest away from single diseases, divorced from the reality of their individual 
and broader contexts, towards more holistic (and realistic) accounts of the ways in 
which poor health manifests in populations. A focus on single diseases brings with it a 
high risk that policy recommendations will be very biomedical (e.g. pharmacological 
management of hypertension) and individualistic in their orientation (e.g. adopting 
unhelpful ‘behaviour’ change approaches (Katikireddi et al. 2013)). In contrast, it is 
                                                 
27 A fairly rudimentary attempt to do this was presented in Bromley (2014). 
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much harder to continue to offer simplistic solutions to scenarios that have been 
clearly presented as highly complex (though not impossible - the absence of actions to 
address the complexity of challenges set out in the Foresight (2008) obesity report 
springs to mind as an example of this).  
The limitations associated with area-based measures of deprivation were noted above. 
One means of addressing this would be to include measures of individual-level 
socioeconomic position, such as occupation-based social class, income level or 
educational attainment (all of which are routinely collected in SHeS), in future 
analyses. However, in terms of identifying mechanisms that might account for the high 
levels of low wellbeing that accompany poor health and social disadvantage, different 
measures of phenomena that could lie on the causal pathway might be beneficial. 
However, Dunn’s (2012) caution that “the greatest challenge for social epidemiology is not to 
achieve more accurate measurement of variables” (p.39) is important to heed here. The 
following recommendations for other measures that might potentially be of value have 
been framed in terms of items that could be added to SHeS. However, this is not 
intended to preclude the possibility of these also being explored using more intensive 
methods, such as qualitative interviews or ethnography. Indeed, for some it is likely 
that they would be more usefully explored solely by these means, without first having 
been included in a survey. Certainly, as Sayer argues, this combination of methods 
should be seen as a basic requirement in order to assess their potential status as 
mechanisms that produce outcomes:  
the discovery of empirical regularities may draw attention to objects whose causal 
powers might be responsible for the pattern and to conditions which are 
necessary for their existence and activation. But in order to confirm these, 
qualitative information is needed on the nature of objects involved and not 
merely more quantitative data on empirical associations. (Sayer 1992, cited in 
Dunn 2012, p.33). 
Chapter 7 has already discussed the value that might be gained from having more 
information about the impact that conditions have on people’s lives, in terms of their 
impairment of functional abilities and, linked to this, the extent to which people’s 
aspirations for their lives are at odds with the realities of their existence. It would 
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certainly be advantageous to have better survey information about these aspects in 
order to create more distinctive measures of multiple condition experiences.  
The high levels of mental distress experienced by younger people with multiple 
conditions in areas of high deprivation, coupled with the accounts of the complexity of 
the lives those patterns reflect (as shown in both studies by O’Brien et al. (2011; 
2014)), suggest that there might be value in having survey measures of these kinds of 
complexities and thus open up the possibility of investigating their role in harming 
wellbeing. A large amount of time in the survey is devoted to establishing how many 
minutes of moderate or vigorous physical activity people expend each week, or how 
many units of alcohol or portions of fruit and vegetables they consume, due to their 
status as potential chronic disease risk factors (and the predominance of ‘behavioural’ 
measures in population surveys, allied to the arguable overemphasis of these kinds of 
accounts of health in UK policy circles (Katikireddi et al. 2013)). Although, as 
discussed in the presentation of some of these risks in Chapter 6, the fact that these 
were proximally-measured phenomena, their framing and interpretation need not be 
located solely at that level. However, measures of other kinds of stresses that 
immiserate people’s lives and damage health are largely absent from SHeS. McCartney 
et al. (2013) provide a detailed examination of the potential impact of welfare reform 
on health inequality among working-age adults in Scotland, but note the lack of good 
measures to assess its impact. For example, while SHeS measures household income 
and receipt of social benefits, these measures do not capture the everyday work of 
living in poverty, or the kinds of assaults that this status brings, such as benefit 
sanctioning, food insecurity, precarious employment and financial insecurity. These 
absences are perhaps illustrative of the points made in Forbes & Wainwright’s (2001) 
critique of official survey measures, noted in Chapter 4, though it is also worth 
highlighting that people’s unwillingness to answer questions covering sensitive topics 
such as these is known to result in high levels of measurement error (Meyer et al. 
2015).  
Chapter 7 made the point that health-inputs rarely provide good explanations of 
health-outputs in the absence of social context. The additional measures of social 
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stressors suggested above would therefore help augment the survey’s ability to capture 
these contextual aspects. However, it must not make the same mistake that medical 
sociology found itself accused of in the past, of making the body largely absent from 
these accounts (Kelly & Field 2004). The lives of people with multiple conditions are 
clearly encroached on by more than (just) the sum of their conditions, but aspects 
directly relating to their conditions are important too. Beyond the functional ability 
measures suggested above, other aspects of living with long-term poor health, such as 
pain, would also be valuable to measure, and would tap a more directly experienced 
(and often miserable) feature of health than measures of named conditions can do. 
The sociological literature on illness work described in Chapter 4 (Corbin & Strauss 
1985; O’Brien et al. 2014) is highly relevant in the context of multiple conditions, one 
aspect of which is contact with health services, but the survey’s measures of this are 
currently too crude to meaningfully differentiate the experiences of people whose lives 
feature multiple appointments. SHeS simply asks whether people had any in-patient 
and out-patient visits in the past year, using a simple binary indicator with no further 
granularity). But illness work is stressful beyond the sheer fact of these encounters. The 
connection between low wellbeing, multiple conditions and marital / partnership 
status would be worth exploring in the context of how people without partners 
manage their illness work, both practically, such as who accompanies them to medical 
appointments, as well as emotionally, in terms of help with the more stressful aspects 
of these encounters. The increasing stigmatisation of dependency explored by Peacock 
et al. (2014) is potentially instructive here in terms of identifying mechanisms that 
might produce low wellbeing among people with multiple conditions, especially at 
younger ages. This combination of circumstances involves multiple discordances 
relative to the experiences of the rest of their peer group and might therefore also 
feature multiple forms of stigma simultaneously.  
The wellbeing patterns by age group presented in Chapter 6 suggest the possibility that 
another one of the many ways in which this group of people have very heterogeneous 
experiences will be related to the length of time they have spent living with multiple 
conditions. An extension of the approach to identifying sub-groups of people with 
multiple conditions based on their experiences, would be to investigate longitudinal 
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patterns in how people acquire their conditions. This could not be done with the 
existing dataset, but the UK has a number of established birth cohorts and other 
sources of longitudinal data that could be used to help distinguish between the 
experiences of people whose lives have featured multiple conditions for many years, 
and those with more recent experience of this status.   
Conclusion 
The literature review in Chapter 2 noted the various different definitional and 
conceptual boundaries that have provoked debates in this field, not least of which is 
the question of whether to define multiplicity as meaning two or more, or three or 
more, simultaneous conditions (e.g. Harrison (2014) argues that the lower of these 
thresholds is too expansive to be useful). In contrast, the overarching conclusion of 
this thesis is that while having two or more conditions can be a useful collective status 
of interest in its own right, changing the boundary at which people gain this collective 
status – or the boundaries between what does and doesn’t count as an individual 
underlying condition - cannot alone address the highly heterogeneous nature of the 
health and wider social experiences that exist within this group. Higher boundary 
thresholds may well be more useful in certain contexts, but heterogeneity will always 
remain. In this way, the state of having multiple conditions could be viewed as a 
preliminary organising characteristic, from which others should then follow, thus 
enabling the duality of their similarity and diversity to be reflected and better 
understood.  
The second key conclusion of this work is that it is valuable for all who seek to 
generate understandings of the lives of others to continually question the perspectives 
adopted and the tools used to do this. Following the format of the question posed by 
James (1963) at the start of this chapter, the corresponding questions that the 
approach taken in this thesis at least attempted to address were “what do they know of 
health, who only health know?” and, allied to this, “what do they know of data, who 
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Appendix A: Literature review supplementary information 
Systematic review MedLine search terms 
1. multimorbid$.mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept, 
rare disease supplementary concept, unique identifier] 
2. multi-morbid$.mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept, 
rare disease supplementary concept, unique identifier] 
3. 1 or 2 
4. limit 3 to (english language and humans) 
5. Comorbidity/ 
6. 4 or 5 
7. systematic review.mp. [mp=title, abstract, original title, name of substance word, 
subject heading word, keyword heading word, protocol supplementary concept, 
rare disease supplementary concept, unique identifier] 
8. 6 and 7 
9. limit 8 to (english language and humans) 
10. limit 9 to yr="2000 -Current" 
 
Systematic Review Appraisal Checklist 
The checklist was developed using criteria from two existing checklists:  
 The Critical Appraisal Skills Programme (CASP) Systematic Review Checklist, 
dated 31.05.13, available from: www.casp-uk.net; and  
 The Centre for Evidence Based Medicine Systematic Review Appraisal 
Checklist, dated 2005, available from: 
http://www.cebm.net/index.aspx?o=1157 
 What question (PICO) did the systematic review address and was it clearly 
focused? 
 Did the authors look for the right type of papers? 
 Is the search strategy replicable? 
 Is it likely that important, relevant studies were missed?  
 Were the criteria used to select articles for inclusion appropriate? 
 Is a PRISMA / PRISMA-style diagram presented? 
 Did the review’s authors do enough to assess the quality of the included 
studies? 
 How are the results presented? 
 What are the overall results of the review? 
 Other points.  
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Appendix C: Applications for data 
Scottish Government Special Dataset Request 
 
Your details 
Please provide the following basic details about yourself. 
 Name Catherine Bromley 
 Job Title PhD Student 
 Organisation Centre for Population Health Sciences, University of Edinburgh 
 Address SCPHRP, 20 West Richmond Street, Edinburgh, EH8 9DX 
 e-mail catherine.bromley@ed.ac.uk 




Provide a brief overview of your research, in particular your key aims and objectives. 
 Title Estimating the prevalence and impact of multimorbidity in adults 
using a general population survey 
 Purpose 
The project has three broad aims:  
1. What is the prevalence of multimorbidity in adults in 
Scotland? 
2. How does multimorbidity prevalence vary across population 
sub-groups? 
3. What is the association between multimorbidity and key 
health outcomes? 
The first stage of the work will establish a definition (or 
definitions) of multimorbidity to be used in stages 2 and 3. The 
development of the definition needs to address the question of 
what counts as a condition. The data request in this application 
relates to this stage of the work. 





Outline your research requirements, including how you plan on conducting your research and the 
timescales involved. 
 Methodology The survey currently records long-term conditions using ICD chapter 
codes. I would like to request access to the free-text ICD data to 
explore these issues:  
1) Does the free-text information entered by interviewers 
offer any qualitative insights into how people describe their 
health conditions?   
2) Can the information collected be used to apply more finely 
grained coding (below chapter-level), to help identify 
whether any multimorbidities are currently lost in the 
coding process? 
3) Could alternative coding could be applied, such as the 
International Classification of Primary Care? 
In addition to asking about long-term conditions, the survey also 
asks about “other health problems”.  The data for this does not 
currently appear in all years’ datasets. Preliminary analysis of 
the 1998 and 2008 data shows that people with long-term 
conditions who also report other health problems have 
significantly worse self-reported health, lower wellbeing and 
higher psychological distress than people with long-term 
conditions but no further health problems. I would therefore like 
to access the free-text answers given to this question, and to 
have the summary data added to all years, to see what kinds of 
health issues people are reporting. It is possible that this could 
reveal new insights about the health of people with long-term 
conditions that goes beyond simple measures of multimorbidity 
that rely on disease counts. 
 Timescale I would like to start this work in early January 2014, and hope to 
complete it by end of March 2014. 





Please identify which variables you require, and what datasets these should be derived from.   
Further information on the variables available within the SHeS are contained on the Data Archive 
website. 
 Variables 1) Special dataset  
2008 adult data (16+) only:  
illsM1-6 (free text – not currently in dataset) 
illcode1-6 (existing var) 
Longill (existing var) 
Limitac1 (existing var) 
HNotWhat (free text – not currently in dataset) 
HNCode1-3 (not currently in dataset) 
HNotAsk (existing var)  
HNote (existing var) 
Sex (existing var) 
Ag16g10 (existing var - if this is too disclosive, a flag identifying if 16-
64 or 65+ - my main analysis will likely focus on 16-64 group). 
A dummy ID (that can be linked back to the dataset later if I want to 
add new codes as a result of this work).  
 
2) Request to add some missing vars (non-disclosive) 
2008/2009/2010/2011 combined file adult data (16+) only: 
HNCode1-3 (not currently in dataset for any years) 
HNote (already in 2008 dataset, missing in 09/10/11) 
HNotAsk (already in 2008 & 2010 datasets, missing in 09 & 11)  
2003 – if these could be added to 2003 as well that would be great, 
but this is not a priority.  
 Data This request relates to the 2003, 2008, 2009, 2010, & 2011 datasets. 
I have chosen 2008 for the detailed analysis of free-text, but any year 
from the 2008-11 period would be fine, if that helps.   
 
Please note, we may recommend that some of your variables are not provided, or are modified in 





Justification and Outcomes 
Please provide justification for the use of a SHeS special dataset (as opposed to other 
alternatives), and how you propose using the resultant analysis. 
 Use of SHeS The Scottish Health Survey is the only source of general population, 
self-reported long-term condition data in Scotland that can be used 
to generate ICD coding. In addition, the question about additional 
health problems has never been analysed to date.  
 Outcomes The primary use of the data will be for my PhD analysis, contributing 
to the development of a measure of multimorbidity that can be used 
to explore differences within the population, and its impact on other 
health outcomes. The ICD and other health problem analysis will 
form the basis of at least one chapter of the final thesis, and I would 
also hope to present the wider results at conferences and in journal 
articles.  
I also hope that the process of looking in depth at the data collected 
about long-term conditions and other health problems will yield 
useful methodological insights about measuring health, in addition 
to substantive results about the profile of this group. This might also 
lead to recommendations about how the data are used that could 




I have read, understood and agreed to the terms and conditions as set out in the SHeS Special 
Dataset Request Pro-forma and Guidelines (April 2013) document. 
 Name Catherine Bromley 




















Details are obtained of up to six types of long-standing illness. The text answers are 
recorded in the variables IlsM1-IllsM6. This should be coded, using the long-standing illness 
codeframes in Appendix 2 and 3, into the variables IllCode 1-6 (appearing immediately 
after each instance of IllsTxt).  
If there are two separate illnesses listed under the same IlsM variable, then these should be 
split as follows. Code first mentioned illness in the IllCode code linked to the IlsM code, 
remove the text of the second illness and put it into the first blank IlsM variable, and code 
the appropriate IllCode variable accordingly. In addition change the More variable (before 
the IlsM that the second illness has been moved to) from No to Yes.  
Rules for coding long-standing illness 
Code 41 Unclassifiable (no other codable complaint) 
Exclusive code - this should only be used when the whole response is too vague to be coded 
into one of codes 01-40. This includes unspecific conditions like old age, war wounds etc 
(see codeframe for examples). This code can only be used in the ‘first mention’ columns. 
The editing program issues a warning if code 41 is used in any of the other columns. 
Code 42 Complaint no longer present 
Exclusive code - again it should be used only when the response given is only about a 
condition (or conditions) that no longer affects the respondent. This code can only be used 
in the ‘first mention’ columns. The editing program issues a warning if code 42 is used in 
any of the other columns. 
Codes 01-40 can be used more than once if two different conditions are mentioned which 
both fall into the same category. 
An exception to this is ‘arthritis and rheumatism’. This is not two conditions, and so should 
not be given two separate codes; instead, code only one occurrence of code 34. (If two 
specific conditions were mentioned - eg osteoarthritis and rheumatoid arthritis - this should 
be coded as two occurrences.) 
If more than 6 illnesses have been typed in by the interviewer, the first 6 mentioned should 
be coded. 
Ilnesses which cannot be coded using the Longstanding Illness Codeframe or the ICD need 






01 Cancer (neoplasm) including lumps, 
masses, tumours and growths and benign 
(non-malignant) lumps and cysts 
Acoustic neuroma 
After effect of cancer (nes) 
All tumours, growths, masses, lumps and 
cysts whether malignant or benign eg. 
tumour on brain, growth in bowel, growth 
on spinal cord, lump in breast 
Cancers sited in any part of the body or 
system eg. Lung, breast, stomach  
Colostomy caused by cancer 




Hysterectomy for cancer of womb 




Part of intestines removed (cancer) 
Pituitary gland removed (cancer) 
Rodent ulcers 
Sarcomas, carcinomas 
Skin cancer, bone cancer 
Wilms tumour 
 
Endocrine/nutritional/metabolic diseases  
 
02 Diabetes  
Incl. Hyperglycaemia 
 
03 Other endocrine/metabolic 
Addison's disease 





Hormone deficiency, deficiency of growth 
hormone, dwarfism 
Hypercalcemia 






Too much cholesterol in blood 
Underactive/overactive thyroid, goitre 
Water/fluid retention 
Wilson's disease 
Thyroid trouble and tiredness - code 03 only 
Overactive thyroid and swelling in neck - code 
03 only. 
 





Alcoholism, recovered not cured alcoholic 
Angelman Syndrome  
Anorexia nervosa 
Anxiety, panic attacks 
Asperger Syndrome 
Autism/Autistic 








Nervous breakdown, neurasthenia, nervous 
trouble 
Phobias 
Schizophrenia, manic depressive 
Senile dementia, forgetfulness, gets confused 
Speech impediment, stammer 
Stress 
 
Alzheimer's disease, degenerative brain 
disease = code 08 
 
05 Mental handicap 
Incl. Down's syndrome, Mongol 
Mentally retarded, subnormal 
Nervous system (central and peripheral 















08 Other problems of nervous system  
Abscess on brain 
Alzheimer's disease 
Bell's palsy 
Brain damage resulting from infection (eg. 
meningitis, encephalitis) or injury 
Carpal tunnel syndrome 
Cerebral palsy (spastic) 





Hydrocephalus, microcephaly, fluid on brain 
Injury to spine resulting in paralysis 
Metachromatic leucodystrophy 
Motor neurone disease 
Multiple Sclerosis (MS), disseminated 
sclerosis 
Muscular dystrophy 




Numbness/loss of feeling in fingers, hand, leg 
etc 
Paraplegia (paralysis of lower limbs) 
Parkinson's disease (paralysis agitans) 
Partially paralysed (nes) 
Physically handicapped - spasticity of all limbs 
Pins and needles in arm 
Post viral syndrome (ME) 












09 Cataract/poor eye sight/blindness 
Incl. operation for cataracts, now need 
glasses 
Bad eyesight, restricted vision, partially 
sighted 
Bad eyesight/nearly blind because of 
cataracts 
Blind in one eye, loss of one eye 
Blindness caused by diabetes 
Blurred vision 
Detached/scarred retina 
Hardening of lens 
Lens implants in both eyes 
Short sighted, long sighted, myopia 
Trouble with eyes (nes), eyes not good (nes) 
Tunnel vision 
 





Dry eye syndrome, trouble with tear ducts, 
watery eyes 
Eye infection, conjunctivitis 
Eyes are light sensitive 
Floater in eye 
Glaucoma 
Haemorrhage behind eye 





Scarred cornea, corneal ulcers 
Squint, lazy eye 




11 Poor hearing/deafness 
Conductive/nerve/noise induced deafness 
Deaf mute/deaf and dumb 
Heard of hearing, slightly deaf 
Otosclerosis 
Poor hearing after mastoid operation 
 
12 Tinnitus/noises in the ear 




13 Meniere's disease/ear complaints 
causing balance problems 
Labryrinthitis,  
loss of balance - inner ear 
Vertigo 
 
14 Other ear complaints 
Incl. otitis media - glue ear 
Disorders of Eustachian tube 
Perforated ear drum (nes) 
Middle/inner ear problems 
Mastoiditis 
Ear trouble (nes),  
Ear problem (wax) 
Ear aches and discharges 
Ear infection 
 





Incl. stroke victim - partially paralysed and 
speech difficulty 
Hemiplegia, apoplexy, cerebral embolism, 
Cerebro - vascular accident 
 
16 Heart attack/angina 
Incl. coronary thrombosis, myocardial 
infarction 
 
17 Hypertension/high blood 
pressure/blood pressure (nes) 
 
18 Other heart problems 
Aortic/mitral valve stenosis, 
Aortic/mitral valve regurgitation 
Aorta replacement 
Atrial Septal Defect (ASD) 
Cardiac asthma 
Cardiac diffusion 
Cardiac problems, heart trouble (nes) 
Dizziness, giddiness, balance problems (nes) 
Hardening of arteries in heart 
Heart disease, heart complaint 
Heart failure 
Heart murmur, palpitations 
Hole in the heart 
Ischaemic heart disease 
Pacemaker 
Pains in chest (nes) 
Pericarditis 
St Vitus dance 
Tachycardia, sick sinus syndrome 
Tired heart 
Valvular heart disease 
Weak heart because of rheumatic fever 
Wolff - Parkinson - White syndrome 
 
Balance problems due to ear complaint = code 
13 
 
19 Piles/haemorrhoids incl. Varicose 
Veins in anus. 
 
20 Varicose veins/phlebitis in lower 
extremities 
Incl. various ulcers, varicose eczema 
 
21 Other blood vessels/embolic 
Arteriosclerosis, hardening of arteries (nes) 
Arterial thrombosis 
Artificial arteries (nes) 
Blocked arteries in leg 
Blood clots (nes) 
Hand Arm Vibration Syndrome (White Finger) 
Hypersensitive to the cold 
Intermittent claudication 




Swollen legs and feet 
Telangiectasia (nes) 
Thrombosis (nes) 
Varicose veins in Oesophagus 
Wright's syndrome 
 











Bronchial asthma, allergic asthma 
Asthma - allergy to house dust/grass/cat fur 
 





25 Other respiratory complaints 
Abscess on larynx 
Adenoid problems, nasal polyps 
Allergy to dust/cat fur 
Bad chest (nes), weak chest - wheezy 
Breathlessness 
Bronchial trouble, chest trouble (nes) 
Catarrh 
Chest infections, get a lot of colds 
Churg-Strauss syndrome 




Damaged lung (nes), lost lower lobe of left 
lung 
Fibrosis of lung 
Furred up airways, collapsed lung 
Lung complaint (nes), lung problems (nes) 
Lung damage by viral pneumonia 
Paralysis of vocal cords 
Pigeon fancier's lung 
Pneumoconiosis, byssinosis, asbestosis and 
other industrial, respiratory disease 
Recurrent pleurisy 
Rhinitis (nes) 
Sinus trouble, sinusitis 
Sore throat, pharyngitis 
Throat infection 
Throat trouble (nes), throat irritation 
Tonsillitis 
Ulcer on lung, fluid on lung 
 
TB (pulmonary tuberculosis) - code 37 
Cystic fibrosis - code 03 
Skin allergy - code 39 
Food allergy - code 27 
Allergy (nes) - code 41 
Pilonidal sinus - code 39 
Sick sinus syndrome - code 18 
Whooping cough - code 37 
 
If complaint is breathlessness with the cause 
also stated, code the cause: 
breathlessness as a result of anaemia (code 
38) 
breathlessness due to hole in heart (code 18) 
breathlessness due to angina (code 16) 
 
Complaints of the digestive system 
 





Hernia (nes), rupture (nes) 
Ulcer (nes) 
 
27 Other digestive complaints 
(stomach, liver, pancreas, bile ducts, small 
intestine - duodenum, jejunum and ileum) 
Cirrhosis of the liver, liver problems 
Food allergies 
Ileostomy 
Indigestion, heart burn, dyspepsia 
Inflamed duodenum 
Liver disease, biliary artesia 
Nervous stomach, acid stomach 
Pancreas problems 
Stomach trouble (nes), abdominal trouble 
(nes) 
Stone in gallbladder, gallbladder problems 
Throat trouble - difficulty in swallowing 




28 Complaints of bowel/colon (large 
intestine, caecum, bowel, colon, rectum) 







Frequent diarrhoea, constipation 
Grumbling appendix 
Hirschsprung's disease 
Irritable bowel, inflammation of bowel 
Polyp on bowel 
Spastic colon 
 
Exclude piles - code 19 
Cancer of stomach/bowel - code 01 
 
29 Complaints of teeth/mouth/tongue 
Cleft palate, hare lip 
Impacted wisdom tooth, gingivitis 
No sense of taste 
Ulcers on tongue, mouth ulcers 
 
Complaints of genito-urinary system 
 
30 Kidney complaints 
Chronic renal failure 
Horseshoe kidney, cystic kidney 








31 Urinary tract infection 
Cystitis, urine infection 
 
32 Other bladder 
problems/incontinence 
Bed wetting, enuresis 
Bladder restriction 
Water trouble (nes) 
Weak bladder, bladder complaint (nes) 
 
Prostate trouble - code 33 
 
33 Reproductive system disorders 








Pelvic inflammatory disease/PID (female) 
Period problems, flooding, pre-menstrual 
tension/syndrome 
Prolapse (nes) if female 
Prolapsed womb 
Prostrate gland trouble 
Turner's syndrome 
Vaginitis, vulvitis, dysmenorrhoea 
 




Arthritis as result of broken limb 
Arthritis/rheumatism in any part of the body 
Gout  (previously code 03) 
Osteoarthritis, rheumatoid arthritis, 
polymyalgia rheumatica 
Polyarteritis Nodosa  (previously code 21) 




35 Back problems/slipped 
disc/spine/neck 
Back trouble, lower back problems, back ache 
Curvature of spine 
Damage, fracture or injury to 
back/spine/neck 
Disc trouble 
Lumbago, inflammation of spinal joint 
Prolapsed invertebral discs 
Schuermann's disease 
Spondylitis, spondylosis 
Worn discs in spine - affects legs 
Exclude if damage/injury to spine results in 
paralysis - code 08 




36 Other problems of 
bones/joints/muscles 
Absence or loss of limb eg. lost leg in war, 
finger amputated, born without arms 
Aching arm, stiff arm, sore arm muscle 
Bad shoulder, bad leg, collapsed knee cap, 
knee cap removed 
Brittle bones, osteoporosis 




Cramp in hand 
Deformity of limbs eg. club foot, claw-hand, 
malformed jaw 
Delayed healing of bones or badly set 
fractures 
Deviated septum 





Flat feet, bunions, 
Fracture, damage or injury to extremities, 
ribs, collarbone, pelvis, skull, eg. knee 
injury, broken leg, gun shot wounds in 
leg/shoulder, can't hold arm out flat - 
broke it as a child, broken nose 
Frozen shoulder 
Hip infection, TB hip 
Hip replacement (nes) 





Physically handicapped (nes) 
Pierre Robin syndrome 
Schlatter's disease 
Sever's disease 
Stiff joints, joint pains, contraction of sinews, 
muscle wastage 
Strained leg muscles, pain in thigh muscles 
Systemic sclerosis, myotonia (nes) 
Tenosynovitis 
Torn muscle in leg, torn ligaments, tendonitis 
Walk with limp as a result of polio, polio 
(nes), after affects of polio (nes) 
Weak legs, leg trouble, pain in legs 
Muscular dystrophy - code 08 
37 Infectious and parasitic disease 
AIDS, AIDS carrier, HIV positive  (previously 
code 03) 
















After effect of Poliomyelitis, meningitis, 
encephalitis - code to site/system 
Ear/throat infections etc - code to site 
 
38 Disorders of blood and blood 
forming organs and immunity disorders 
Anaemia, pernicious anaemia  
Blood condition (nes), blood deficiency 
Haemophilia 
Idiopathic Thrombochopenic Purpura (ITP) 
Immunodeficiences 
Polycthaemia (blood thickening), blood to 
thick 
Purpura (nes) 
Removal of spleen 
Sarcoidosis (previously code 37) 




Leukaemia - code 01 
 
39 Skin complaints 
abscess in groin 
acne 
birth mark 
burned arm (nes) 












Psoriasis, psoriasis arthritis (also code 
arthritis) 
skin allergies, leaf rash, angio-oedema 
skin rashes and irritations 
skin ulcer, ulcer on limb (nes) 
 
Rodent ulcer - code 01 
Varicose ulcer, varicose eczema - code 20 
 
40 Other complaints 
adhesions 
dumb, no speech 
fainting 
hair falling out, alopecia 
insomnia 





Deaf and dumb - code 11 only 
 
41 Unclassifiable (no other codable 
complaint) 
after affects of meningitis (nes) 
allergy (nes), allergic reaction to some drugs 
(nes) 
electrical treatment on cheek (nes) 
embarrassing itch (nes) 
Forester’s disease (nes) 
general infirmity 
generally run down (nes) 
glass in head - too near temple to be removed 
(nes) 
had meningitis - left me susceptible to other 
things (nes) 
internal bleeding (nes) 
ipinotaligia 
old age/weak with old age 
swollen glands (nes) 
tiredness (nes) 
war wound (nes), road accident injury (nes) 
weight loss (nes) 
 
42 Complaint no longer present 
 
Only use this code if it is actually stated that 
the complaint no longer affects the informant. 
 
Exclude if complaint kept under control by 





Appendix E: Questionnaire material 
The Warwick-Edinburgh Mental Wellbeing Scale (WEMWBS) 
 
Please read this carefully: 
Below are some statements about feelings and thoughts. 
Please tick the box that best describes your experience of each over the last 2 
weeks 
 
 None of 
the  
time 
Rarely Some of 
the  
time 
Often All of the 
 time 
I’ve been feeling optimistic 
about the future 
     
I’ve been feeling useful      
I’ve been feeling relaxed      
I’ve been feeling interested in 
other people 
     
I’ve had energy to spare      
I’ve been dealing with problems 
well 
     
I’ve been thinking clearly      
I’ve been feeling good about 
myself 
     
I’ve been feeling close to other 
people 
     
I’ve been feeling confident      
I’ve been able to make up my 
own mind about things 
     
I’ve been feeling loved      
I’ve been interested in new 
things 
     
I’ve been feeling cheerful      
© NHS Health Scotland, University of Warwick and University of Edinburgh, 2006, all rights 
reserved. [Note: Formatting has been simplified to save space.] 
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The General Health Questionnaire 12 (GHQ12) 
 
GENERAL HEALTH OVER THE LAST FEW WEEKS 
Please read this carefully: 
We should like to know how your health has been in general over the past few 
weeks. Please answer ALL the questions by ticking the box below the answer 
which you think most applies to you. 
Been able to concentrate on 









Lost much sleep over worry? Not at 
all 




























Felt constantly under strain? Not at 
all 


















Been able to enjoy your normal 
day-to-day activities? 








Been able to face up to your 
problems? 



















Been losing confidence in yourself? Not at 
all 





























General Health Questionnaire (GHQ-12) David Goldberg 1978; reproduced by permission 
of NFER-NELSON. [Note: formatting has been simplified and boxes removed to save space.]  
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The Clinical Interview Schedule – revised (CIS-R)  
The following questions were asked face-to-face by nurses using computer-assisted 
personal interviewing (CAPI). The following is a transcript of the CAPI programme, including 
the routing instructions.  
Depression 
ASK ALL WITH NURSE VISIT 
[AnxInt] 
I'm now going to ask you some questions about how you've been feeling lately and if you've 
been feeling depressed, worried or anxious. 
NURSE: This is the start of the anxiety, depression and self-harm questions. Some people 
might be uncomfortable answering some of the questions or might find them difficult. 
If the respondent is uncomfortable answering any question or appears distressed at any 
point you might need to give them some time to compose themselves before carrying on 
with the rest of the visit. 
If you need to skip a question just press <Ctrl R>. If they don't wish to answer any further 
questions in this section press <Ctrl R> at each question until you get to the next set of 
questions. 
Press <1> and <Enter> to continue. 
 
[G1] 
Almost everyone becomes sad, miserable or depressed at times. 





During the past month, have you been able to enjoy or take an interest in things as much as 
you usually do? 
1 Yes 
2 No/no enjoyment or interest 
 
IF G1 = Yes THEN 
[G4] 
NURSE: PLEASE USE INFORMANTS OWN WORDS IF POSSIBLE 




IF G2 = No THEN 
[G5] 
NURSE: PLEASE USE INFORMANTS OWN WORDS IF POSSIBLE 
In the past week have you been able to enjoy or take an interest in things as much as usual? 
1 Yes 




IF (G4 = Yes) OR IF (G5 = No/no enjoyment or interest) THEN 
[G6] 
Since last [Sunday / Monday / Tuesday / Wednesday / Thursday / Friday / Saturday] on how 
many days have you felt [depressed or unable to take an interest in things / sad, miserable 
or depressed / unable to enjoy or take an interest in things]? 
1 4 days or more 
2 1 to 3 days 
3 None 
IF (G4 = Yes) OR IF (G5 = No/no enjoyment or interest) THEN 
[G7] 
Have you felt [depressed or unable to take an interest in things / sad, miserable or 
depressed /unable to enjoy or take an interest in things] for more than 3 hours in total (on 




IF (G4 = Yes) OR IF (G5 = No/no enjoyment) THEN 
[G9] 
In the past week when you felt sad, miserable or depressed/unable to enjoy or take an 
interest in things, did you ever become happier when something nice happened, or when 
you were in company? 
1 Yes, at least once 
2 No 
 
IF (G4 = Yes) OR IF (G5 = No/no enjoyment) THEN 
[G10] 
SHOW CARD B 
How long have you been feeling sad, miserable or depressed/unable to enjoy or take an 
interest in things as you have described? 
1 less than 2 weeks 
2 2 weeks but less than 6 months 
3 6 months but less than 1 year 
4 1 year but less than 2 years 
5 2 years but less than 5 years 
6 5 years but less than 10 years 
7 10 years or more 
Anxiety 
ASK ALL WITH NURSE VISIT 
[J1] 
Have you been feeling anxious or nervous in the past month? 
2 No 
 
IF J1 = No THEN 
[J2] 






ASK ALL WITH NURSE VISIT 
[J3] 
Some people have phobias; they get nervous or uncomfortable about specific things or 
situations when there is no real danger. For instance they may get extremely anxious when 
in confined spaces, or they may have a fear of heights. Others become nervous at the sight 
of things like blood or spiders. 
In the past month have you felt anxious, nervous or tense about any specific things when 




IF RESPONDENT HAS EXPERIENCED ANXIETY AND PHOBIA THEN 
[J5] 
In the past month, when you felt anxious/nervous/tense, was this always brought on by the 
phobia about some specific situation or thing or did you sometimes feel generally 
anxious/nervous/tense? 
1 Always brought on by phobia 
2 Sometimes generally anxious 
 
IF RESPONDENT HAS EXPERIENCED ANXIETY AND PHOBIA AND IF J5 = Sometimes 
generally anxious THEN 
[J6] 
The next questions are concerned with general anxiety/nervousness/tension only. 
I will ask you about the anxiety which is brought on by the phobia about specific things or 
situations later. 
On how many of the past seven days have you felt generally anxious/nervous/tense? 
1 4 days or more 
2 1 to 3 days 
3 None 
 
IF RESPONDENT HAS EXPERIENCED GENERAL ANXIETY ONLY THEN 
[J7] 
On how many of the past seven days have you felt generally anxious/nervous/tense? 
1 4 days or more 
2 1 to 3 days 
3 None 
IF RESPONDENT HAS EXPERIENCED ANXIETY FOR AT LEAST 1 DAY (AT J6 OR J7) THEN 
[J8] 
In the past week, has your anxiety/nervousness/tension been: 
RUNNING PROMPT 
1 ...very unpleasant 
2 ...a little unpleasant 





SHOW CARD C 
In the past week, when you've been anxious/nervous/tense, have you had any of the 




IF RESPONDENT HAS EXPERIENCED ANY OF THE SYMPTOMS LISTED ON SHOWCARD C 
[J9A]* 
SHOW CARD C 
Which of these symptoms did you have when you felt anxious/nervous/tense? 
CODE ALL THAT APPLY 
1 Heart racing or pounding [J9A1] 
2 Hands sweating or shaking [J9A2] 
3 Feeling dizzy [J9A3] 
4 Difficulty getting your breath [J9A4] 
5 Butterflies in stomach [J9A5] 
6 Dry mouth [J9A6] 
7 Nausea or feeling as though you wanted to vomit [J9A7] 
 
IF RESPONDENT HAS EXPERIENCED ANXIETY FOR AT LEAST 1 DAY (AT J6 OR J7) THEN 
[J10] 






How long have you had these feelings of general anxiety/nervousness/tension as you 
described? 
SHOW CARD B AGAIN 
1 less than 2 weeks 
2 2 weeks but less than 6 months 
3 6 months but less than 1 year 
4 1 year but less than 2 years 




Appendix F: SPSS syntax to create the multiple conditions 
measure 
 
Stage 1: ungrouping the long-term condition chapters 
Counting the conditions 
mis vals longill08 illcode1 illcode2 illcode3 illcode4 illcode5 illcode6 (). 
 
DO REPEAT xcomp=xcompm1 xcompm2 xcompm3 xcompm4 xcompm5 xcompm6 
xcompm7 xcompm8 xcompm9 xcompm10 xcompm11 xcompm12 xcompm13 xcompm14 
xcompm15 xcompm16 xcompm17 xcompm18 xcompm19 xcompm20 xcompm21 
xcompm22 xcompm23 xcompm24 xcompm25 xcompm26 xcompm27 xcompm28 
xcompm29 xcompm30 xcompm31 xcompm32 xcompm33 xcompm34 xcompm35 
xcompm36 xcompm37 xcompm38 xcompm39 xcompm40 xcompm41 xcompm42 xcompm . 
 
COMPUTE xcomp=0. 
IF (longill08<0) xcomp=-9. 
END REPEAT. 
 
DO REPEAT xill=illcode1 illcode2 illcode3 illcode4 illcode5 illcode6. 
IF (xill=1) xcompm1=1. 
IF (xill=2) xcompm2=1. 
IF (xill=3) xcompm3=1. 
IF (xill=4) xcompm4=1. 
IF (xill=5) xcompm5=1. 
IF (xill=6) xcompm6=1. 
IF (xill=7) xcompm7=1. 
IF (xill=8) xcompm8=1. 
IF (xill=9) xcompm9=1. 
IF (xill=10) xcompm10=1. 
IF (xill=11) xcompm11=1. 
IF (xill=12) xcompm12=1. 
IF (xill=13) xcompm13=1. 
IF (xill=14) xcompm14=1. 
IF (xill=15) xcompm15=1. 
IF (xill=16) xcompm16=1. 
IF (xill=17) xcompm17=1. 
IF (xill=18) xcompm18=1. 
IF (xill=19) xcompm19=1. 
IF (xill=20) xcompm20=1. 
IF (xill=21) xcompm21=1. 
IF (xill=22) xcompm22=1. 
IF (xill=23) xcompm23=1. 
IF (xill=24) xcompm24=1. 
IF (xill=25) xcompm25=1. 
IF (xill=26) xcompm26=1. 
IF (xill=27) xcompm27=1. 
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IF (xill=28) xcompm28=1. 
IF (xill=29) xcompm29=1. 
IF (xill=30) xcompm30=1. 
IF (xill=31) xcompm31=1. 
IF (xill=32) xcompm32=1. 
IF (xill=33) xcompm33=1. 
IF (xill=34) xcompm34=1. 
IF (xill=35) xcompm35=1. 
IF (xill=36) xcompm36=1. 
IF (xill=37) xcompm37=1. 
IF (xill=38) xcompm38=1. 
IF (xill=39) xcompm39=1. 
IF (xill=40) xcompm40=1. 
IF (xill=41) xcompm41=1. 
IF (xill=42) xcompm42=1. 
END REPEAT. 
 
IF (longill08 = 2) xcompm = 1. 
COMPUTE xcompm99 = 0 . 
IF (longill08 = 1 & ANY(illcode1,41,42,-1,-8,-9)) xcompm99 = 1 . 
IF (longill08<0) xcompm99 = -9. 
exe. 
VARIABLE LABELS xcompm1 '(D) Neoplasms & benign growths' 
 /xcompm2 '(D) Diabetes' 
 /xcompm3 '(D) Other endocrine / met' 
 /xcompm4 '(D) Mental illness/anxiety etc' 
 /xcompm5 '(D) Learning disability' 
 /xcompm6 '(D) Epilepsy' 
 /xcompm7 '(D) Migraine/headaches' 
 /xcompm8 '(D) Other problems of Nervous System'  
 /xcompm9 '(D) cataract/blindness' 
 /xcompm10 '(D) Other Eye complaints' 
 /xcompm11 '(D) Poor hearing/deafness' 
 /xcompm12 '(D) Tinnutus etc' 
 /xcompm13 "(D) Meniere's / balance problems" 
 /xcompm14 '(D) Other Ear complaints' 
 /xcompm15 '(D) Stroke / cerebral haem' 
 /xcompm16 '(D) Heart attack / angina' 
 /xcompm17 '(D) High blood pressure' 
 /xcompm18 '(D) Other heart problems' 
 /xcompm19 '(D) Piles / haemorrhoids' 
 /xcompm20 '(D) Varicose veins' 
 /xcompm21 '(D) Other blood vessels / embolic' 
 /xcompm22 '(D) Bronchitis/emphysema' 
 /xcompm23 '(D) Asthma' 
 /xcompm24 '(D) Hay fever' 
 /xcompm25 '(D) Other respiratory complaints (inc sinus)' 
 /xcompm26 '(D) Stomach ulcer / abnominal hernia' 
 /xcompm27 '(D) Other digestive complaints (stomach / liver / bile / pancreas / small int' 
 /xcompm28 '(D) Complaints of bowel / large intestine' 
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 /xcompm29 '(D) Complaints of teeth/mouth/tongue' 
 /xcompm30 '(D) Kidney complaints' 
 /xcompm31 '(D) UTI' 
 /xcompm32 '(D) Other bladder problems' 
 /xcompm33 '(D) Reproductive system disorders' 
 /xcompm34 '(D) Arthritis/rheumatism/fibrositis' 
 /xcompm35 '(D) Back problems/slipped disc/spine/neck' 
 /xcompm36 '(D) Other problems of bones/joints/muscles' 
 /xcompm37 '(D) Infectious and parasitic disease' 
 /xcompm38 '(D) Disorders of blood and blood forming organs and immunity disorders' 
 /xcompm39 '(D) Skin complaints' 
 /xcompm40 '(D) Other complaints' 
 /xcompm41 '(D) Unclassifiable' 
 /xcompm42 '(D) No longer present' 
 /xcompm '(D) No long standing illness' 
 /xcompm99 "(D) Unclass/NLP/inadeq describe" . 
 
VALUE LABELS xcompm1 TO xcompm99 
0 'no condition present' 
1 'has condition'. 
 
**New condition count. 
 
IF (longill08 = 2) xcondcnt = 0 . 
DO IF (longill08 = 1). 
COUNT xcondcnt = xcompm1 TO xcompm40 (1) . 
END IF . 
IF (longill08 = 1 & (any(illcode1,41,42,97,99) | illcode1<0)) xcondcnt = 1 . 
IF (longill08<0) xcondcnt = -9. 
VARIABLE LABEL xcondcnt "(D) New: Number of UNgrouped condition categories" . 
VALUE LABELS xcondcnt 
0 'no LS illness'. 
fre xcondcnt. 
 
***The 3 cases coded 42 (no longer present) at illcode1 recoded to 0 LTC. 
if illcode1=42 xcondcnt=0. 
 
***And this should be applied to original var. 
 
if illcode1=42 and longill08=1  condcnt=0. 
 
**The case coded 99 at illcode1 and 13 at illcode2 is multimorbid, so correct the original 
vars. 
if cpserialA=2050603101 condcnt=2. 
if cpserialA=2050603101 xcondcnt=2. 
 
Summary measure of multiple conditions 
 
recode condcnt xcondcnt (2 thru hi=2) (else=copy) into condcnt_2 xcondcnt_2. 
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recode condcnt xcondcnt (3 thru hi=3) (else=copy) into condcnt_3 xcondcnt_3.  
exe. 
Var label condcnt_2 "(D) Original condition count: 2+ conditions". 
Var label xcondcnt_2 "(D) Ungrouped chapters condition count: 2+ conditions". 
Var label condcnt_3 "(D) Original condition count: 3+ conditions". 
Var label xcondcnt_3 "(D) Ungrouped chapters condition count: 3+ conditions". 
 
Stage 1: including all coded long-term conditions 
Counting the conditions 
 
count Cancer= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (1). 
count Diabetes= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (2). 
count OthEndc= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (3). 
count Psych= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (4). 
count LearnD= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (5). 
count Epileps= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (6). 
count Migraine= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (7). 
count OthNerv= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (8). 
count BadEyes= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (9). 
count OthEyes= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (10). 
count Deaf= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (11). 
count Tinnit= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (12). 
count Meniere= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (13). 
count OthEars= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (14). 
count Stroke= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (15). 
count MI= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (16). 
count HBP= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (17). 
count OthHrt= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (18). 
count Piles= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (19). 
count Varic= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (20). 
count OthBlod= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (21). 
count Bronch= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (22). 
count Asthma= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (23). 
count Hayf= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (24). 
count OthResp= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (25). 
count Ulcer= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (26). 
count OthDig= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (27). 
count Bowel= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (28). 
count Mouth= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (29). 
count Kidney= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (30). 
count UTI= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (31). 
count OthBlad= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (32). 
count Reprod= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (33). 
count Arthritis= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (34). 
count BackP= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (35). 
count OthMusc= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (36). 
count infect = IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (37). 
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count Blood= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (38). 
count skin= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (39). 
count Other= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (40). 
count unclass= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (41). 
count Cured= IllCode1 IllCode2 IllCode3 IllCode4 IllCode5 IllCode6 (42). 
Exe. 
 
***Make binaries of these vars. 
Recode Cancer Diabetes OthEndc Psych LearnD Epileps Migraine OthNerv BadEyes OthEyes 
Deaf Tinnit Meniere OthEars Stroke MI HBP OthHrt Piles Varic OthBlod Bronch Asthma Hayf 
OthResp Ulcer OthDig Bowel Mouth Kidney UTI OthBlad Reprod Arthritis BackP OthMusc 
infect Blood skin Other unclass Cured (1 thru hi=1) (else=copy) into Cancer2 Diabetes2 
OthEndc2 Psych2 LearnD2 Epileps2 Migraine2 OthNerv2 BadEyes2 OthEyes2 Deaf2 Tinnit2 
Meniere2 OthEars2 Stroke2 MI2 HBP2 OthHrt2 Piles2 Varic2 OthBlod2 Bronch2 Asthma2 
Hayf2 OthResp2 Ulcer2 OthDig2 Bowel2 Mouth2 Kidney2 UTI2 OthBlad2 Reprod2 Arthritis2 
BackP2 OthMusc2 infect2 Blood2 skin2 Other2 unclass2 Cured2. 
exe. 
 
If longill08 LT 0 cancer = -1 . 
if longill08 LT 0 Diabetes = -1 . 
if longill08 LT 0 OthEndc = -1 . 
if longill08 LT 0 Psych = -1 . 
if longill08 LT 0 LearnD = -1 . 
if longill08 LT 0 Epileps = -1 . 
if longill08 LT 0 Migraine = -1 . 
if longill08 LT 0 OthNerv = -1 . 
if longill08 LT 0 BadEyes = -1 . 
if longill08 LT 0 OthEyes = -1 . 
if longill08 LT 0 Deaf = -1 . 
if longill08 LT 0 Tinnit = -1 . 
if longill08 LT 0 Meniere = -1 . 
if longill08 LT 0 OthEars = -1 . 
if longill08 LT 0 Stroke = -1 . 
if longill08 LT 0 MI = -1 . 
if longill08 LT 0 HBP = -1 . 
if longill08 LT 0 OthHrt = -1 . 
if longill08 LT 0 Piles = -1 . 
if longill08 LT 0 Varic = -1 . 
if longill08 LT 0 OthBlod = -1 . 
if longill08 LT 0 Bronch = -1 . 
if longill08 LT 0 Asthma = -1 . 
if longill08 LT 0 Hayf = -1 . 
if longill08 LT 0 OthResp = -1 . 
if longill08 LT 0 Ulcer = -1 . 
if longill08 LT 0 OthDig = -1 . 
if longill08 LT 0 Bowel = -1 . 
if longill08 LT 0 Mouth = -1 . 
if longill08 LT 0 Kidney = -1 . 
if longill08 LT 0 UTI = -1 . 
if longill08 LT 0 OthBlad = -1 . 
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if longill08 LT 0 Reprod = -1 . 
if longill08 LT 0 Arthritis = -1 . 
if longill08 LT 0 BackP = -1 . 
if longill08 LT 0 OthMusc = -1 . 
if longill08 LT 0 infect = -1 . 
if longill08 LT 0 Blood = -1 . 
if longill08 LT 0 skin = -1 . 
if longill08 LT 0 Other = -1 . 
if longill08 LT 0 unclass = -1 . 
if longill08 LT 0 Cured = -1 . 
if longill08 LT 0 Cancer2 = -1 . 
if longill08 LT 0 Diabetes2 = -1 . 
if longill08 LT 0 OthEndc2 = -1 . 
if longill08 LT 0 Psych2 = -1 . 
if longill08 LT 0 LearnD2 = -1 . 
if longill08 LT 0 Epileps2 = -1 . 
if longill08 LT 0 Migraine2 = -1 . 
if longill08 LT 0 OthNerv2 = -1 . 
if longill08 LT 0 BadEyes2 = -1 . 
if longill08 LT 0 OthEyes2 = -1 . 
if longill08 LT 0 Deaf2 = -1 . 
if longill08 LT 0 Tinnit2 = -1 . 
if longill08 LT 0 Meniere2 = -1 . 
if longill08 LT 0 OthEars2 = -1 . 
if longill08 LT 0 Stroke2 = -1 . 
if longill08 LT 0 MI2 = -1 . 
if longill08 LT 0 HBP2 = -1 . 
if longill08 LT 0 OthHrt2 = -1 . 
if longill08 LT 0 Piles2 = -1 . 
if longill08 LT 0 Varic2 = -1 . 
if longill08 LT 0 OthBlod2 = -1 . 
if longill08 LT 0 Bronch2 = -1 . 
if longill08 LT 0 Asthma2 = -1 . 
if longill08 LT 0 Hayf2 = -1 . 
if longill08 LT 0 OthResp2 = -1 . 
if longill08 LT 0 Ulcer2 = -1 . 
if longill08 LT 0 OthDig2 = -1 . 
if longill08 LT 0 Bowel2 = -1 . 
if longill08 LT 0 Mouth2 = -1 . 
if longill08 LT 0 Kidney2 = -1 . 
if longill08 LT 0 UTI2 = -1 . 
if longill08 LT 0 OthBlad2 = -1 . 
if longill08 LT 0 Reprod2 = -1 . 
if longill08 LT 0 Arthritis2 = -1 . 
if longill08 LT 0 BackP2 = -1 . 
if longill08 LT 0 OthMusc2 = -1 . 
if longill08 LT 0 infect2 = -1 . 
if longill08 LT 0 Blood2 = -1 . 
if longill08 LT 0 skin2 = -1 . 
if longill08 LT 0 Other2 = -1 . 
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if longill08 LT 0 unclass2 = -1 . 
if longill08 LT 0 Cured2 = -1 . 
exe.  
val labs cancer2 TO cured2 1 "Has condition" 0 "Does not" -1 "Missing".  
fre cancer2 TO cured2. 
fre cancer to cured. 
 
miss vals cancer2 TO cured2 (lo thru -1). 
miss vals cancer TO cured (lo thru -1). 
 
 
***FROM HERE ON THE SYNTAX IS COUNTING MULTIPLE CODES WITHIN CONDITIONS. 
 
count conds1=  Cancer Diabetes OthEndc Psych LearnD Epileps Migraine OthNerv BadEyes 
OthEyes Deaf Tinnit Meniere OthEars Stroke MI HBP OthHrt Piles Varic OthBlod Bronch 
Asthma Hayf OthResp Ulcer OthDig Bowel Mouth Kidney UTI OthBlad Reprod Arthritis 
BackP OthMusc infect Blood skin Other unclass (1). 
fre conds1. 
 
count conds2=  Cancer Diabetes OthEndc Psych LearnD Epileps Migraine OthNerv BadEyes 
OthEyes Deaf Tinnit Meniere OthEars Stroke MI HBP OthHrt Piles Varic OthBlod Bronch 
Asthma Hayf OthResp Ulcer OthDig Bowel Mouth Kidney UTI OthBlad Reprod Arthritis 
BackP OthMusc infect Blood skin Other unclass (2). 
fre conds2. 
 
count conds3=  Cancer Diabetes OthEndc Psych LearnD Epileps Migraine OthNerv BadEyes 
OthEyes Deaf Tinnit Meniere OthEars Stroke MI HBP OthHrt Piles Varic OthBlod Bronch 
Asthma Hayf OthResp Ulcer OthDig Bowel Mouth Kidney UTI OthBlad Reprod Arthritis 
BackP OthMusc infect Blood skin Other unclass (3). 
fre conds3. 
 
count conds4=  Cancer Diabetes OthEndc Psych LearnD Epileps Migraine OthNerv BadEyes 
OthEyes Deaf Tinnit Meniere OthEars Stroke MI HBP OthHrt Piles Varic OthBlod Bronch 
Asthma Hayf OthResp Ulcer OthDig Bowel Mouth Kidney UTI OthBlad Reprod Arthritis 
BackP OthMusc infect Blood skin Other unclass (4). 
fre conds4. 
 
count conds5=  Cancer Diabetes OthEndc Psych LearnD Epileps Migraine OthNerv BadEyes 
OthEyes Deaf Tinnit Meniere  
    OthEars Stroke MI HBP OthHrt Piles Varic OthBlod Bronch Asthma Hayf OthResp Ulcer 
OthDig Bowel  




count conds6=  Cancer Diabetes OthEndc Psych LearnD Epileps Migraine OthNerv BadEyes 
OthEyes Deaf Tinnit Meniere OthEars Stroke MI HBP OthHrt Piles Varic OthBlod Bronch 
Asthma Hayf OthResp Ulcer OthDig Bowel Mouth Kidney UTI OthBlad Reprod Arthritis 





***CONDITION COUNT VARIABLE. 
 
miss vals longill08 illcode1 (). 
compute conds1x=-99. 
if longill08=2 conds1x=0. 
if conds1=0 conds1x=0. 
if conds1 gt 0 conds1x=conds1. 
if conds2=1 conds1x=conds1+2. 
if conds2=2 conds1x=conds1+4. 
if conds3=1 conds1x=conds1+3. 
if conds4=1 conds1x=conds1+4. 
if conds6=1 conds1x=conds1+6. 
if illcode1=99 and longill08=1  conds1x=1. 
if illcode1=42 and longill08=1  conds1x=0. 
if illcode1=-1 and longill08=1  conds1x=1. 
if longill08 LT 0 conds1x=longill08. 
exe. 
Var lab conds1x "(D) UNgrouped condition categories and all conditions counted". 
fre conds1x. 
 
*Here is the check that identifies the person with a code 99 at illcode1 and code 13 at 
illcode2, do not adjust the underlying binary vars. 
 
temp. 
sel if illcode1=99. 
list cpserialA illcode1 illcode2 illcode3 conds1x. 
 
*Can only be corrected by serial number as the code 99 conditions were not included in the 
condition count binaries. 
 




*Correct it for condcnt. 
fre condcnt xcondcnt. 
if cpserialA=2050603101 condcnt=2. 
if cpserialA=2050603101 xcondcnt=2. 
 
*Recode the people with resolved conditions. 
if illcode1=42 and longill08=1  condcnt=0. 
if illcode1=42 and longill08=1  xcondcnt=0. 
 
Summary measure of multiple conditions 
 
recode conds1x (2 thru hi=2) (else=copy) into conds1x_2. 




Var label conds1x_2 "(D) Ungrouped chapters and all conds counted: 2+ conditions". 
Var label conds1x_3 "(D) Ungrouped chapters and all conds counted: 3+ conditions". 
miss vals conds1x_2 conds1x_3 (lo thru -1). 
 
*Breakdown of change in definition. 
 
miss vals conds1x (). 
Compute MMNew_ST1=-99. 
if (conds1x=1 and condcnt=0) MMNew_ST1=3. 
if (conds1x GE 3) and (condcnt LT conds1x) MMNew_ST1=5. 
if (conds1x GE 2 and condcnt LT 2) MMNew_ST1=4. 
if conds1x=condcnt and condcnt=0 MMNew_ST1=0. 
if conds1x=condcnt and condcnt=1 MMNew_ST1=1. 
if conds1x=condcnt and condcnt GE 2 MMNew_ST1=2. 
if conds1x lt 1 MMNew_ST1=conds1x. 
exe. 
var label MMNew_ST1 "(D) New MM measure (ungrouped/all counted) compared with 
original (grouped)". 
val labels MMNew_ST1  
0 "No change: 0 conditions" 
1 "No change: 1 condition" 
2 "No change: >1 condition (MM)" 
3 "From 0 conditions to 1" 
4 "From 0 or 1 to >1 (newly MM)" 
5 "From >1 to >2 (already MM)". 
 
Stage 2: counting other health problems 
Counting the conditions 
count OHP_Cancer= HNCode1 HNCode2 HNCode3 (1). 
count OHP_Diabetes= HNCode1 HNCode2 HNCode3 (2). 
count OHP_OthEndc= HNCode1 HNCode2 HNCode3 (3). 
count OHP_Psych= HNCode1 HNCode2 HNCode3 (4). 
count OHP_LearnD= HNCode1 HNCode2 HNCode3 (5). 
count OHP_Epileps= HNCode1 HNCode2 HNCode3 (6). 
count OHP_Migraine= HNCode1 HNCode2 HNCode3 (7). 
count OHP_OthNerv= HNCode1 HNCode2 HNCode3 (8). 
count OHP_BadEyes= HNCode1 HNCode2 HNCode3 (9). 
count OHP_OthEyes= HNCode1 HNCode2 HNCode3 (10). 
count OHP_Deaf= HNCode1 HNCode2 HNCode3 (11). 
count OHP_Tinnit= HNCode1 HNCode2 HNCode3 (12). 
count OHP_Meniere= HNCode1 HNCode2 HNCode3 (13). 
count OHP_OthEars= HNCode1 HNCode2 HNCode3 (14). 
count OHP_Stroke= HNCode1 HNCode2 HNCode3 (15). 
count OHP_MI= HNCode1 HNCode2 HNCode3 (16). 
count OHP_HBP= HNCode1 HNCode2 HNCode3 (17). 
count OHP_OthHrt= HNCode1 HNCode2 HNCode3 (18). 
count OHP_Piles= HNCode1 HNCode2 HNCode3 (19). 
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count OHP_Varic= HNCode1 HNCode2 HNCode3 (20). 
count OHP_OthBlod= HNCode1 HNCode2 HNCode3 (21). 
count OHP_Bronch= HNCode1 HNCode2 HNCode3 (22). 
count OHP_Asthma= HNCode1 HNCode2 HNCode3 (23). 
count OHP_Hayf= HNCode1 HNCode2 HNCode3 (24). 
count OHP_OthResp= HNCode1 HNCode2 HNCode3 (25). 
count OHP_Ulcer= HNCode1 HNCode2 HNCode3 (26). 
count OHP_OthDig= HNCode1 HNCode2 HNCode3 (27). 
count OHP_Bowel= HNCode1 HNCode2 HNCode3 (28). 
count OHP_Mouth= HNCode1 HNCode2 HNCode3 (29). 
count OHP_Kidney= HNCode1 HNCode2 HNCode3 (30). 
count OHP_UTI= HNCode1 HNCode2 HNCode3 (31). 
count OHP_OthBlad= HNCode1 HNCode2 HNCode3 (32). 
count OHP_Reprod= HNCode1 HNCode2 HNCode3 (33). 
count OHP_Arthritis= HNCode1 HNCode2 HNCode3 (34). 
count OHP_BackP= HNCode1 HNCode2 HNCode3 (35). 
count OHP_OthMusc= HNCode1 HNCode2 HNCode3 (36). 
count OHP_infect = HNCode1 HNCode2 HNCode3 (37). 
count OHP_Blood= HNCode1 HNCode2 HNCode3 (38). 
count OHP_skin= HNCode1 HNCode2 HNCode3 (39). 
count OHP_Other= HNCode1 HNCode2 HNCode3 (40). 
count OHP_unclass= HNCode1 HNCode2 HNCode3 (41). 
count OHP_Cured= HNCode1 HNCode2 HNCode3 (42). 
 
*Make a summary DV of info. 
Recode HNote (-1, 1=1) (2,3=2) into Anyoth. 
exe. 
var label anyoth "(D) Whether mentioned another health problem". 
val labs anyoth 1"No (not mentioned, just repeated)" 2 "Yes - new condition mentioned". 
 
miss vals hnotask  HNote (). 
if anyoth=1 OHP_cancer = -1 . 
if anyoth=1 OHP_Diabetes = -1 . 
if anyoth=1 OHP_OthEndc = -1 . 
if anyoth=1 OHP_Psych = -1 . 
if anyoth=1 OHP_LearnD = -1 . 
if anyoth=1 OHP_Epileps = -1 . 
if anyoth=1 OHP_Migraine = -1 . 
if anyoth=1 OHP_OthNerv = -1 . 
if anyoth=1 OHP_BadEyes = -1 . 
if anyoth=1 OHP_OthEyes = -1 . 
if anyoth=1 OHP_Deaf = -1 . 
if anyoth=1 OHP_Tinnit = -1 . 
if anyoth=1 OHP_Meniere = -1 . 
if anyoth=1 OHP_OthEars = -1 . 
if anyoth=1 OHP_Stroke = -1 . 
if anyoth=1 OHP_MI = -1 . 
if anyoth=1 OHP_HBP = -1 . 
if anyoth=1 OHP_OthHrt = -1 . 
if anyoth=1 OHP_Piles = -1 . 
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if anyoth=1 OHP_Varic = -1 . 
if anyoth=1 OHP_OthBlod = -1 . 
if anyoth=1 OHP_Bronch = -1 . 
if anyoth=1 OHP_Asthma = -1 . 
if anyoth=1 OHP_Hayf = -1 . 
if anyoth=1 OHP_OthResp = -1 . 
if anyoth=1 OHP_Ulcer = -1 . 
if anyoth=1 OHP_OthDig = -1 . 
if anyoth=1 OHP_Bowel = -1 . 
if anyoth=1 OHP_Mouth = -1 . 
if anyoth=1 OHP_Kidney = -1 . 
if anyoth=1 OHP_UTI = -1 . 
if anyoth=1 OHP_OthBlad = -1 . 
if anyoth=1 OHP_Reprod = -1 . 
if anyoth=1 OHP_Arthritis = -1 . 
if anyoth=1 OHP_BackP = -1 . 
if anyoth=1 OHP_OthMusc = -1 . 
if anyoth=1 OHP_infect = -1 . 
if anyoth=1 OHP_Blood = -1 . 
if anyoth=1 OHP_skin = -1 . 
if anyoth=1 OHP_Other = -1 . 
if anyoth=1 OHP_unclass = -1 . 
if anyoth=1 OHP_Cured = -1 . 
exe. 
 
miss vals OHP_Cancer TO OHP_Cured (-1). 
 
***Make binaries of these vars. 
Recode  OHP_Cancer OHP_Diabetes OHP_OthEndc OHP_Psych OHP_LearnD OHP_Epileps 
OHP_Migraine OHP_OthNerv OHP_BadEyes OHP_OthEyes OHP_Deaf OHP_Tinnit 
OHP_Meniere OHP_OthEars OHP_Stroke OHP_MI OHP_HBP OHP_OthHrt OHP_Piles 
OHP_Varic OHP_OthBlod OHP_Bronch OHP_Asthma OHP_Hayf OHP_OthResp OHP_Ulcer 
OHP_OthDig OHP_Bowel OHP_Mouth OHP_Kidney OHP_UTI OHP_OthBlad OHP_Reprod 
OHP_Arthritis OHP_BackP OHP_OthMusc OHP_infect OHP_Blood OHP_skin OHP_Other 
OHP_unclass OHP_Cured (1 thru hi=1) (else=copy) into OHP_Cancer2 OHP_Diabetes2 
OHP_OthEndc2 OHP_Psych2 OHP_LearnD2 OHP_Epileps2 OHP_Migraine2 OHP_OthNerv2 
OHP_BadEyes2 OHP_OthEyes2 OHP_Deaf2 OHP_Tinnit2 OHP_Meniere2 OHP_OthEars2 
OHP_Stroke2 OHP_MI2 OHP_HBP2 OHP_OthHrt2 OHP_Piles2 OHP_Varic2 OHP_OthBlod2 
OHP_Bronch2 OHP_Asthma2 OHP_Hayf2 OHP_OthResp2 OHP_Ulcer2 OHP_OthDig2 
OHP_Bowel2 OHP_Mouth2 OHP_Kidney2 OHP_UTI2 OHP_OthBlad2 OHP_Reprod2 
OHP_Arthritis2 OHP_BackP2 OHP_OthMusc2 OHP_infect2 OHP_Blood2 OHP_skin2 
OHP_Other2 OHP_unclass2 OHP_Cured2. 
exe. 
val labs OHP_cancer2 TO OHP_cured2 1 "Has condition" 0 "Does not" -1 "Missing". 
 
 
**Then count across conditions. 
count numoth1 =  OHP_Cancer OHP_Diabetes OHP_OthEndc OHP_Psych OHP_LearnD 
OHP_Epileps OHP_Migraine OHP_OthNerv OHP_BadEyes OHP_OthEyes OHP_Deaf 
OHP_Tinnit OHP_Meniere OHP_OthEars OHP_Stroke OHP_MI OHP_HBP OHP_OthHrt 
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OHP_Piles OHP_Varic OHP_OthBlod OHP_Bronch OHP_Asthma OHP_Hayf OHP_OthResp 
OHP_Ulcer OHP_OthDig OHP_Bowel OHP_Mouth OHP_Kidney OHP_UTI OHP_OthBlad 
OHP_Reprod OHP_Arthritis OHP_BackP OHP_OthMusc OHP_infect OHP_Blood OHP_skin 
OHP_Other OHP_unclass (1). 
if anyoth=1 numoth1=0. 
exe. 
 
count numoth2 =  OHP_Cancer OHP_Diabetes OHP_OthEndc OHP_Psych OHP_LearnD 
OHP_Epileps OHP_Migraine OHP_OthNerv OHP_BadEyes OHP_OthEyes OHP_Deaf 
OHP_Tinnit OHP_Meniere OHP_OthEars OHP_Stroke OHP_MI OHP_HBP OHP_OthHrt 
OHP_Piles OHP_Varic OHP_OthBlod OHP_Bronch OHP_Asthma OHP_Hayf OHP_OthResp 
OHP_Ulcer OHP_OthDig OHP_Bowel OHP_Mouth OHP_Kidney OHP_UTI OHP_OthBlad 
OHP_Reprod OHP_Arthritis OHP_BackP OHP_OthMusc OHP_infect OHP_Blood OHP_skin 
OHP_Other OHP_unclass (2). 
if anyoth=1 numoth2=0. 
exe. 
 
count numoth3 =  OHP_Cancer OHP_Diabetes OHP_OthEndc OHP_Psych OHP_LearnD 
OHP_Epileps OHP_Migraine OHP_OthNerv OHP_BadEyes OHP_OthEyes OHP_Deaf 
OHP_Tinnit OHP_Meniere OHP_OthEars OHP_Stroke OHP_MI OHP_HBP OHP_OthHrt 
OHP_Piles OHP_Varic OHP_OthBlod OHP_Bronch OHP_Asthma OHP_Hayf OHP_OthResp 
OHP_Ulcer OHP_OthDig OHP_Bowel OHP_Mouth OHP_Kidney OHP_UTI OHP_OthBlad 
OHP_Reprod OHP_Arthritis OHP_BackP OHP_OthMusc OHP_infect OHP_Blood OHP_skin 
OHP_Other OHP_unclass (3). 
if anyoth=1 numoth3=0. 
exe. 
 
var labels numoth1 "(D) Number of other conditions (counting across conditions)". 
var labels numoth2 "(D) Number with 2 of the same other conditions". 
var labels numoth3 "(D) Number with 3 of the same other conditions". 
 
*Total number of other conditions. 
 
compute tot_numoth=0. 
if anyoth=1 tot_numoth=0. 
if numoth1=1 tot_numoth=tot_numoth+1. 
if numoth1=2 tot_numoth=tot_numoth+2. 
if numoth1=3 tot_numoth=tot_numoth+3. 
if numoth2=1 tot_numoth=tot_numoth+2. 
if numoth3=1 tot_numoth=tot_numoth+3. 
exe. 
 
if tot_numoth=0 and anyoth=2 and OHP_cured=0 tot_numoth=1. 
exe. 




Adding other health problems to the long-term condition count 
All other problems 
 
miss vals conds1x tot_numoth () .  
compute conds1x_OHP=-99. 
if tot_numoth=1  conds1x_OHP=conds1x+1. 
if tot_numoth=2  conds1x_OHP=conds1x+2. 
if tot_numoth=3  conds1x_OHP=conds1x+3. 
if tot_numoth=0  conds1x_OHP=conds1x. 
exe. 
var label conds1x_OHP "(D) Number of conditions, inc all other problems". 
 
All other problems if general health <good 
 
weight off. 
miss vals conds1x tot_numoth () .  
compute conds1x_OHPB=-99. 
if tot_numoth=1  conds1x_OHPB=conds1x+1. 
if tot_numoth=2  conds1x_OHPB=conds1x+2. 
if tot_numoth=3  conds1x_OHPB=conds1x+3. 
if tot_numoth=0  conds1x_OHPB=conds1x. 
if genhelf2=1 conds1x_OHPB=conds1x. 
exe. 
VAR LABS conds1x_OHPB "(D) Number of conditions, inc other problems only if genhelf fair-
bad". 
 
Summary measure of multiple conditions 
All other problems 
 
recode  conds1x_OHP (2 thru hi=2) (else=copy) into MMOHP. 
exe. 
var labels MMOHP "(D) 2 or more conditions, inc other health problems". 
val labs MMOHP 0 "0 conditions" 1 "1 condition" 2 "2 or more". 
 
miss vals MMOHP (lo thru -1). 
 
*Breakdown of change in definition. 
 
miss vals conds1x_OHP (). 
Compute MMNew_ST2a=-99. 
if (conds1x_OHP=1 and condcnt=0) MMNew_ST2a=3. 
if (conds1x_OHP GE 3) and (condcnt LT conds1x_OHP) MMNew_ST2a=5. 
if (conds1x_OHP GE 2 and condcnt LT 2) MMNew_ST2a=4. 
if conds1x_OHP=condcnt and condcnt=0 MMNew_ST2a=0. 
if conds1x_OHP=condcnt and condcnt=1 MMNew_ST2a=1. 
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if conds1x_OHP=condcnt and condcnt GE 2 MMNew_ST2a=2. 
if conds1x_OHP lt 1 MMNew_ST2a=conds1x_OHP. 
exe. 
var label MMNew_ST2a "(D) New MM measure (all OHPs added) compared with original 
(grouped)". 
val labels MMNew_ST2a 
0 "No change: 0 conditions" 
1 "No change: 1 condition" 
2 "No change: >1 condition (MM)" 
3 "From 0 conditions to 1" 
4 "From 0 or 1 to >1 (newly MM)" 
5 "From >1 to >2 (already MM)". 
fre MMNew_ST2a. 
 
All other problems if general health <good 
 
recode  conds1x_OHPB (2 thru hi=2) (else=copy) into MMOHPB. 
exe. 
var labels MMOHPB "(D) 2 or more conditions, inc other health problems only if genhelf 
fair-bad". 
val labs MMOHPB 0 "0 conditions" 1 "1 condition" 2 "2 or more". 
 
miss vals MMOHPB (lo thru -1). 
 
*Breakdown of change in definition. 
Compute MMNew_ST2b=-99. 
if (conds1x_OHPB=1 and condcnt=0) MMNew_ST2b=3. 
if (conds1x_OHPB GE 3) and (condcnt LT conds1x_OHPB) MMNew_ST2b=5. 
if (conds1x_OHPB GE 2 and condcnt LT 2) MMNew_ST2b=4. 
if conds1x_OHPB=condcnt and condcnt=0 MMNew_ST2b=0. 
if conds1x_OHPB=condcnt and condcnt=1 MMNew_ST2b=1. 
if conds1x_OHPB=condcnt and condcnt GE 2 MMNew_ST2b=2. 
if conds1x_OHPB lt 1 MMNew_ST2b=conds1x_OHPB. 
exe. 
var label MMNew_ST2b "(D) New MM measure (OHPs added if health <good) compared 
with original (grouped)". 
val labels MMNew_ST2b 
0 "No change: 0 conditions" 
1 "No change: 1 condition" 
2 "No change: >1 condition (MM)" 
3 "From 0 conditions to 1" 
4 "From 0 or 1 to >1 (newly MM)" 




Stage 3: undeclared hypertension, diabetes, MI & stroke 
Identifying undeclared conditions 
Hypertension 
 
miss vals CURRBP HBP2 (). 
compute HBP_UD=-99. 
if CURRBP=1 and HBP2=0 HBP_UD=1. 
if CURRBP=1 and HBP2=1 HBP_UD=0. 
if CURRBP=2 HBP_UD=0. 
if CURRBP LT 0 | HBP2 LT 0 HBP_UD=-1. 
exe. 
Var lab HBP_UD "(D) Undeclared hypertension". 
miss vals HBP_UD (-1). 
 
Diabetes 
miss vals diabete2 Diabetes2 (). 
compute DIA_UD=-99. 
if diabete2=1 and Diabetes2 =0 DIA_UD=1. 
if diabete2=1 and Diabetes2 =1 DIA_UD=0. 
if diabete2=2 DIA_UD=0. 
if diabete2 LT 0 | Diabetes2  LT 0 DIA_UD=-1. 
exe. 
Var lab DIA_UD "(D) Undeclared diabetes". 
miss vals DIA_UD (-1). 
 
MI / angina 
 
*This requires a combined measure of any MI / angina. 
 
miss vals heartdef angidef (). 
compute MIAng_dr=-99. 
if angidef=1 or  heartdef=1 MIAng_dr=1. 
if angidef=2 and heartdef=2 MIAng_dr=2. 
if angidef=1 and (heartdef LT 0 ) MIAng_dr=1. 
if heartdef=1 and (angidef LT 0 ) MIAng_dr=1. 
if angidef=2 and (heartdef LT 0 ) MIAng_dr=2. 
if heartdef=2 and (angidef LT 0 ) MIAng_dr=2. 
exe. 
var lab MIAng_dr "(D) Whether had MI or angina". 
 
*And requires a measure of whether MI / angina was recent. 
 
miss vals  recangi recheart (). 
compute MIAngRec_dr=-99. 
if MIAng_dr=1 and (recangi=1 or  recheart=1) MIAngRec_dr=1. 
if MIAng_dr=1 and (recangi=2 and recheart=2) MIAngRec_dr=2. 
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if MIAng_dr=1 and (recangi=-1 and recheart=2)  MIAngRec_dr=2. 
if MIAng_dr=1 and (recangi=2 and recheart=-1)  MIAngRec_dr=2. 
if MIAng_dr=2 MIAngRec_dr=3.  
exe. 
var lab MIAngRec_dr "(D) Whether had MI or angina in past year". 
 
*This is the measure of undeclared recent MI/angina. 
 
miss vals MIAngrec_dr MI2 (). 
compute MIA_UD=-99. 
if MIAngrec_dr=1 and MI2  =0 MIA_UD=1. 
if MIAngrec_dr=1 and MI2  =1 MIA_UD=0. 
if MIAngrec_dr=0 MIA_UD=0. 
if MIAngrec_dr=3 MIA_UD=0. 
if MIAngrec_dr LT 0 | MI2  LT 0 MIA_UD=-1. 
exe. 
Var lab MIA_UD "(D) Undeclared MI/angina". 
fre MIA_UD. 
miss vals MIA_UD (-1). 




miss vals RECSTRO3 STROKE2 (). 
compute STR_UD=-99. 
if RECSTRO3=1 and STROKE2=0 STR_UD=1. 
if RECSTRO3=1 and STROKE2=1 STR_UD=0. 
if RECSTRO3=0 STR_UD=0. 
if RECSTRO3 LT 0 | STROKE2 LT 0 STR_UD=-1.  
exe. 
Var lab STR_UD "(D) Undeclared recent stroke". 
miss vals STR_UD (). 
 
Adding undeclared conditions to the long-term condition count 
 
compute conds1x_def2=conds1x. 
if HBP_UD=1 conds1x_def2=conds1x_def2+1. 
if DIA_UD=1 conds1x_def2=conds1x_def2+1. 
if MIA_UD=1 conds1x_def2=conds1x_def2+1. 
if STR_UD=1 conds1x_def2=conds1x_def2+1. 
 
exe. 
var labels conds1x_def2 "(D) Number of conditions, undeclared HBP, diabetes, MI/angina & 
stroke". 
 




recode  conds1x_def2 (2 thru hi=2) (else=copy) into MMDef2. 
exe. 
var labels MMDef2 "(D) 2 or more conditions, inc undeclared HBP, diabetes, MI/angina & 
stroke". 
val labs MMDef2 0 "0 conditions" 1 "1 condition" 2 "2 or more". 
 
*Breakdown of change in definition. 
 
miss vals conds1x_def2 (). 
Compute MMNew_ST3=-99. 
if (conds1x_def2=1 and condcnt=0) MMNew_ST3=3. 
if (conds1x_def2 GE 3) and (condcnt LT conds1x_def2) MMNew_ST3=5. 
if (conds1x_def2 GE 2 and condcnt LT 2) MMNew_ST3=4. 
if conds1x_def2=condcnt and condcnt=0 MMNew_ST3=0. 
if conds1x_def2=condcnt and condcnt=1 MMNew_ST3=1. 
if conds1x_def2=condcnt and condcnt GE 2 MMNew_ST3=2. 
if conds1x_def2 lt 1 MMNew_ST3=conds1x_def2. 
exe. 
var label MMNew_ST3 "(D) New MM measure (undeclared conds) compared with original 
(grouped)". 
val labels MMNew_ST3  
0 "No change: 0 conditions" 
1 "No change: 1 condition" 
2 "No change: >1 condition (MM)" 
3 "From 0 conditions to 1" 
4 "From 0 or 1 to >1 (newly MM)" 
5 "From >1 to >2 (already MM)". 
 
Creating the new measure 
Counting all the conditions 
*Start with the condition count that includes all long-term conditions and other health 
problems if general health <good, and add the newly identified CVD conditions. 
 
compute conds1x_final=conds1x_OHPB. 
if HBP_UD=1 conds1x_final = conds1x_final +1. 
if DIA_UD=1 conds1x_final = conds1x_final +1. 
if MIA_UD=1 conds1x_final = conds1x_final +1. 
if STR_UD=1 conds1x_final = conds1x_final +1. 
exe. 
var labels conds1x_final "(D) Number of conditions, inc OHP (if genhelf fair-bad), 
undeclared HBP, diabetes & MI/angina & stroke". 
 
New summary measure of multiple conditions 
recode  conds1x_final (2 thru hi=2) (else=copy) into MMDef_final. 
exe. 
var labels MMDef_final "(D) 2 or more conditions, inc OHP (if genhelf fair-bad), undeclared 
HBP, diabetes & MI/angina & stroke". 




Breakdown of change in definition. 
 
miss vals conds1x_final (). 
Compute MMNew_fin=-99. 
if (conds1x_final=1 and condcnt=0) MMNew_fin=3. 
if (conds1x_final GE 3) and (condcnt LT conds1x_final) MMNew_fin=5. 
if (conds1x_final GE 2 and condcnt LT 2) MMNew_fin=4. 
if conds1x_final=condcnt and condcnt=0 MMNew_fin=0. 
if conds1x_final=condcnt and condcnt=1 MMNew_fin=1. 
if conds1x_final=condcnt and condcnt GE 2 MMNew_fin=2. 
if conds1x_final lt 1 MMNew_fin=conds1x_final. 
exe. 
var label MMNew_fin "(D) New MM measure (Final Def) compared with original 
(grouped)". 
val labels MMNew_fin  
0 "No change: 0 conditions" 
1 "No change: 1 condition" 
2 "No change: >1 condition (MM)" 
3 "From 0 conditions to 1" 
4 "From 0 or 1 to >1 (newly MM)" 
5 "From >1 to >2 (already MM)". 
fre MMNew_fin. 
 
With limiting conditions identified 
miss vals mmdef_final (). 
compute MMDef_finallim=-99. 
if MMDef_final=0 MMDef_finallim =0. 
if MMDef_final=1 and Limitill GT 1 MMDef_finallim =1. 
if MMDef_final=1 and Limitill=1 MMDef_finallim =2. 
if MMDef_final=2 and Limitill GT 1 MMDef_finallim =3. 
if MMDef_final=2 and Limitill=1 MMDef_finallim =4. 
if MMDef1_finalLT 0 MMDef_finallim =MMDef_final. 
exe. 
var lab MMDef_finallim "(D) Final definition with limiting conditions identified". 
val labs MMDef_finallim 0 "No conditions" 1 "1 non-limiting condition" 2 "1 limiting 
condition" 3 "2 or more conds, 0 limiting" 4 "2 or more conditions, at least 1 limiting". 
fre MMDef1Lim. 
 
Additional variables for 1998 survival analysis (Chapter 5) 
Hypertension 
*Uses the information about undeclared hypertension and condition count (ungrouped 
chapters, all conditions counted). 
 
miss vals hbp_ud conds1x_2 (). 
compute MMNot_HBP2=-99. 
if conds1x_2 =1 and HBP_UD=1 MMNot_HBP2=1. 
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if conds1x_2 =1 and HBP_UD le 0 MMNot_HBP2=2. 
if conds1x_2 =2 and HBP_UD=1 MMNot_HBP2=3. 
if conds1x_2 =2 and HBP_UD le 0 MMNot_HBP2=4. 
if conds1x_2 =0 and HBP_UD=1 MMNot_HBP2=5. 
if conds1x_2 =0 and HBP_UD le 0 MMNot_HBP2=6. 
if conds1x_2 lt 0 MMNot_HBP2=conds1x_2. 
exe. 
 
var label MMNot_HBP2 "(D) MM & UDH". 
val labels MMNot_HBP2 
1 "UDH & 1 condition" 2 "No UDH & 1 condition" 3 "UDH & >1 condition" 4 "No UDH & >1 




if conds1x_2=2 and BMIvg4 =4 MMObese=1. 
if conds1x_2=1 and BMIvg4 =4 MMObese=2. 
if conds1x_2=0 and BMIvg4 =4 MMObese=3. 
if conds1x_2=2 and BMIvg4 LT 4 MMObese=4. 
if conds1x_2=1 and BMIvg4 LT 4 MMObese=5. 
if conds1x_2=0 and BMIvg4 LT 4 MMObese=6. 
If BMIvg4 LT 1 MMObese=-1. 
exe. 
 
Var lab MMObese "(D) MM status (ungrouped & all counted) and obesity". 
val labs MMObese -1 “No BMI” 1 "MM & obese" 2 "1 condition & obese" 3 "0 conditions & 
obese" 4 "MM & not obese" 5 "1 condition & not obese" 6 "0 conditions & not obese". 
 
Other health problems (all included) 
compute OHPMM=-99. 
if conds1x_2=2 and hnotask=1 OHPMM=1. 
if conds1x_2=1 and hnotask=1 OHPMM=2. 
if conds1x_2=0 and hnotask=1 OHPMM=3. 
if conds1x_2=2 and hnotask=2 OHPMM=4. 
if conds1x_2=1 and hnotask=2 OHPMM=5. 
if conds1x_2=0 and hnotask=2 OHPMM=6. 
exe. 
 
Var lab OHPMM "(D) MM status (ungrouped & all counted) and OHP". 
val labs OHPMM 1 "MM & OHP" 2 "1 condition & OHP" 3 "0 conditions & OHP" 4 "MM & no 
OHP" 5 "1 condition & no OHP" 6 "0 conditions & no OHP". 
fre OHPMM. 
 
Other health problems (if general health <good) 
compute OHPBMM=-99. 
if conds1x_2=2 and hnotask=1 and genhelf GT 2 OHPBMM=1. 
if conds1x_2=1 and hnotask=1 and genhelf GT 2 OHPBMM=2. 
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if conds1x_2=0 and hnotask=1 and genhelf GT 2 OHPBMM=3. 
if conds1x_2=2 and (hnotask=2 OR (hnotask=1 and genhelf LT 3)) OHPBMM=4. 
if conds1x_2=1 and (hnotask=2 OR (hnotask=1 and genhelf LT 3)) OHPBMM=5. 
if conds1x_2=0 and (hnotask=2 OR (hnotask=1 and genhelf LT 3)) OHPBMM=6. 
exe. 
 
Var lab OHPBMM "(D) MM status (ungrouped & all counted) and OHP if genhelf <good". 
val labs OHPBMM 1 "MM & OHP" 2 "1 condition & OHP" 3 "0 conditions & OHP" 4 "MM & 
no OHP" 5 "1 condition & no OHP" 6 "0 conditions & no OHP". 
fre OHPBMM. 
 
Additional variables for 1998 survival analysis (Chapter 6) 
GHQ12 
*Variable to identify people with GHQ12 score >=4, in combination with the final multiple 
conditions definition (called MMDef1 in 1998 file). 
 
miss vals MMDef1 ghqg2 (). 
compute MMDef1_GHQ=-99. 
if mmdef1=0 and (ghqg2=1 or ghqg2=2) MMDef1_GHQ=0. 
if mmdef1=0 and (ghqg2=3) MMDef1_GHQ=1. 
if mmdef1=1 and (ghqg2=1 or ghqg2=2) MMDef1_GHQ=2. 
if mmdef1=1 and (ghqg2=3) MMDef1_GHQ=3. 
if mmdef1=2 and (ghqg2=1 or ghqg2=2) MMDef1_GHQ=4. 
if mmdef1=2 and (ghqg2=3) MMDef1_GHQ=5. 
if mmdef1 LT 0 or GHQg2 LT 0 MMDef1_GHQ=-1. 
exe. 
 
var lab mmdef1_ghq "(D) MM measure with GHQ scores integrated". 
val labs mmdef1_ghq  
-1 "Missing data" 0 "No conditions, GHQ <4" 1 "No conditions, GHQ >=4" 2 "1 condition, 
GHQ <4" 3 "1 condition, GHQ >=4" 4 "2 conditions, GHQ <4" 5 "2 conditions, GHQ >=4". 
miss vals mmdef1_ghq (-1). 
 
Limiting conditions 
Used the variable MMDef_FinalLim (syntax above). 
 
Carstairs deprivation 
*Variable to identify people living in the Carstairs most deprived quartile, in combination 
with the final multiple conditions definition (called MMDef1 in 1998 file). 
 
miss vals MMDef1 carstg4 (). 
compute MMDef1_car=-99. 
if mmdef1=0 and (carstg4 ne 4) MMDef1_car=0. 
if mmdef1=0 and (carstg4=4) MMDef1_car=1. 
if mmdef1=1 and (carstg4 ne 4) MMDef1_car=2. 
if mmdef1=1 and (carstg4=4) MMDef1_car=3. 
if mmdef1=2 and (carstg4 ne 4) MMDef1_car=4. 
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if mmdef1=2 and (carstg4=4) MMDef1_car=5. 
if mmdef1 LT 0 or carstg4 LT 0 MMDef1_car=-1. 
exe. 
 
var lab mmdef1_car "(D) MM measure with Carstairs integrated". 
val labs mmdef1_car  
0 "No conditions, not deprived" 1 "No conditions, deprived" 2 "1 condition, not deprived" 3 
"1 condition, deprived" 4 "2 conditions, not deprived" 5 "2 conditions, deprived". 




Appendix G: Supplementary material Chapter 5 
Undeclared hypertension survival analysis 
Log-log plots 
Figure G1: Log-log plot of undeclared hypertension and survival (to illustrate non-
proportional hazards in survival analysis presented in Chapter 5, Figure 5.3) 
 
Sample sizes 
Table G1: Unweighted sample sizes for survival analysis of undeclared hypertension 
 Events Censored Total 
1 condition, & UDH 87 127 214 
1 condition, no UDH 310 1685 1995 
2 or more conditions, & 
UDH 
106 117 223 
2 or more conditions, no 
UDH 
364 800 1164 
No conditions, & UDH 57 166 223 




Other health problems survival analysis 
Sample sizes 
Table G2: Unweighted sample sizes for survival analysis of other health problems 
 Events Censored Total 
1 condition, & OHP 66 227 293 
1 condition, no OHP 331 1585 1916 
2 or more conditions, & 
OHP 
90 148 238 
2 or more conditions, no 
OHP 
380 769 1149 
No conditions, & OHP 61 560 621 
No conditions, no OHP 330 3758 4088 
 
Obesity survival analysis 
Sample sizes 
Table G3: Unweighted sample sizes for survival analysis of BMI >30 
 Events Censored Total 
1 condition, & BMI >30 76 393 469 
1 condition, BMI <30 253 1257 1510 
2 or more conditions, & 
BMI >30 
139 280 419 
2 or more conditions, 
BMI <30 
257 537 794 
No conditions, & BMI 
>30 
81 700 781 




Original definition of multiple conditions survival analysis 
Log-log plots 
 
Figure G2: Log-log plot of original multiple conditions definition and survival (to illustrate 
proportional hazards in survival analysis presented in Chapter 5, Figure 5.10) 
 
Sample sizes 
Table G4: Unweighted samples for survival analysis (original multiple conditions definition) 
 Events Censored Total 
No conditions 394 4326 4720 
1 condition 438 1907 2345 




2 or more conditions 
366 
 
New definition of multiple conditions survival analysis 
Log-log plots 
Figure G3: Log-log plot of new definition of multiple conditions and survival (to illustrate 
proportional hazards in survival analysis presented in Chapter 5, Figure 5.11) 
 
Sample sizes 
Table G5: Unweighted sample sizes for survival analysis of new definition of multiple 
conditions 
 Events Censored Total 
No conditions 318 4069 4387 
1 condition 320 1831 2151 




2 or more conditions 
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Estimated odds ratios for having multiple conditions 
Table G6: Unadjusted and adjusted odds ratios for having multiple conditions by sex and 
SIMD quintile  
Multiple conditions (>1)  Unadjusted 
OR 
95% CIa Age-group 
adjusted OR  
95% CIa 
Sex (p<0.001)     
Men (reference category) 1.0  1.0  
Women 1.2 1.2-1.3 1.1 1.1-1.2 
     
SIMD quintile (p<0.001)     
5th least deprived (reference 
category) 
1.0  1.0  
4th  1.2 
[p=0.002] 1.1-1.3 1.2 1.1-1.3 
3rd  1.5 1.4-1.6 1.6 1.4-1.8 
2nd  1.7 1.5-1.8 2.0 1.8-2.2 
1st most deprived 2.1 1.9-2.2 2.8 2.5-3.1 




Appendix H: Sample sizes for Chapter 6 charts 
 
Figure 6.1 Prevalence of a BMI in the overweight range, and prevalence of being an ex-
smoker, by condition number (0, 1, 2 or more) and SIMD quintile  
& 
Figure 6.2 Prevalence of eating <2 portions of fruit and vegetables per day, and prevalence of 
current smoking, by condition number (0, 1, 2 or more) and SIMD quintile 
& 
Figure 6.3 Prevalence of being active for <30 minutes per week, and prevalence of a BMI in 










of fruit & veg 
p/day 
SIMD least deprived quintile      
No conditions 2366 2736 2752 2757 
One condition 1048 1227 1228 1230 
Two or more conditions 859 1092 1092 1092 
4th quintile     
No conditions 2844 3251 3268 3273 
One condition 1429 1661 1663 1665 
Two or more conditions 1235 1546 1546 1551 
3rd quintile     
No conditions 2441 2843 2857 2860 
One condition 1281 1492 1494 1497 
Two or more conditions 1359 1741 1745 1745 
2nd quintile     
No conditions 2105 2425 2443 2445 
One condition 1092 1272 1274 1276 
Two or more conditions 1326 1759 1759 1763 
SIMD most deprived quintile     
No conditions 1905 2250 2270 2276 
One condition 1056 1291 1299 1301 




Figure 6.4 Prevalence of GHQ12 score >4 and low wellbeing (SWEWMBS >1 SD below mean), 
by condition number (0, 1, 2 or more) and SIMD quintile 
 GHQ12 score >4 SWEWMBS >1 SD 
below mean 
SIMD least deprived quintile   
No conditions 2563 2557 
One condition 1147 1143 
Two or more conditions 987 985 
4th quintile   
No conditions 3042 3034 
One condition 1536 1540 
Two or more conditions 1391 1394 
3rd quintile   
No conditions 2657 2657 
One condition 1381 1375 
Two or more conditions 1569 1571 
2nd quintile   
No conditions 2256 2253 
One condition 1174 1175 
Two or more conditions 1549 1556 
SIMD most deprived quintile   
No conditions 2062 2070 
One condition 1138 1147 




Figure 6.5 Forest plot of risks associated with having multiple conditions (2 or more versus 0 















Has risk factor 6601 4566 / 
3151 
4030 4147 1581 
Reference category 5844 2847 8485 8351 9764 
      
Age group      
16-24 1051 987 1100 1097 1003 
25-34 1538 1373 1543 1542 1422 
35-44 2000 1758 2004 2003 1850 
45-54 2296 2003 2302 2298 2115 
55-64 2254 1919 2256 2254 2077 
65-74 1967 1678 1969 1968 1767 
75+ 1339 970 1341 1336 1111 
      
SIMD quintile      
5th least deprived 2224 1938 2234 2231 2054 
4th  2870 2520 2887 2885 2648 
3rd 2666 2292 2679 2675 2443 
2nd 2345 2014 2359 2354 2131 
1st most deprived 2340 1924 2356 2353 2069 
 
Figure 6.6 Forest plot of risks associated with having multiple conditions (2 or more versus 0 















Has risk factor 7519 4468 / 
3947 
4489 5704 1905 
Reference category 8660 4544 11767 10524 12983 
      
Age group      
16-24 1405 1210 1453 1452 1351 
25-34 2158 1745 2159 2156 2024 
35-44 2816 2360 2821 2818 2651 
45-54 2923 2473 2931 2926 2754 
55-64 2803 2331 2807 2803 2602 
65-74 2232 1824 2237 2234 2016 
75+ 1842 1241 1848 1839 1490 
      
SIMD quintile      
5th least deprived 2830 2335 2884 2841 2631 
4th  3588 2988 3602 3592 3320 
3rd 3410 2789 3423 3421 3160 
2nd 3111 2509 3125 3122 2853 




Figure 6.7 Individual WEMWBS items by number of conditions (0-5 or more)  
& 
Figure 6.8 Individual SWEMWBS item mean scores by number of conditions (0-5 or more) 
Note: total sample size varies by question (26489-26614), figures are presented for the lowest of the 
range 





Five or more 849 
 
Figure 6.9 Individual SWEMWBS item mean scores by number of conditions (0, 1, 2 or more) 
No conditions 12670 
One 6444 
Two or more 7375 
 
Figure 6.10 Prevalence of SWEMWBS >1 SD below mean, and >1 SD above mean, by condition 
number (0-5 or more) 





Five or more 841 
 
Figure 6.11 Prevalence of SWEMWBS >1 SD below mean, by age group and condition number 
(0, 1, 2 or more) 
 16-24 25-34 35-44 45-54 55-65 65-74 75+ 
No conditions 1823 2483 2853 2488 1614 917 393 
One 390 645 984 1267 1361 1042 691 
Two or more 141 318 664 1114 1704 1834 1517 
 
Figure 6.12 Prevalence of SWEMWBS score >1 SD below mean by age group and condition 
number (0-5 or more) 
Note: sample sizes below 100 are emboldened 
 16-44 45-64 65+ 
No conditions 7159 4102 1310 
One 2019 2628 1733 
Two 714 1386 1443 
Three 259 738 954 
Four 81 362 504 




Figure 6.13 Prevalence of SWEMWBS >1 SD below mean, by condition number (0, 1, 2 or more) 
and SIMD quintile  








No conditions 2557 3034 2657 2253 2070 
One 1143 1540 1375 1175 1147 
Two 985 1394 1571 1556 1776 
 
Figure 6.14 Individual SWEMWBS item mean scores by SIMD quintile – among people with 
multiple conditions 
& 
Figure 6.15 Individual SWEMWBS item mean scores by SIMD quintile – among people with one 
condition 
Note: total sample size varies by question (7375-7429 multiple conditions; 6444-6476 one 
condition), figures are presented for the lowest of the range 




5th least deprived 997 1151 
4th  1408 1555 
3rd 1592 1390 
2nd 1575 1186 
1st most deprived 1803 1162 
 
Figure 6.16 Prevalence of SWEMWBS score >1 SD below mean by condition number (0, 1 2 or 
more), age group and SIMD quintile 
 16-44 45-64 65+ 
SIMD 5th least deprived quintile    
No conditions 1296 957 304 
One condition 275 506 362 
Two or more conditions 105 345 535 
4th quintile    
No conditions 1616 1071 347 
One condition 425 673 442 
Two or more conditions 186 522 686 
3rd quintile    
No conditions 1470 887 300 
One condition 421 563 391 
Two or more conditions 227 596 748 
2nd quintile    
No conditions 1394 664 195 
One condition 415 460 300 
Two or more conditions 243 580 733 
SIMD 1st most deprived quintile    
No conditions 1383 523 164 
One condition 483 426 238 




Figure 6.17 Prevalence of SWEMWBS >1 S D below mean by condition number (1, 2 or more), 





16-44   
One condition 1181 838 
Two or more conditions 252 871 
45-64   
One condition 1762 866 
Two or more conditions 708 2110 
65+   
One condition 1281 452 
Two or more conditions 842 2499 
 
Figure 6.18 Prevalence of SWEMWBS >1 SD below mean by condition number (1, 2 or more), 





SIMD 5th least deprived quintile   
One condition 816 327 
Two or more conditions 360 625 
4th quintile   
One condition 1051 489 
Two or more conditions 391 1003 
3rd quintile   
One condition 924 451 
Two or more conditions 400 1171 
2nd quintile   
One condition 760 415 
Two or more conditions 334 1222 
SIMD 1st most deprived quintile   
One condition 673 474 
Two or more conditions 317 1459 
 
Figure 6.19 Prevalence of low levels of life satisfaction (scores of 0-5) by condition number (0, 
1, 2 or more) and age group 
 16-24 25-34 35-44 45-54 55-65 65-74 75+ 
No conditions 1972 2699 3059 2664 1729 1007 486 
One 418 689 1046 1349 1453 1165 824 
Two or more 154 338 710 1207 1872 2020 1856 
 
Figure 6.20 Prevalence of SWEMWBS >1 SD below mean, by age group and condition number 
(0, 1, 2 or more) – original data  




Figure 6.21 Prevalence of SWEMWBS >1 SD below mean, by age group and condition number 
(0, 1, 2 or more) – following multiple imputation of missing data  
 16-24 25-34 35-44 45-54 55-65 65-74 75+ 
No conditions 1977 2674 3063 2671 1730 1009 486 
One 421 690 1049 1352 1457 1166 834 
Two or more 155 338 713 1210 1876 2031 1869 
 
Figure 6.22 Prevalence of limiting and non-limiting conditions among people with conditions, 
by age group and condition number (1, 2 or more) 
 16-44 45-64 65+ 
One condition 2160 2809 2000 
Two conditions 1206 3086 3900 
 
Figure 6.23 Prevalence of limiting and non-limiting conditions among people with conditions, 
by SIMD quintile and condition number (1, 2 or more) 








One condition 1230 1665 1497 1276 1301 
Two conditions 1092 1551 1745 1763 2041 
 
Figure 6.24 Prevalence of living in owner-occupied housing by condition number (0, 1, 2 or 
more) and age group 
 16-24 25-34 35-44 45-54 55-65 65-74 75+ 
No conditions 1975 2673 3061 2662 1725 1009 482 
One 421 689 1047 1348 1451 1164 831 
Two or more 155 338 712 1210 1871 2027 1867 
 
Figure 6.25 Proportion of adults who were married or cohabiting, by condition number (0, 1, 2 
or more) and age group 
 16-24 25-34 35-44 45-54 55-65 65-74 75+ 
No conditions 1977 2673 3063 2671 1728 1009 488 
One 421 690 1048 1352 1456 1166 834 
Two or more 155 338 713 1210 1874 2031 1868 
 
Figure 6.26 Kaplan-Meier plot of survival among adults aged 16-54, for the five long-term and 
limiting condition status groups (14.9 years’ follow-up), SHeS 1998-SMR linked data 
 Events Censored Total 
No conditions 92 3469 3561 
1 non-limiting condition 31 799 830 
1 limiting condition 37 520 557 
2 or more conditions, 0 
limiting 
13 155 168 
2 or more conditions, at 
least 1 limiting 




Figure 6.27 Kaplan-Meier plot of survival among adults aged 16-54, for the six long-term 
condition and Carstairs deprivation status groups (14.9 years’ follow-up), SHeS 1998-SMR linked data 
 Events Censored Total 
No conditions, not 
deprived 
63 2658 2721 
No conditions, deprived 29 811 540 
1 condition, not 
deprived 
39 996 1035 
1 condition, deprived 29 323 352 
2 or more conditions, 
not deprived 
49 401 450 
2 or more conditions, 
deprived 
39 222 261 
 
Figure 6.28 Kaplan-Meier plot of survival among adults aged 16-54, for the six long-term 
condition and GHQ12 status groups (14.9 years’ follow-up), SHeS 1998-SMR linked data 
 Events Censored Total 
No conditions, GHQ <4 78 3080 3158 
No conditions, GHQ >4 14 368 382 
1 condition, GHQ <4 45 1037 1082 
1 condition, GHQ >4 23 270 293 
2 or more conditions, 
GHQ <4  
46 377 423 
2 or more conditions, 
GHQ >4 




Appendix I: Supplementary material for Chapter 6 
Imputation  
Method  
Multiple imputation (MI) was carried out using SPSS v19 (IBM, 2010). Missing data 
occurs in a number of ways, with the literature (for example, Sterne et al. (2009)) 
distinguishing between the following situations: 
 Missing completely at random (the missing and observed values have no 
systematic differences; a rare occurrence) 
 Missing at random (differences in the observed data can account for systematic 
differences between missing and observed data) 
 Missing not at random (differences between missing and observed data remain 
even if the observed data have been taken into account) 
Little’s MCAR test was applied to assess the assumption that the data missing from 
SWEMWBS was missing completely at random. This yielded a significant result 
(p<0.001), hence the data could not be considered to be missing completely at 
random. Tables 6.7 and 6.8 in Chapter 6 illustrate some of the factors associated with 
missing SWEMWBS data.  
Strategies for handling missing data include complete case analyses, which was adopted 
for the majority of the analyses in Chapter 6, and is the predominant method used in 
most epidemiological studies with missing data (see, for example, Karahalios et al.’s 
2012 review of cohort studies). However, the bias associated with complete case 
analyses, arising from the potential for people with missing data to be systematically 
different to those with complete data, resulted in this additional investigation of the 
data. An alternative method of handling missing data, weighting, can be used to adjust 
the results using what information is available about the people for whom all data are 
missing - the whole dataset uses non-response weights based on characteristics 
measured at the household level, and within households, using the age and sex of non-
respondents. Imputation can also be used to assign plausible values for participants 
who did not complete certain items of interest, but who did take part in the rest of the 
survey. Various imputation mechanisms exist, with the simplest being to assign the 
mean value for the observed data to the missing cases, which overcomes the problem 
of loss of statistical power associated with missing data, but introduces distortion to 
the overall distribution of the data (Gelman and Hill, 2006). Eekhout et al. (2014) 
suggest that mean imputation results in considerable bias when more than 10% of 
cases are missing (SWEMWBS data was missing in just under 10% of cases). 
Furthermore, imputing methods that use a single step do not account for the 
uncertainty associated with the imputed values, and leads to an underestimation of the 
standard errors. 
MI was the approach chosen to explore here. This overcomes the problem of 
underestimating standard errors by creating multiple datasets, each with their own set 
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of imputed values, and generating estimates based on pooling these multiple sources 
(which acknowledges the uncertainty associated with the single imputed estimates). As 
the SWEMWBS data were missing in around 10% of cases, 10 imputation datasets 
were created, following advice suggested in Allison (2012), though others suggest as 
many as 20-100 imputation datasets might be appropriate (Graham et al. 2007). As 
SWEMWBS is a composite score derived from 7 individual questions, the missing 
data could be imputed individually for each item, or overall for the total score. The 
latter approach was followed, largely for its simplicity, though some argue that this is in 
fact the more effective approach to take (Simons et al. 2015), while others (Eekhout et 
al. 2014) suggest otherwise.  
SPSS can specify particular methods and constraints for the MI, in this case the full 
conditional specification was selected, which uses the Markov chain Monte Carlo 
method to impute values. As the values that SWEMWBS can take are constrained by 
the way the scale is constructed to always be integers that fall in the range 7-35, the 
same constraints were placed on the imputed values. The imputation model included 
the following variables: sex, age (in ten year groups), GHQ12 scores (continuous), 
highest educational qualification obtained, SIMD quintile, life satisfaction (as a 
continuous measure), and self-rated health.  
Results 
Table I1 : Comparison of original and imputed values for prevalence of low wellbeing by 
condition number (0, 1, 2 or more) and age group (figures underlying Figures 6.20 & 6.21, 
Chapter 6) 
% low wellbeing 16-24 25-34 35-44 45-54 55-64 65-74 75+ 
        
No conditions        
Original 11.3 7.8 6.6 6.6 4.6 3.3 6.7 
Imputed 11.0 7.9 7.0 6.9 4.8 4.2 7.8 
One condition        
Original 15.2 18.2 15.0 13.1 9.3 5.7 8.3 
Imputed 15.1 19.0 15.7 13.4 9.8 6.8 10.2 
Two or more conditions        
Original 26.7 32.6 37.3 30.9 22.9 13.2 18.9 




Life satisfaction regression  
 
Table I2 : Estimated odds ratios for low life satisfaction (score of 0-5), by condition status, 
with and without adjustment for age, sex and area deprivation  
 OR  95% CIa 
Condition status (p<0.001)   
Unadjusted   
One non-limiting condition (reference 
category) 
1.0  
No conditions 0.8 0.7-0.9 
One limiting condition  3.0 2.6-3.5 





Two or more conditions, at least one limiting  5.4 4.8-6.2 
   
Adjustedb   
One non-limiting condition (reference 
category) 
1.0  
No conditions 0.8 0.7-0.9 
One limiting condition  2.7 2.3-3.1 





Two or more conditions, at least one limiting  5.1 4.5-5.8 
   
Age group (p<0.001)   
16-24 0.4 0.3-0.4 
25-34 0.7 0.6-0.8 
35-44 0.8 0.7-0.9 
45-54 (reference category) 1.0  
55-64 0.7 0.6-0.8 
65-74 0.4 0.4-0.5 
75+ 0.4 0.3-0.4 
   
SIMD quintile (p<0.001)   
5th least deprived (reference category) 1.0  
4th  1.2 
[p=0.002] 
1.1-1.4 
3rd  1.6 1.4-1.9 
2nd  1.9 1.6-2.1 
1st most deprived 2.4 2.1-2.8 
   
Partnership status (p<0.001)   
Married / cohabiting (reference category) 1.0  
No resident partner: single, never married 2.4 2.2-2.7 
No resident partner: divorced / separated / 
widowed  
2.3 2.1-2.6 
ap value for all ORs <0.001, unless stated otherwise. 




Allison, P. 2012. Why You Probably Need More Imputations Than You Think. 
[Online]. Available at: http://statisticalhorizons.com/more-imputations. 
[Accessed: November 17, 2015].  
Eekhout, I. et al., 2014. Missing data in a multi-item instrument were best handled by 
multiple imputation at the item score level. Journal of Clinical Epidemiology. 67: 
335-342. 
Gelman, A. and Hill, J. 2006. Data analysis using regression and multilevel models. 
Cambridge University Press. 
Graham, J. 2007. How Many Imputations are Really Needed? Some Practical 
Clarifications of Multiple Imputation Theory. Prevention Science. 8: 206-213. 
IBM, 2010. IBM SPSS Missing Values 19. IBM.  
Karahalios, A. et al. 2012. A review of the reporting and handling of missing data in 
cohort studies with repeated assessment of exposure measures. BMC Medical 
Research Methodology. 12:96. 
Simons, C. et al., 2015. Multiple imputation to deal with missing EQ-5D-3L data: 
Should we impute individual domains or the actual index? Quality of Life Research. 
24 (4): 805-815. 
Sterne, J. et al., 2009. Multiple imputation for missing data in epidemiological and 
clinical research: potential and pitfalls. BMJ; 338:b2393. 
380 
 
Full regression results (Tables 6.3 and 6.6) 
 
Table I3: Unadjusted and adjusted odds ratios for low wellbeing by condition number – full 
results from Table 6.3 (Chapter 6) 




95% CIa Adjusted 
ORb  
95% CIa 
Number of conditions (p<0.001)     
No conditions 0.6 0.5-0.6 0.5 0.4-0.6 
One condition (reference category) 1.0    
Two  1.6 1.5-1.8 1.8 1.6-2.0 
Three 2.4 2.1-2.7 2.8 2.4-3.2 
Four 3.0 2.5-3.5 3.4 2.8-4.1 
Five or more 4.3 3.6-5.1 5.2 4.3-6.2 
     
Two or more 2.2 2.0-2.5 2.4 2.2-2.7 
     
Sex (p=0.013)c     
Men (reference category)   1.0  
Women   1.1 1.02-1.2 
     
Age group (p<0.001)     
16-24   1.1 [n.s.] 0.9-1.3  
25-34   1.1 [n.s.] 1.0-1.3 
35-44   1.1 [n.s.] 1.0-1.2 
45-54 (reference category)   1.0  
55-64   0.7 0.6-0.8 
65-74   0.3 0.3-0.4 
75+   0.5 0.4-0.6 
     
SIMD quintile (p<0.001)     
5th least deprived (reference 
category) 
  1.0  
4th    1.3 1.1-1.5 
3rd    1.7 1.5-1.9 
2nd    2.0 1.8-2.3 
1st most deprived   2.5 2.2-2.9 
     
Partnership status (p<0.001)     
Married / cohabiting (reference 
category) 
  1.0  
No resident partner: single, never 
married 
  1.6 1.5-1.8 
No resident partner: divorced / 
separated / widowed  
  1.8 1.6-2.0 
ap value for all ORs <0.001, unless stated otherwise. 
badjusted for sex, age, area deprivation & partnership status. 




Table I4: Unadjusted and adjusted odds ratios for low wellbeing by limiting condition status 
– full results from Table 6.6 (Chapter 6) 




95% CIa Adjusted 
ORb  
95% CIa 
     
Condition status (p<0.001)     
One non-limiting condition 
(reference category) 
1.0  1.0  
No conditions 0.9 0.8-1.0 0.7 0.6-0.8 
One limiting condition  2.5 2.1-2.9 2.1 1.8-2.5 
Two or more conditions, no 






Two or more conditions, at least 
one limiting  
4.2 3.7-4.7 4.3 3.7-4.9 
     
Sex (p=0.02)     
Men (reference category)   1.0  
Women   1.1 1.01-1.2 
     
Age group (p<0.001)     
16-24   1.1 [n.s.] 0.9-1.3 
25-34   1.1 [n.s.] 0.9-1.2 
35-44   1.1 [n.s.] 0.9-1.2 
45-54 (reference category)   1.0  
55-64   0.7 0.6-0.8 
65-74   0.4 0.3-0.4 
75+   0.5 0.4-0.6 
     
SIMD quintile (p<0.001)     
5th least deprived (reference 
category) 
  1.0  
4th    1.2 1.1-1.4 
3rd    1.7 1.4-1.9 
2nd    2.0 1.7-2.3 
1st most deprived   2.4 2.1-2.8 
     
Partnership status (p<0.001)     
Married / cohabiting (reference 
category) 
  1.0  
No resident partner: single, never 
married 
  1.6 1.4-1.8 
No resident partner: divorced / 
separated / widowed  
  1.7 1.6-1.9 
ap value for all ORs <0.001, unless stated otherwise. 
badjusted for sex, age, area deprivation & partnership status. 
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Appendix J: Supplementary material for Chapter 7 
 
Table J1:  Prevalence of reporting long-term conditions and other health problems, SHeS 
2008-2011 and 2012-2013 compared. 
 Any long-term condition Any other health 
problem 
Year % % 
2008-2011 42.1 14.7 
2012-2013 44.8 12.0 
   
Sample size   
2008-2011 28,772 28,765 
2012-2013 9702 9706 
 
Table J2:  Correspondence between unprompted and directly reported conditions, SHeS 
2008-2011 and 2012-2013 compared. 
 Proportion of those 
who mentioned a 
long-term condition, 
who also directly-
reported a doctor 
diagnosis of it 
Proportion of those 
with directly-reported 
doctor-diagnosed 
conditions, who also 
mentioned them as a 
long-term condition 
Level of agreement 
(Kappa value) 
2008-2011 % %  
Hypertension 98 28 Moderate-poor 
(0.39) 
Diabetes 97 73 Excellent (0.83) 
2012-2013    
Hypertension 98 35 Moderate (0.47) 




Figure J1: Prevalence of low wellbeing (>1 SD below mean) by age group and number 
of conditions (two or more and three or more compared) 
 
 
Note: due to the small sample size (40) for people aged 16-24 with three or more conditions, figures 
for this group have not been presented. The sample size for the 25-34 age group with three or more 
conditions is only 88, so estimates should be treated with caution. 
